{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Selection criteria\n",
    "type: small molecule  \n",
    "group: approved  \n",
    "route: oral"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import untangle\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import os\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "%matplotlib inline"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "collapsed": true
   },
   "source": [
    "### Parsing Drugbank XML"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "#takes 5 minutes\n",
    "filename = \"drugbank_20180402.xml\" # DrugBank Version 5.1.0 (release date: 2018.04.20) \n",
    "obj = untangle.parse(filename)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Building a dataframe to small molecule data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 88,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugbank_id</th>\n",
       "      <th>name</th>\n",
       "      <th>min dosage strength value</th>\n",
       "      <th>min dosage strength unit</th>\n",
       "      <th>max dosage strength value</th>\n",
       "      <th>max dosage strength unit</th>\n",
       "      <th>route</th>\n",
       "      <th>form</th>\n",
       "      <th>group</th>\n",
       "      <th>kinase inhibitor category</th>\n",
       "      <th>cas</th>\n",
       "      <th>smiles</th>\n",
       "      <th>ALOGPS solubility value</th>\n",
       "      <th>ALOGPS solubility unit</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "Empty DataFrame\n",
       "Columns: [drugbank_id, name, min dosage strength value, min dosage strength unit, max dosage strength value, max dosage strength unit, route, form, group, kinase inhibitor category, cas, smiles, ALOGPS solubility value, ALOGPS solubility unit]\n",
       "Index: []"
      ]
     },
     "execution_count": 88,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Data Frame of DrugBank Small Molecule Type Drugs\n",
    "df_drugbank_sm = pd.DataFrame(columns=[\"drugbank_id\",\"name\",\"min dosage strength value\", \n",
    "                                       \"min dosage strength unit\", \"max dosage strength value\",\n",
    "                                       \"max dosage strength unit\",\"route\", \"form\",\"group\",\n",
    "                                       \"kinase inhibitor category\",\"cas\",\"smiles\",\n",
    "                                       \"ALOGPS solubility value\", \"ALOGPS solubility unit\"])\n",
    "df_drugbank_sm"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Bivalirudin\n",
      "Goserelin\n",
      "Gramicidin D\n",
      "Desmopressin\n",
      "Cetrorelix\n",
      "Vasopressin\n",
      "Daptomycin\n",
      "Cyclosporine\n",
      "Felypressin\n",
      "Octreotide\n",
      "Abarelix\n",
      "Pyridoxal Phosphate\n",
      "Cyanocobalamin\n",
      "Tetrahydrofolic acid\n",
      "Histidine\n",
      "Ademetionine\n",
      "Pyruvic acid\n",
      "L-Phenylalanine\n",
      "Biotin\n",
      "Choline\n",
      "L-Lysine\n",
      "L-Arginine\n",
      "Vitamin C\n",
      "Spermine\n",
      "L-Aspartic Acid\n",
      "Ornithine\n",
      "L-Glutamine\n",
      "Adenosine monophosphate\n",
      "Alpha-Linolenic Acid\n",
      "Serine\n",
      "Methionine\n",
      "L-Tyrosine\n",
      "Calcitriol\n",
      "Lutein\n",
      "Cystine\n",
      "Succinic acid\n",
      "Riboflavin\n",
      "N-Acetylglucosamine\n",
      "Glutamic Acid\n",
      "Glutathione\n",
      "Phosphatidyl serine\n",
      "Glycine\n",
      "Calcidiol\n",
      "Pyridoxal\n",
      "Creatine\n",
      "L-Leucine\n",
      "L-Tryptophan\n",
      "L-Cysteine\n",
      "Thiamine\n",
      "Ergocalciferol\n",
      "Dihomo-gamma-linolenic acid\n",
      "L-Citrulline\n",
      "L-Threonine\n",
      "NADH\n",
      "Folic Acid\n",
      "Icosapent\n",
      "L-Alanine\n",
      "L-Valine\n",
      "Vitamin A\n",
      "Vitamin E\n",
      "Pyridoxine\n",
      "Lipoic Acid\n",
      "L-Isoleucine\n",
      "Aspartame\n",
      "Cholecalciferol\n",
      "Menadione\n",
      "ATP\n",
      "L-Proline\n",
      "Adenine\n",
      "L-Asparagine\n",
      "Pravastatin\n",
      "Fluvoxamine\n",
      "Valsartan\n",
      "Ramipril\n",
      "Masoprocol\n",
      "Flunisolide\n",
      "Baclofen\n",
      "Amphetamine\n",
      "Pentagastrin\n",
      "Nicotine\n",
      "Cevimeline\n",
      "Lorazepam\n",
      "Esmolol\n",
      "Bortezomib\n",
      "Ethchlorvynol\n",
      "Carbidopa\n",
      "Phentermine\n",
      "Indecainide\n",
      "Tramadol\n",
      "Vidarabine\n",
      "Betaxolol\n",
      "Fluconazole\n",
      "Troglitazone\n",
      "Oseltamivir\n",
      "Erythromycin\n",
      "Hydroxocobalamin\n",
      "Caffeine\n",
      "Succinylcholine\n",
      "Sildenafil\n",
      "Dofetilide\n",
      "Pyrimethamine\n",
      "Reserpine\n",
      "Azithromycin\n",
      "Ticlopidine\n",
      "Trospium\n",
      "Adapalene\n",
      "Midodrine\n",
      "Remikiren\n",
      "Pantoprazole\n",
      "Torasemide\n",
      "Citalopram\n",
      "Eletriptan\n",
      "Bethanidine\n",
      "Moxifloxacin\n",
      "Oxyphenonium\n",
      "Nelfinavir\n",
      "Isoetarine\n",
      "Glimepiride\n",
      "Diflorasone\n",
      "Indinavir\n",
      "Gadodiamide\n",
      "Guanadrel\n",
      "Lovastatin\n",
      "Enflurane\n",
      "Cefotiam\n",
      "Pregabalin\n",
      "Temazepam\n",
      "Methyclothiazide\n",
      "Aminosalicylic Acid\n",
      "Reboxetine\n",
      "Milrinone\n",
      "Pipobroman\n",
      "Butabarbital\n",
      "Nevirapine\n",
      "Oxiconazole\n",
      "Alclometasone\n",
      "Butalbital\n",
      "Cladribine\n",
      "Ranolazine\n",
      "Mesalazine\n",
      "Benzatropine\n",
      "Ziprasidone\n",
      "Methysergide\n",
      "Cabergoline\n",
      "Idoxuridine\n",
      "Dapsone\n",
      "Terconazole\n",
      "Phenytoin\n",
      "Medrysone\n",
      "Doxycycline\n",
      "Diethylstilbestrol\n",
      "Lymecycline\n",
      "Clotrimazole\n",
      "Calcium Acetate\n",
      "Sulfanilamide\n",
      "Cycloserine\n",
      "Anagrelide\n",
      "Carmustine\n",
      "Sulfisoxazole\n",
      "Metoprolol\n",
      "Crotamiton\n",
      "Dicoumarol\n",
      "Cefmenoxime\n",
      "Ropinirole\n",
      "Chlorotrianisene\n",
      "Isradipine\n",
      "Diatrizoate\n",
      "Betazole\n",
      "Topiramate\n",
      "Cefmetazole\n",
      "Olmesartan\n",
      "Amsacrine\n",
      "Theophylline\n",
      "Argatroban\n",
      "Liothyronine\n",
      "Disopyramide\n",
      "Lidocaine\n",
      "Pamidronate\n",
      "Clemastine\n",
      "Acarbose\n",
      "Venlafaxine\n",
      "Conjugated estrogens\n",
      "Travoprost\n",
      "Amcinonide\n",
      "Atomoxetine\n",
      "Bleomycin\n",
      "Chlorambucil\n",
      "Etomidate\n",
      "Raltitrexed\n",
      "Etonogestrel\n",
      "Morphine\n",
      "Ropivacaine\n",
      "Bupivacaine\n",
      "Dapiprazole\n",
      "Penciclovir\n",
      "Tenofovir disoproxil\n",
      "Flucloxacillin\n",
      "Tranexamic Acid\n",
      "Ertapenem\n",
      "Desogestrel\n",
      "Mitomycin\n",
      "Talbutal\n",
      "Bexarotene\n",
      "Ibutilide\n",
      "Vindesine\n",
      "Chlorthalidone\n",
      "Ethoxzolamide\n",
      "Pentobarbital\n",
      "Valproic Acid\n",
      "Capreomycin\n",
      "Zolmitriptan\n",
      "Acetaminophen\n",
      "Gefitinib\n",
      "Codeine\n",
      "Piperacillin\n",
      "Dihydroergotamine\n",
      "Amitriptyline\n",
      "Floxuridine\n",
      "Tolcapone\n",
      "Fluorometholone\n",
      "Nitroprusside\n",
      "Calcium Gluceptate\n",
      "Hydromorphone\n",
      "Indomethacin\n",
      "Ethambutol\n",
      "Metformin\n",
      "Ipratropium bromide\n",
      "Methadone\n",
      "Olanzapine\n",
      "Atenolol\n",
      "Nitrofural\n",
      "Pimecrolimus\n",
      "Omeprazole\n",
      "Pyrazinamide\n",
      "Metixene\n",
      "Cetirizine\n",
      "Terfenadine\n",
      "Diltiazem\n",
      "Protriptyline\n",
      "Aminohippuric acid\n",
      "Alfuzosin\n",
      "Trimethadione\n",
      "Nitisinone\n",
      "Clobazam\n",
      "Minoxidil\n",
      "Megestrol acetate\n",
      "Tioguanine\n",
      "Methylergometrine\n",
      "Buclizine\n",
      "Aztreonam\n",
      "Chlorzoxazone\n",
      "Aminoglutethimide\n",
      "Mefloquine\n",
      "Sulfadiazine\n",
      "Sapropterin\n",
      "Vinorelbine\n",
      "Anidulafungin\n",
      "Clozapine\n",
      "Sucralfate\n",
      "Grepafloxacin\n",
      "Doxylamine\n",
      "Levonorgestrel\n",
      "Norepinephrine\n",
      "Cidofovir\n",
      "Mirtazapine\n",
      "Meprobamate\n",
      "Thiethylperazine\n",
      "Timolol\n",
      "Treprostinil\n",
      "Colestipol\n",
      "Trihexyphenidyl\n",
      "Palonosetron\n",
      "Dydrogesterone\n",
      "Mexiletine\n",
      "Dexrazoxane\n",
      "Amlodipine\n",
      "Tacrine\n",
      "Oxyphencyclimine\n",
      "Triamterene\n",
      "Valrubicin\n",
      "Procyclidine\n",
      "Phenylephrine\n",
      "Carbimazole\n",
      "Digoxin\n",
      "Sulpiride\n",
      "Ethopropazine\n",
      "Nimodipine\n",
      "Beclomethasone dipropionate\n",
      "Carisoprodol\n",
      "Progesterone\n",
      "Phenylpropanolamine\n",
      "Sorafenib\n",
      "Zoledronic acid\n",
      "Griseofulvin\n",
      "Nisoldipine\n",
      "Eszopiclone\n",
      "Ceruletide\n",
      "Alprazolam\n",
      "Dexbrompheniramine\n",
      "Gentian Violet\n",
      "Ardeparin\n",
      "Loxapine\n",
      "Remoxipride\n",
      "Mupirocin\n",
      "Carbachol\n",
      "Rosiglitazone\n",
      "Pramipexole\n",
      "Acetohexamide\n",
      "Ampicillin\n",
      "Metocurine Iodide\n",
      "Phenoxymethylpenicillin\n",
      "Secobarbital\n",
      "Miglustat\n",
      "Promazine\n",
      "Spironolactone\n",
      "Methylphenidate\n",
      "Methocarbamol\n",
      "Hyoscyamine\n",
      "Zolpidem\n",
      "Famciclovir\n",
      "Triprolidine\n",
      "Streptozocin\n",
      "Carboprost Tromethamine\n",
      "Cefpiramide\n",
      "Lindane\n",
      "Trifluridine\n",
      "Prochlorperazine\n",
      "Cyproheptadine\n",
      "Nitric Oxide\n",
      "Bendroflumethiazide\n",
      "Allopurinol\n",
      "Ceftazidime\n",
      "Cerivastatin\n",
      "Trimethoprim\n",
      "Gemcitabine\n",
      "Entecavir\n",
      "Betamethasone\n",
      "Teniposide\n",
      "Epirubicin\n",
      "Chloramphenicol\n",
      "Loracarbef\n",
      "Lansoprazole\n",
      "Dipivefrin\n",
      "Droperidol\n",
      "Levothyroxine\n",
      "Framycetin\n",
      "Clomocycline\n",
      "Pethidine\n",
      "Loratadine\n",
      "Cefalotin\n",
      "Prazosin\n",
      "Imipramine\n",
      "Acitretin\n",
      "Verteporfin\n",
      "Nabumetone\n",
      "Methylscopolamine bromide\n",
      "Metharbital\n",
      "Sodium Tetradecyl Sulfate\n",
      "Ketorolac\n",
      "Picrotoxin\n",
      "Enoxacin\n",
      "Quinine\n",
      "Tenoxicam\n",
      "Dronabinol\n",
      "Montelukast\n",
      "Fluoxetine\n",
      "Hexylcaine\n",
      "Methohexital\n",
      "Chlordiazepoxide\n",
      "Duloxetine\n",
      "Chlorpromazine\n",
      "Rimantadine\n",
      "Amikacin\n",
      "Lenalidomide\n",
      "Raloxifene\n",
      "Celecoxib\n",
      "Gallamine Triethiodide\n",
      "Brimonidine\n",
      "Dicloxacillin\n",
      "Nabilone\n",
      "Pefloxacin\n",
      "Altretamine\n",
      "Sotalol\n",
      "Buspirone\n",
      "Miglitol\n",
      "Fosinopril\n",
      "Cefotaxime\n",
      "Entacapone\n",
      "Zidovudine\n",
      "Darifenacin\n",
      "Oxycodone\n",
      "Phenindione\n",
      "Flutamide\n",
      "Tolmetin\n",
      "Cimetidine\n",
      "Haloperidol\n",
      "Ritonavir\n",
      "Levallorphan\n",
      "Tridihexethyl\n",
      "Nitazoxanide\n",
      "Triflupromazine\n",
      "Dextrothyroxine\n",
      "Acetyldigitoxin\n",
      "Vancomycin\n",
      "Aminocaproic Acid\n",
      "Dextromethorphan\n",
      "Cisplatin\n",
      "Bentoquatam\n",
      "Anisotropine Methylbromide\n",
      "Albendazole\n",
      "Trandolapril\n",
      "Caspofungin\n",
      "Carteolol\n",
      "Bentiromide\n",
      "Alitretinoin\n",
      "Metolazone\n",
      "Tolnaftate\n",
      "Oxaliplatin\n",
      "Cinchocaine\n",
      "Lercanidipine\n",
      "Foscarnet\n",
      "Erlotinib\n",
      "Cyclophosphamide\n",
      "Mephenytoin\n",
      "Rofecoxib\n",
      "Chlormerodrin\n",
      "Cefdinir\n",
      "Guanidine\n",
      "Ciprofloxacin\n",
      "Gadoversetamide\n",
      "Toremifene\n",
      "Nortriptyline\n",
      "Vincristine\n",
      "Benazepril\n",
      "Amoxapine\n",
      "Fluorouracil\n",
      "Pyridostigmine\n",
      "Adinazolam\n",
      "Desoximetasone\n",
      "Azelaic Acid\n",
      "Zafirlukast\n",
      "Propylthiouracil\n",
      "Acetohydroxamic Acid\n",
      "Pentostatin\n",
      "Methoxsalen\n",
      "Piroxicam\n",
      "Lamotrigine\n",
      "Perflutren\n",
      "Hydroxyzine\n",
      "Zanamivir\n",
      "Bosentan\n",
      "Tigecycline\n",
      "Doxapram\n",
      "Benzthiazide\n",
      "Methotrexate\n",
      "Carbamazepine\n",
      "Cisatracurium besylate\n",
      "Succimer\n",
      "Cephalexin\n",
      "Cinnarizine\n",
      "Fondaparinux sodium\n",
      "Vinblastine\n",
      "Propranolol\n",
      "Atropine\n",
      "Fenoprofen\n",
      "Fenfluramine\n",
      "Clonidine\n",
      "Sulfamethizole\n",
      "Valaciclovir\n",
      "Carbenicillin\n",
      "Mazindol\n",
      "Valdecoxib\n",
      "Lactulose\n",
      "Voriconazole\n",
      "L-Carnitine\n",
      "Enalapril\n",
      "Nizatidine\n",
      "Diclofenac\n",
      "Cinalukast\n",
      "Fluticasone propionate\n",
      "Lisuride\n",
      "Doxazosin\n",
      "Fluocinolone Acetonide\n",
      "Piperazine\n",
      "Ethosuximide\n",
      "Amiloride\n",
      "Oxytetracycline\n",
      "Ulobetasol\n",
      "Gadoteridol\n",
      "Labetalol\n",
      "Thiopental\n",
      "Monobenzone\n",
      "Linezolid\n",
      "Ivermectin\n",
      "Medroxyprogesterone acetate\n",
      "Cisapride\n",
      "Sulindac\n",
      "Cyclothiazide\n",
      "Nafcillin\n",
      "Chloroquine\n",
      "Ethionamide\n",
      "Metaraminol\n",
      "Butorphanol\n",
      "Bisoprolol\n",
      "Amodiaquine\n",
      "Furazolidone\n",
      "Rifabutin\n",
      "Candoxatril\n",
      "Paramethadione\n",
      "Demeclocycline\n",
      "Imatinib\n",
      "Triamcinolone\n",
      "Oxandrolone\n",
      "Nicardipine\n",
      "Fluphenazine\n",
      "Testosterone\n",
      "Efavirenz\n",
      "Bacitracin\n",
      "Niacin\n",
      "Clorazepate\n",
      "Guanabenz\n",
      "Alendronic acid\n",
      "Clofarabine\n",
      "Docosanol\n",
      "Dexmedetomidine\n",
      "Sulfacetamide\n",
      "Prednisone\n",
      "Clofibrate\n",
      "Astemizole\n",
      "Inulin\n",
      "Butoconazole\n",
      "Adenosine\n",
      "Simvastatin\n",
      "Pemetrexed\n",
      "Mebendazole\n",
      "Gonadorelin\n",
      "Dyclonine\n",
      "Nystatin\n",
      "Dextropropoxyphene\n",
      "Mitotane\n",
      "Stavudine\n",
      "Leucovorin\n",
      "Dyphylline\n",
      "Pentazocine\n",
      "Magnesium sulfate\n",
      "Latanoprost\n",
      "Estrone\n",
      "Trazodone\n",
      "Mecamylamine\n",
      "Sevelamer\n",
      "Acamprosate\n",
      "Metaxalone\n",
      "Verapamil\n",
      "Trimethobenzamide\n",
      "Flumethasone\n",
      "Sulfametopyrazine\n",
      "Nilutamide\n",
      "Nafarelin\n",
      "Epinephrine\n",
      "Sumatriptan\n",
      "Pirenzepine\n",
      "Cefixime\n",
      "Chlorpropamide\n",
      "Aprepitant\n",
      "Galantamine\n",
      "Tamoxifen\n",
      "Benzyl Benzoate\n",
      "Isoflurophate\n",
      "Losartan\n",
      "Thioridazine\n",
      "Moricizine\n",
      "Amphotericin B\n",
      "Warfarin\n",
      "Midazolam\n",
      "Tobramycin\n",
      "Trovafloxacin\n",
      "Pentosan Polysulfate\n",
      "Fludrocortisone\n",
      "Mycophenolate mofetil\n",
      "Cephaloglycin\n",
      "Flurazepam\n",
      "Moexipril\n",
      "Phentolamine\n",
      "Fluorescein\n",
      "Daunorubicin\n",
      "Furosemide\n",
      "Ergotamine\n",
      "Tizanidine\n",
      "Nitrofurantoin\n",
      "Nicergoline\n",
      "Eplerenone\n",
      "Amprenavir\n",
      "Icodextrin\n",
      "Methazolamide\n",
      "Naltrexone\n",
      "Delavirdine\n",
      "Tamsulosin\n",
      "Porfimer sodium\n",
      "Sufentanil\n",
      "Lamivudine\n",
      "Ibandronate\n",
      "Diethylcarbamazine\n",
      "Flurbiprofen\n",
      "Oxacillin\n",
      "Apomorphine\n",
      "Paroxetine\n",
      "Nedocromil\n",
      "Norethisterone\n",
      "Adefovir Dipivoxil\n",
      "Azatadine\n",
      "Clodronic Acid\n",
      "Procaine\n",
      "Lisinopril\n",
      "Methoxamine\n",
      "Imiquimod\n",
      "Homatropine Methylbromide\n",
      "Trimipramine\n",
      "Nitroglycerin\n",
      "Rocuronium\n",
      "Diphemanil Methylsulfate\n",
      "Thiabendazole\n",
      "Nateglinide\n",
      "Atracurium besylate\n",
      "Pralidoxime\n",
      "Risperidone\n",
      "Naftifine\n",
      "Esomeprazole\n",
      "Meclizine\n",
      "Pentamidine\n",
      "Hetacillin\n",
      "Riluzole\n",
      "Hydrocortisone\n",
      "Mannitol\n",
      "Gadobenic acid\n",
      "Zileuton\n",
      "Modafinil\n",
      "Deferoxamine\n",
      "Scopolamine\n",
      "Carbinoxamine\n",
      "Etodolac\n",
      "Prilocaine\n",
      "Epinastine\n",
      "Tranylcypromine\n",
      "Isoflurane\n",
      "Ethotoin\n",
      "Tretinoin\n",
      "Hexachlorophene\n",
      "Dolasetron\n",
      "Clopidogrel\n",
      "Tetracycline\n",
      "Meropenem\n",
      "Potassium Chloride\n",
      "Irinotecan\n",
      "Methimazole\n",
      "Mometasone\n",
      "Metyrosine\n",
      "Clavulanate\n",
      "Benzquinamide\n",
      "Olopatadine\n",
      "Hydrocortamate\n",
      "Alprostadil\n",
      "Clidinium\n",
      "Malathion\n",
      "Etoposide\n",
      "Hydroflumethiazide\n",
      "Tirofiban\n",
      "Oxcarbazepine\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Propiomazine\n",
      "Roxithromycin\n",
      "Nalidixic Acid\n",
      "Phenelzine\n",
      "Polymyxin B Sulfate\n",
      "Propantheline\n",
      "Estradiol\n",
      "Mefenamic acid\n",
      "Cryptenamine\n",
      "Marimastat\n",
      "Aciclovir\n",
      "Naproxen\n",
      "Gadopentetate dimeglumine\n",
      "Perindopril\n",
      "Uracil mustard\n",
      "Tripelennamine\n",
      "Haloprogin\n",
      "Primidone\n",
      "Sulfasalazine\n",
      "Candesartan cilexetil\n",
      "Tolazoline\n",
      "Gentamicin\n",
      "Tazarotene\n",
      "Fenoldopam\n",
      "Halazepam\n",
      "Alfentanil\n",
      "Colistin\n",
      "Dicyclomine\n",
      "Minaprine\n",
      "Pentoxifylline\n",
      "Proparacaine\n",
      "Indapamide\n",
      "Tropicamide\n",
      "Biperiden\n",
      "Ribavirin\n",
      "Phenylbutazone\n",
      "Fentanyl\n",
      "Meloxicam\n",
      "Sodium lauryl sulfate\n",
      "Orciprenaline\n",
      "Rosoxacin\n",
      "Propofol\n",
      "Acetazolamide\n",
      "Tadalafil\n",
      "Carprofen\n",
      "Disulfiram\n",
      "Ethynodiol diacetate\n",
      "Enprofylline\n",
      "Menthol\n",
      "Natamycin\n",
      "Cinoxacin\n",
      "Fosfomycin\n",
      "Diazepam\n",
      "Phenmetrazine\n",
      "Trifluoperazine\n",
      "Phensuximide\n",
      "Cefaclor\n",
      "Mifepristone\n",
      "Brompheniramine\n",
      "Loperamide\n",
      "Progabide\n",
      "Clocortolone\n",
      "Tolazamide\n",
      "Hydroxypropyl cellulose\n",
      "Dobutamine\n",
      "Oxazepam\n",
      "Donepezil\n",
      "Nalbuphine\n",
      "Clofazimine\n",
      "Flurandrenolide\n",
      "Cysteamine\n",
      "Levamisole\n",
      "Methylphenobarbital\n",
      "Perphenazine\n",
      "Dacarbazine\n",
      "Pseudoephedrine\n",
      "Temozolomide\n",
      "Levorphanol\n",
      "Aminolevulinic acid\n",
      "Chlorphenesin\n",
      "Terbinafine\n",
      "Drostanolone\n",
      "Penicillamine\n",
      "Prednisolone\n",
      "Diflunisal\n",
      "Vardenafil\n",
      "Ranitidine\n",
      "Tacrolimus\n",
      "Benzphetamine\n",
      "Alprenolol\n",
      "Ritodrine\n",
      "Benzonatate\n",
      "Dorzolamide\n",
      "Suprofen\n",
      "Terbutaline\n",
      "Conivaptan\n",
      "Loteprednol\n",
      "Guaifenesin\n",
      "Flupentixol\n",
      "Eprosartan\n",
      "Sirolimus\n",
      "Chlorhexidine\n",
      "Emtricitabine\n",
      "Chlorothiazide\n",
      "Quinapril\n",
      "Clomifene\n",
      "Isosorbide Dinitrate\n",
      "Risedronate\n",
      "Pemirolast\n",
      "Omapatrilat\n",
      "Bumetanide\n",
      "Mechlorethamine\n",
      "Granisetron\n",
      "Dienestrol\n",
      "Sulfapyridine\n",
      "Oxybuprocaine\n",
      "Iron Dextran\n",
      "Testolactone\n",
      "Benzylpenicilloyl Polylysine\n",
      "Rimexolone\n",
      "Triazolam\n",
      "Ethanol\n",
      "Remifentanil\n",
      "Didanosine\n",
      "Bitolterol\n",
      "Methdilazine\n",
      "Etacrynic acid\n",
      "Ondansetron\n",
      "Bimatoprost\n",
      "Tiagabine\n",
      "Cocaine\n",
      "Quinidine\n",
      "Zonisamide\n",
      "Paricalcitol\n",
      "Tinidazole\n",
      "Repaglinide\n",
      "Anileridine\n",
      "Phenformin\n",
      "Amantadine\n",
      "Metronidazole\n",
      "Dinoprostone\n",
      "Almotriptan\n",
      "Spectinomycin\n",
      "Ketotifen\n",
      "Buprenorphine\n",
      "Levosimendan\n",
      "Ceforanide\n",
      "Cyclobenzaprine\n",
      "Phenoxybenzamine\n",
      "Etretinate\n",
      "Famotidine\n",
      "Azacitidine\n",
      "Misoprostol\n",
      "Colesevelam\n",
      "Methacycline\n",
      "Tipranavir\n",
      "Mesoridazine\n",
      "Maprotiline\n",
      "Oxymetazoline\n",
      "Salicylic acid\n",
      "Diethylpropion\n",
      "Salmeterol\n",
      "Meclofenamic acid\n",
      "Methantheline\n",
      "Hexafluronium\n",
      "Cycrimine\n",
      "Zalcitabine\n",
      "Demecarium\n",
      "Acetylsalicylic acid\n",
      "Phenprocoumon\n",
      "Fulvestrant\n",
      "Mezlocillin\n",
      "Felbamate\n",
      "Fexofenadine\n",
      "Isoniazid\n",
      "Naratriptan\n",
      "Rizatriptan\n",
      "Dirithromycin\n",
      "Netilmicin\n",
      "Hydrocodone\n",
      "Norgestimate\n",
      "Carboplatin\n",
      "Methylprednisolone\n",
      "Pindolol\n",
      "Mepivacaine\n",
      "Zaleplon\n",
      "Bromfenac\n",
      "Apraclonidine\n",
      "Ethiodized oil\n",
      "Telmisartan\n",
      "Desloratadine\n",
      "Methyldopa\n",
      "Alosetron\n",
      "Dactinomycin\n",
      "Selenium Sulfide\n",
      "Azelastine\n",
      "Ezetimibe\n",
      "Edetic Acid\n",
      "Dipyridamole\n",
      "Telithromycin\n",
      "Ethinyl Estradiol\n",
      "Lomefloxacin\n",
      "Cyclopentolate\n",
      "Ramelteon\n",
      "Physostigmine\n",
      "Isotretinoin\n",
      "Formoterol\n",
      "Nandrolone phenpropionate\n",
      "Dimenhydrinate\n",
      "Glycopyrronium\n",
      "Cytarabine\n",
      "Dopamine\n",
      "Rivastigmine\n",
      "Exemestane\n",
      "Oxaprozin\n",
      "Methyl aminolevulinate\n",
      "Azathioprine\n",
      "Neomycin\n",
      "Auranofin\n",
      "Gabapentin\n",
      "Doxorubicin\n",
      "Frovatriptan\n",
      "Hydrochlorothiazide\n",
      "Cyclacillin\n",
      "Salbutamol\n",
      "Levobupivacaine\n",
      "Cromoglicic acid\n",
      "Ganciclovir\n",
      "Hydroxyurea\n",
      "Letrozole\n",
      "Tioconazole\n",
      "Busulfan\n",
      "Ketoprofen\n",
      "Edrophonium\n",
      "Metyrapone\n",
      "Cinacalcet\n",
      "Clobetasol propionate\n",
      "Balsalazide\n",
      "Sulfamethoxazole\n",
      "Glyburide\n",
      "Minocycline\n",
      "Guanfacine\n",
      "Bethanechol\n",
      "Isosorbide Mononitrate\n",
      "Trichlormethiazide\n",
      "Phylloquinone\n",
      "Felodipine\n",
      "Mycophenolic acid\n",
      "Amlexanox\n",
      "Ketoconazole\n",
      "Methoxyflurane\n",
      "Irbesartan\n",
      "Topotecan\n",
      "Ethinamate\n",
      "Probenecid\n",
      "Mercaptopurine\n",
      "Cerulenin\n",
      "Procainamide\n",
      "Tolterodine\n",
      "Selegiline\n",
      "Carphenazine\n",
      "Fenofibrate\n",
      "Hydroxystilbamidine Isethionate\n",
      "Thalidomide\n",
      "Melphalan\n",
      "Memantine\n",
      "Gatifloxacin\n",
      "Rifampicin\n",
      "Lubiprostone\n",
      "Fluocinonide\n",
      "Abacavir\n",
      "Ergoloid mesylate\n",
      "Ibuprofen\n",
      "Novobiocin\n",
      "Benzylpenicillin\n",
      "Nitrendipine\n",
      "Mimosine\n",
      "Tocainide\n",
      "Echothiophate\n",
      "Praziquantel\n",
      "Norfloxacin\n",
      "Amoxicillin\n",
      "Azlocillin\n",
      "Oxybutynin\n",
      "Acetophenazine\n",
      "Isoprenaline\n",
      "Melatonin\n",
      "Cefditoren\n",
      "Glipizide\n",
      "Clonazepam\n",
      "Promethazine\n",
      "Dihydrotachysterol\n",
      "Mequitazine\n",
      "Atazanavir\n",
      "Fludarabine\n",
      "Perhexiline\n",
      "Diphenhydramine\n",
      "Atorvastatin\n",
      "Etidronic acid\n",
      "Deslanoside\n",
      "Tegaserod\n",
      "Vigabatrin\n",
      "Diphenoxylate\n",
      "Streptomycin\n",
      "Orlistat\n",
      "Emedastine\n",
      "Pilocarpine\n",
      "Benzocaine\n",
      "Primaquine\n",
      "Iloprost\n",
      "Deserpidine\n",
      "Pentolinium\n",
      "Butenafine\n",
      "Ouabain\n",
      "Dimethyl sulfoxide\n",
      "Hesperetin\n",
      "Fluvastatin\n",
      "Oxamniquine\n",
      "Leflunomide\n",
      "Rosuvastatin\n",
      "Flucytosine\n",
      "Pimozide\n",
      "Capecitabine\n",
      "Arbutamine\n",
      "Quinacrine\n",
      "Sertraline\n",
      "Sibutramine\n",
      "Levocabastine\n",
      "Methyprylon\n",
      "Trilostane\n",
      "Heparin\n",
      "Miconazole\n",
      "Colistimethate\n",
      "Cefuroxime\n",
      "Papaverine\n",
      "Chlorphenamine\n",
      "Nifedipine\n",
      "Trimethaphan\n",
      "Atovaquone\n",
      "Amiodarone\n",
      "Diazoxide\n",
      "Gliclazide\n",
      "Phenacemide\n",
      "Ambenonium\n",
      "Proflavine\n",
      "Tolbutamide\n",
      "Anisindione\n",
      "Dutasteride\n",
      "Econazole\n",
      "Bicalutamide\n",
      "Rabeprazole\n",
      "Prednicarbate\n",
      "Proguanil\n",
      "Pioglitazone\n",
      "Tiludronic acid\n",
      "Desoxycorticosterone Pivalate\n",
      "Doxacurium chloride\n",
      "Carvedilol\n",
      "Levofloxacin\n",
      "Sulfinpyrazone\n",
      "Cefapirin\n",
      "Cefadroxil\n",
      "Micafungin\n",
      "Doxepin\n",
      "Amifostine\n",
      "Diclofenamide\n",
      "Sulfoxone\n",
      "Diphenylpyraline\n",
      "Cloxacillin\n",
      "Flavoxate\n",
      "Nefazodone\n",
      "Cefprozil\n",
      "Desipramine\n",
      "Candicidin\n",
      "Sertaconazole\n",
      "Thiamylal\n",
      "Gemifloxacin\n",
      "Bupropion\n",
      "Trimetrexate\n",
      "Bretylium\n",
      "Halothane\n",
      "Dinoprost Tromethamine\n",
      "Chloroprocaine\n",
      "Terazosin\n",
      "Amdinocillin\n",
      "Calcium Chloride\n",
      "Ofloxacin\n",
      "Cilostazol\n",
      "Itraconazole\n",
      "Procarbazine\n",
      "Arsenic trioxide\n",
      "Guanethidine\n",
      "Moclobemide\n",
      "Kanamycin\n",
      "Orphenadrine\n",
      "Phenobarbital\n",
      "Escitalopram\n",
      "Cyclizine\n",
      "Idarubicin\n",
      "Chlormezanone\n",
      "Podofilox\n",
      "Rescinnamine\n",
      "Ifosfamide\n",
      "Propafenone\n",
      "Naloxone\n",
      "Domperidone\n",
      "Fluoxymesterone\n",
      "Pergolide\n",
      "Iophendylate\n",
      "Ciclopirox\n",
      "Desflurane\n",
      "Clindamycin\n",
      "Dexfenfluramine\n",
      "Oxymorphone\n",
      "Acebutolol\n",
      "Brinzolamide\n",
      "Flecainide\n",
      "Estramustine\n",
      "Captopril\n",
      "Zopiclone\n",
      "Tubocurarine\n",
      "Bromocriptine\n",
      "Rifapentine\n",
      "Levetiracetam\n",
      "Nadolol\n",
      "Mitoxantrone\n",
      "Flumazenil\n",
      "Lomustine\n",
      "Ridogrel\n",
      "Sparfloxacin\n",
      "Dezocine\n",
      "Levobunolol\n",
      "Clarithromycin\n",
      "Ceftriaxone\n",
      "Fomepizole\n",
      "Metipranolol\n",
      "Estazolam\n",
      "Finasteride\n",
      "Anastrozole\n",
      "Halofantrine\n",
      "Dantrolene\n",
      "Rifaximin\n",
      "Ketamine\n",
      "Budesonide\n",
      "Aminophylline\n",
      "Quetiapine\n",
      "Enoxaparin\n",
      "Mivacurium\n",
      "Levomethadyl Acetate\n",
      "Encainide\n",
      "Paclitaxel\n",
      "Pemoline\n",
      "Diphenidol\n",
      "Saquinavir\n",
      "Metoclopramide\n",
      "Dexamethasone\n",
      "Levodopa\n",
      "Sevoflurane\n",
      "Bromodiphenhydramine\n",
      "Aripiprazole\n",
      "Chlorprothixene\n",
      "Epoprostenol\n",
      "Gemfibrozil\n",
      "Clomipramine\n",
      "Chloroxine\n",
      "Bepridil\n",
      "Decamethonium\n",
      "Alimemazine\n",
      "Isocarboxazid\n",
      "Docetaxel\n",
      "Iodixanol\n",
      "Olsalazine\n",
      "Gliquidone\n",
      "Mitiglinide\n",
      "Ergonovine\n",
      "Dasatinib\n",
      "Lisdexamfetamine\n",
      "Retapamulin\n",
      "Lapatinib\n",
      "Desonide\n",
      "Sitagliptin\n",
      "Decitabine\n",
      "Posaconazole\n",
      "Darunavir\n",
      "Telbivudine\n",
      "Sinecatechins\n",
      "Paliperidone\n",
      "Sunitinib\n",
      "Varenicline\n",
      "Arformoterol\n",
      "Hydralazine\n",
      "Nelarabine\n",
      "Carbetocin\n",
      "Lumiracoxib\n",
      "Tetracosactide\n",
      "Fenoterol\n",
      "Glisoxepide\n",
      "Pirbuterol\n",
      "Bismuth Subsalicylate\n",
      "Bevantolol\n",
      "Glucosamine\n",
      "Practolol\n",
      "Sulfacytine\n",
      "Sulfadoxine\n",
      "Rolitetracycline\n",
      "Oxtriphylline\n",
      "Fosamprenavir\n",
      "Fosphenytoin\n",
      "Josamycin\n",
      "Kava\n",
      "St. John's Wort\n",
      "Polythiazide\n",
      "Quinethazone\n",
      "Cefamandole\n",
      "Cefazolin\n",
      "Cefonicid\n",
      "Cefoperazone\n",
      "Cefotetan\n",
      "Cefoxitin\n",
      "Ceftizoxime\n",
      "Cefradine\n",
      "Metocurine\n",
      "Pancuronium\n",
      "Pipecuronium\n",
      "Vecuronium\n",
      "Cilazapril\n",
      "Dihydroquinidine barbiturate\n",
      "Forasartan\n",
      "Tolevamer\n",
      "Potassium\n",
      "Quinidine barbiturate\n",
      "Saprisartan\n",
      "Spirapril\n",
      "Tasosartan\n",
      "Amobarbital\n",
      "Aprobarbital\n",
      "Butethal\n",
      "Heptabarbital\n",
      "Hexobarbital\n",
      "Lithium\n",
      "Mestranol\n",
      "Penbutolol\n",
      "Iohexol\n",
      "Ephedra\n",
      "Ephedrine\n",
      "Mephentermine\n",
      "Procaterol\n",
      "Rasagiline\n",
      "Quinupristin\n",
      "Aluminium\n",
      "Calcium\n",
      "Aluminium monostearate\n",
      "Magnesium oxide\n",
      "Magnesium\n",
      "Cortisone acetate\n",
      "Ginkgo biloba\n",
      "Glycodiazine\n",
      "Paramethasone\n",
      "Mibefradil\n",
      "Sodium bicarbonate\n",
      "Yohimbine\n",
      "Bezafibrate\n",
      "Colchicine\n",
      "Drospirenone\n",
      "Digitoxin\n",
      "Magnesium salicylate\n",
      "Salsalate\n",
      "Neostigmine\n",
      "Choline magnesium trisalicylate\n",
      "Methotrimeprazine\n",
      "Ginseng\n",
      "Temafloxacin\n",
      "Danazol\n",
      "Clenbuterol\n",
      "Bambuterol\n",
      "Tiotropium\n",
      "Ciclesonide\n",
      "Pranlukast\n",
      "Theobromine\n",
      "Cefepime\n",
      "Cefacetrile\n",
      "Ceftibuten\n",
      "Cefpodoxime\n",
      "Acenocoumarol\n",
      "Antrafenine\n",
      "Testosterone propionate\n",
      "Paromomycin\n",
      "Nitroxoline\n",
      "Stepronin\n",
      "Aminophenazone\n",
      "Alizapride\n",
      "Ajmaline\n",
      "Amrinone\n",
      "Oxybenzone\n",
      "Aprindine\n",
      "Almitrine\n",
      "Allylestrenol\n",
      "Cholestyramine\n",
      "Methadyl Acetate\n",
      "19-norandrostenedione\n",
      "Antipyrine\n",
      "Alfacalcidol\n",
      "Glutethimide\n",
      "Phenazopyridine\n",
      "3-Methylthiofentanyl\n",
      "Gamma Hydroxybutyric Acid\n",
      "5-Methoxy-N,N-diisopropyltryptamine\n",
      "MMDA\n",
      "19-Nor-5-androstenedione\n",
      "Dimethylthiambutene\n",
      "Bufotenine\n",
      "Alpha-methyltryptamine\n",
      "4-Methylaminorex\n",
      "19-Nor-4-androstenedione\n",
      "Dihydroetorphine\n",
      "1-Androstenedione\n",
      "Heroin\n",
      "Beta-hydroxyfentanyl\n",
      "Midomafetamine\n",
      "19-Nor-5-androstenediol\n",
      "5-androstenedione\n",
      "2,5-Dimethoxy-4-(n)-propylthiophenethylamine\n",
      "Bezitramide\n",
      "Diethyltryptamine\n",
      "Dimenoxadol\n",
      "Etonitazene\n",
      "Fencamfamine\n",
      "Furethidine\n",
      "2,5-Dimethoxyamphetamine\n",
      "Ethylmorphine\n",
      "2,5-Dimethoxy-4-ethylamphetamine\n",
      "Ethylmethylthiambutene\n",
      "Acetorphine\n",
      "α-methylthiofentanyl\n",
      "Bolasterone\n",
      "4-Methoxyamphetamine\n",
      "Betaprodine\n",
      "17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene\n",
      "Dioxaphetyl butyrate\n",
      "Haloxazolam\n",
      "Codeine methylbromide\n",
      "Desmethylprodine\n",
      "BA-2664\n",
      "Cyprenorphine\n",
      "1-Testosterone\n",
      "Fenethylline\n",
      "Barbital\n",
      "4-Bromo-2,5-dimethoxyamphetamine\n",
      "4-Hydroxytestosterone\n",
      "Cathine\n",
      "Embutramide\n",
      "Dimethyltryptamine\n",
      "Camazepam\n",
      "Aminorex\n",
      "Dipipanone\n",
      "Ethylestrenol\n",
      "Chloral betaine\n",
      "Dichloralphenazone\n",
      "Barbituric acid derivative\n",
      "Etorphine\n",
      "Alphamethadol\n",
      "Alphameprodine\n",
      "Oxabolone\n",
      "Difenoxin\n",
      "Diampromide\n",
      "1-Androstenediol\n",
      "Etoxeridine\n",
      "1-Phenylcyclohexylamine\n",
      "3,4-Methylenedioxyamphetamine\n",
      "Dehydrochloromethyltestosterone\n",
      "Delorazepam\n",
      "Hydromorphinol\n",
      "17Alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane\n",
      "Furazabol\n",
      "Benzoylecgonine\n",
      "3,4,5-Trimethoxyamphetamine\n",
      "Benzethidine\n",
      "Tenocyclidine\n",
      "Clostebol\n",
      "Betacetylmethadol\n",
      "Clonitazene\n",
      "Androstenediol\n",
      "Ecgonine\n",
      "4-Androstenediol\n",
      "Clortermine\n",
      "4-Methyl-2,5-dimethoxyamphetamine\n",
      "Dextromoramide\n",
      "5alpha-androstane-3alpha,17beta-diol\n",
      "Desomorphine\n",
      "α-Methylacetylfentanyl\n",
      "Diethylthiambutene\n",
      "Chlorhexadol\n",
      "Carfentanil\n",
      "Androstenedione\n",
      "4-Bromo-2,5-dimethoxyphenethylamine\n",
      "Acetyldihydrocodeine\n",
      "1-Piperidinocyclohexanecarbonitrile\n",
      "17alpha-methyl-4-hydroxynandrolone\n",
      "Boldenone\n",
      "Allylprodine\n",
      "18-methyl-19-nortestosterone\n",
      "Flunitrazepam\n",
      "Ethyl loflazepate\n",
      "Etryptamine\n",
      "Drotebanol\n",
      "Diprenorphine\n",
      "Rolicyclidine\n",
      "Fenproporex\n",
      "Dihydrocodeine\n",
      "Betameprodine\n",
      "Cloxazolam\n",
      "Bolandiol\n",
      "Alphacetylmethadol\n",
      "Chlorphentermine\n",
      "α-Methylfentanyl\n",
      "Bromazepam\n",
      "Clotiazepam\n",
      "Cathinone\n",
      "Androstanedione\n",
      "1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine\n",
      "Chloral hydrate\n",
      "Calusterone\n",
      "Dihydromorphine\n",
      "Methylenedioxyethamphetamine\n",
      "Fludiazepam\n",
      "Codeine-N-oxide\n",
      "Formebolone\n",
      "Ohmefentanyl\n",
      "3-Methylfentanyl\n",
      "Methyl-1-testosterone\n",
      "Benzylmorphine\n",
      "Attapulgite\n",
      "Kaolin\n",
      "Dextroamphetamine\n",
      "Methamphetamine\n",
      "Metrizamide\n",
      "Phendimetrazine\n",
      "Oxprenolol\n",
      "Sulfamerazine\n",
      "Sulfamethazine\n",
      "Liotrix\n",
      "Ursodeoxycholic acid\n",
      "Ketazolam\n",
      "Prazepam\n",
      "Quazepam\n",
      "Everolimus\n",
      "Solifenacin\n",
      "Iron\n",
      "Zinc\n",
      "Cinolazepam\n",
      "Nitrazepam\n",
      "Cilastatin\n",
      "Imipenem\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Probucol\n",
      "Tiaprofenic acid\n",
      "Lopinavir\n",
      "Bacampicillin\n",
      "Meticillin\n",
      "Pivampicillin\n",
      "Pivmecillinam\n",
      "Tazobactam\n",
      "Ticarcillin\n",
      "Propericiazine\n",
      "Deferasirox\n",
      "Valganciclovir\n",
      "Hydroxychloroquine\n",
      "Amyl Nitrite\n",
      "Erythrityl Tetranitrate\n",
      "Acepromazine\n",
      "Aceprometazine\n",
      "Alverine\n",
      "Molindone\n",
      "Phenindamine\n",
      "Pheniramine\n",
      "Pipotiazine\n",
      "Thioproperazine\n",
      "Thiothixene\n",
      "Zuclopenthixol\n",
      "Isopropamide\n",
      "Pargyline\n",
      "Lincomycin\n",
      "Etoricoxib\n",
      "5-Fluorouridine\n",
      "SC-74020\n",
      "Methyl Nonanoate (Ester)\n",
      "Alpha-Phosphoribosylpyrophosphoric Acid\n",
      "Deoxy-2-Fluoro-B-D-Cellotrioside\n",
      "2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine\n",
      "2,2-Dimethylthiazolidine-4-Carboxylic Acid;(Dmt)Thiazolidine\n",
      "Clorocruoro Hem\n",
      "3,7,11,15-Tetramethyl-Hexadecan-1-Ol\n",
      "Sorbitol\n",
      "N-Methyl-Pyridoxal-5'-Phosphate\n",
      "(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One\n",
      "(5z)-2-[(1s,2r)-1-Amino-2-Hydroxypropyl]-5-[(4-Amino-1h-Indol-3-Yl)Methylene]-3-(2-Hydroxyethyl)-3,5-Dihydro-4h-Imidazol-4-One\n",
      "O1-Methyl-Glucose\n",
      "Thymidine-5'-Phosphate\n",
      "3,6-Dihydroxy-Xanthene-9-Propionic Acid\n",
      "Genistein\n",
      "N-Acetylmethionine\n",
      "Daxalipram\n",
      "O1-Methyl-4-Deoxy-4-Thio-Beta-D-Glucose\n",
      "7-Methyl-Gpppa\n",
      "trans-2-hydroxycinnamic acid\n",
      "Methyl 4,6-O-[(1r)-1-Carboxyethylidene]-Beta-D-Galactopyranoside\n",
      "4-Hydroxybenzoyl Coenzyme A\n",
      "L-gulonic acid 6-phosphate\n",
      "Roflumilast\n",
      "2-Amino-3-[4-Hydroxy-6-Oxo-3-(2-Phenyl-Cyclopropylimino)-Cyclohexa-1,4-Dienyl]-Propionic Acid\n",
      "1'-Deazo-Thiamin Diphosphate\n",
      "3-(1,10-Phenanthrol-2-Yl)-L-Alanine\n",
      "1-(5-phospho-D-ribosyl)-ATP\n",
      "Trans-O-Hydroxy-Alpha-Methyl Cinnamate\n",
      "Lambda-Bis(2,2'-Bipyridine)-(5-Methyl-2-2'-Bipyridine)-C9-Adamantane Ruthenium (II)\n",
      "(S)-Des-Me-Ampa\n",
      "ZK-800270\n",
      "D-Myo-Inositol-Hexasulphate\n",
      "8-azaguanine\n",
      "Nanaomycin D\n",
      "Virginiamycin M1\n",
      "Propyl Acetate\n",
      "4-(Hydroxymercury)Benzoic Acid\n",
      "2,3-Dihydroxy-Benzoic Acid\n",
      "Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine\n",
      "[2-(1-Amino-2-Hydroxy-Propyl)-4-(4-Fluoro-1h-Indol-3-Ylmethyl)-5-Hydroxy-Imidazol-1-Yl]-Acetic Acid\n",
      "Methacrylyl-Coenzyme A\n",
      "Trinitrotoluene\n",
      "Fumaric Acid\n",
      "RU84687\n",
      "Propyl Trihydrogen Diphosphate\n",
      "Benzene Hexacarboxylic Acid\n",
      "6'-Methyl-Thiamin Diphosphate\n",
      "Chymostatin\n",
      "1-Hydroxy-1-Thio-Glycerol\n",
      "Topiroxostat\n",
      "N,N-dimethylarginine\n",
      "beta-Mannobiose\n",
      "P-Cresol\n",
      "Inhibitor Idd 384\n",
      "Bis(Adenosine)-5'-Triphosphate\n",
      "Indole Naphthyridinone\n",
      "Dithioerythritol\n",
      "D-tartaric acid\n",
      "N-Hydroxy-4-Phosphono-Butanamide\n",
      "beta-cellotriose\n",
      "Rutin\n",
      "(4e)-4-Aminohex-4-Enoic Acid\n",
      "AICA ribonucleotide\n",
      "1,2-Dichloro-Propane\n",
      "2-(3,4-Dihydroxyphenyl)Acetic Acid\n",
      "N-(2-Ferrocenylethyl)Maleimide\n",
      "2,4-Dihydroxy-Trans Cinnamic Acid\n",
      "Bis(5-Amidino-Benzimidazolyl)Methane\n",
      "2-Bromo-6-Chloro-Purine\n",
      "L-Alfa-Lysophosphatidylcholine, Lauroyl\n",
      "Prasterone\n",
      "2-phospho-D-glyceric acid\n",
      "Porphyrin Fe(III)\n",
      "2,3,4,5,6-Pentafluorobenzyl Alcohol\n",
      "(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester\n",
      "Udp-Alpha-D-Xylopyranose\n",
      "N-Methyl-Lysine\n",
      "7,8-Diamino-Nonanoic Acid\n",
      "2-Propenyl-N-Acetyl-Neuramic Acid\n",
      "Bis(Adenosine)-5'-Pentaphosphate\n",
      "Cetrimonium\n",
      "Thio-Maltopentaose\n",
      "(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid\n",
      "Analogue of Indinavir Drug\n",
      "{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid\n",
      "Reduced Threonine\n",
      "2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide\n",
      "2-Aminophenol\n",
      "Isocitric Acid\n",
      "3-[Aminoethylphosphoryl]-[1,2-Di-Palmitoyl]-Sn-Glycerol\n",
      "(1s,3s,4s)-1,3,4-Triphospho-Myo-Inositol\n",
      "(S)-Wiskostatin\n",
      "(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One\n",
      "L-Phospholactate\n",
      "3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid\n",
      "3-Chloroalaninate\n",
      "[3-(Dodecanoylamino)Propyl](Hydroxy)Dimethylammonium\n",
      "Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester\n",
      "Phosphorylcolamine\n",
      "Allo-Isoleucine\n",
      "2-Amino-4-Butyl-5-Propylselenazole\n",
      "CRA_17693\n",
      "(3r)-1-Acetyl-3-Methylpiperidine\n",
      "Camphor\n",
      "N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester\n",
      "D-Leucine\n",
      "Coprogen\n",
      "N-Benzyl-4-Sulfamoyl-Benzamide\n",
      "1,2-Dimethoxyethane\n",
      "1-naphthaleneacetic acid\n",
      "3,3',5,5'-Tetraiodothyroacetic Acid\n",
      "S-adenosyl-L-homocysteine\n",
      "4-Oxo-Nicotinamide-Adenine Dinucleotide Phosphate\n",
      "3,4-Dihydroxy-1-Methylquinolin-2(1h)-One\n",
      "N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone\n",
      "4-phospho-L-threonic acid\n",
      "3-Iodo-Tyrosine\n",
      "Kojic acid\n",
      "2-Methoxy-3-Isopropylpyrazine\n",
      "4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine\n",
      "Acetoacetic Acid\n",
      "7-thionicotinamide-adenine-dinucleotide phosphate\n",
      "Dalfopristin\n",
      "(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid\n",
      "Beta-(2-Naphthyl)-Alanine\n",
      "Hemi-Babim\n",
      "Methylumbelliferyl Sialic Acid\n",
      "CRA_10991\n",
      "3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione\n",
      "4-[3-Carboxymethyl-3-(4-Phosphonooxy-Benzyl)-Ureido]-4-[(3-Cyclohexyl-Propyl)-Methyl-Carbamoyl]Butyric Acid\n",
      "Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester\n",
      "Dihydroxyacetone\n",
      "M-Cresol\n",
      "Coa-S-Trimethylene-Acetyl-Tryptamine\n",
      "8-Amino-1,3-Dimethyl-3,7-Dihydropurine-2,6-Dione\n",
      "Glycerol-2-Phosphate\n",
      "Fusicoccin\n",
      "2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One\n",
      "Pantothenic acid\n",
      "4-Flourobenzenesulfonamide\n",
      "Dimethylallyl Diphosphate\n",
      "D-Alanine\n",
      "4-Imino-5-Methidyl-2-Methylpyrimidine\n",
      "1-Amino-2,3-Dihydroxy-5-Hydroxymethyl Cyclohex-5-Ene\n",
      "Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate\n",
      "Piclamilast\n",
      "Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate\n",
      "SB-409513\n",
      "bis(molybdopterin)tungsten cofactor\n",
      "Phenyl Boronic Acid\n",
      "Quinolinic Acid\n",
      "(2R)-2-(aminomethyl)-2,4-dihydroxy-5-oxo-3-(2-oxoethyl)-2,5-dihydro-1h-imidazol-3-ium\n",
      "Ethyl Dihydrogen Diphosphate\n",
      "4-Hydroxy-3-Methyl Butyl Diphosphate\n",
      "N,4-Dihydroxy-N-Oxo-3-(Sulfooxy)Benzenaminium\n",
      "(4r)-7aza-7,8-Dihydrolimonene\n",
      "2-(Trimethylammonium)Ethyl Thiol\n",
      "2-Ammoniobut-3-Enoate, 2-Amino-3-Butenoate\n",
      "Monoisopropylphosphorylserine\n",
      "10-{4-Dimethylamino-5-[4-Hydroxy-6-Methyl-5-(6-Methyl-5-Oxo-Tetrahydro-Pyran-2-Yloxy)-Tetrahydro-Pyrane-2-Yloxy]-6-Methyl-Tetrahydro-Pyran-2-Yloxy}-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione\n",
      "N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea\n",
      "Thiarsahydroxy-Cysteine\n",
      "1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine\n",
      "[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester\n",
      "3h-Indole-5,6-Diol\n",
      "Adenosine-3'-5'-Diphosphate\n",
      "Pyridoxyl-Glutamic Acid-5'-Monophosphate\n",
      "2-Tridecanoyloxy-Pentadecanoic Acid\n",
      "Nz-(Dicarboxymethyl)Lysine\n",
      "Castanospermine\n",
      "Threonine-Aspartic Ester\n",
      "O3-Sulfonylgalactose\n",
      "Phosphoenolpyruvate\n",
      "Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide\n",
      "L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide\n",
      "(4R,5R)-1,2-dithiane-4,5-diol\n",
      "Beta-D-Glucopyranose Spirohydantoin\n",
      "(3s)-Tetrahydrofuran-3-Yl (1r,2s)-3-[4-((1r)-2-{[(S)-Amino(Hydroxy)Methyl]Oxy}-2,3-Dihydro-1h-Inden-1-Yl)-2-Benzyl-3-Oxopyrrolidin-2-Yl]-1-Benzyl-2-Hydroxypropylcarbamate\n",
      "2-Amino-8-Methylquinazolin-4(3h)-One\n",
      "N-Butyl Isocyanide\n",
      "2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide\n",
      "Methylamine\n",
      "Desulfo-Coenzyme A\n",
      "{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid\n",
      "Tryptophanyl-5'amp\n",
      "4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid\n",
      "L-2-Amino-4-(Guanidinooxy)Butyric Acid\n",
      "(9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene\n",
      "4r-Fluoro-N6-Ethanimidoyl-L-Lysine\n",
      "[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone\n",
      "O-acetyl-L-serine\n",
      "6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone\n",
      "Propylene glycol\n",
      "2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate\n",
      "4,6-Dideoxyglucose\n",
      "3'-Phosphate-Adenosine-5'-Diphosphate\n",
      "3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione\n",
      "N,N-dimethylformamide\n",
      "Oxidized Coenzyme A\n",
      "N-Carbamyl-D-Valine\n",
      "3,4-Dihydrouracil\n",
      "(2s,3s,8s,9s)-3-Amino-9-Methoxy-2,6,8-Trimethyl-10-Phenyldeca-4,6-Dienoic Acid\n",
      "Tetrabutylammonium Ion\n",
      "Kaempherol\n",
      "Bacteriochlorophyll A\n",
      "5-Bromonicotinamide\n",
      "5-(Hydroxy-Methyl-Amino)-3-Methyl-Pyrrolidine-2-Carboxylic Acid\n",
      "Pimelic Acid\n",
      "Phosphoaspartate\n",
      "[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate\n",
      "4-Diphosphocytidyl-2-C-Methyl-D-Erythritol 2-Phosphate\n",
      "Cordycepin Triphosphate\n",
      "Uridine diphosphate glucose\n",
      "Isopropyl beta-D-thiogalactopyranoside\n",
      "Inositol 1,3,4,5-Tetrakisphosphate\n",
      "5'-Guanosine-Diphosphate-Monothiophosphate\n",
      "3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide\n",
      "RU79256\n",
      "Glycyl-L-a-Aminopimelyl-E-(D-2-Aminoethyl)Phosphonate\n",
      "1,4-dithio-alpha-D-glucopyranose\n",
      "[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester\n",
      "2-deoxy-2-acetamido-beta-D-galactose-4-sulfate\n",
      "Epothilone D\n",
      "Tropinone\n",
      "8-Azaxanthine\n",
      "Bis(5-Amidino-2-Benzimidazolyl)Methanone\n",
      "N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide\n",
      "Benzophenone\n",
      "(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid\n",
      "3,4-Dihydroxycinnamic Acid\n",
      "2-Methylpentane-1,2,4-Triol\n",
      "(2s)-2-Amino-4-(Methylsulfanyl)-1-Pyridin-2-Ylbutane-1,1-Diol\n",
      "N-(Sulfanylacetyl)Tyrosylprolylmethioninamide\n",
      "2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One\n",
      "D-Galctopyranosyl-1-On\n",
      "Inhibitor BEA369\n",
      "4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide\n",
      "16,17-Androstene-3-Ol\n",
      "N,N-Bis(3-(D-gluconamido)propyl)deoxycholamide\n",
      "Tl-3-093\n",
      "Hyperforin\n",
      "N6-Benzyl Adenosine-5'-Diphosphate\n",
      "Aspartyl-Adenosine-5'-Monophosphate\n",
      "M-Aminophenylboronic Acid\n",
      "2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride\n",
      "(2S,3S)-2-azanyl-3-methyl-pentanedioic acid\n",
      "Nd1-Phosphonohistidine\n",
      "Sucrosofate\n",
      "1-Ethyl-Pyrrolidine-2,5-Dione\n",
      "5-Bromo-2'-Deoxyuridine-5'-Monophosphate\n",
      "D-Xylitol\n",
      "2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine\n",
      "3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-Benzoic Acid\n",
      "RU85493\n",
      "Alpha-Cyclodextrin (Cyclohexa-Amylose)\n",
      "Sinefungin\n",
      "N-Methylmesoporphyrin\n",
      "2,2':6',2''-Terpyridine Platinum(Ii)\n",
      "D-glucose\n",
      "S-Hydroxycysteine\n",
      "Putrescine\n",
      "[Methyltelluro]Acetate\n",
      "Pentanal\n",
      "1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose\n",
      "Xylose-Derived Lactam Oxime\n",
      "Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam\n",
      "L-Xylulose 5-Phosphate\n",
      "Benzhydroxamic Acid\n",
      "2'-Chloro-Biphenyl-2,3-Diol\n",
      "Carboxymycobactin S\n",
      "Duroquinone\n",
      "5-Chloryl-2,4,6-Quinazolinetriamine\n",
      "2,4-Dihydroxy-3,3-Dimethyl-Butyrate\n",
      "Dcka, 5,7-Dichlorokynurenic Acid\n",
      "5-Methylpyrrole\n",
      "7-Hydroxystaurosporine\n",
      "N-Methyl-N-(10-Methylundecanoyl)-D-Seryl-L-Alanyl-N~1~-[(7s,10s,13s)-13-Carboxy-3,18-Dihydroxy-10-Methyl-8,11-Dioxo-9,12-Diazatricyclo[13.3.1.1~2,6~]Icosa-1(19),2(20),3,5,15,17-Hexaen-7-Yl]-N~1~-Methylglycinamide\n",
      "3-{[(1r)-1-Benzyl-2-Sulfanylethyl]Amino}-3-Oxopropanoic Acid\n",
      "alpha-D-arabinofuranose\n",
      "Guanosine-2'-Monophosphate\n",
      "L-Histidine Beta Naphthylamide\n",
      "5-Amidino-Benzimidazole\n",
      "Balanol Analog 2\n",
      "6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid\n",
      "Formic Acid\n",
      "(S)-blebbistatin\n",
      "4-Carbamoyl-1-Beta-D-Ribofuranosyl-Imidazolium-5-Olate-5'-Phosphate\n",
      "3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione\n",
      "RU78262\n",
      "1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One\n",
      "2-Amino-N,3,3-Trimethylbutanamide\n",
      "N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea\n",
      "Gpi-1046\n",
      "1,N6-Ethenoadenine\n",
      "Inhibitor of P38 Kinase\n",
      "Rolipram\n",
      "1,4-Butanediol\n",
      "Taurine\n",
      "3-Chlorophenol\n",
      "5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine\n",
      "3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester\n",
      "7n-Methyl-8-Hydroguanosine-5'-Diphosphate\n",
      "Cytidine 3'-monophosphate\n",
      "Phosphonotyrosine\n",
      "Phenylethane Boronic Acid\n",
      "AL5424\n",
      "2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate\n",
      "Di-Stearoyl-3-Sn-Phosphatidylethanolamine\n",
      "N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide\n",
      "2-Thioethenamine\n",
      "Trifluoroacetonyl Coenzyme A\n",
      "Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide\n",
      "trans-urocanic acid\n",
      "Guanosine-5'-Monophosphate\n",
      "O-Benzylsulfonyl-Serine\n",
      "2-Amino-3-[5-(Amino-Carboxy-Methyl)-2,3-Dihydro-Isoxazol-3-Ylsulfanyl]-Propionic Acid\n",
      "AMPCPR\n",
      "Aminoanthracene\n",
      "6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine\n",
      "7,9-Dimethylguanine\n",
      "Methyl alpha-D-mannoside\n",
      "Para-Iodo-D-Phenylalanine Hydroxamic Acid\n",
      "3,6-Anhydro-D-Galactose-2-Sulfate\n",
      "D-Mannuronic Acid\n",
      "2(S)-Amino-6-Boronohexanoic Acid\n",
      "4-[2-(3-Benzyloxycarbonylamino-4-Cyclohexyl-1-Hydroxy-2-Oxo-Butylamino)-5-Guanidino-Pentanoylamino]-4-(1-Carboxy-2-Cyclohexyl-Ethylcarbamoyl)-Butyric Acid\n",
      "N-Alpha-L-Acetyl-Arginine\n",
      "3-Fluoro-2-Methyl-Aniline\n",
      "Cocarboxylase\n",
      "6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine\n",
      "Carbobenzoxy-Pro-Lys-Phe-Y(Po2)-Ala-Pro-Ome\n",
      "Cholesterol-Sulfate\n",
      "Tu-514\n",
      "Coenzyme A\n",
      "N-(5'-Phosphopyridoxyl)-D-Alanine\n",
      "2-(Pyrido[1,2-E]Purin-4-Yl)Amino-Ethanol\n",
      "5-Methylcytidine-5'-Monophosphate\n",
      "3-Methylpyridine\n",
      "3-Bromo-7-Nitroindazole\n",
      "2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol\n",
      "5,10,15,20-Tetrakis(4-Sulpfonatophenyl)-21h,23h-Porphine\n",
      "5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine\n",
      "2-Aminoprop-2-Enamide\n",
      "5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine\n",
      "2-Oxo-3-Pentenoic Acid\n",
      "Br-Coeleneterazine\n",
      "alpha-D-glucose 6-phosphate\n",
      "1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine\n",
      "L-756,423\n",
      "Staurosporine\n",
      "N-(Phosphonoacetyl)-L-Ornithine\n",
      "Monoazido-Mu-Oxo-Diiron\n",
      "Compound 9\n",
      "Dihydrofolic Acid\n",
      "R048-8071\n",
      "Imidazole-Derived Cellobiose\n",
      "Amido Phenyl Pyruvic Acid\n",
      "Acetyl Dithranol\n",
      "Alrestatin\n",
      "Fidarestat\n",
      "4-Amino-5-Hydroxymethyl-2-Methylpyrimidine\n",
      "8-Oxo-2'-Deoxy-Guanosine-5'-Monophosphate\n",
      "3-phenylpropionic acid\n",
      "L-D-(a-Aminoadipoyl)-L-Cysteinyl-D-Valine\n",
      "Furo[2,3d]Pyrimidine Antifolate\n",
      "N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine\n",
      "(1R,2R,3S,4R,6S)-3,4,6-Trihydroxy-5-{[(S)-hydroxy(3-hydroxy-2-oxopropoxy)phosphoryl]oxy}-1,2-cyclohexanediyl bis[dihydrogen (phosphate)]\n",
      "N-Cyclohexyl-N'-(4-Iodophenyl)Urea\n",
      "Alpha-Ribazole-5'-Phosphate\n",
      "(6S)-5,6,7,8-tetrahydrofolate\n",
      "1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid\n",
      "N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide\n",
      "Tridolgosir\n",
      "1-Hexadecylsulfonyl Fluoride\n",
      "2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide\n",
      "2,4-Diamino-4,6-Dihydroxypyrimidine\n",
      "D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide\n",
      "S-Acetyl-Cysteine\n",
      "Isoluminol\n",
      "2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol\n",
      "1,2-Dipalmitoyl-Phosphatidyl-Glycerole\n",
      "N-(3-(Aminomethyl)Benzyl)Acetamidine\n",
      "Amylamine\n",
      "N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid\n",
      "2-(1,1'-Biphenyl-4-Yl)Propanoic Acid\n",
      "1,2,4-Triazole-Carboxamidine\n",
      "2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide\n",
      "3-[N-[Benzyloxycarbonyl]-Phenylalaninyl-Amino]-5-Phenyl-Pentane-1-Sulfonic Acid 4-Nitro-Phenyl Ester\n",
      "Indirubin-3'-Monoxime\n",
      "Ribose-5-phosphate\n",
      "Gabaculine\n",
      "N-Butyl-Benzenesulfonamide\n",
      "Prostaglandin D2\n",
      "(S)-AMPA\n",
      "SU4984\n",
      "Adenosine-5-Diphosphoribose\n",
      "Cyclohexanone\n",
      "Cellobiose\n",
      "N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine\n",
      "CRA_16847\n",
      "4-Deoxylactose\n",
      "N7-Methyl-Formycin A\n",
      "Triglu-5-Formyl-Tetrahydrofolate\n",
      "Delta-Amino Valeric Acid\n",
      "N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide\n",
      "L-2-Amino-4-[2-Aminophenyl]-4-Oxobutanoic Acid\n",
      "WAY-151693\n",
      "2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid\n",
      "Biliverdine IX Alpha\n",
      "Butenoic Acid\n",
      "(1s)-1(9-Deazahypoxanthin-9yl)1,4-Dideoxy-1,4-Imino-D-Ribitol-5-Phosphate\n",
      "6-phospho-D-gluconic acid\n",
      "L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide\n",
      "Triglyme\n",
      "Aminooxyacetic acid\n",
      "1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene\n",
      "Bis-Benzamidine\n",
      "Phosphoaminophosphonic Acid Guanylate Ester\n",
      "N,N-dimethylglycine\n",
      "CRA_17312\n",
      "1-Aminocyclopropanecarboxylic Acid\n",
      "(3,4-Dihydroxy-Phenyl)-Triphenyl-Arsonium\n",
      "3,5-Difluorobenzenesulfonamide\n",
      "Norleucine Phosphonate\n",
      "CP-526423\n",
      "A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor\n",
      "4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine\n",
      "Cholesteryl Linoleate\n",
      "5-Phospho-D-Arabinohydroxamic Acid\n",
      "N-2-Thiophen-2-Yl-Acetamide Boronic Acid\n",
      "Isatin\n",
      "FR221647\n",
      "Cytidine\n",
      "Adenosine-2'-5'-Diphosphate\n",
      "S-azabisabolene\n",
      "Methyl alpha-galactoside\n",
      "(S,R)-fidarestat\n",
      "DMP450\n",
      "2-Chlorodideoxyadenosine\n",
      "2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine\n",
      "3,5-Dinitrocatechol\n",
      "[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid\n",
      "Leucine - Reduced Carbonyl\n",
      "2-Aminoethanimidic Acid\n",
      "Hadacidin\n",
      "Protoporphyrin Ix Containing Co\n",
      "3-Hydroxyisoxazole-4-Carboxylic Acid\n",
      "Zk-806450\n",
      "6-Methylpurine\n",
      "Para-Isopropylaniline\n",
      "Daidzin\n",
      "Olomoucine\n",
      "CP-271485\n",
      "6-Hydroxymethyl-7,8-Dihydropterin\n",
      "6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol\n",
      "Butyramide\n",
      "4-iodo-acetamido phenylboronic acid\n",
      "Glycochenodeoxycholic Acid\n",
      "(2s,3s)-Trans-2,3-Dihydro-3-Hydroxyanthranilic Acid\n",
      "Adamantanone\n",
      "4-Carboxycinnamic Acid\n",
      "Methylphosphonic Acid Diisopropyl Ester\n",
      "[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester\n",
      "Dihydroorotic Acid\n",
      "Vanillic acid\n",
      "N-1-Methylheptylformamide\n",
      "Zenarestat\n",
      "Chlorophyll A\n",
      "Xanthine\n",
      "4-{2,6,8-Trioxo-9-[(2R,3S,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate\n",
      "Cephalosporin Analog\n",
      "Molybdenum Cofactor\n",
      "Diethyl 4-Methylbenzylphosphonate\n",
      "(2e)-N-Allyl-4-{[3-(4-Bromophenyl)-5-Fluoro-1-Methyl-1h-Indazol-6-Yl]Oxy}-N-Methyl-2-Buten-1-Amine\n",
      "N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide\n",
      "S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea\n",
      "Pyridoxamine-5'-Phosphate\n",
      "N-Isopropyl-N'-Hydroxyguanidine\n",
      "1,2-diacyl-sn-glycero-3-phosphoinositol\n",
      "Butyl alcohol\n",
      "Atrazine Glutathione Conjugate\n",
      "Cyclo-Tetrametavanadate\n",
      "3-Amino-4-Oxybenzyl-2-Butanone\n",
      "Methionine Phosphonate\n",
      "K-252a\n",
      "3-Sulfinoalanine\n",
      "2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid\n",
      "Balanol Analog 8\n",
      "Sulfopyruvate\n",
      "(1s)-1-(9-Deazaadenin-9-Yl)-1,4,5-Trideoxy-1,4-Imino-5-Methylthio-D-Ribitol\n",
      "(R)-Propylene glycol\n",
      "S-Butyryl-Cystein\n",
      "Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester\n",
      "5'-O-(N-Ethyl-Sulfamoyl)Adenosine\n",
      "2,5-Xylidine\n",
      "N-Sulfo-Flavin Mononucleotide\n",
      "Zinc Trihydroxide\n",
      "Propidium\n",
      "N,N-Dimethyl-L-Alanine\n",
      "Bromopurine\n",
      "9,10-Deepithio-9,10-Didehydroacanthifolicin\n",
      "1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One\n",
      "2,5-Dideoxy-2,5-Imino-D-Glucitol\n",
      "Co(III)-(Deuteroporphyrin IX)\n",
      "D-Glutamine\n",
      "Malonic acid\n",
      "Mercury Acetate Ion\n",
      "1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine\n",
      "Phenylacetaldehyde\n",
      "O-Trifluoromethylphenyl Anthranilic Acid\n",
      "Myristoyl-Coa\n",
      "2'-Deoxyguanosine-5'-Triphosphate\n",
      "Hybrid Between B and C Type Hemes (Protoporphyrin Ixcontaining Fe)\n",
      "Adenosine-5'-Ditungstate\n",
      "D-1,4-dithiothreitol\n",
      "2,4-Dihydroxy-7-(Methyloxy)-2h-1,4-Benzoxazin-3(4h)-One\n",
      "N-Acetyl-D-Galactosamine 6-Sulfate\n",
      "Equilin\n",
      "N-Methylmesoporphyrin Containing Copper\n",
      "2',3'-Dideoxyadenosine-5'-Triphosphate\n",
      "(S)-oxalosuccinic acid\n",
      "(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One\n",
      "Phenylethyl alcohol\n",
      "8-Benzyl-2-Hydroxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One\n",
      "3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine\n",
      "Uridine-Diphosphate-N-Acetylgalactosamine\n",
      "4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide\n",
      "2-Bromoacetyl Group\n",
      "1,3-Dedimethyl-1,3-Divinyl Heme\n",
      "3-[N-[Benzyloxycarbonyl]-Phenylalaninyl-Amino]-5-Phenyl-Pentane-1-Sulfonylmethylbenzene\n",
      "Malonate Ion\n",
      "1,3-Butanediol\n",
      "Acetone Cyanohydrin\n",
      "6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One\n",
      "7-Nitroindazole\n",
      "Pyridoxine phosphate\n",
      "Hexane-1,6-Diol\n",
      "N-Methyl-N-Propargyl-1(R)-Aminoindan\n",
      "Metanitrophenyl-Alpha-D-Galactoside\n",
      "6,7-Dioxo-5h-8-Ribitylaminolumazine\n",
      "Furoyl-Leucine\n",
      "S-Methylcysteine\n",
      "Dpb-T\n",
      "N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside\n",
      "3-Cyclohexyl-1-Propylsulfonic Acid\n",
      "AL7089A\n",
      "4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide\n",
      "2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine\n",
      "LY231514 Tetra Glu\n",
      "Taxifolin\n",
      "1,2-Di-N-Pentanoyl-Sn-Glycero-3-Dithiophosphocholine\n",
      "3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium\n",
      "4,5-Dihydroxy-Tetrahydro-Pyran-2-Carboxylic Acid\n",
      "2-deoxy-2-fluoro-β-D-galactose\n",
      "5'-O-[(L-methionyl)-sulphamoyl]adenosine\n",
      "Immucillin-G\n",
      "1,2-Dihydroxybenzene\n",
      "6-hydroxy-D-norleucine\n",
      "S-Ethylisothiourea\n",
      "L-methionine (R)-S-oxide\n",
      "Glycinamide Ribonucleotide\n",
      "Maltotetraose\n",
      "4-(Methylsulfanyl)-2-Oxobutanoic Acid\n",
      "Laevulinic Acid\n",
      "Quinacrine mustard\n",
      "8-Benzyl-2-Hydroperoxy-2-(4-Hydroxy-Benzyl)-6-(4-Hydroxy-Phenyl)-2h-Imidazo[1,2-a]Pyrazin-3-One\n",
      "Cyclohexane Propionic Acid\n",
      "4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide\n",
      "7-Deazaguanine\n",
      "Hydrolyzed Cephalothin\n",
      "3-Methyl-5-Sulfo-Pyrrolidine-2-Carboxylic Acid\n",
      "2-Ethoxyethanol\n",
      "O-Succinylbenzoate\n",
      "Iodophenyl\n",
      "(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol\n",
      "Trifluoro-thiamin phosphate\n",
      "GM6001\n",
      "2'-Deoxyuridine\n",
      "N-Bromoacetyl-Aminoethyl Phosphate\n",
      "SR11254\n",
      "3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide\n",
      "4-Oxosebacic Acid\n",
      "Platelet Activating Factor\n",
      "Orotic Acid\n",
      "Glyceraldehyde-3-Phosphate\n",
      "O2-Sulfo-Glucuronic Acid\n",
      "Ethyl-Trimethyl-Silane\n",
      "Flufenamic Acid\n",
      "Argininosuccinate\n",
      "4-(Acetylamino)-3-Amino Benzoic Acid\n",
      "[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium\n",
      "Dimethylallyl S-Thiolodiphosphate\n",
      "S-(2-Oxo)Pentadecylcoa\n",
      "Porphobilinogen\n",
      "2,6-Dimethyl-7-Octen-2-Ol\n",
      "7-Keto-8-Aminopelargonic Acid\n",
      "[2-Aminomethyl-5-Oxo-4-(4-Oxo-Cyclohexa-2,5-Dienylmethyl)-4,5-Dihydro-Imidazol-1-Yl] -Acetaldehyde\n",
      "(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide\n",
      "1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea\n",
      "7,8-Dihydro-7,7-Dimethyl-6-Hydroxypterin\n",
      "Benzoylformic Acid\n",
      "(R)-Mandelic acid\n",
      "Formycin\n",
      "5'-Deoxy-5'-Methylthioadenosine\n",
      "2-Phenylamino-Ethanesulfonic Acid\n",
      "Protoporphyrin\n",
      "2-Amino-3-(4-Amino-1h-Indol-3-Yl)Propanoic Acid\n",
      "2-(2-Hydroxy-Phenyl)-3h-Benzoimidazole-5-Carboxamidine\n",
      "CRA_9334\n",
      "2-Aminopropanedioic Acid\n",
      "3-{2,6,8-trioxo-9-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate\n",
      "Irosustat\n",
      "(2S)-2,3-bis{[(3R,7R)-3,7,11,15-tetramethylhexadecyl]oxy}propyl (2R)-2-hydroxy-3-[(hydroxyphosphinato)oxy]propyl phosphate\n",
      "(5R,6S,7S,8S)-5-hydroxymethyl-6,7,8-trihydroxy-tetrazolo[1,5-A]piperidine\n",
      "N-[3-(Dimethylamino)Propyl]-2-({[4-({[4-(Formylamino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-1-Methyl-1h-Pyrrol-2-Yl]Carbonyl}Amino)-5-Isopropyl-1,3-Thiazole-4-Carboxamide\n",
      "1-Hydroxy-3-Methylbutane\n",
      "2-Amino-6-Chloropyrazine\n",
      "5-Hydroxyamino-3-Methyl-Pyrrolidine-2-Carboxylic Acid\n",
      "Arginineamide\n",
      "Calcipotriol\n",
      "5,10-Methylene-6-Hydrofolic Acid\n",
      "N3, N4-Dimethylarginine\n",
      "(5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione\n",
      "Prostaglandin B2\n",
      "4,5-Dehydro-D-Glucuronic Acid\n",
      "Palmitoyl-Linoleoyl Phosphatidylcholine\n",
      "N-(1-Carboxy-3-Phenylpropyl)Phenylalanyl-Alpha-Asparagine\n",
      "4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium\n",
      "5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine\n",
      "3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium\n",
      "Methyl Methylsulfinylmethyl Sulfide\n",
      "beta-D-galactose 6-phosphate\n",
      "4-{2-(4-Fluoro-Benzyl)-6-Methyl-5-[(5-Methyl-Isoxazole-3-Carbonyl)-Amino]-4-Oxo-Heptanoylamino}-5-(2-Oxo-Pyrrolidin-3-Yl)-Pentanoic Acid Ethyl Ester\n",
      "Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate\n",
      "Cyclic Guanosine Monophosphate\n",
      "1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid\n",
      "Alpha-D-Galactose-1-Phosphate\n",
      "2-deoxy-2-fluoro-alpha-D-mannosyl fluoride\n",
      "5,6-Dihydroxy-Nadp\n",
      "1-N-Acetyl-Beta-D-Glucosamine\n",
      "5-(3-Amino-4,4-Dihyroxy-Butylsulfanylmethyl)-Tetrahydro-Furan-2,3,4-Triol\n",
      "Heparin Disaccharide I-S\n",
      "EM-1745\n",
      "5-Iodo-2'-Deoxyuridine-5'-Monophosphate\n",
      "Isopropyl Alcohol\n",
      "1-Hydroxyamine-2-Isobutylmalonic Acid\n",
      "Triethylene glycol\n",
      "2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid\n",
      "Carbenoxolone\n",
      "(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid\n",
      "Flavin-N7 Protonated-Adenine Dinucleotide\n",
      "Deoxyuridine-5'-Triphosphate\n",
      "(R)-2-Hydroxy-3-Sulfopropanoic Acid\n",
      "2-Aminothiazoline\n",
      "RU83876\n",
      "S-(D-Carboxybutyl)-L-Homocysteine\n",
      "Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate\n",
      "Allyl-{6-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-Hexyl-}-Methyl-Amin\n",
      "N-Acetyl-Serine\n",
      "Mdl 101,146\n",
      "2-Methoxyestradiol\n",
      "3,6,9,12,15-Pentaoxaheptadecane\n",
      "Selenocysteine\n",
      "3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside\n",
      "2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid\n",
      "Fluoro-Phosphite Ion\n",
      "Nicotinamide-Adenine-Dinucleotide-5-Hydroxy-4-Oxonorvaline\n",
      "N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide\n",
      "3-(Benzyloxy)Pyridin-2-Amine\n",
      "Heparin Disaccharide Iii-S\n",
      "4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine\n",
      "Adenosine-5'-Rp-Alpha-Thio-Triphosphate\n",
      "4-Imidazolmethylene-5-Imidazolone Chromophore\n",
      "Methyl-O3-(Alpha-D-Mannose)-Alpha-D-Mannose\n",
      "LY374571\n",
      "9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine\n",
      "Bis-Napthyl Beta-Ketophosphonic Acid\n",
      "S-Methyl Thiocysteine Group\n",
      "Aminobenzoic acid\n",
      "2'-Monophosphoadenosine-5'-Diphosphate\n",
      "2-Amino-3-(Diethoxy-Phosphoryloxy)-Propionic Acid\n",
      "1,10-Phenanthroline\n",
      "CRA_10762\n",
      "(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine\n",
      "N-Acetyl-L-Citrulline\n",
      "3-Aza-2,3-Dihydrogeranyl Diphosphate\n",
      "Nz-(1-Carboxyethyl)-Lysine\n",
      "2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid\n",
      "2,5-Dimethylpyrimidin-4-Amine\n",
      "Adenosine Monotungstate\n",
      "Xylose-Derived Imidazole\n",
      "Myricetin\n",
      "D-gluconhydroximo-1,5-lactam\n",
      "Guanine\n",
      "MMI-175\n",
      "Beta-D-Glucose\n",
      "2'-Deoxyinosine\n",
      "nor-NOHA\n",
      "Namn\n",
      "Tolrestat\n",
      "(E)-2-Fluoro-P-Hydroxycinnamate\n",
      "D-threo-neopterin\n",
      "Leucine Phosphonic Acid\n",
      "Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "5-Bromo-N[2-(Dimethylamino)Ethyl]-9-Aminoacridine-4-Carboxamide\n",
      "2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One\n",
      "D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate\n",
      "Oxiranpseudoglucose\n",
      "3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol\n",
      "Methylethylamine\n",
      "O-(2-Acetamido-2-Deoxy-Alpha-D-Galactopyranosyl)-L-Serine\n",
      "6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine\n",
      "L-Rhamnitol\n",
      "5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione\n",
      "4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid\n",
      "5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine\n",
      "2-Fluoroaniline\n",
      "1-Deoxy-1-Thio-Heptaethylene Glycol\n",
      "12-Bromododecanoic Acid\n",
      "N-Valeric Acid\n",
      "6-O-Cyclohexylmethyl Guanine\n",
      "(3s)-3-Amino-1-(Cyclopropylamino)Heptane-2,2-Diol\n",
      "(1r,4s)-2-Azabornane\n",
      "2-Acetyl-3-[(4-Amino-2-Methyl-5-Pyrimidinyl)Methyl]-4-Methyl-5-(4,6,6-Trihydroxy-3,5-Dioxa-4,6-Diphosphahex-1-Yl)Thiazolium Inner Salt P,P'-Dioxide\n",
      "2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2\n",
      "Tetrahydropyran\n",
      "Hydroxyethylcysteine\n",
      "(3s,8ar)-3-(1h-Imidazol-5-Ylmethyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione\n",
      "N-Octyl-2-Hydroxyethyl Sulfoxide\n",
      "2-Ribofuranosyl-3-Iodo-2,3-Dihydro-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine\n",
      "2,4,6-Tribromophenol\n",
      "(R,R)-2,3-Butanediol\n",
      "Ethyl Oxo(Piperidin-1-Yl)Acetate\n",
      "[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,\n",
      "Uridine-5'-Diphosphate-Mannose\n",
      "Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside\n",
      "Thiopyrophosphate\n",
      "Geldanamycin\n",
      "Hexadecyl Octanoate\n",
      "Carboxyatractyloside\n",
      "2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline\n",
      "Quinaldic Acid\n",
      "4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide\n",
      "Trehalose-6-Phosphate\n",
      "Cytidine-5'-Triphosphate\n",
      "RU90395\n",
      "{[(2,2-Dihydroxy-Ethyl)-(2,3,4,5-Tetrahydroxy-6-Phosphonooxy-Hexyl)-Amino]-Methyl}-Phosphonic Acid\n",
      "4-(2-Thienyl)Butyric Acid\n",
      "Aminomethylcyclohexane\n",
      "2-{4-[(2s)-2-[({[(1s)-1-Carboxy-2-Phenylethyl]Amino}Carbonyl)Amino]-3-Oxo-3-(Pentylamino)Propyl]Phenoxy}Malonic Acid\n",
      "(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid\n",
      "3-O-Methylfructose in Linear Form\n",
      "2-Butyl-5,6-Dihydro-1h-Imidazo[4,5-D]Pyridazine-4,7-Dione\n",
      "Dioxyselenocysteine\n",
      "Methicillin Acyl-Serine\n",
      "2-Deoxy-2-Amino Glucitol-6-Phosphate\n",
      "Glutamine Hydroxamate\n",
      "3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione\n",
      "N-Tridecanoic Acid\n",
      "3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid\n",
      "2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid\n",
      "Thymidine-5'-Triphosphate\n",
      "Trihydroxyantimonite(Iii)\n",
      "5-(6-Amino-9h-Purin-9-Yl)-4-Hydroxytetrahydrofuran-3-Yl Dihydrogen Phosphate\n",
      "Fluoresceinylthioureido\n",
      "Aracytidine 5'-monophosphate\n",
      "Undecyl-Phosphinic Acid Butyl Ester\n",
      "S-(2,4-dinitrophenyl)glutathione\n",
      "4-Guanidinobenzoic Acid\n",
      "Hydrogenobyrinic Acid\n",
      "S-Methyl Phosphocysteine\n",
      "Thiocoumarin\n",
      "2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine\n",
      "Benzylamine\n",
      "Methoxy arachidonyl fluorophosphonate\n",
      "4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid\n",
      "L-methionine (S)-S-oxide\n",
      "12-Phenylheme\n",
      "4,6-dideoxy-4-amino-beta-D-glucopyranoside\n",
      "D-Glycero-D-Mannopyranose-7-Phosphate\n",
      "Nojirimycine Tetrazole\n",
      "6-Hydroxy-7,8-Dihydro Purine Nucleoside\n",
      "6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine\n",
      "Bmsc-0013\n",
      "Deoxyguanidinoproclavaminic acid\n",
      "[Cyclohexylethyl]-[[[[4-[2-Methyl-1-Imidazolyl-Butyl]Phenyl]Acetyl]-Seryl]-Lysinyl]-Amine\n",
      "(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide\n",
      "(S)-4-bromo-3-hydroxy-3-methylbutyl diphosphate\n",
      "N-Benzylformamide\n",
      "Phosphonothreonine\n",
      "Etheno-Nad\n",
      "Cytidine 5'-Diphosphoglycerol\n",
      "Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid\n",
      "2-Hydroxyethyl Disulfide\n",
      "1-(2-Ethanone)-2-Hydroxy-2-(1-Amino-2-Methyl-2-Ethanol)-4-(2-Dimethyl)Ethane-Imidazoline-5-One;Chromophore (Thr-Leu-Gly)\n",
      "9-Methylguanine\n",
      "(Diaminomethyl-Methyl-Amino)-Acetic Acid\n",
      "4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine\n",
      "Ghavamiol\n",
      "Hydantocidin-5'-Phosphate\n",
      "Alpha-Hydroxy-Beta-Phenyl-Propionic Acid\n",
      "9-(4-hydroxybutyl)-N2-phenylguanine\n",
      "1-Deoxy-D-xylulose 5-phosphate\n",
      "L-Alpha-Glycerophosphorylserine\n",
      "Carba-Nicotinamide-Adenine-Dinucleotide\n",
      "Dinor-N(Omega)-Hydroxy-L-Arginine\n",
      "6-(Dihydroxy-Isobutyl)-Thymine\n",
      "N~2~-Succinylarginine\n",
      "8-Hydroxy-2'-Deoxyguanosine\n",
      "4-(Carboxyvin-2-Yl)Phenylboronic Acid\n",
      "[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid\n",
      "N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl)\n",
      "2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid\n",
      "4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One\n",
      "Isopentyl Pyrophosphate\n",
      "Farnesol\n",
      "'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine\n",
      "2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine\n",
      "1,6-Fructose Diphosphate (Linear Form)\n",
      "Thymol\n",
      "(2Z)-3-{[Oxido(oxo)phosphoranyl]oxy}-2-phenylacrylate\n",
      "3-Phosphoglycerol\n",
      "O5'-(4-(3-{2-[2-((R)-3-Hydroxy-4-(Trimethylammonio)-1-Oxo-Butyl)Sulfanyl-Ethylcarbamoyl]-Ethylcarbamoyl}-(R)-3-Hydroxy-2,2-Dimethyl-Propyl)-1-Hydroxy-3-Oxido-1,3-Dioxo-2,4-Dioxa-1,3-Diphosphabut-1-Yl) 3'-Phospho-Adenosine\n",
      "D-Glutamic Acid\n",
      "N-Acetylalanine\n",
      "Indirubin-5-Sulphonate\n",
      "Ditiocarb\n",
      "2,5,7-Trihydroxynaphthoquinone\n",
      "Phosphonopyruvate\n",
      "2-aminooxyethyl-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl]-methyl-sulfonium\n",
      "2',3'-O-{4-[Hydroxy(oxido)-λ5-azanylidene]-2,6-dinitro-2,5-cyclohexadiene-1,1-diyl}adenosine 5'-(tetrahydrogen triphosphate)\n",
      "D-galactohydroximo-1,5-lactam\n",
      "CRA_10655\n",
      "Cyclic Adenosine Monophosphate\n",
      "Tetrazolyl Histidine\n",
      "5-N-Acetyl-4-Amino-6-Diethylcarboxamide-4,5-Dihydro-2h-Pyran-2-Carboxylic Acid\n",
      "gamma-Aminobutyric acid\n",
      "Isobutyric Acid\n",
      "2,4,6-Triaminoquinazoline\n",
      "2-Allylphenol\n",
      "Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide\n",
      "(2r)-2,3-Dihydroxypropanal\n",
      "2-Hydroxy-5-({1-[(4-Methylphenoxy)Methyl]-3-Oxoprop-1-Enyl}Amino)-L-Tyrosine\n",
      "N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide\n",
      "(10S)-10-Formyl-5,8,10-Trideazafolic Acid\n",
      "4-Hydroxybutan-1-Aminium\n",
      "(4s)-5-Fluoro-L-Leucine\n",
      "Pyrrole-2-Carboxylate\n",
      "N-(6-{[3-(4-Bromophenyl)-1,2-Benzisothiazol-6-Yl]Oxy}Hexyl)-N-Methylprop-2-En-1-Amine\n",
      "Fexaramine\n",
      "Vorinostat\n",
      "Guanosine-5'-Diphosphate-Rhamnose\n",
      "D-glucitol 6-phosphate\n",
      "3'-O-Acetylthymidine-5'-Diphosphate\n",
      "8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine\n",
      "6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine\n",
      "Geranyl Diphosphate\n",
      "Glutathionylspermidine Disulfide\n",
      "Sulfoquinovose-Uridine-C1,5'-Diphosphate\n",
      "SP4160\n",
      "D-Phenylalanine\n",
      "Phosphoramidon\n",
      "N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine\n",
      "6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine\n",
      "[(1S)-1-acetamido-2-(4-chlorophenyl)ethyl]-[(2S)-2-amino-3-hydroxy-3-oxo-propoxy]-dihydroxy-boron\n",
      "Beta-D-Fructopyranose\n",
      "Quinonoid 7,8-Tetrahydrobiopterin\n",
      "Hexanoyl-CoA\n",
      "4-Dimethylamino-N-(6-Hydroxycarbamoyethyl)Benzamide-N-Hydroxy-7-(4-Dimethyla Minobenzoyl)Aminoheptanamide\n",
      "8-Hydroxy-4-(1-Hydroxyethyl)Quinoline-2-Carboxylic Acid\n",
      "PD173955\n",
      "Peldesine\n",
      "2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate\n",
      "PD150606\n",
      "2-Amino-6-Oxo-Hexanoic Acid\n",
      "BV4\n",
      "2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate\n",
      "BV2\n",
      "F-Loop of Vitamin B12\n",
      "Mesoheme\n",
      "Glycyl-L-Alpha-Amino-Epsilon-Pimelyl-D-Alanyl-D-Alanine\n",
      "Acrylic Acid\n",
      "Pentaglyme\n",
      "5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid\n",
      "D-(L-a-Aminoadipoyl)-L-Cysteinyl-D-Isodehydrovaline\n",
      "N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine\n",
      "4-(Hydroxymethyl)Benzamidine\n",
      "4,7-Dimethyl-[1,10]Phenanthroline\n",
      "Colforsin\n",
      "Moxalactam Derivative\n",
      "Se-Ethyl-Isoselenourea\n",
      "Abequose\n",
      "5,6-Dimethylbenzimidazole\n",
      "Carbaphosphonate\n",
      "7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid\n",
      "2'-Deoxycytidine\n",
      "Bulgecin A\n",
      "Alpha,Beta-Methyleneadenosine-5'-Triphosphate\n",
      "[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala\n",
      "N-Alpha-Acetyl-3,5-Diiodotyrosylglycine\n",
      "2,6-Diamino-8-Propylsulfanylmethyl-3h-Quinazoline-4-One\n",
      "5-N-Acetyl-3-(1-Ethylpropyl)-1-Cyclohexene-1-Carboxylic Acid\n",
      "4-Hydroxyphenylglycine\n",
      "AL7182\n",
      "1-Amino-6-Cyclohex-3-Enylmethyloxypurine\n",
      "2-Deoxy-Glucose-6-Phosphate\n",
      "2-Butanol\n",
      "Adenosine Phosphonoacetic Acid\n",
      "N-Acetyl-P-Nitrophenylserinol\n",
      "4-Hydroxy-L-Threonine-5-Monophosphate\n",
      "N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide\n",
      "Balanol Analog 1\n",
      "Decylamine-N,N-Dimethyl-N-Oxide\n",
      "1(R)-1-Acetamido-2-(3-Carboxyphenyl)Ethyl Boronic Acid\n",
      "Compound 19\n",
      "FR117016\n",
      "1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane\n",
      "Ethyl Dimethyl Ammonio Propane Sulfonate\n",
      "Bromo-Dodecanol\n",
      "Sp7343-Sp7964\n",
      "Latrunculin A\n",
      "2-(Oxalyl-Amino)-Benzoic Acid\n",
      "Aminophosphonic Acid-Guanylate Ester\n",
      "Homoserine Lactone\n",
      "(2r)-2-{[Formyl(Hydroxy)Amino]Methyl}Hexanoic Acid\n",
      "Phenylferricrocin-Iron\n",
      "4,4'-Biphenyldiboronic Acid\n",
      "1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide\n",
      "Inhibitor Bea403\n",
      "L-xylitol 5-phosphate\n",
      "4-nitrophenyl-beta-D-galactoside\n",
      "Cibacron Blue\n",
      "N-[O-Phosphono-Pyridoxyl]-Isoleucine\n",
      "9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid\n",
      "Oxaloacetate Ion\n",
      "Terlipressin\n",
      "4-methylumbelliferyl α-D-glucoside\n",
      "Fumagillin\n",
      "Heptanamide\n",
      "[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate\n",
      "N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate\n",
      "N-Omega-Propyl-L-Arginine\n",
      "3,4-Epoxybutyl-Alpha-D-Glucopyranoside\n",
      "Nitrosoethane\n",
      "N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide\n",
      "(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium\n",
      "3-Amino-3-Oxopropanoic Acid\n",
      "Tri-Chloro-Acetaldehyde\n",
      "{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)\n",
      "L-[(N-Hydroxyamino)Carbonyl]Phenylalanine\n",
      "6-Hydroxy-Flavin-Adenine Dinucleotide\n",
      "D-Aspartic Acid\n",
      "LY-294002\n",
      "Glucosamine 6-Phosphate\n",
      "2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Allopyranoside\n",
      "Cholic Acid\n",
      "Filaminast\n",
      "Adenosine-5'-Diphosphate-2',3'-Vanadate\n",
      "Novo Nordisk a/S Compound\n",
      "2-Amino-4-(Hydroxymethyl-Phosphinyl)Butanoic Acid\n",
      "1-Butane Boronic Acid\n",
      "(1R,2S)-2-Phenylcyclopropanaminium\n",
      "(C8-R)-Hydantocidin 5'-Phosphate\n",
      "Factor IIIm\n",
      "Je-2147, Ag1776, Kni-764\n",
      "RB106\n",
      "4-Deoxy-Alpha-D-Glucose\n",
      "1-Methylimidazole\n",
      "(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium\n",
      "4-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Butyricacid\n",
      "(4-Hydroxymaltosephenyl)Glycine\n",
      "2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol\n",
      "D-naphthyl-1-acetamido boronic acid alanine\n",
      "2-Deoxy-2-Aminogalactose\n",
      "Cyanamide\n",
      "Dinitrophenylene\n",
      "Meta Vanadate\n",
      "Inhibitor Bea428\n",
      "5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine\n",
      "3-Methylphenylalanine\n",
      "Undecyl-Beta-D-Maltopyranoside\n",
      "2,3-Didehydroalanine\n",
      "S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine\n",
      "NU1025\n",
      "Glycocholic acid\n",
      "(4S,5S)-1,2-dithiane-4,5-diol\n",
      "Pantoyl Adenylate\n",
      "O1-Pentyl-Mannose\n",
      "6-Aminohexyl-Uridine-C1,5'-Diphosphate\n",
      "Hydroxyaminovaline\n",
      "N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid\n",
      "4-Oxoretinol\n",
      "3-Deoxy-D-Glucosamine\n",
      "Nicotinamide\n",
      "XV638\n",
      "Fusidic Acid\n",
      "(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide\n",
      "6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine\n",
      "Mercaptocarboxylate Inhibitor\n",
      "Pentyl Trihydrogen Diphosphate\n",
      "Resveratrol\n",
      "2,3,-Dihydroxybenzoylserine\n",
      "4-{2,6,8-Trioxo-9-[(2S,3R,4R)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate\n",
      "Sorbinil\n",
      "Acetylamino-Acetic Acid\n",
      "3'-Uridinemonophosphate\n",
      "Compound 18\n",
      "7-Methyl-Guanosine-5'-Triphosphate\n",
      "Cellotetraose\n",
      "C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide\n",
      "Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide\n",
      "4-Iodopyrazole\n",
      "4-O-methyl-beta-D-glucuronic acid\n",
      "4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide\n",
      "Delta-2-Albomycin A1\n",
      "2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid\n",
      "2-Phosphoglycolic Acid\n",
      "N-Butyl-N'-Hydroxyguanidine\n",
      "7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester\n",
      "SD146\n",
      "4-Methylthio-Alpha-D-Mannose\n",
      "Ethylmercurithiosalicylic acid\n",
      "Nicotinamide Adenine Dinucleotide Acetone Adduct\n",
      "Purvalanol\n",
      "4-Deoxy-D-Mannuronic Acid\n",
      "2-Amino-3-Oxo-4-Sulfo-Butyric Acid\n",
      "Acetamide\n",
      "Adenosine-5'-Pentaphosphate\n",
      "3-Indolebutyric Acid\n",
      "CD564\n",
      "Kifunensine\n",
      "beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranose\n",
      "RPR131247\n",
      "Uridine\n",
      "Phthalic Acid\n",
      "N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl)Glycyl-L-Arginine-N-Phenylamide\n",
      "Pyromellitic Acid\n",
      "S-(Methylmercury)-L-Cysteine\n",
      "Glycocyamine\n",
      "Tosyl-D-Proline\n",
      "Selenoinosine\n",
      "9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine\n",
      "1-3 Sugar Ring of Pentamannosyl 6-Phosphate\n",
      "1,2,5,6-Tetrahydro-4h-Pyrrolo(3,2,1-Ij)Quinolin-4-One\n",
      "Pyrazole\n",
      "Indolylpropionic Acid\n",
      "4-Methylumbelliferyl Chitobiose\n",
      "1,6-Di-O-Phosphono-D-Allitol\n",
      "S-Mercaptocysteine\n",
      "RU79072\n",
      "5-Mercapto-2-Nitro-Benzoic Acid\n",
      "R-9-(2-hydroxypropyl)adenine\n",
      "(3r)-3-{[(Benzyloxy)Carbonyl]Amino}-2-Oxo-4-Phenylbutane-1-Diazonium\n",
      "3-Hydroxy-Myristic Acid\n",
      "Tert-Butyloxycarbonyl Group\n",
      "7-Alpha-D-Ribofuranosyl-2-Aminopurine-5'-Phosphate\n",
      "Sucrose\n",
      "(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid\n",
      "1,3-Propandiol\n",
      "1-Hexadecanosulfonic Acid\n",
      "Diundecyl Phosphatidyl Choline\n",
      "2,5-Anhydroglucitol-1,6-Biphosphate\n",
      "Dodecane-Trimethylamine\n",
      "Beta-3-Cysteine\n",
      "4-{(Z)-[2-[3-(Methylsulfanyl)Propanoyl]-5-Oxo-1-(2-Oxoethyl)-1,5-Dihydro-4h-Imidazol-4-Ylidene]Methyl}Benzenolate\n",
      "4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate\n",
      "N-[4-(2-{2-[3-(2-Bromo-Acetylamino)-Propionylamino]-3-Hydroxy-Propionylamino}-Ethyl)-Phenyl]-Oxalamic Acid\n",
      "N-[2(S)-Cyclopentyl-1(R)-Hydroxy-3(R)Methyl]-5-[(2(S)-Tertiary-Butylamino-Carbonyl)-4-(N1-(2)-(N-Methylpiperazinyl)-3-Chloro-Pyrazinyl-5-Carbonyl)-Piperazino]-4(S)-Hydroxy-2(R)-Phenylmethyl-Pentanamide\n",
      "2-Anhydro-3-Fluoro-Quinic Acid\n",
      "N-Acetylmannosaminitol\n",
      "(S)-acetoin\n",
      "Pregnenolone\n",
      "Phenyl-Uridine-5'-Diphosphate\n",
      "Deglucobalhimycin\n",
      "Isochorismic Acid\n",
      "N-[5'-O-Phosphono-Ribofuranosyl]-2-[2-Hydroxy-2-[4-[Glutamic Acid]-N-Carbonylphenyl]-3-[2-Amino-4-Hydroxy-Quinazolin-6-Yl]-Propanylamino]-Acetamide\n",
      "P-Anisic Acid\n",
      "9-Deazainosine\n",
      "3-Nitrophenylboronic Acid\n",
      "Alpha-Methylene Adenosine Monophosphate\n",
      "N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide\n",
      "5-Hydroxymethylene-6-Hydrofolic Acid\n",
      "2,3 -Anhydro-Quinic Acid\n",
      "5-Aminocarbonyl-3-Nitrophenyl-Alpha-D-Galactopyranose\n",
      "3-Phenyl-1,2-Propandiol\n",
      "A-98881\n",
      "Uracil arabinose-3'-phosphate\n",
      "2-Methoxyethanol\n",
      "3-deoxy-D-lyxo-hexonic acid\n",
      "Trifluorofurnesyl Diphosphate\n",
      "Brodimoprim-4,6-Dicarboxylate\n",
      "N-(2-Acetamido)Iminodiacetic Acid\n",
      "Diethylphosphono Group\n",
      "(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide\n",
      "2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone\n",
      "3'-Deazo-Thiamin Diphosphate\n",
      "7-(1-Methyl-1,2,3-Triazol-4-Yl)-6-Formyl-2,7-Dihydro-[1,4]Thiazepine-3-Carboxylic Acid, Brl42715, C6-(N1-Methyl-1,2,3-Triazolylmethylene)Penem\n",
      "5-Exo-Hydroxycamphor\n",
      "Iodo-Willardiine\n",
      "Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester\n",
      "1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct\n",
      "Canaline\n",
      "Para-Bromobenzyl Alcohol\n",
      "Phosphonoacetic Acid\n",
      "N-Pyridoxyl-Glycine-5-Monophosphate\n",
      "Methylphosphonic Acid Ester Group\n",
      "7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid\n",
      "5-Fluorolevulinic Acid\n",
      "4-(Acetylamino)-3-[(Aminoacetyl)Amino]Benzoic Acid\n",
      "FR236913\n",
      "Dihydrogenphosphate Ion\n",
      "Siroheme\n",
      "[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine\n",
      "IDD552\n",
      "Alpha-D-Glucose 1,6-Bisphosphate\n",
      "Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate\n",
      "O4-Sulfonylgalactose\n",
      "3,4-Dihydro-2h-Pyrrolium-5-Carboxylate\n",
      "2,4-Dihydroxybenzoic Acid\n",
      "4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid\n",
      "[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid\n",
      "9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide\n",
      "alpha-D-glucose-1-phosphate\n",
      "S-Adenosyl-1,8-Diamino-3-Thiooctane\n",
      "Methylphosphinic Acid\n",
      "L-thioproline\n",
      "(2s,3r)-1-Amino-2-Methylbutane-2,3-Diol\n",
      "{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol\n",
      "N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate\n",
      "(1-Tert-Butyl-5-Hydroxy-1h-Pyrazol-4-Yl)-(6-Methanesulfonyl-4'-Methoxy-2-Methyl-Biphenyl-3-Yl)-Methanone\n",
      "Thiocamphor\n",
      "Domoic Acid\n",
      "D-Proline\n",
      "Aetiocholanolone\n",
      "N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline\n",
      "Methyl-Carbamic Acid Ethyl Ester\n",
      "Guanosine\n",
      "3-(4-Benzenesulfonyl-Thiophene-2-Sulfonylamino)-Phenylboronic Acid\n",
      "Soraphen A\n",
      "Calyculin A\n",
      "4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide\n",
      "Gluco-Phenylimidazole\n",
      "Biliverdin Ix Gamma Chromophore\n",
      "Glucosamine 4-Phosphate\n",
      "Dansylamide\n",
      "D-Mannose 1-Phosphate\n",
      "3''-(Beta-Chloroethyl)-2'',4''-Dioxo-3, 5''-Spiro-Oxazolidino-4-Deacetoxy-Vinblastine\n",
      "3-amino-5-phenylpentane\n",
      "N-Allyl-Aniline\n",
      "3-Butylthiolane 1-Oxide\n",
      "Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone\n",
      "1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One\n",
      "CRA_1802\n",
      "3-(4-Carbamoyl-1-Carboxy-2-Methylsulfonyl-Buta-1,3-Dienylamino)-Indolizine-2-Carboxylic Acid\n",
      "Arotinoid acid\n",
      "3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid\n",
      "2,3-Di-O-Sulfo-Alpha-D-Glucopyranose\n",
      "N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide\n",
      "4-(4-Hydroxy-3-Isopropylphenylthio)-2-Isopropylphenol\n",
      "Cyanocinnoline\n",
      "2',3'-Dideoxycytidine-5'-Monophosphate\n",
      "Beta-Cyclohexyl-Alanine\n",
      "4-Imino-5-Methidyl-2-Trifluoromethylpyrimidine\n",
      "2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate\n",
      "FKB-001\n",
      "4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose\n",
      "6-Hydroxyuridine-5'-Phosphate\n",
      "Tricyclazole\n",
      "L-2-Amino-6-Methylene-Pimelic Acid\n",
      "D-Methionine\n",
      "Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester\n",
      "3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol\n",
      "Methylthioinosine\n",
      "Acetylphosphate\n",
      "5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone\n",
      "N-Carboxymethionine\n",
      "alpha-D-mannose 6-phosphate\n",
      "Stanolone\n",
      "3'-Phosphate-Adenosine-5'-Phosphate Sulfate\n",
      "BV3\n",
      "Beta-3-Serine\n",
      "Phosphoric Acid Mono-[3,4-Dihydroxy-5-(5-Hydroxy-Benzoimidazol-1-Yl)Tetrahydro-Furan-2-Ylmethyl] Ester\n",
      "(2s,4s)-Alpha-Campholinic Acid\n",
      "2-Amino-Vinyl-Phosphate\n",
      "RU78783\n",
      "5-(2-Chlorophenyl)Furan-2-Carboxylic Acid\n",
      "Octanoyl-Coenzyme A\n",
      "2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine\n",
      "Propanoyl-CoA\n",
      "(6e)-6-[(2e,4e,6e)-3,7-Dimethylnona-2,4,6,8-Tetraenylidene]-1,5,5-Trimethylcyclohexene\n",
      "4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine\n",
      "[(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate\n",
      "N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide\n",
      "6-(4-Difluoromethoxy-3-Methoxy-Phenyl)-2h-Pyridazin-3-One\n",
      "2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine\n",
      "Zn(Ii)-(20-Oxo-Protoporphyrin Ix)\n",
      "(South)-Methanocarba-Thymidine\n",
      "Hexafluoroacetone Hydrate\n",
      "Biphenyl-2,3-Diol\n",
      "(4R)-limonene 1α,2α-epoxide\n",
      "Piretanide\n",
      "Mixed Carbamic Phosphoric Acid Anhydride of 7,8-Diaminononanic Acid\n",
      "3-Amino-6-Hydroxy-Tyrosine\n",
      "K201\n",
      "Adenosine 5'-[γ-thio]triphosphate\n",
      "Coa-S-Acetyl Tryptamine\n",
      "(R)-Bicalutamide\n",
      "5'-Deoxy-5'-(Methylthio)-Tubercidin\n",
      "9-(6-deoxy-alpha-L-talofuranosyl)-6-methylpurine\n",
      "Diglyme\n",
      "4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid\n",
      "Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate\n",
      "Heptanoic Acid\n",
      "(4s)-2-[(1e)-1-Aminoprop-1-Enyl]-4,5-Dihydro-1,3-Thiazole-4-Carboxylic Acid\n",
      "3-(1-Aminoethyl)Nonanedioic Acid\n",
      "Inositol 1,3-Bisphosphate\n",
      "N-(4-Aminobutanoyl)-S-(4-Methoxybenzyl)-L-Cysteinylglycine\n",
      "alpha-L-iduronic acid\n",
      "Carpropamide\n",
      "2-Fluoro-2'-Deoxyadenosine\n",
      "Fosmidomycin\n",
      "2-Acetyl-Protoporphyrin Ix\n",
      "Hymenialdisine\n",
      "3-Hydroxypyruvic Acid\n",
      "Alpha-Aminoisobutyric Acid\n",
      "2-Thiomethyl-3-Phenylpropanoic Acid\n",
      "(Carboxyhydroxyamino)Ethanoic Acid\n",
      "Ricinoleic Acid\n",
      "Pentasulfide-Sulfur\n",
      "Orotidine-5'-Monophosphate\n",
      "Selenomethionine Selenoxide\n",
      "Oxitriptan\n",
      "1-Carboxyethylaminomethyl-4-Aminomethylbenzene\n",
      "Rhamnose\n",
      "Benzimidazole\n",
      "(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine\n",
      "8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One\n",
      "Ndelta-(N'-Sulphodiaminophosphinyl)-L-Ornithine\n",
      "Fluoro-Willardiine\n",
      "N-Ethylmaleimide\n",
      "Penicillin G Acyl-Serine\n",
      "4-Methyl-5-Hydroxyethylthiazole\n",
      "2-Propyl-Aniline\n",
      "2-Amino-4-(2-Amino-Ethoxy)-Butyric Acid\n",
      "1-Benzyl-(R)-Propylamine\n",
      "4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide\n",
      "4-(4-Chlorophenyl)Imidazole\n",
      "GE-2270A\n",
      "Uridine-5'-monophosphate 2-deoxy-2-fluoro-galactopyranosyl-monophosphate ester\n",
      "PNU177836\n",
      "Beta-Hydroxyleucine\n",
      "N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane\n",
      "Thymidine-5'-(Dithio)Phosphate\n",
      "Vitamin B6 Complexed with 2-Amino-Hexanoic Acid\n",
      "Bombykol\n",
      "Para-Mercury-Benzenesulfonic Acid\n",
      "4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline\n",
      "8-Iodo-Guanine\n",
      "N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide\n",
      "Cysteine-S-Acetamide\n",
      "Imino-Tryptophan\n",
      "CRA_10972\n",
      "C16-Fatty-Acyl-Substrate-Mimic\n",
      "S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea\n",
      "1-Deoxy-6-O-Phosphono-1-[(Phosphonomethyl)Amino]-L-Threo-Hexitol\n",
      "8-Methyl-9-Oxoguanine\n",
      "Cacodylic acid\n",
      "Cyclohexylammonium Ion\n",
      "2-(Thiomethylene)-4-Methylpentanoic Acid\n",
      "Methyltrienolone\n",
      "Quisqualate\n",
      "S-9-(2-hydroxypropyl)adenine\n",
      "Peridinin\n",
      "p-Iodophenol\n",
      "Glutathione Sulfonic Acid\n",
      "1-[(1s)-Carboxy-2-(Methylsulfinyl)Ethyl]-(3r)-[(5s)-5-Amino-5-Carboxypentanamido]-(4r)-Sulfanylazetidin-2-One\n",
      "3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium\n",
      "Arsanilic acid\n",
      "9r,13r-Opda\n",
      "5-fluoro-beta-L-gulosyl fluoride\n",
      "2-[(2-Oxo-2-Piperidin-1-Ylethyl)Thio]-6-(Trifluoromethyl)Pyrimidin-4(1h)-One\n",
      "Patupilone\n",
      "Adenosine-5'-(Dithio)Phosphate\n",
      "Phenylalanine-N-Sulfonamide\n",
      "Di(N-Acetyl-D-Glucosamine)\n",
      "6-Hydroxy-1,6-Dihydro Purine Nucleoside\n",
      "CRA_1801\n",
      "Lauric Acid\n",
      "3,4-Dimethylaniline\n",
      "4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine\n",
      "5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide\n",
      "Ulapualide A\n",
      "3-{2,6,8-trioxo-9-[(2R,3S,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate\n",
      "1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine\n",
      "2-Methyl-3-(2-Aminothiazolo)Propanal\n",
      "(S)-oct-1-en-3-ol\n",
      "Phosphoglycolohydroxamic Acid\n",
      "1h-Benoximidazole-2-Carboxylic Acid\n",
      "4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole\n",
      "Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide\n",
      "S-Octylglutathione\n",
      "1-Methyloxy-4-Sulfone-Benzene\n",
      "D-Levofloxacin\n",
      "1,8-Di-Hydroxy-4-Nitro-Anthraquinone\n",
      "Oxidized Acetyl Dithranol\n",
      "LY341770\n",
      "4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide\n",
      "Nitrilotriacetic Acid\n",
      "UDP-alpha-D-glucuronic acid\n",
      "5-Phosphoarabinonic Acid\n",
      "(S)-2-Amino-3-(6h-Selenolo[2,3-B]-Pyrrol-4-Yl)-Propionic Acid\n",
      "1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea\n",
      "Pantothenyl-Aminoethanol-Acetate Pivalic Acid\n",
      "7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide\n",
      "L-Alpha-Phosphatidyl-Beta-Oleoyl-Gamma-Palmitoyl-Phosphatidylethanolamine\n",
      "6-Carboxymethyluracil\n",
      "S-Selanyl Cysteine\n",
      "Tetrahydrofuran-2-Carboxylic Acid\n",
      "Dazoxiben\n",
      "1-Aminocyclopropylphosphonate\n",
      "Bromoform\n",
      "4-Piperidino-Piperidine\n",
      "Malonaldehyde\n",
      "2-Aminobenzyl alcohol\n",
      "Acetoacetyl-CoA\n",
      "Sri-9662\n",
      "(R)-N-(1-Methyl-Hexyl)-Formamide\n",
      "(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone\n",
      "N-(1-Benzyl-3-{[3-(1,3-Dioxo-1,3-Dihydro-Isoindol-2-Yl)-Propionyl]-[2-(Hexahydro-Benzo[1,3]Dioxol-5-Yl)-Ethyl]-Amino}-2-Hydroxy-Propyl)-4-Benzyloxy-3,5-Dimethoxy-Benzamide\n",
      "3-Decyl-2,5-Dioxo-4-Hydroxy-3-Pyrroline\n",
      "7-Nitroindazole-2-Carboxamidine\n",
      "D-Lactic acid\n",
      "4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid\n",
      "Zebularine\n",
      "Cytidine-5'-Diphospho-Beta-D-Xylose\n",
      "Selenazole-4-Carboxyamide-Adenine Dinucleotide\n",
      "4-Methylidene-5-One\n",
      "2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone\n",
      "3-Methoxybenzamide\n",
      "7-Deaza-7-Cyano-Guanine\n",
      "(Diphosphono)Aminophosphonic Acid\n",
      "AHA047\n",
      "3-Amino-4-{3-[2-(2-Propoxy-Ethoxy)-Ethoxy]-Propylamino}-Cyclobut-3-Ene-1,2-Dione\n",
      "PASBN\n",
      "Alpha-Ribazole-5'-Phosphate Derivative\n",
      "Crc200 (Chiron-Behring)\n",
      "6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide\n",
      "IC261\n",
      "Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine\n",
      "Glycolic acid\n",
      "N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide\n",
      "2-(Sec-Butyl)Thiazole\n",
      "Pidolic Acid\n",
      "Ethylaminobenzylmethylcarbonyl Group\n",
      "4-Amido-4-Carbamoyl-Butyric Acid\n",
      "5-Hydroxymethyl-Chonduritol\n",
      "8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine\n",
      "3,5-Dihydro-5-Methylidene-4h-Imidazol-4-On\n",
      "Tetramethylammonium Ion\n",
      "N-Aminoethylmorpholine\n",
      "Pmp-Hydroxyisoxazole, Pyridoxamine-5-Phosphate-Hydroxyisoxazole\n",
      "[Methylseleno]Acetate\n",
      "5-Amino 6-Nitro Uracil\n",
      "6-Nitroindazole\n",
      "Ribose-1-Phosphate\n",
      "2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid\n",
      "Thymidine-5'- Diphosphate\n",
      "RU82129\n",
      "5-Hydroxy Norvaline\n",
      "scyllo-inositol\n",
      "Beta-Alanine\n",
      "4-phospho-D-erythronic acid\n",
      "N-Acetyl-D-Allosamine\n",
      "2-Chlorophenol\n",
      "Glucosamine 1-Phosphate\n",
      "6-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Hexanoic Acid\n",
      "3-Fluoro-2-(Phosphonooxy)Propanoic Acid\n",
      "PAS219\n",
      "5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide\n",
      "5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate\n",
      "2-Carboxypropyl-Coenzyme A\n",
      "1-(5-Chloroindol-3-Yl)-3-Hydroxy-3-(2h-Tetrazol-5-Yl)-Propenone\n",
      "Para-Toluene Sulfonate\n",
      "(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid\n",
      "5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid\n",
      "2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Mant-Adp\n",
      "Benzamidine\n",
      "Acetylcholine\n",
      "[3-(1,3,2-Dioxaborolan-2-Yloxy)Propyl]Guanidine\n",
      "S-P-Nitrobenzyloxycarbonylglutathione\n",
      "3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid\n",
      "2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole\n",
      "2-Aminopimelic Acid\n",
      "[2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid\n",
      "4-Iodobenzo[B]Thiophene-2-Carboxamidine\n",
      "8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine\n",
      "Perchlorate\n",
      "6-[5-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Pentanoylamino]-Hexanoic Acid\n",
      "4-Carboxyphenylboronic Acid\n",
      "3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril\n",
      "Alpha-L-Arabinose\n",
      "Nonan-1-Ol\n",
      "N-Omega-Hydroxy-L-Arginine\n",
      "4-Methyl-5-Hydroxyethylthiazole Phosphate\n",
      "2-deazo-6-thiophosphate guanosine-5'-monophosphate\n",
      "Flavin adenine dinucleotide\n",
      "Phosphomethylphosphonic Acid Adenosyl Ester\n",
      "2',3'-Dideoxythymidine-5'-Monophosphate\n",
      "(Mu-4-Sulfido)-Tetra-Nuclear Copper Ion\n",
      "B-2-Octylglucoside\n",
      "3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol\n",
      "{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid\n",
      "1-(2-Deoxy-2-Fluoro-3-O-Phosphono-Beta-L-Ribofuranosyl)Pyrimidine-2,4(1h,3h)-Dione\n",
      "D-Glucuronic Acid\n",
      "N,O-Didansyl-L-Tyrosine\n",
      "D-Myo-Inositol-1,4-Bisphosphate\n",
      "CRA_8696\n",
      "N-Pyridoxyl-7-Keto-8-Aminopelargonic Acid-5'-Monophosphate\n",
      "Thymidine-5'-Diphospho-Beta-D-Xylose\n",
      "4-Hydroxy-1,2,5-Thiadiazole-3-Carboxylic Acid\n",
      "2-oxopropyl-CoM\n",
      "6-Amino-1-Methylpurine\n",
      "2-Dimethylamino-Ethyl-Diphosphate\n",
      "Acetic acid\n",
      "Pentabromophenol\n",
      "Nicotinamide Adenine Dinucleotide Cyclohexanone\n",
      "(S)-Hmg-Coa\n",
      "Dephospho Coenzyme A\n",
      "Indole-3-Propanol Phosphate\n",
      "Tubercidin\n",
      "CRA_10433\n",
      "Phosphonoacetaldehyde\n",
      "Propyl alcohol\n",
      "KB-141\n",
      "5-methylbenzimidazole\n",
      "Guanosine-2',3'-Cyclophosphorothioate\n",
      "Sinapoyl Coenzyme A\n",
      "4,5-Dimethyl-1,2-Phenylenediamine\n",
      "2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione\n",
      "Alpha-Fluoro-Carboxymethyldethia Coenzyme a Complex\n",
      "1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester\n",
      "5-Amino-3-Methyl-Pyrrolidine-2-Carboxylic Acid\n",
      "1-Beta-Ribofuranosyl-1,3-Diazepinone\n",
      "U-Pi-a-Pi\n",
      "6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid\n",
      "Cu-Cyclam\n",
      "N-Octanoyl-B-D-Fructofuranosyl-a-D-Glucopyranoside,Sucrose Monocaproylate\n",
      "3-Oxiran-2ylalanine\n",
      "3r-Hydroxydecanoyl-Coa\n",
      "Stearic acid\n",
      "beta-L-methyl-fucose\n",
      "Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester\n",
      "4-Nitrophenyl-Ara\n",
      "6-Hydroxymethylpterin\n",
      "Thio-Maltohexaose\n",
      "4-Methoxy-E-Rhodomycin T\n",
      "7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate\n",
      "D-Cysteine\n",
      "2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide\n",
      "Sphingosine\n",
      "5-(Aminomethyl)-2-Methylpyrimidin-4-Amine\n",
      "Pyrroloquinoline Quinone\n",
      "Duvoglustat\n",
      "2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid\n",
      "Beta-1,2,3,4,6-Penta-O-Galloyl-D-Glucopyranose\n",
      "Oteracil\n",
      "4-Aminohydrocinnamic Acid\n",
      "(3-Formyl-but-3-Enyl)-Phosphonic Acid\n",
      "4-Deoxyglucarate\n",
      "Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone\n",
      "Vinylglycine\n",
      "(2s,5s)-5-Carboxymethylproline\n",
      "(1'r,2's)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-Yl)Adenine\n",
      "DPI59\n",
      "N-Acetyl-N'-Beta-D-Glucopyranosyl Urea\n",
      "11-Deoxy-Beta-Rhodomycin\n",
      "FR233623\n",
      "AL7099A\n",
      "dATP\n",
      "Diphthamide\n",
      "2-Formyl-Protoporphryn Ix\n",
      "D-Tryptophan\n",
      "Trifluoroethanol\n",
      "Nicotinamide Mononucleotide\n",
      "5-[Bis-2(Chloro-Ethyl)-Amino]-2,4-Dintro-Benzamide\n",
      "2-Oxo-4-Methylpentanoic Acid\n",
      "Adenosine-5'-Propylphosphate\n",
      "3-(5-Amino-7-oxo-3,7-dihydro-2H-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(2-{[2-(hydroxymethyl)phenyl]sulfanyl}benzyl)benzamide\n",
      "2-[(2e,6e,10e,14e,18e,22e,26e)-3,7,11,15,19,23,27,31-Octamethyldotriaconta-2,6,10,14,18,22,26,30-Octaenyl]Phenol\n",
      "Phosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester\n",
      "(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone\n",
      "N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(alpha-D-galactopyranosyloxy)-5-nitrobenzamide\n",
      "(2s)-4-(Beta-Alanylamino)-2-Aminobutanoic Acid\n",
      "2,3-Dihydroxy-5-Oxo-Hexanedioate\n",
      "3,5-Difluoroaniline\n",
      "3',5'-Dinitro-N-Acetyl-L-Thyronine\n",
      "(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid\n",
      "1-Amino-1-Carbonyl Pentane\n",
      "P-Aminophenyl-Alpha-D-Galactopyranoside\n",
      "4-Fluorobenzylamine\n",
      "(S)-2-[4-(Aminomethyl)-1h-1,2,3-Triazol-1-Yl]-4-Methylpentanoic Acid\n",
      "S-4-Nitrobutyryl-Coa\n",
      "Beta-L-Arabinose\n",
      "Flavin mononucleotide\n",
      "2-(Phosphonooxy)Butanoic Acid\n",
      "2'-O-Methyl-3'-Methyl-3'-Deoxy-Arabinofuranosyl-Thymine-5'-Phosphate\n",
      "2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole\n",
      "RWJ-51084\n",
      "D-Lysine\n",
      "(2s)-Pyrrolidin-2-Ylmethylamine\n",
      "4-Phenyl-1h-Imidazole\n",
      "Phenol\n",
      "(6R)-Folinic acid\n",
      "5-[1-(Acetylamino)-3-Methylbutyl]-2,5-Anhydro-3,4-Dideoxy-4-(Methoxycarbonyl)Pentonic Acid\n",
      "2'-Deoxycytidine 5'-triphosphate\n",
      "2',6'-Dichloro-Biphenyl-2,6-Diol\n",
      "1,6-Diaminohexane\n",
      "Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]\n",
      "Thiocellobiose\n",
      "Dodecyl-Coa\n",
      "Glutaral\n",
      "1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine\n",
      "RU82197\n",
      "4,6-Dideoxy-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino}hexopyranose\n",
      "2,6-Difluorobenzenesulfonamide\n",
      "4-Bromo-3-(5'-Carboxy-4'-Chloro-2'-Fluorophenyl)-1-Methyl-5-Trifluoromethyl-Pyrazol\n",
      "3'-Oxo-Adenosine\n",
      "2'-5'dideoxyuridine\n",
      "2-Amino-3-Mercapto-Propionamide\n",
      "4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid\n",
      "alpha-maltotriose\n",
      "D-Treitol\n",
      "Dodecyl-Alpha-D-Maltoside\n",
      "P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate\n",
      "2'-Deoxymaltose\n",
      "beta-L-fucose\n",
      "2,6-Anhydro-3-Deoxy-D-Erythro-Hex-2-Enonic Acid\n",
      "2',4,4'-Trihydroxychalcone\n",
      "C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide\n",
      "4-(2-Amino-Ethoxy)-2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-but-3-Enoic Acid\n",
      "5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide\n",
      "Thiarsa Dihydroxy Cysteine\n",
      "L-naphthyl-1-acetamido boronic acid alanine\n",
      "4-Deoxy-4-Amino-Beta-D-Glucose\n",
      "3-Phosphono-D-alanine\n",
      "9-Methyl Uric Acid\n",
      "1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide\n",
      "Glutathionylspermidine\n",
      "Lactose Sialic Acid\n",
      "Benzylsulfinic Acid\n",
      "Phenylphosphate\n",
      "N-Succinyl Phenylglycine\n",
      "Pterin Cytosine Dinucleotide\n",
      "2-Allyl-6-Methyl-Phenol\n",
      "4,5,6,7-Tetrachloro-3h-Isobenzofuran-1-One\n",
      "3-deoxy-D-arabino-hexonic acid\n",
      "7-Deaza-7-Aminomethyl-Guanine\n",
      "N5-Iminoethyl-L-Ornithine\n",
      "RU78300\n",
      "4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide\n",
      "L-Leucyl-Hydroxylamine\n",
      "N-Cyclohexyltaurine\n",
      "Glutathione disulfide\n",
      "3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide\n",
      "Brivudine\n",
      "Cephalosporin C\n",
      "Fluorotryptophane\n",
      "Guanosine 3'-monophosphate\n",
      "1,4-Diethylene Dioxide\n",
      "Heme C\n",
      "6-Hydro-1-Methyladenosine-5'-Monophosphate\n",
      "(S)-ATPA\n",
      "3-Amino-Alanine\n",
      "4-Amino-2-Deoxy-2,3-Dehydro-N-Neuraminic Acid\n",
      "1-(Isopropylamino)-3-(1-Naphthyloxy)-2-Propanol\n",
      "Maltose\n",
      "Tyrosyladenylate\n",
      "deoxycytidylyl-3',5'-guanosine\n",
      "{1-[(3-Hydroxy-Methyl-5-Phosphonooxy-Methyl-Pyridin-4-Ylmethyl)-Amino]-Ethyl}-Phosphonic Acid\n",
      "dioxothiomolybdenum(VI) ion\n",
      "2-Pyridinethiol\n",
      "S-(N-Hydroxy-N-Iodophenylcarbamoyl)Glutathione\n",
      "N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine\n",
      "5,6-Cyclic-Tetrahydropteridine\n",
      "(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester\n",
      "1-Bromopropane-2-Ol\n",
      "BIA\n",
      "1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea\n",
      "Heptyl-Beta-D-Glucopyranoside\n",
      "3-Iodo-Benzyl Alcohol\n",
      "3-[(1-Amino-2-Carboxy-Ethyl)-Hydroxy-Phosphinoyl]-2-Methyl-Propionic Acid\n",
      "Coa-S-Acetyl 5-Bromotryptamine\n",
      "4-(Acetylamino)-3-Guanidinobenzoic Acid\n",
      "Malate Like Intermediate\n",
      "Inositol-(1,3,4,5,6)-Pentakisphosphate\n",
      "Beta-Mercaptoethanol\n",
      "3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol\n",
      "Triethyl Phosphate\n",
      "Huperzine B\n",
      "8-Bromo-Adenosine-5'-Monophosphate\n",
      "Cobalt Hexammine Ion\n",
      "Sri-9439\n",
      "S-Arsonocysteine\n",
      "2-Iminobiotin\n",
      "2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole\n",
      "5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine\n",
      "(S)-Mandelic acid\n",
      "7n-Methyl-8-Hydroguanosine-5'-Triphosphate\n",
      "M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene\n",
      "N-Acetylproline\n",
      "2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate\n",
      "N-Dimethyl-Lysine\n",
      "3-Acetylpyridine Adenine Dinucleotide\n",
      "N-Carbamyl-D-Methionine\n",
      "4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline\n",
      "Imidazole\n",
      "PF-00356231\n",
      "5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione\n",
      "9-Aminophenanthrene\n",
      "FR239087\n",
      "Modified Ribosylated Glutamyl Ester\n",
      "3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One\n",
      "ZK-806711\n",
      "3,5-Diiodotyrosine\n",
      "'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine\n",
      "4-Amino-1-[(1s,3r,4r,7s)-7-Hydroxy-1-(Hydroxymethyl)-2,5-Dioxabicyclo[2.2.1]Hept-3-Yl]-5-Methylpyrimidin-2(1h)-One\n",
      "2-Carboxyethylphosphonic Acid\n",
      "L-Tyrosinamide\n",
      "Hexadecanal\n",
      "S-oxy-L-cysteine\n",
      "5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide\n",
      "Fica\n",
      "4-Methylimidazole\n",
      "4-Fluorotryptophane\n",
      "N-Hydroxy-N-Isopropyloxamic Acid\n",
      "3-[(2,4-Dichlorobenzoyl)(Isopropyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid\n",
      "alpha-D-Xylopyranose\n",
      "N-Propyl-Tartramic Acid\n",
      "Chromophore (Met-Tyr-Gly)\n",
      "(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester\n",
      "(3s,6s,9r,10r,11s,12s,13e,15e,18s,21s)-18-{(1e,3e,7s,8s)-9-[(2s,3r,4s,5s,6r,9s,11s)-9-Ethyl-4-Hydroxy-3,5,11-Trimethyl-8-Oxo-1-Oxa-7-Azaspiro[5.5]Undec-2-Yl]-8-Hydroxy-1,7-Dimethylnona-1,3-Dienyl}-10,12-Dihydroxy-3-(3-Hydroxybenzyl)-6-Isopropyl-11-Methyl-\n",
      "Enalkiren\n",
      "(E)-(2r,3r,4s,5r)-3,4,5-Trihydroxy-2-Methoxy-8,8-Dimethyl-Non-6-Enoic Acid ((3s,6r)-6-Hydroxy-2-Oxo-Azepan-3-Yl)-Amide\n",
      "Uridine-Diphosphate-N-Acetylglucosamine\n",
      "Ethyl Isocyanide\n",
      "3-(P-Tolyl)Propionic Acid\n",
      "1D-myo-inositol 1,4,5-trisphosphate\n",
      "1,2-Di-1-(3,7,11,15-Tetramethyl-Hexadecane)-Sn-Glycero-3-Phosphate\n",
      "Cytidine-5'-Monophosphate\n",
      "N2-[(Benzyloxy)carbonyl]-N-[(3R)-1-{N-[(benzyloxy)carbonyl]-L-leucyl}-4-oxo-3-pyrrolidinyl]-L-leucinamide\n",
      "O1-Methyl-4-Deoxy-4-Thio-Alpha-D-Glucose\n",
      "4-Nitrocatechol\n",
      "gamma-Glutamylcysteine\n",
      "Octahydroindole-2-Carboxylic Acid\n",
      "4-hydroxycoumarin\n",
      "2-Hydroxymethyl-Pyrrolidine-3,4-Diol\n",
      "6-hydroxy-L-norleucine\n",
      "Deoxyuridine-5'-Diphosphate\n",
      "5-Thio-a/B-D-Mannopyranosylamine\n",
      "3-Thiaoctanoyl-Coenzyme A\n",
      "Thiamine(1+) monophosphate\n",
      "1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid\n",
      "Diacetyldeuteroheme\n",
      "Uracil\n",
      "2,4-Deoxy-4-Guanidino-5-N-Acetyl-Neuraminic Acid\n",
      "2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione\n",
      "1,3-Thiazole-4-Carboxylic Acid\n",
      "S-Adenosyl-L-Homoselenocysteine\n",
      "Ubenimex\n",
      "2s,4r-4-Methylglutamate\n",
      "Digalactosyl Diacyl Glycerol (Dgdg)\n",
      "Delta-(L-Alpha-Aminoadipoyl)-L-Cysteinyl-D-Vinylglycine\n",
      "SU9516\n",
      "Cardiolipin\n",
      "(2s)-Hydroxy(4-Hydroxyphenyl)Ethanenitrile\n",
      "Beta-Amino Isobutyrate\n",
      "{3-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-2-Methyl-Propyl}-Phosphonic Acid\n",
      "3[N-Morpholino]Propane Sulfonic Acid\n",
      "Uridine-5'-Diphosphate\n",
      "Gallichrome\n",
      "2-{1-[2-(2-Amino-Thiazol-4-Yl)-2-Methoxyimino-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid\n",
      "Lysophosphatidylglycerol\n",
      "4,6-dideoxy-4-amino-alpha-D-glucose\n",
      "N-Hexadecanoylglycine\n",
      "2-Benzyl-3-Iodopropanoic Acid\n",
      "2-[5-Hydroxy-3-Methyl-1-(2-Methyl-4-Sulfo-Phenyl)-1h-Pyrazol-4-Ylazo]-4-Sulfo-Benzoic Acid\n",
      "Bis(5-Amidino-Benzimidazolyl)Methanone Zinc\n",
      "(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime\n",
      "(3S)-3-(dioxidosulfanyl)-N-[(1E)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine\n",
      "3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside\n",
      "Uridylyl-2'-5'-Phospho-Adenosine\n",
      "2'-Deoxyuridine 3'-Monophosphate\n",
      "N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine\n",
      "Cephalothin Group\n",
      "1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3\n",
      "3-Trimethylsilylsuccinic Acid\n",
      "(R)—N[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester\n",
      "3-methyl-benzene-1,2-diol\n",
      "(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid\n",
      "N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide\n",
      "N(4)-adenosyl-N(4)-methyl-2,4-diaminobutanoic acid\n",
      "Sparfosic acid\n",
      "Violaxanthin\n",
      "2'-Monophosphoadenosine 5'-Diphosphoribose\n",
      "Thymine\n",
      "Formycin-5'-Monophosphate\n",
      "BMS184394\n",
      "Naringenin\n",
      "1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide\n",
      "Heme D\n",
      "Trypanothione\n",
      "6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid\n",
      "Cyclohexyl-Hexyl-Beta-D-Maltoside\n",
      "N5-Methylglutamine\n",
      "Reactive Red 1 Dye\n",
      "1-[4-Carboxy-2-(3-Pentylamino)Phenyl]-5,5'-Di(Hydroxymethyl)Pyrrolidin-2-One\n",
      "Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine\n",
      "1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole\n",
      "2'-O-Acetyl Adenosine-5-Diphosphoribose\n",
      "8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione\n",
      "Brequinar Analog\n",
      "5,10-Dimethylene Tetrahydromethanopterin\n",
      "8-Demethyl-8-Dimethylamino-Flavin-Adenine-Dinucleotide\n",
      "4-Benzoylamino-4-{1-{1-Carbamoyl-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-Butyric Acid\n",
      "L-Alpha-Glycerophosphorylethanolamine\n",
      "Alpha-D-Fucose\n",
      "Phosphomethylphosphonic Acid Guanosyl Ester\n",
      "3-Aminosuccinimide\n",
      "Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose\n",
      "2-Keto-3-Deoxygluconate\n",
      "3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole\n",
      "2'-Deoxyguanosine-5'-Diphosphate\n",
      "lambda-bis(2,2'-bipyridine)imidazole osmium (II)\n",
      "7-Methylguanosine\n",
      "4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose\n",
      "Alvocidib\n",
      "O-Sulfo-L-Serine\n",
      "Mercaptomethyl Phosphonate\n",
      "Malate Ion\n",
      "Tricosanoic Acid\n",
      "Galactose-uridine-5'-diphosphate\n",
      "(4s)-4-{[(2s)-2-Amino-3-Oxopropyl]Sulfanyl}-L-Homoserinate\n",
      "4-Acetyl-4-Guanidino-6-Methyl(Propyl)Carboxamide-4,5-Dihydro-2h-Pyran-2-Carboxylic Acid\n",
      "9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine\n",
      "2,6-Diaminoquinazolin-4(3h)-One\n",
      "9-Deazaadenine\n",
      "6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One\n",
      "1-Ethoxy-2-(2-Methoxyethoxy)Ethane\n",
      "2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide\n",
      "6-O-Phosphoryl Inosine Monophosphate\n",
      "alpha-D-galacturonic acid\n",
      "Uridine-2',3'-Vanadate\n",
      "(S)-2-Amino-3-(4h-Selenolo[3,2-B]-Pyrrol-6-Yl)-Propionic Acid\n",
      "2-Methoxy-4-Vinyl-Phenol\n",
      "Equilenin\n",
      "Eniluracil\n",
      "[Methylthio]Acetate\n",
      "Mevalonic acid\n",
      "6-Chloro-2-Fluoropurine\n",
      "Aspartic Acid-4-Carboxymethyl Ester\n",
      "Brequinar\n",
      "N-{3-[4-(3-Amino-Propyl)-Piperazin-1-Yl]-Propyl}-3-(2-Thiophen-2-Yl-Acetylamino)-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide\n",
      "RU79073\n",
      "AL5927\n",
      "9-Beta-D-Xylofuranosyl-Adenine\n",
      "Acylated Ceftazidime\n",
      "Flavin-Adenine Dinucleotide-N5-Isobutyl Ketone\n",
      "Phosphomethylphosphonic Acid Guanylate Ester\n",
      "Glycoluril\n",
      "3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide\n",
      "Z-Pro-Prolinal\n",
      "Benzoyl-Arginine-Alanine-Methyl Ketone\n",
      "[4-(4-Hydroxy-Benzyl)-2-(2-Hydroxy-1-Methyl-Ethyl)-5-Oxo-Imidazolidin-1-Yl]-Acetic Acid\n",
      "2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose\n",
      "Norcamphor\n",
      "10-Propargyl-5,8-Dideazafolic Acid\n",
      "L-Myo-Inositol-1-Phosphate\n",
      "1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate\n",
      "S-Phosphocysteine\n",
      "N-({4-[(1R)-4-[(2R,4S,5S)-2,4-diamino-6-oxohexahydropyrimidin-5-yl]-1-(2,2,2-trifluoro-1,1-dihydroxyethyl)butyl]phenyl}carbonyl)-L-glutamic acid\n",
      "3-deoxy-α-D-manno-oct-2-ulopyranosonic acid\n",
      "Biotinyl P-Nitroaniline\n",
      "Isopenicillin N\n",
      "(3R,4R)-3-Hydroxy-4-(hydroxymethyl)-1-[(4-oxo-4,4a,5,7a-tetrahydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]pyrrolidinium\n",
      "3-Tyrosine\n",
      "Glutaric Acid\n",
      "5-Iodouracil\n",
      "CRA_11092\n",
      "2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400\n",
      "N-{1-[5-(1-Carbamoyl-2-Mercapto-Ethylcarbamoyl)-Pentylcarbamoyl]-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethyl}-3-{2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Acetylamino}-Succinamic Acid\n",
      "Sp-876\n",
      "Cyclohexylformamide\n",
      "P-Hydroxybenzaldehyde\n",
      "Tetrahydrodeoxyuridine\n",
      "(4r)-2-Methylpentane-2,4-Diol\n",
      "1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine\n",
      "Spermidine\n",
      "alpha-N-Acetyl-D-galactosamine\n",
      "Butyric Acid\n",
      "4,5-Dehydro-L-Iduronic Acid\n",
      "Tris-Hydroxymethyl-Methyl-Ammonium\n",
      "3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide\n",
      "FR230513\n",
      "WRR-99\n",
      "Ferricrocin-Iron\n",
      "Phencyclidine\n",
      "N-Pyridoxyl-Threonine-5-Monophosphate\n",
      "Alpha-Benzyl-Aminobenzyl-Phosphonic Acid\n",
      "Pyruvamide\n",
      "Glucose-6-Phosphate\n",
      "N~2~-Succinylornithine\n",
      "(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One\n",
      "4-Thio-beta-D-glucopyranose\n",
      "Oxyphenbutazone\n",
      "(3R,4R,5S,6R)-6-Fluoro-3,4,5-trihydroxytetrahydro-2H-pyran-2-olate\n",
      "Pyruvaldehyde\n",
      "Diphenylacetic Acid\n",
      "Alpha-Ketomalonic Acid\n",
      "2,6-Diaminopimelic Acid\n",
      "RU82209\n",
      "Pterin-6-Yl-Methyl-Monophosphate\n",
      "N7-Methyl-Guanosine-5'-Monophosphate\n",
      "1,2,4-Triazole\n",
      "CRA_9785\n",
      "N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide\n",
      "Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine\n",
      "Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]\n",
      "Capric acid\n",
      "5-deoxyflavanone\n",
      "S-Benzyl-Glutathione\n",
      "Glucaric acid\n",
      "Tiratricol\n",
      "(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid\n",
      "(S)-Rolipram\n",
      "[(1R)-1-acetamido-2-(4-chlorophenyl)ethyl]-[(2S)-2-amino-3-hydroxy-3-oxo-propoxy]-dihydroxy-boron\n",
      "Diminazene\n",
      "3-Deoxyguanosine\n",
      "Alpha,Alpha,Alpha-Trifluoro-P-Cresol\n",
      "L-2-amino-4-methoxy-cis-but-3-enoic acid\n",
      "3-Hydroxybutyryl-Coenzyme A\n",
      "4-Hydroxyphenacyl Coenzyme A\n",
      "Methylcobalamin\n",
      "Ribostamycin\n",
      "Kabiramide C\n",
      "Modified Acarbose Hexasaccharide\n",
      "2-(Acetylamino)-2-Deoxy-4-O-Beta-D-Galactopyranosyl-Alpha-D-Glucopyranose\n",
      "Deoxycholic Acid\n",
      "L-709,587\n",
      "2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione\n",
      "9-(4-Hydroxyphenyl)-2,7-Phenanthroline\n",
      "7-(Carboxyamino)-8-Amino-Nonanoic Acid\n",
      "5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione\n",
      "Adamantane\n",
      "ISO24\n",
      "Pyridoxal-5'-Phosphate-N-Oxide\n",
      "2-Iodobenzylthio Group\n",
      "3-(4-Hydroxy-3-Imino-6-Oxo-Cyclohexa-1,4-Dienyl)-Alanine\n",
      "Argifin\n",
      "Lpc-Ether\n",
      "1,3-Di(N-Propyloxy-a-Mannopyranosyl)-Carbomyl 5-Methyazido-Benzene\n",
      "Ethanesulfonic Acid\n",
      "Glycinamid\n",
      "Guanidine-3-Propanol\n",
      "Cytidyl-2'-5'-Phospho-Guanosine\n",
      "1-Guanidinium-7-Aminoheptane\n",
      "Beta-Hydroxyaspartic Acid\n",
      "2'-deoxyuridine 5'-alpha,beta-imido-diphosphate\n",
      "Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide\n",
      "CRA_1144\n",
      "3-Hydroxyanthranilic Acid\n",
      "Phosphonoacetohydroxamic Acid\n",
      "2,3-di-O-phytanyl-sn-glycerol\n",
      "3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid\n",
      "2-{N'-[2-(5-Amino-1-Phenylcarbamoyl-Pentylcarbamoyl)-Hexyl]-Hydrazinomethyl}-Hexanoic Acid(5-Amino-1-Phenylcarbamoyl-Pentyl)-Amide\n",
      "[{(5-Chloro-2-Pyridinyl)Amino} Methylene]-1,1-Bisphosphonate\n",
      "(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One\n",
      "Picric acid\n",
      "beta-D-Galactopyranuronic acid\n",
      "5-{[Ethyl(Methyl)Amino]Methyl}-2-Methyl-5,6-Dihydropyrimidin-4-Amine\n",
      "S,S-Propylthiocysteine\n",
      "Tribenuron Methyl\n",
      "1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose\n",
      "2-{1-[2-Amino-2-(4-Hydroxy-Phenyl)-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid\n",
      "Butylamine\n",
      "4-Iodo-L-phenylalanine\n",
      "Cysteinesulfonic Acid\n",
      "Vitamin B6 Complexed with 2-Amino-Pentanoic Acid\n",
      "1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol\n",
      "UP5\n",
      "3'-Azido-3'-Deoxythymidine-5'-Monophosphate\n",
      "Acetic Acid Salicyloyl-Amino-Ester\n",
      "1-(5'-Phospho-Beta-D-Ribofuranosyl)Barbituric Acid\n",
      "4-Fluorophenethyl Alcohol\n",
      "2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid\n",
      "4-(3,12,14-Trihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One\n",
      "9-N-Phenylmethylamino-Tacrine\n",
      "Beta(2-Thienyl)Alanine\n",
      "2,3-Dihydroxy-Valerianic Acid\n",
      "Cystein-S-Yl Cacodylate\n",
      "N-Cyclohexyl-N'-Decylurea\n",
      "(6,7-Difluoro-Quinazolin-4-Yl)-(1-Methyl-2,2-Diphenyl-Ethyl)-Amine\n",
      "2-Hydroxy-Tryptophan\n",
      "Tartronate\n",
      "Dibenzofuran-4,6-Dicarboxylic Acid\n",
      "2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid\n",
      "Uridine monophosphate\n",
      "S-(P-Nitrobenzyl)Glutathione\n",
      "4-Diphosphocytidyl-2-C-Methyl-D-Erythritol\n",
      "3-Hydroxy-Propanoic Acid\n",
      "(Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide\n",
      "WRR-112\n",
      "1-Hexadecanosulfonyl-O-L-Serine\n",
      "N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide\n",
      "N-Phenylthiourea\n",
      "Piritrexim\n",
      "Lanosterol\n",
      "4-Sulfonamide-[1-(4-Aminobutane)]Benzamide\n",
      "5-Mercaptoethanol-2-Decenoyl-Coenzyme A\n",
      "Succinyl-Coenzyme A\n",
      "D-Threonine\n",
      "Vanoxerine\n",
      "2-[4-[[(S)-1-[[(S)-2-[[(Rs)-3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl]Aminocarbonyl]Pyrrolidin-1-Yl-]Carbonyl]-2-Methylpropyl]Aminocarbonyl]Benzoylamino]Acetic Acid\n",
      "Cyclohexanol\n",
      "12-Hydroxydodecanoic Acid\n",
      "6-Methylamino-5-Nitroisocytosine\n",
      "1-Hydroxy-2-S-Glutathionyl-3-Para-Nitrophenoxy-Propane\n",
      "S-Ethyl-N-Phenyl-Isothiourea\n",
      "Adenosine 5'-phosphosulfate\n",
      "Bicine\n",
      "N5-(1-Imino-3-Butenyl)-L-Ornithine\n",
      "6-Hydroxy-6-Methyl-Heptan-3-One\n",
      "RU85053\n",
      "4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid\n",
      "5'-Fluoro-5'-Deoxyadenosine\n",
      "3-Hydroxy-4-(3,4,5-Trihydroxy-Tetrahydro-Pyran-2-Yloxy)-Piperidin-2-One\n",
      "6-Aza-Ump\n",
      "N-Ethyl-5'-Carboxamido Adenosine\n",
      "Z-Dehydrobutyrine\n",
      "N-acetyl-alpha-neuraminic acid\n",
      "3,4-Dihydro-5-Methyl-Isoquinolinone\n",
      "2'-Deoxy-Thymidine-Beta-L-Rhamnose\n",
      "(1s,2s)-1-Amino-1-(1,3-Thiazol-2-Yl)Propan-2-Ol\n",
      "Phosphomethylphosphonic Acid-Guanylate Ester\n",
      "Purine Riboside-5'-Monophosphate\n",
      "Coproporphyrin I\n",
      "p-Chlorobenzoic acid\n",
      "2-Amino-5-Hydroxy-Benzimidazole\n",
      "3,9-Dimethyladenine\n",
      "S-2-(Boronoethyl)-L-Cysteine\n",
      "Etheno-Nadp\n",
      "Ethylene Dichloride\n",
      "Xylarohydroxamate\n",
      "9-(2-Deoxy-Beta-D-Ribofuranosyl)-6-Methylpurine\n",
      "2-Cyclopropylmethylenepropanal\n",
      "4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One\n",
      "Pantothenoylaminoethenethiol\n",
      "3-Hydroxyimino Quinic Acid\n",
      "N-acetyl-alpha-D-glucosamine\n",
      "2-Methylbutanoic Acid\n",
      "Compound 4-D\n",
      "Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate\n",
      "Arabinose-5-phosphate\n",
      "3-Amino-4,5-Dihydroxy-Cyclohex-1-Enecarboxylate\n",
      "3ar,5r,6s,7r,7ar-5-Hydroxymethyl-2-Methyl-5,6,7,7a-Tetrahydro-3ah-Pyrano[3,2-D]Thiazole-6,7-Diol\n",
      "Methyl-[4-(4-Piperidine-1-Ylmethyl-Phenyl)-Cyclohexyl]-Carbaminic Acid-(4-Chlorophenyl)-Ester\n",
      "4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole\n",
      "Isovaleric Acid\n",
      "2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose\n",
      "P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid\n",
      "Flurbiprofen Methyl Ester\n",
      "Tromethamine\n",
      "Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate\n",
      "Doconexent\n",
      "(Tert-Butyloxycarbonyl)-Alanyl-Alanyl-Amine\n",
      "Radicicol\n",
      "FG-9041\n",
      "Dihydrolipoic Acid\n",
      "5-Fluoro-2'-Deoxyuridine-5'-Monophosphate\n",
      "5-Methyl-2'-Deoxypseudouridine\n",
      "4-Hydroperoxy-2-Methoxy-Phenol\n",
      "2'-cytidylic acid\n",
      "Propanoic Acid\n",
      "Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide\n",
      "N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3\n",
      "D-Eritadenine\n",
      "N-Hydroxyguanidine\n",
      "Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine\n",
      "2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol\n",
      "alpha-D-quinovopyranose\n",
      "Glutamyl Group\n",
      "D-Dethiobiotin\n",
      "Lactaldehyde\n",
      "Rbt205 Inhibitor\n",
      "Glucosaminyl-(Alpha-6)-D-Myo-Inositol\n",
      "2-Aminoquinazolin-4(3h)-One\n",
      "2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid\n",
      "N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea\n",
      "Phenacetin\n",
      "Elaidoylamide\n",
      "(3r,5r)-7-((1r,2r,6s,8r,8as)-2,6-Dimethyl-8-{[(2r)-2-Methylbutanoyl]Oxy}-1,2,6,7,8,8a-Hexahydronaphthalen-1-Yl)-3,5-Dihydroxyheptanoic Acid\n",
      "[5-hydroxy-6-methyl-4-({[(4E)-3-oxo-1,2-oxazolidin-4-ylidene]amino}methyl)pyridin-3-yl]methyl dihydrogen phosphate\n",
      "GC-24\n",
      "2,3-Dimethylimidazolium Ion\n",
      "S-Dioxymethionine\n",
      "(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid\n",
      "5-Amino-1h-Pyrimidine-2,4-Dione\n",
      "Benzoic Acid\n",
      "Trifluoroalanine\n",
      "2-Dehydropantoate\n",
      "Palmitic Acid\n",
      "3-Aminomethyl-Pyridinium-Adenine-Dinucleotide\n",
      "2'-Deoxycytidine-5'-Monophosphate\n",
      "Trifluoromethionine\n",
      "2'-deoxyuridylic acid\n",
      "Lysine Nz-Carboxylic Acid\n",
      "1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol\n",
      "Inhibitor Msa367\n",
      "5-Bromothienyldeoxyuridine\n",
      "1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester\n",
      "Hexamidine\n",
      "9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine\n",
      "3-Methylglutamic acid\n",
      "Histidinol\n",
      "3-{2,6,8-trioxo-9-[(2S,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate\n",
      "2-Decenoyl N-Acetyl Cysteamine\n",
      "2-(N-Morpholino)-Ethanesulfonic Acid\n",
      "Fucitol\n",
      "Difluoromethionine\n",
      "2,4-Diaminobutyric Acid\n",
      "N-[Tosyl-D-Prolinyl]Amino-Ethanethiol\n",
      "Salicylhydroxamic Acid\n",
      "(2s,5r,6r)-6-{[(6r)-6-(Glycylamino)-7-Oxido-7-Oxoheptanoyl]Amino}-3,3-Dimethyl-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptane-2-Carboxylate\n",
      "2-Amino-3-Hydroxy-3-Phosphonooxy-Propionic Acid\n",
      "Ethyl Dihydrogen Phosphate\n",
      "Epigallocatechin\n",
      "7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline\n",
      "Rhodamine 6G\n",
      "5,6-Diaminouracil\n",
      "(3s)-3,4-Di-N-Hexanoyloxybutyl-1-Phosphocholine\n",
      "RU78299\n",
      "Pseudouridine-5'-Monophosphate\n",
      "Phosphorylated Dihydropteroate\n",
      "[(Z)-octadec-9-enyl] (2R)-2,3-bis(oxidanyl)propanoate\n",
      "3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium\n",
      "2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole\n",
      "(3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine\n",
      "N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide\n",
      "1,3,5-Trichloro-Benzene\n",
      "Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide\n",
      "D-Tyrosine\n",
      "Tetra(Imidazole)Diaquacopper (Ii)\n",
      "Y-700\n",
      "2-Chloro-6-Methyl-Aniline\n",
      "Formaldehyde\n",
      "N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide\n",
      "P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate\n",
      "5-Hydroxymethyluridine-2'-Deoxy-5'-Monophosphate\n",
      "Gamma-Carboxy-Glutamic Acid\n",
      "Benzenesulfinic acid\n",
      "Cilomilast\n",
      "Jaspisamide A\n",
      "Carbazole Butanoic Acid\n",
      "Eucalyptol\n",
      "Reactive Red 6 hapten\n",
      "Pentane-1,5-Diamine\n",
      "L-Threonohydroxamate 4-Phosphate\n",
      "L-Eflornithine\n",
      "1,4-dithio-beta-D-glucopyranose\n",
      "S-Acetonylcysteine\n",
      "1-Thio-Beta-D-Glucopyranose\n",
      "N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide\n",
      "(2r,3r,4s,5r)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium\n",
      "Tetrahydrooxazine\n",
      "2-O-methyl fucose\n",
      "Monothioglycerol\n",
      "6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine\n",
      "Prostaglandin G2\n",
      "Meta-Nitro-Tyrosine\n",
      "3-Dehydroquinic Acid\n",
      "5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine\n",
      "Ara-Alpha(1,3)-Xyl\n",
      "lambda-bis(2,2'-bipyridine)imidazole ruthenium (II)\n",
      "2,3-Dideoxyfucose\n",
      "(4e,8e,12z,16z)-N,N,4,8,13,17,21-Heptamethyldocosa-4,8,12,16,20-Pentaen-1-Amine\n",
      "Thieno[2,3-B]Pyridine-2-Carboxamidine\n",
      "AL4623\n",
      "N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide\n",
      "alpha-L-methyl-fucose\n",
      "Batimastat\n",
      "MT-Immucillin-H\n",
      "5-Alpha-Androstane-3-Beta,17beta-Diol\n",
      "Carboxyethyllumazine\n",
      "Phenylpyruvic acid\n",
      "1-Menaphthyl Glutathione Conjugate\n",
      "Biopterin\n",
      "Alpha-Adenosine Monophosphate\n",
      "N-Allyl-6-{[3-(4-bromophenyl)-1-methyl-1H-indazol-6-yl]oxy}-N-methyl-1-hexanamine\n",
      "S-(N-Hydroxy-N-Bromophenylcarbamoyl)Glutathione\n",
      "N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide\n",
      "1,5-Bis(N-Benzyloxycarbonyl-L-Leucinyl)Carbohydrazide\n",
      "5-N-Allyl-Arginine\n",
      "Thionicotinamide-Adenine-Dinucleotide\n",
      "N-Propargyl-1(S)-Aminoindan\n",
      "Malachite Green\n",
      "Triphosphoric acid\n",
      "Hydroxyphenyl Propionic Acid\n",
      "3-Chloro-4-Hydroxyphenylglycine\n",
      "9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine\n",
      "2-Methyl-2-Propanol\n",
      "5-Oxo-Pyrrolidine-2-Carbaldehyde\n",
      "Oxalic Acid\n",
      "Tmr\n",
      "Urea\n",
      "Succinamide-Coa\n",
      "2-Phenylheme\n",
      "N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide\n",
      "Inhibitor Bea322\n",
      "Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate\n",
      "S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea\n",
      "L-Xylopyranose\n",
      "4'-Phosphopantetheine\n",
      "Coenzyme F420\n",
      "[2-(1-amino-2-hydroxy-propyl)-4-(1H-indol-3-ylmethylene)-5-oxo-4,5-dihydro-imidazol-1-yl]-acetaldehyde\n",
      "2-Amino-3-Ketobutyric Acid\n",
      "4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine\n",
      "N-Ethyl Retinamide\n",
      "6S-5,6,7,8-Tetrahydrobiopterin\n",
      "Ethyl-Carbamic Acid Methyl Ester\n",
      "N-Methyl-Alpha-Beta-Dehydroalanine\n",
      "4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline\n",
      "Feruloyl Coenzyme A\n",
      "5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone\n",
      "Freselestat\n",
      "5-Alpha-Androstane-3-Beta,17-Alpha-Diol\n",
      "Glycyl-L-Alpha-Amino-Epsilon-Pimelyl-D-Alanine\n",
      "Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol\n",
      "D-Serine\n",
      "4-Methyl-Pyrroline-5-Carboxylic Acid\n",
      "Diguanosine-5'-Triphosphate\n",
      "LFA703\n",
      "C-1027 Aromatized Chromophore\n",
      "Protoporphyrin Ix Containing Zn\n",
      "1,4-Dideoxy-O2-Sulfo-Glucuronic Acid\n",
      "1-Deoxy-Ribofuranose-5'-Phosphate\n",
      "Erythose-4-Phosphate\n",
      "Deacetoxycephalosporin-C\n",
      "4-Hydroxy-3,4-Dihydro-1h-Pyrimidin-2-One\n",
      "Oxamic Acid\n",
      "Heptanyl-P-Phenol\n",
      "Carboxylic PRPP\n",
      "D-Asparagine\n",
      "5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One\n",
      "N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium\n",
      "3,4-Dihydroxybenzoic Acid\n",
      "D-Xylulose\n",
      "6-Chloropurine Riboside, 5'-Monophosphate\n",
      "(2-Sulfanyl-3-Phenylpropanoyl)-Phe-Tyr\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide\n",
      "N-acetyl-D-glucosamine-6-phosphate\n",
      "9-(6-deoxy-beta-D-allofuranosyl)-6-methylpurine\n",
      "L-Thiocitrulline\n",
      "1-deoxymannojirimycin\n",
      "Inositol 2,4,5-trisphosphate\n",
      "SP2456\n",
      "7-methyl-guanosine-5'-triphosphate-5'-guanosine\n",
      "N,O6-Disulfo-Glucosamine\n",
      "Cp-Coeleneterazine\n",
      "2c-Methyl-D-Erythritol 2,4-Cyclodiphosphate\n",
      "Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate\n",
      "S-(Dimethylarsenic)Cysteine\n",
      "4-Hydroxy-Aconitate Ion\n",
      "Clorobiocin\n",
      "Dodecyl Sulfate\n",
      "1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine\n",
      "(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid\n",
      "Acarbose Derived Hexasaccharide\n",
      "2-Amino-4h-1,3-Benzoxathiin-4-Ol\n",
      "3-{2,6,8-trioxo-9-[(2R,3R,4R)-2,3,4,5-tetrahydroxypentyl]-1,2,3,6,8,9-hexahydro-7H-purin-7-Yl}propyl dihydrogen phosphate\n",
      "L-Homoarginine\n",
      "Mercuribenzoic Acid\n",
      "Phosphorylisopropane\n",
      "N-Trimethyllysine\n",
      "Tyrosinal\n",
      "1-[Glycerolylphosphonyl]-2-[8-(2-Hexyl-Cyclopropyl)-Octanal-1-Yl]-3-[Hexadecanal-1-Yl]-Glycerol\n",
      "4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole\n",
      "1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid\n",
      "Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid\n",
      "(Molybdopterin-S,S)-Dioxo-Thio-Molybdenum(V)\n",
      "Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide\n",
      "R-azabisabolene\n",
      "6-Methyl-Formycin A\n",
      "2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine\n",
      "2,6-Diamino-Hexanoic Acid Amide\n",
      "D-Allopyranose\n",
      "4'-nitrophenyl-3i-thiolaminaritrioside\n",
      "2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid\n",
      "3-(Benzoylamino)-L-Alanine\n",
      "4-Methyl Valeric Acid\n",
      "Ethanolamine\n",
      "Betadex\n",
      "3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol\n",
      "L-histidinol phosphate\n",
      "[2-(Methyleneamine)-4-(4-Hydroxy-Benzylidine)-5-Oxo-4,5-Dihydro-Imidazol-1-Yl]-Acetaldehyde\n",
      "Butylphosphonate\n",
      "Bromo-Willardiine\n",
      "6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid\n",
      "4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide\n",
      "{4-[(2S)-2-Acetamido-3-({(1S)-1-[3-carbamoyl-4-(cyclohexylmethoxy)phenyl]ethyl}amino)-3-oxopropyl]-2-phosphonophenoxy}acetic acid\n",
      "2,6-Diamino-8-(2-Dimethylaminoethylsulfanylmethyl)-3h-Quinazolin-4-One\n",
      "Uridine 5'-triphosphate\n",
      "[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone\n",
      "Bromo-WR99210\n",
      "Bis(5-Amidino-Benzimidazolyl)Methane Zinc\n",
      "Dimethyl Propionate Ester Heme\n",
      "2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide\n",
      "2'-(4-Dimethylaminophenyl)-5-(4-Methyl-1-Piperazinyl)-2,5'-Bi-Benzimidazole\n",
      "(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine\n",
      "1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide\n",
      "Alsterpaullone\n",
      "Methionine Phosphinate\n",
      "2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid\n",
      "N-Methyl-N-Propargyl-3-(2,4-Dichlorophenoxy)Propylamine\n",
      "S-Isopropyl-Isothiourea\n",
      "4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol\n",
      "MF268\n",
      "Guanosine-5',3'-Tetraphosphate\n",
      "Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester\n",
      "N'-L-Seryl-3'-Amino-(3'-Deoxy)-Adenosine\n",
      "Pseudotropine\n",
      "D-Arginine\n",
      "Tyvelose\n",
      "Phenylalanine Amide\n",
      "1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole\n",
      "Serine Vanadate\n",
      "Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide\n",
      "Z-Ala Prolinal\n",
      "Ribulose-5-Phosphate\n",
      "Pinacol[[2-Amino-Alpha-(1-Carboxy-1-Methylethoxyimino)-4-Thiazoleacetyl]Amino]Methaneboronate\n",
      "Coenzyme a Persulfide\n",
      "N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine\n",
      "Ergosterol\n",
      "3-Oxo-Pentadecanoic Acid\n",
      "N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide\n",
      "Nitrocefin Acyl-Serine\n",
      "2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol\n",
      "Carboxymycobactin T\n",
      "4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid\n",
      "Methylmalonyl-Coenzyme A\n",
      "Methyl beta-galactoside\n",
      "[Pterin-6-Yl Methanyl]-Phosphonophosphate\n",
      "N-Carbamoyl-Alanine\n",
      "Coelenteramide\n",
      "N-Propyl Isocyanide\n",
      "5-Phenylvaleric Acid\n",
      "3,4-Dimethylphenol\n",
      "Hypophosphite\n",
      "9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine\n",
      "2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium\n",
      "Beta-Dadf, Msa, Multisubstrate Adduct Inhibitor\n",
      "D-[(Amino)Carbonyl]Phenylalanine\n",
      "8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide\n",
      "(5-Methyl-6-Oxo-1,6-Dihydro-Pyridin-3-Yl)-1,2-Dideoxy-Ribofuranose-5-Monophosphate\n",
      "Alpha-Amino-2-Indanacetic Acid\n",
      "Beta-D-Fucose\n",
      "2-Methylleucine\n",
      "Nogalaviketone\n",
      "N-Cyclopentyl-N-Cyclobutylformamide\n",
      "para-Coumaric Acid\n",
      "4-Hydroxybenzyl Coenzyme A\n",
      "Fudp\n",
      "5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine\n",
      "6-Deoxyerythronolide B\n",
      "Cpad\n",
      "Alpha-Methylisocitric Acid\n",
      "N-{3-[4-(3-aminopropyl)piperazin-1-yl]propyl}-3-(beta-D-galactopyranosyloxy)-5-nitrobenzamide\n",
      "Alpha-ketoisovalerate\n",
      "N-Acetyl-L-Glutamate\n",
      "Hypoxanthine\n",
      "Heptane-1,2,3-Triol\n",
      "RU78191\n",
      "(4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide\n",
      "Decyloxy-Methanol\n",
      "N'-Pyridoxyl-Lysine-5'-Monophosphate\n",
      "2-deoxy-2-fluoro-α-D-mannose\n",
      "1-[Pyrrol-1-Yl-2,5-Dione-Methoxymethyl]-Pyrrole-2,5-Dione\n",
      "2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside\n",
      "Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate\n",
      "N-(Allyloxycarbonyl)-4-[N-(Carboxy-Formyl)-2-(Benzoic Acid)-Amino]-L-Phenylalaninyl-Amino-Butyloxy-(6-Hydroxy-Benzoic Acid Methyl Ester)\n",
      "AL5300\n",
      "RH-1\n",
      "Apstatin\n",
      "Undecanal\n",
      "4-Hydroxy-2-Butanone\n",
      "9-Deazahypoxanthine\n",
      "5-Amino-5-Deoxy-Cellobiono-1,5-Lactam\n",
      "Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose\n",
      "Balanol\n",
      "Deamido-Nad+\n",
      "(1,10 Phenanthroline)-(Tri-Carbon Monoxide) Rhenium (I)\n",
      "N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide\n",
      "2-Amino-Adenosine\n",
      "3-Methylcytosine\n",
      "3-Methyladenine\n",
      "N-Heptylformamide\n",
      "Fotemustine\n",
      "[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester\n",
      "(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide\n",
      "[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine\n",
      "2-Nitro-P-Cresol\n",
      "Balhimycin\n",
      "1-Octadecyl-2-Acetamido-2-Deoxy-Sn-Glycerol-3-Phosphoethylmethyl Sulfide\n",
      "N-Formylpiperidine\n",
      "3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine\n",
      "Berberine\n",
      "Allolactose\n",
      "4-(N,N-Dimethylamino)Cinnamoyl-Coa\n",
      "N-Coeleneterazine\n",
      "Hexatantalum Dodecabromide\n",
      "4-Methyl-1,2-Benzenediol\n",
      "Guanosine-3'-Monophosphate-5'-Diphosphate\n",
      "beta-D-glucose 6-phosphate\n",
      "(P-Iodophenylacetylamino)Methylphosphinic Acid\n",
      "Aurodox\n",
      "N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine\n",
      "N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane\n",
      "beta-D-arabinofuranose 5-phosphate\n",
      "5-Nitroso-6-Ribityl-Amino-2,4(1h,3h)-Pyrimidinedione\n",
      "Willardiine\n",
      "5-Methoxybenzimidazole\n",
      "10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione\n",
      "S-Hexylglutathione\n",
      "Degraded Cephaloridine\n",
      "5-Fluoro-4-(S)-Hydroxy-3,4-Dihydropyrimidine\n",
      "Lysophosphotidylserine\n",
      "Guanosine-5'-Triphosphate\n",
      "2,4-Dinitro,5-[Bis(2-Bromoethyl)Amino]-N-(2',3'-Dioxopropyl)Benzamide\n",
      "6-Hydroxypropylthymine\n",
      "1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide\n",
      "2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol\n",
      "3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide\n",
      "Indole-3-Glycerol Phosphate\n",
      "Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone\n",
      "Nicotinyl alcohol\n",
      "I-Coeleneterazine\n",
      "Lauryl Dimethylamine-N-Oxide\n",
      "(R)-Rolipram\n",
      "Threonine Derivative\n",
      "4-Methyl-Histidine\n",
      "2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid\n",
      "S-Hydroxymethyl Glutathione\n",
      "N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide\n",
      "2-Fluoro-2-Deoxy-Beta-D-Galactopyranosyl-Beta-D-Glucopyranose\n",
      "Aspartate Beryllium Trifluoride\n",
      "N-[(Aminooxy)Carbonyl]Aniline\n",
      "6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin\n",
      "Beta-Hydroxytryptophane\n",
      "Pyrophosphoric acid\n",
      "Propionamide\n",
      "5-Nitro-6-Ribityl-Amino-2,4(1h,3h)-Pyrimidinedione\n",
      "5-Phenylsulfanyl-2,4-Quinazolinediamine\n",
      "1,4-Deoxy-4-((5-Hydroxymethyl-2,3,4-Trihydroxycyclohex-5-Enyl)Amino)Fructose\n",
      "Valpromide\n",
      "Anthranilic acid\n",
      "Aceglutamide\n",
      "2-Amino-5-Bromo-6-Phenylpyrimidin-4-Ol\n",
      "3,5-Diaminophthalhydrazide\n",
      "4-bromo-3-hydroxy-3-methyl butyl diphosphate\n",
      "D-Isovaline\n",
      "[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine\n",
      "Fructose\n",
      "3'-1-Carboxy-1-Phosphonooxy-Ethoxy-Uridine-Diphosphate-N-Acetylglucosamine\n",
      "Mdl-29951\n",
      "Phosporic Acid Mono-[3,4-Dihydroxy-5-(5-Methoxy-Benzoimidazol-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester\n",
      "4-(3,14-Dihydroxy-10,13-Dimethyl-Hexadecahydro-Cyclopenta[a]Phenanthren-17-Yl)-5h-Furan-2-One\n",
      "Di-Stearoyl-3-Sn-Phosphatidylcholine\n",
      "Benzofuran\n",
      "4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide\n",
      "(S)-2-Amino-4-[(2s,3r)-2,3,5-Trihydroxy-4-Oxo-Pentyl]Mercapto-Butyric Acid\n",
      "Methylmalonic Acid\n",
      "Norvaline\n",
      "N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea\n",
      "(9S,10S)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene\n",
      "MDL72527\n",
      "N2-(Carboxyethyl)-L-Arginine\n",
      "Inhibitor Bea425\n",
      "Skf 107457\n",
      "L-Homoserine\n",
      "Chitotriose\n",
      "Heptulose-2-Phosphate\n",
      "Pteroic Acid\n",
      "Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine\n",
      "Formycin B\n",
      "1-Monohexanoyl-2-Hydroxy-Sn-Glycero-3-Phosphate\n",
      "Matairesinol\n",
      "Histidyl-Adenosine Monophosphate\n",
      "Isoformononetin\n",
      "3-Mercuri-4-Aminobenzenesulfonamide\n",
      "[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid\n",
      "Thymidine-3',5'-Diphosphate\n",
      "Nz2-Tryptophan\n",
      "N-(5-Amino-5-Carboxypentyl)Glutamic Acid\n",
      "3-(3,4-Dimethoxyphenyl)Propionic Acid\n",
      "Dequalinium\n",
      "BV1\n",
      "(2R,3R,4R,5R,6R)-3-fluoro-2,4-dihydroxy-5-[(1-hydroxyethylidene)amino]-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid\n",
      "2-Iminiopropanoate\n",
      "N-Cyclohexyl-N'-(Propyl)Phenyl Urea\n",
      "4-Nitrophenyl Phosphate\n",
      "CRA_9076\n",
      "Quercetin\n",
      "L-2-amino-3-butynoic acid\n",
      "1-Deaza-Adenosine\n",
      "Trivanadate\n",
      "CGP 4832\n",
      "Didecyldimethylammonium\n",
      "Sparsomycin\n",
      "Nitroarginine\n",
      "Oleic Acid\n",
      "N-Methyldehydrobutyrine\n",
      "Dihydro-Acarbose\n",
      "9-Amino-2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid\n",
      "(2r)-Amino(3,5-Dihydroxyphenyl)Acetic Acid\n",
      "7,10,13-Tri(Carboxymethyl)-5,15-Dioxo-4,7,10,13,16-Pentaaza-1,19-Dithianonadecane\n",
      "Nitromethyldethia Coenzyme A\n",
      "Tetra(Imidazole)Diaquacopper (I)\n",
      "N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide\n",
      "(Hydroxyethyloxy)Tri(Ethyloxy)Octane\n",
      "N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide\n",
      "4-Amino Hexanoic Acid\n",
      "2-Amino-3-(1h-Indol-3-Yl)-Propan-1-Ol\n",
      "Tris(Hydroxyethyl)Aminomethane\n",
      "N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid\n",
      "2-Amino-6-Aminomethyl-8-Phenylsulfanylmethyl-3h-Quinazolin-4-One\n",
      "(1S)-1-C-{(2R)-6-[(2R)-2-Butanyl]-5,10-dihydroxy-4-oxo-1,2,3,4-tetrahydro-2-anthracenyl}-5-deoxy-1-O-methyl-D-xylulose\n",
      "N-Pyridoxyl-2-Methylalanine-5-Phosphate\n",
      "P-Hydroxybenzoic Acid\n",
      "5-Methyluridine 5'-Monophosphate\n",
      "(2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide\n",
      "CRA_23653\n",
      "beta-(1->4)-galactotriose\n",
      "Zinc Substituted Heme C\n",
      "Butyrylthiocholine\n",
      "N-Carbamoyl-L-Aspartate\n",
      "Tretazicar\n",
      "8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine\n",
      "Inhibitor Bea388\n",
      "4-(1-Amino-1-Carboxy-Ethyl)-Benzoic Acid\n",
      "Palmitoleic Acid\n",
      "Seocalcitol\n",
      "7n-Methyl-8-Hydroguanosine-5'-Monophosphate\n",
      "9-(5,5-Difluoro-5-Phosphonopentyl)Guanine\n",
      "Carbamic Acid\n",
      "3-(7-hydroxy-8-ribityllumazine-6-yl) propionic acid\n",
      "Geneticin\n",
      "(10R)-10-Formyl-5,8,10-Trideazafolic Acid\n",
      "N-acetyl-beta-neuraminic acid\n",
      "5-(6-D-Ribitylamino-2,4-Dihydroxypyrimidin-5-Yl)-1-Pentyl-Phosphonic Acid\n",
      "Dipicolinic Acid\n",
      "Methylumbelliferyl Chitotriose\n",
      "Cyclotheonamide A\n",
      "(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid\n",
      "3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester\n",
      "Citric Acid\n",
      "8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine\n",
      "5,4'-Dideoxyflavanone\n",
      "N-Acetyl Serotonin\n",
      "N-[N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-Butyl]-Guanidine\n",
      "Fructose -6-Phosphate\n",
      "2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide\n",
      "3-Isopropylmalic Acid\n",
      "((2r,3s,5r)-3-Hydroxy-5-(4-Hydroxy-2-Oxo-3,4-Dihydropyrimidin-1(2h)-Yl)-Tetrahydrofuran-2-Yl)Methyldihydrogen Phosphate\n",
      "2-[4-(4-Chlorophenyl)Cyclohexylidene]-3,4-Dihydroxy-1(2h)-Naphthalenone\n",
      "2-deoxy-2-fluoro-α-D-glucose\n",
      "2-Bromo-6-Hydroxy-Purine\n",
      "L-proline betaine\n",
      "{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid\n",
      "beta-D-Ribopyranose\n",
      "(S)-5-(4-Benzyloxy-Phenyl)-4-(7-Phenyl-Heptanoylamino)-Pentanoic Acid\n",
      "2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine\n",
      "Genz-10850\n",
      "[2-Cytidylate-O'-Phosphonyloxyl]-Ethyl-Trimethyl-Ammonium\n",
      "Oxfenicine\n",
      "4-[(Isopropylamino)Methyl]Phenylalanine\n",
      "7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid\n",
      "5-Phosphoribosyl-1-(Beta-Methylene) Pyrophosphate\n",
      "N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea\n",
      "5-Oxo-L-Norleucine\n",
      "7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide\n",
      "3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One\n",
      "Maleic Acid\n",
      "(1s,3r,4r,6s)-1,3,4,6-Tetrapkisphosphate\n",
      "Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate\n",
      "4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One\n",
      "4-O-methyl-alpha-D-glucuronic acid\n",
      "L-Gluconic Acid\n",
      "5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine\n",
      "5-Hydroxy-N-Propargyl-1(R)-Aminoindan\n",
      "D-4-hydroxyphenylglycine\n",
      "2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide\n",
      "4-Phenylbutylamine\n",
      "2,3-Difluorobenzyl Alcohol\n",
      "(3S)-3-methyl-D-aspartic acid\n",
      "1-Methylcytosine\n",
      "Guanosine-5'-Diphosphate\n",
      "D-[(N-Hydroxyamino)Carbonyl]Phenylalanine\n",
      "3,3-Dichloro-2-Phosphonomethyl-Acrylic Acid\n",
      "Nα-[(2S)-2-{[(S)-[(1S)-1-{[(Benzyloxy)carbonyl]amino}-2-phenylethyl](hydroxy)phosphoryl]methyl}-5-phenylpentanoyl]-L-tryptophanamide\n",
      "2-Bromo-2-Propene-1-Ol\n",
      "N-Hexylphosphonate Ethyl Ester\n",
      "LY249543\n",
      "2-Amino-3-(Cystein-S-Yl)-Isoxazolidin-5-Yl-Acetic Acid\n",
      "Ovalicin\n",
      "Phenethylamine\n",
      "Dihydroxyacetone phosphate\n",
      "Phosphatidylethanolamine\n",
      "Shikimate-3-Phosphate\n",
      "Isoquinoline\n",
      "Bilh 434\n",
      "Monastrol\n",
      "2-{2-[2-2-(Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethanol\n",
      "Octamethylenediamine\n",
      "6-hydroxydopa quinone\n",
      "Inosine\n",
      "1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea\n",
      "Methyl Isocyanide\n",
      "SB220025\n",
      "Carbocisteine\n",
      "2-[(Dioxidophosphoranyl)oxy]benzoate\n",
      "S-(3-Iodobenzyl)Glutathione\n",
      "7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid\n",
      "Glyoxylic acid\n",
      "7,8-dimethylalloxazine\n",
      "(2r,4s)-2-Methyl-2,3,3,4-Tetrahydroxytetrahydrofuran\n",
      "3-Dehydroshikimate\n",
      "Taurocholic Acid\n",
      "(S)-propane-1,2-diol\n",
      "Argadin\n",
      "Aconitate Ion\n",
      "beta-D-Ribose-5-phosphate\n",
      "{(1s)-1-Benzyl-4-[3-Carbamoyl-1-(1-Carbamoyl-2-Phenyl-Ethylcarbamoyl)-(S)-Propylcarbamoyl]-2-Oxo-5-Phenyl-Pentyl}-Carbamic Acid Tert-Butyl Ester\n",
      "9-Deazaguanine\n",
      "Pteric Acid\n",
      "Vinylsulphonic Acid\n",
      "Benzo[B]Thiophene-2-Boronic Acid\n",
      "Methyldiazene\n",
      "Adenosine Diphosphate 5-(Beta-Ethyl)-4-Methyl-Thiazole-2-Carboxylic Acid\n",
      "Mesobiliverdin Iv Alpha\n",
      "(R)-acetoin\n",
      "Arecoline\n",
      "3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate\n",
      "Debromohymenialdisine\n",
      "Bb-3497\n",
      "1,3,2-Dioxaborolan-2-Ol\n",
      "S-sulphocysteine\n",
      "AL6528\n",
      "Di-Linoleoyl-3-Sn-Phosphatidylcholine\n",
      "4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide\n",
      "4-Carboxy-5-(1-Pentyl)Hexylsulfanyl-1,2,3-Triazole\n",
      "13-Acetylphorbol\n",
      "3-Hydroxy-3-Methyl-Glutaric Acid\n",
      "3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide\n",
      "N-Methyl-N-(Methylbenzyl)Formamide\n",
      "Diureido-Acetate\n",
      "Crotonaldehyde\n",
      "2-Deoxy-Beta-D-Galactose\n",
      "L-Valinol\n",
      "Fe-Mesopone\n",
      "3-Deazacytidine\n",
      "4,6-O-(1-Carboxyethylidene)-Beta-D-Glucose\n",
      "1-Hydroxy-2-Amino-3-Cyclohexylpropane\n",
      "4-Carboxy-4-Aminobutanal\n",
      "Ado-P-Ch2-P-Ps-Ado\n",
      "Aeruginosin 98-B\n",
      "Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]\n",
      "Soneclosan\n",
      "3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide\n",
      "Phosphoaminophosphonic Acid-Adenylate Ester\n",
      "Thiodigalactoside\n",
      "Alpha-D-Glucose-1-Phosphate-6-Vanadate\n",
      "Lactic Acid\n",
      "L-erythro-7,8-dihydrobiopterin\n",
      "[Formylmethyl]Trimethyl-Ammonium, N,N,N-Trimethylammonium Acetaldehyde\n",
      "Allosamizoline\n",
      "2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid\n",
      "3-(Phosphonomethyl)Pyridine-2-Carboxylic Acid\n",
      "4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol\n",
      "Ncs-Chromophore\n",
      "Naphthalene Trisulfonate\n",
      "3-Phenylpropylamine\n",
      "Alpha-N-Dichloroacetyl-P-Aminophenylserinol\n",
      "Heptamolybdate\n",
      "3-Amino-1-Chloro-4-Phenyl-Butanol-2-Yl\n",
      "R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid\n",
      "P-Nitrophenol\n",
      "Adenylosuccinic Acid\n",
      "D-norleucine\n",
      "Nicotinamide Adenine Dinucleotide 3-Pentanone Adduct\n",
      "2-Amino-4-Mercapto-Butyric Acid\n",
      "Coproporphyrin I Containing Co(Iii)\n",
      "RPR128515\n",
      "7,8-Dihydroneopterin\n",
      "Alpha-Methyl-N-Acetyl-D-Glucosamine\n",
      "3-[[N-[4-Methyl-Piperazinyl]Carbonyl]-Phenylalaninyl-Amino]-5-Phenyl-Pentane-1-Sulfonic Acid Benzyloxy-Amide\n",
      "4'-Hydroxyflavanone\n",
      "3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile\n",
      "4-Epi-Vancosaminyl Derivative of Vancomycin\n",
      "ZK-805623\n",
      "N''-{3-[(3s,8ar)-1,4-Dioxooctahydropyrrolo[1,2-a]Pyrazin-3-Yl]Propyl}Guanidine\n",
      "Naphthyridine Inhibitor\n",
      "3-Fluorotyrosine\n",
      "Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline\n",
      "BVDU-MP\n",
      "Modified Acarbose Pentasaccharide\n",
      "Nebularine\n",
      "2-Fluoroadenosine\n",
      "2-(2-Oxo-1,2-Dihydro-Pyridin-3-Yl)-1h-Benzoimidazole-5-Carboxamidine\n",
      "Tetrafluoroaluminate Ion\n",
      "Mercuric iodide\n",
      "Benzo[B]Thiophene-2-Carboxamidine\n",
      "1,4-Dithiothreitol\n",
      "2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene\n",
      "5-(3,3-Dihydroxypropeny)-3-Methoxy-Benzene-1,2-Diol\n",
      "Heptyl 1-Thiohexopyranoside\n",
      "4-Methylpiperazin-1-Yl Carbonyl Group\n",
      "Aminoquinuride\n",
      "4-O-(4,6-Dideoxy-4-{[4-[(4-O-Hexopyranosylhexopyranosyl)Oxy]-5,6-Dihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}Hexopyranosyl)Hexopyranose\n",
      "Alpha-Aminobutyric Acid\n",
      "N,N,N-trimethylglycinium\n",
      "Arsenous acid\n",
      "2'-Deoxyguanosine-5'-Monophosphate\n",
      "2,2-Dichloro-1-Methanesulfinyl-3-Methyl-Cyclopropanecarboxylic Acid [1-(4-Bromo-Phenyl)-Ethyl]-Amide\n",
      "3,4-Dichloroisocoumarin\n",
      "(C8-S)-Hydantocidin 5'-Phosphate\n",
      "Coproporphyrinogen III\n",
      "Tetrabromo-2-Benzotriazole\n",
      "3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol\n",
      "N-Formylmethionine\n",
      "Lactose\n",
      "SR12813\n",
      "N-(5'-phosphopyridoxyl)-L-alanine\n",
      "Afimoxifene\n",
      "1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester\n",
      "CRA_10656\n",
      "2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol\n",
      "(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol\n",
      "Alpha-L-Fucose\n",
      "1-Anilino-8-Naphthalene Sulfonate\n",
      "Trencam-3,2-Hopo\n",
      "N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine\n",
      "Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine\n",
      "4-Nitro-Inden-1-One\n",
      "3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole\n",
      "Meso-Erythritol\n",
      "Cmp-2-Keto-3-Deoxy-Octulosonic Acid\n",
      "2-deoxy-2-fluoro-β-D-mannose\n",
      "L-Phenylalaninol\n",
      "Deoxythymidine\n",
      "(2s)-2,8-Diaminooctanoic Acid\n",
      "N-Methylleucine\n",
      "(6r,7r)-3-[(Acetyloxy)Methyl]-7-{[(6s)-6-(Glycylamino)-7-Oxido-7-Oxoheptanoyl]Amino}-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Octane-2-Carboxylate\n",
      "Guanidinoethylmercaptosuccinic acid\n",
      "3-(Mercaptomethylene)Pyridine\n",
      "Diisopropylphosphono Group\n",
      "2-(acetylamino)-2-deoxy-4-O-sulfo-alpha-D-galactopyranose\n",
      "Fructose-6-Phosphate\n",
      "Dihydroxy(oxo)molybdenum(6+)\n",
      "RU81843\n",
      "4-Phospho-D-Erythronohydroxamic Acid\n",
      "2'-Monophosphoadenosine-5'-Diphosphoribose\n",
      "Aspartate Semialdehyde\n",
      "R-Styrene Oxide\n",
      "4-acetamidobenzoic acid\n",
      "Camphane\n",
      "WRR-204\n",
      "Sp-722\n",
      "(3s)-2,3,4,5-Tetrahydropyridin-3-Amine\n",
      "8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine\n",
      "Chlorophyll B\n",
      "Methyl(6s)-1-Thio-L-Manno-Hexodialdo-6,2-Pyranoside\n",
      "N-Methylnaloxonium\n",
      "3-phospho-D-glyceric acid\n",
      "N-Succinyl Methionine\n",
      "2-Isobutyl-3-Methoxypyrazine\n",
      "N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide\n",
      "Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester\n",
      "6-deoxy-2-O-methyl-alpha-L-galactopyranose\n",
      "2-Deoxy-Glucitol-6-Phosphate\n",
      "Dipyrromethane Cofactor\n",
      "3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol\n",
      "Caprylic acid\n",
      "(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione\n",
      "GSHNA\n",
      "Dexfosfoserine\n",
      "Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate\n",
      "Malonyl-CoA\n",
      "2-(Carboxymethoxy)-5-[(2s)-2-({(2s)-2-[(3-Carboxypropanoyl)Amino] -3-Phenylpropanoyl}Amino)-3-Oxo-3-(Pentylamino)Propyl]Benzoic Acid\n",
      "L-Glycero-D-Manno-Heptopyranose\n",
      "Beta-Hydroxyasparagine\n",
      "2,4-Dinitrophenol\n",
      "Desvancosaminyl Vancomycin\n",
      "S,S-(2-Hydroxyethyl)Thiocysteine\n",
      "Benzylcysteine\n",
      "Indole\n",
      "2-Amino-P-Cresol\n",
      "5-Nitroindazole\n",
      "L-Tryptophanamide\n",
      "threo-3-methyl-L-aspartic acid\n",
      "Glyphosate\n",
      "Cholesterol\n",
      "(8ar)-Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione\n",
      "3'-Azido-3'-Deoxythymidine-5'-Diphosphate\n",
      "2,6-Diamino-8-(1h-Imidazol-2-Ylsulfanylmethyl)-3h-Quinazoline-4-One\n",
      "1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide\n",
      "Afegostat\n",
      "3-Deaza-Adenosine\n",
      "Inhibitor Bea409\n",
      "4-Deoxy-D-Glucuronic Acid\n",
      "4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide\n",
      "beta-D-fructofuranose 1,6-bisphosphate\n",
      "Niflumic Acid\n",
      "2-Oxobutanoic Acid\n",
      "8-Bromoadenosine-5'-Diphosphate\n",
      "Cytidine-5'-Diphosphate\n",
      "3-[(1s)-1-(Dimethylamino)Ethyl]Phenol\n",
      "Arachidonic Acid\n",
      "N-(Chlorophenyl)-N'-Hydroxyguanidine\n",
      "4,7-Dioxosebacic Acid\n",
      "4-Acetamido-2,4-Didexoy-D-Glycero-Beta-D-Galacto-Octopyranosylphosphonic Acid\n",
      "Tricarballylic Acid\n",
      "CRA_9678\n",
      "Gluconolactone\n",
      "4-(Acetylamino)-3-[(Hydroxyacetyl)Amino]Benzoic Acid\n",
      "Inosinic Acid\n",
      "Chromophore (Gly-Tyr-Gly)\n",
      "5-Aminoimidazole Ribonucleoside\n",
      "Formic Acid Benzyl Ester\n",
      "Latamoxef\n",
      "Trioxsalen\n",
      "Thiotepa\n",
      "Estriol\n",
      "Estrone sulfate\n",
      "Quinestrol\n",
      "Fleroxacin\n",
      "1-(1-phenylcyclopentyl)methylamine\n",
      "(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide\n",
      "N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-\n",
      "1-Methyl-2-quinolone\n",
      "1-benzylimidazole\n",
      "IMAZAQUIN\n",
      "5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid\n",
      "Phenyldehydroalanine\n",
      "DEHYDRO-2(S)-AMINO-6-BORONOHEXANOIC ACID\n",
      "2-bromophenol\n",
      "2'-O-BUTYL-5-METHYLURIDINE\n",
      "N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE\n",
      "(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID\n",
      "N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE\n",
      "3-Bromo-3-buten-1-ol\n",
      "3-({1-[3-CARBAMIMIDOYL-1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-PROPYLCARBAMOYL]-2-METHYL-BUTYLSULFAMOYL}-METHYL)-BENZOIC ACID\n",
      "3-hydroxyglutaric acid\n",
      "(E)-(4S,6S)-8-METHYL-6-((S)-3-METHYL-2-{(S)-2-[(5-METHYL-ISOXAZOLE-3-CARBONYL)-AMINO]-PROPIONYLAMINO}-BUTYRYLAMINO)-5-OXO-4-((R)-2-OXO-PYRROLIDIN-3-YLMETHYL)-NON-2-ENOIC ACID BENZYL ESTER\n",
      "4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-β-D-mannopyranosyl}-D-glucopyranuronic acid\n",
      "[4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE]\n",
      "2-AMINO-4-CHLORO-3-HYDROXYBENZOIC ACID\n",
      "Aniracetam\n",
      "4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE\n",
      "4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE\n",
      "PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE\n",
      "2'-DEOXY-5-FORMYLCYTIDINE-5'-MONOPHOSPHATE\n",
      "5-iodotubercidin\n",
      "5-Aminoisoquinoline\n",
      "2-[2-ETHANESULFONYLAMINO-3-(5-PROPOXY-1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIMIDOYL-BENZYLAMIDE)\n",
      "PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE\n",
      "9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE\n",
      "INHIBITOR Q8467 OF DUPONT MERCK\n",
      "7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin\n",
      "N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE\n",
      "(E)-(4S,6S)-6-((S)-2-{(S)-2-[(FURAN-2-CARBONYL)-AMINO]-3-METHYL-BUTYRYLAMINO}-3-METHYL-BUTYRYLAMINO)-8-METHYL-5-OXO-4-((R)-2-OXO-PYRROLIDIN-3-YLMETHYL)-NON-2-ENOIC ACID ETHYL ESTER\n",
      "(R)-tacrine(10)-hupyridone\n",
      "(S)-tacrine(10)-hupyridone\n",
      "TACRINE(8)-4-AMINOQUINOLINE\n",
      "(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM\n",
      "4,6-DIDEOXY-4-{[4-[(4-O-HEXOPYRANOSYLHEXOPYRANOSYL)OXY]-5,6-DIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}HEXOPYRANOSYL-(1->4)HEXOPYRANOSYL-(1->4)HEXOPYRANOSE\n",
      "ACETOPHENONE\n",
      "Cycloleucine\n",
      "N-ACETYLHISTAMINE\n",
      "2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE\n",
      "DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME)\n",
      "Apramycin\n",
      "Cyclouridine\n",
      "Allosamidin\n",
      "Aplyronine A\n",
      "Aldosterone\n",
      "Atpenin A5\n",
      "4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE\n",
      "N-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine\n",
      "N-BENZYLOXYCARBONYL-L-SERINE-BETALACTONE\n",
      "Glutamine t-butyl ester\n",
      "6-Bromo-1-hexanol\n",
      "2,5-DI-(TERT-BUTYL)-1,4,BENZOHYDROQUINONE\n",
      "Biphenylalanine\n",
      "Naphthalene-2,6-disulfonic acid\n",
      "3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID\n",
      "7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID\n",
      "4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID\n",
      "4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID\n",
      "5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID\n",
      "Dibromothymoquinone\n",
      "BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA\n",
      "S-propylamine-L-cysteine\n",
      "TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S\n",
      "5-[(3AS,4R,6AR)-2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL]PENTANOIC ACID\n",
      "BIOTINOL-5-AMP\n",
      "Corticosterone\n",
      "CBZ-LEU-LEU-TYR-CH2F\n",
      "4-PIPERIDIN-4-YLBUTANAL\n",
      "Metoprine\n",
      "1,3,4-TRIHYDROXY-5-(3-PHENOXYPROPYL)-CYCLOHEXANE-1-CARBOXYLIC A CID\n",
      "Carboxin\n",
      "(1S,2R,3S,4R,5S)-8-AZABICYCLO[3.2.1]OCTANE-1,2,3,4-TETROL\n",
      "(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE\n",
      "Choline alfoscerate\n",
      "Cis-tetracosenoyl sulfatide\n",
      "OLOMOUCINE II\n",
      "2-KETO-6-PHOSPHATE-D-GLUCONIC ACID, ALPHA-FURANOSE FORM\n",
      "Cyclohexyl-pentyl-maltoside\n",
      "Coumarin\n",
      "CHROMOPHORE (LYS-TYR-GLY)\n",
      "CHROMOPHORE (HIS-TYR-GLY)\n",
      "CHROMOPHORE (GLU-TYR-GLY)\n",
      "TRIAZOLOPYRIMIDINE\n",
      "L-CYSTEIN-S-1-(IMINOMETHYL)-L-ORNITHINE\n",
      "cyclic 3',5'-thymidine monophosphate\n",
      "4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE\n",
      "2-HYDROXY-3,5-DIIODOBENZOIC ACID\n",
      "Dansyllysine\n",
      "N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE\n",
      "H TYPE II TRISACCHARIDE\n",
      "H TYPE I TRISACCHARIDE\n",
      "GALACTOSE GREASE\n",
      "BETA-METHYLLACTOSIDE\n",
      "Octylphenoxy polyethoxyethanol\n",
      "(2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE\n",
      "BIS(HEXAMETHYLENE)TRIAMINE\n",
      "1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE\n",
      "CHROMOPHORE (ASP-TYR-GLY)\n",
      "DIMETHYL THIOPHOSPHATE\n",
      "Methylecgonine\n",
      "2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID\n",
      "Camptothecin\n",
      "2'-O-[1-ETHYL-1H-IMIDAZOL)] THYMIDINE-5'-MONOPHOSPHATE\n",
      "Ethyl (2E)-4-({(2S)-2-[(N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-valyl)amino]-2-phenylacetyl}amino)-5-[(3S)-2-oxo-3-pyrrolidinyl]-2-pentenoate\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE\n",
      "2,6-anhydro-3-deoxy-3-fluoronononic acid\n",
      "FARNESYL THIOPYROPHOSPHATE\n",
      "4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN\n",
      "TRANS-4-(GUANIDINOMETHYL)-CYCLOHEXANE-L-YL-D-3-CYCLOHEXYLALANYL-L-AZETIDINE-2-YL-D-TYROSINYL-L-HOMOARGININAMIDE\n",
      "N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE\n",
      "gamma-butyrolactone\n",
      "GLUTATHIONE SULFINATE\n",
      "S-METHYL-GLUTATHIONE\n",
      "S-[(2E)-3,7-DIMETHYLOCTA-2,6-DIENYL] TRIHYDROGENTHIODIPHOSPHATE\n",
      "HESPERIDIN\n",
      "20-hydroxycholesterol\n",
      "(3BETA)-CHOLEST-5-ENE-3,25-DIOL\n",
      "(3BETA,7BETA)-CHOLEST-5-ENE-3,7-DIOL\n",
      "Hydroxyfasudil\n",
      "(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE\n",
      "(3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE\n",
      "(E)-(S)-4-[(S)-4-METHYL-2-((S)-3-METHYL-2{(S)-2-[(5-METHYL-ISOXAZOLE-3- CARBONYL)-AMINO]-PROPIONYLAMINO}-BUTYRYLAMINO)-PENTANOYLAMINO]-5-((S)-2- OXO-PYRROLIDIN-3-YL)-PENT-2-ENOIC ACID ETHYL ESTER\n",
      "Iodipamide\n",
      "ANILINOMETHYL GLUCO-PHENYLIMIDAZOLE\n",
      "4-Iodo-D-phenylalanine\n",
      "ISOPENTENYL PYROPHOSPHATE\n",
      "IMIDAZOPYRIDAZIN 1\n",
      "2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE\n",
      "2''-O-[N-(3-(aminopropyl)2-aminoethyl]paromomycin\n",
      "(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-β-L-idopyranosyl)-2-O-{2-[(piperidin-3-ylmethyl)amino]ethyl}-β-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-α-D-glucopyranoside\n",
      "DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE\n",
      "S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE\n",
      "N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE\n",
      "2-(3-CHLORO-6-{[2,2-DIFLUORO-2-(1-OXIDOPYRIDIN-2-YL)ETHYL]AMINO}-1-OXIDOPYRIDIN-2-YL)-N-[1-(3-CHLOROPHENYL)ETHYL]ACETAMIDE\n",
      "2-(3-GUANIDINOPHENYL)-3-MERCAPTOPROPANOIC ACID\n",
      "(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE\n",
      "Licofelone\n",
      "7,8,10-TRIMETHYLBENZO[G]PTERIDINE-2,4(3H,10H)-DIONE\n",
      "N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA\n",
      "Lividomycin A\n",
      "GENTAMICIN C1A\n",
      "1-ACETYL-2-LYSO-SN-GLYCERO-3-PHOSPHOETHANOLAMINE\n",
      "N-(4-MORPHOLINE)CARBONYL-B-(1-NAPHTHYL)-L-ALANINE-L-LEUCINE BORONIC ACID\n",
      "1,6-DI-O-PHOSPHONO-D-MANNITOL\n",
      "Citraconic acid\n",
      "MONOGALACTOSYL-DIACYLGLYCEROL\n",
      "2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE\n",
      "(S)-HYDROXY(PHENYL)ACETONITRILE\n",
      "Motuporin\n",
      "4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE\n",
      "MOXALACTAM (HYDROLYZED)\n",
      "Myxothiazol\n",
      "(2R)-2-{(1R)-2-oxo-1-[(2-thienylacetyl)amino]ethyl}-5,6-dihydro-2h-1,3-thiazine-4-carboxylic acid\n",
      "Nimesulide\n",
      "2-HYDROXY-1,4-NAPHTHOQUINONE\n",
      "2-OXOQUINOLINE\n",
      "(10E,12Z)-octadeca-10,12-dienoic acid\n",
      "11-TRANS-13-TRANS-15-CIS-OCTADECATRIENOIC ACID\n",
      "OXIMINOARYLSULFONAMIDE\n",
      "2-(3-OXO-PROPYLSULFANYLCARBONYL)-ETHANETHIOLATE\n",
      "OREGON GREEN 488 CARBOXYLATE\n",
      "Purvalanol A\n",
      "Phosphatidyl ethanol\n",
      "9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE\n",
      "GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE\n",
      "PROPYL-1-PHOSPHATE\n",
      "2-[(3,5-Dichloro-4-trioxidanylphenyl)amino]benzoic acid\n",
      "GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE\n",
      "2-[2-ETHANESULFONYLAMINO-3-(1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIM IDOYL-BENZYLAMIDE)\n",
      "PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)\n",
      "PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)\n",
      "PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]\n",
      "N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE\n",
      "1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM\n",
      "[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE\n",
      "N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE\n",
      "N-[1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-3-METHYLSULFANYL-PROPYL]-3-HYDROXY-2-PROPOXYAMINO-BUTYRAMID\n",
      "Pyrithiamine Pyrophosphate\n",
      "5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE\n",
      "O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL\n",
      "1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE\n",
      "1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE\n",
      "METHYL (3R)-3-{[(3R)-3-{[(3R)-3-HYDROXYBUTANOYL]OXY}BUTANOYL]OXY}BUTANOATE\n",
      "Reidispongiolide A\n",
      "Reidispongiolide C\n",
      "(2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol\n",
      "(R)-4-Nitrostyrene oxide\n",
      "SC45647\n",
      "ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE\n",
      "Sulfatide\n",
      "5-hydroxyvaleric acid\n",
      "(S)-4-Nitrostyrene oxide\n",
      "Sphinxolide B\n",
      "(R)-1-phenylethanol\n",
      "Streptolydigin\n",
      "Suramin\n",
      "Tanaproget\n",
      "Tagetitoxin\n",
      "5-methyltetrahydrofolic acid\n",
      "2,5-bis-o-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-d-glucitol\n",
      "2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL\n",
      "2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL\n",
      "1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol\n",
      "Bifonazole\n",
      "Thenoyltrifluoroacetone\n",
      "Inecalcitol\n",
      "Triazolopyridine\n",
      "THIO-ATPA\n",
      "5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole\n",
      "1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID\n",
      "(11E)-OCTADEC-11-ENOIC ACID\n",
      "D-ERITHRO-2,3-DIAMINO-BUTYRIC ACID\n",
      "Verdoheme\n",
      "L-threo-2,3-diamino-butyric acid\n",
      "Virginiamycin S1\n",
      "(5-BROMO-4-CHLORO-3-INDOLYL)-A-D-MANNOSE\n",
      "4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE\n",
      "Neamine\n",
      "SALOPHEN-10-PROPIONATE IRON CHELATE\n",
      "Salophen-10-carboxylate iron chelate\n",
      "Salophen iron chelate\n",
      "Benoxaprofen\n",
      "Bithionol\n",
      "Bunamiodyl\n",
      "Clioquinol\n",
      "Danthron\n",
      "Metamizole\n",
      "Iproniazid\n",
      "Methapyrilene\n",
      "Nialamide\n",
      "Nomifensine\n",
      "Oxeladin\n",
      "Oxyphenisatin\n",
      "Phenolphthalein\n",
      "Prenylamine\n",
      "Thenalidine\n",
      "Ethyl carbamate\n",
      "Zomepirac\n",
      "Lysergic Acid Diethylamide\n",
      "Buformin\n",
      "Ticrynafen\n",
      "Zimelidine\n",
      "Methaqualone\n",
      "Rapacuronium\n",
      "Maraviroc\n",
      "Amineptine\n",
      "Clofedanol\n",
      "Cyclandelate\n",
      "Cyproterone acetate\n",
      "Debrisoquin\n",
      "Flunarizine\n",
      "Fluspirilene\n",
      "Mepenzolate\n",
      "Tetrabenazine\n",
      "Ixabepilone\n",
      "Celiprolol\n",
      "Roxadustat\n",
      "AZD0947\n",
      "Cediranib\n",
      "Posizolid\n",
      "Biricodar dicitrate\n",
      "Implitapide\n",
      "Binodenoson\n",
      "Febuxostat\n",
      "Dronedarone\n",
      "Dexloxiglumide\n",
      "Brasofensine\n",
      "Tirapazamine\n",
      "Zanapezil\n",
      "Isatoribine\n",
      "Nebivolol\n",
      "Merimepodib\n",
      "Lefradafiban\n",
      "Huperzine A\n",
      "Omacetaxine mepesuccinate\n",
      "Halofuginone\n",
      "Lintitript\n",
      "Nilotinib\n",
      "Olcegepant\n",
      "Oleoyl-estrone\n",
      "Lorcaserin\n",
      "Osanetant\n",
      "Piboserod\n",
      "Picoplatin\n",
      "Pralnacasan\n",
      "Vildagliptin\n",
      "Voacamine\n",
      "Voglibose\n",
      "Vatalanib\n",
      "Enoximone\n",
      "Elacridar\n",
      "Edotecarin\n",
      "Darusentan\n",
      "Dapoxetine\n",
      "Cilansetron\n",
      "Calanolide A\n",
      "Brecanavir\n",
      "Bifeprunox\n",
      "Bicifadine\n",
      "Bepotastine\n",
      "Becocalcidiol\n",
      "Phenserine\n",
      "AZD3409\n",
      "Vapreotide\n",
      "Milnacipran\n",
      "Ximelagatran\n",
      "Pagoclone\n",
      "Tesmilifene\n",
      "Flibanserin\n",
      "Sitamaquine\n",
      "Oxibendazole\n",
      "Oritavancin\n",
      "Stannsoporfin\n",
      "Idronoxil\n",
      "Renzapride\n",
      "Ceftobiprole\n",
      "Clevidipine\n",
      "Itopride\n",
      "Neramexane\n",
      "NM100060\n",
      "XP12B\n",
      "DG031\n",
      "Permethrin\n",
      "Afamelanotide\n",
      "Eritoran\n",
      "Rifalazil\n",
      "Tagatose\n",
      "Ospemifene\n",
      "Crofelemer\n",
      "Tamibarotene\n",
      "LX201\n",
      "Acadesine\n",
      "Iloperidone\n",
      "Altropane\n",
      "Lofexidine\n",
      "Pirfenidone\n",
      "Ramoplanin\n",
      "Ezogabine\n",
      "Tecadenoson\n",
      "Pumactant\n",
      "Azimilide\n",
      "Tipifarnib\n",
      "Troxacitabine\n",
      "Lucanthone\n",
      "PH94B\n",
      "Lesopitron\n",
      "Reglixane\n",
      "Canfosfamide\n",
      "AP1903\n",
      "Banoxantrone\n",
      "Plitidepsin\n",
      "SP1049C\n",
      "Lemuteporfin\n",
      "Talampanel\n",
      "Denufosol\n",
      "XL784\n",
      "AP5346\n",
      "AT1022\n",
      "Satraplatin\n",
      "ATL1102\n",
      "AGRO100\n",
      "MBO7133\n",
      "PSN9301\n",
      "Imexon\n",
      "AC162352\n",
      "CCX282\n",
      "Apadenoson\n",
      "SGS-742\n",
      "EG004\n",
      "XEN2174\n",
      "Ingenol Mebutate\n",
      "XL999\n",
      "Belinostat\n",
      "Ataluren\n",
      "YSIL6\n",
      "Migalastat\n",
      "ANA380\n",
      "EMZ702\n",
      "Amonafide\n",
      "ATL1101\n",
      "CTA018\n",
      "Arimoclomol\n",
      "DG041\n",
      "Lancovutide\n",
      "XP19986\n",
      "REV131\n",
      "INCB7839\n",
      "Ularitide\n",
      "Eprotirome\n",
      "Grn163l\n",
      "AT7519\n",
      "Anatibant\n",
      "Indacaterol\n",
      "RP101\n",
      "SGS518\n",
      "GSK159797\n",
      "PSN357\n",
      "Obinepitide\n",
      "V1003\n",
      "CX717\n",
      "Cannabinor\n",
      "DDP733\n",
      "ADL5859\n",
      "BZL101\n",
      "MF101\n",
      "MB-07803\n",
      "AN0128\n",
      "RG2417\n",
      "EGS21\n",
      "Erdosteine\n",
      "ILY101\n",
      "R1626\n",
      "GFT14\n",
      "Mitoquinone\n",
      "INCB13739\n",
      "ATG002\n",
      "ATG003\n",
      "ADX10059\n",
      "ACE393\n",
      "AV608\n",
      "SRT501\n",
      "TG-100801\n",
      "Fenretinide\n",
      "SLV319\n",
      "AER001\n",
      "HY10275\n",
      "OBE101\n",
      "JB991\n",
      "ARX201\n",
      "TM30339\n",
      "Ganaxolone\n",
      "Tiomolibdate ion\n",
      "FP0011\n",
      "M0002\n",
      "CDP323\n",
      "AX200\n",
      "Cimicoxib\n",
      "LY2140023\n",
      "Leptin\n",
      "Ancrod\n",
      "Prinomastat\n",
      "Rupintrivir\n",
      "AN-9\n",
      "Asimadoline\n",
      "Pleconaril\n",
      "16-Bromoepiandrosterone\n",
      "EHT899\n",
      "Trabectedin\n",
      "AP5280\n",
      "105AD7\n",
      "EHC18\n",
      "NN344\n",
      "Thymectacin\n",
      "R1204\n",
      "Rilapladib\n",
      "AT1391\n",
      "R1295\n",
      "Gemcabene\n",
      "ARC183\n",
      "SC12267\n",
      "PYM50018\n",
      "ANA971\n",
      "Aminocandin\n",
      "Elsamitrucin\n",
      "INCB3284\n",
      "TTP889\n",
      "ND1251\n",
      "VP025\n",
      "Tanespimycin\n",
      "Vibriolysin\n",
      "Lobeline\n",
      "LY2181308\n",
      "ND7001\n",
      "OXI-4503\n",
      "PEV3A\n",
      "TH0318\n",
      "XL820\n",
      "CYT997\n",
      "CG0070\n",
      "XL844\n",
      "CAD106\n",
      "TST10088\n",
      "NGX267\n",
      "Pretomanid\n",
      "CR665\n",
      "SL017\n",
      "KC706\n",
      "PM02734\n",
      "CCX915\n",
      "Topsalysin\n",
      "Elafin\n",
      "PV903\n",
      "LY2275796\n",
      "APD668\n",
      "Vintafolide\n",
      "AT9283\n",
      "Benzimate\n",
      "E-2012\n",
      "AT3022\n",
      "PTC299\n",
      "CX501\n",
      "DG051\n",
      "DLO6001\n",
      "DLO6002\n",
      "LX6171\n",
      "BTA798\n",
      "AS1409\n",
      "MLN0415\n",
      "XL228\n",
      "TRO19622\n",
      "SQ-109\n",
      "Elafibranor\n",
      "KD3010\n",
      "EPC2407\n",
      "XL281\n",
      "Atl146e\n",
      "MB07811\n",
      "KB002\n",
      "ADC4022\n",
      "ACR325\n",
      "Sofalcone\n",
      "CYC116\n",
      "LX1031\n",
      "AT2220\n",
      "V24343\n",
      "SPP1148\n",
      "XL418\n",
      "CX157\n",
      "SD118\n",
      "SYM001\n",
      "SF1126\n",
      "PS386113\n",
      "HE3286\n",
      "KD7040\n",
      "GMX1777\n",
      "Crisaborole\n",
      "Alisertib\n",
      "Pracinostat\n",
      "REP8839\n",
      "AM103\n",
      "BTA9881\n",
      "APD791\n",
      "RDEA806\n",
      "Beraprost\n",
      "AC3056\n",
      "Tetrodotoxin\n",
      "AP1081\n",
      "LGD2941\n",
      "NRP409\n",
      "Cobimetinib\n",
      "XL765\n",
      "XL019\n",
      "G4544\n",
      "Silver sulfadiazine\n",
      "Methsuximide\n",
      "FavId\n",
      "Fenoxaprop-ethyl\n",
      "Proellex\n",
      "Ronacaleret\n",
      "Gallium nitrate\n",
      "Oxypurinol\n",
      "Caprospinol\n",
      "NPI 32101\n",
      "Ecabet\n",
      "Ibudilast\n",
      "iCo-007\n",
      "Rotigotine\n",
      "Samarium (153Sm) lexidronam\n",
      "S-8184\n",
      "MCC\n",
      "CA4P\n",
      "SB-249553\n",
      "anecortave acetate\n",
      "Tarenflurbil\n",
      "SPP 301\n",
      "IDM-1\n",
      "IDM-2\n",
      "Vandetanib\n",
      "Eldecalcitol\n",
      "Motexafin lutetium\n",
      "Paclitaxel docosahexaenoic acid\n",
      "Tetomilast\n",
      "PTI-801\n",
      "LAX-101\n",
      "OMS-103HP\n",
      "WX-G250\n",
      "CHF-1512\n",
      "ANX-510\n",
      "TP-508\n",
      "FP-1096\n",
      "NVS antibody\n",
      "MP4\n",
      "MC-1\n",
      "Pimavanserin\n",
      "TAK-475\n",
      "ATG-Fresenius S\n",
      "INKP-102\n",
      "Ranirestat\n",
      "VGV-1\n",
      "TC-5231\n",
      "MN-305\n",
      "ATL-2502\n",
      "Arundic acid\n",
      "SO-101\n",
      "WL-1002\n",
      "AP-1034\n",
      "Dexlansoprazole\n",
      "Fx-1006A\n",
      "CMC 001\n",
      "SR-123781A\n",
      "SSR-126517E\n",
      "LIC-477\n",
      "ROX-888\n",
      "BF-200 ALA\n",
      "Actelion-1\n",
      "HZT-501\n",
      "NOVA-22007\n",
      "ACR-16\n",
      "CP-945598\n",
      "Rindopepimut\n",
      "Chlorfenson\n",
      "DOTMP HO-166\n",
      "Histamine\n",
      "Iodine\n",
      "Pimagedine\n",
      "Carbopol 974P\n",
      "PRO 2000\n",
      "AE-941\n",
      "WF10\n",
      "INS 316\n",
      "liposomal prostaglandin E1\n",
      "NOV-002\n",
      "Corticorelin\n",
      "Amibegron\n",
      "C31G\n",
      "Succinobucol\n",
      "ME-609\n",
      "CEP-1347\n",
      "AZD 3355\n",
      "GTI-2501\n",
      "TBC-3711\n",
      "Emricasan\n",
      "NCX 701\n",
      "NCX 1022\n",
      "Talmapimod\n",
      "Tifuvirtide\n",
      "Pipendoxifene\n",
      "OSI-461\n",
      "GW-501516\n",
      "GW 468816\n",
      "GW 597599\n",
      "ADX-10061\n",
      "gallium maltolate\n",
      "CP-122721\n",
      "OPC-14523\n",
      "ORG-34517\n",
      "Canertinib\n",
      "talactoferrin alpha\n",
      "motexafin gadolinium\n",
      "VLTS-589\n",
      "MLN-977\n",
      "DAS-431 IV\n",
      "rGLP-1\n",
      "ABT-510\n",
      "SRP 299\n",
      "Etiprednol dicloacetate\n",
      "ADL 10-0101\n",
      "Iroxanadine\n",
      "LJP 1082\n",
      "AVI-4557\n",
      "PX-12\n",
      "FM-VP4\n",
      "PYM50028\n",
      "P54\n",
      "PH-284\n",
      "Paliroden\n",
      "SR 121463\n",
      "ETC-588\n",
      "OSI-7904L\n",
      "Pozanicline\n",
      "Ezatiostat\n",
      "OPC-28326\n",
      "Chlorotoxin I-131\n",
      "ISS-1018\n",
      "NOX-700\n",
      "Tandutinib\n",
      "R673\n",
      "R667\n",
      "R411\n",
      "R450\n",
      "VX-702\n",
      "omega interferon\n",
      "QR-334\n",
      "T487\n",
      "Golotimod\n",
      "WX-UK1\n",
      "Pradefovir Mesylate\n",
      "CZEN 002\n",
      "PBI-1402\n",
      "Recombinant alpha 1-antitrypsin\n",
      "7-ethyl-10-hydroxycamptothecin\n",
      "PCL-016\n",
      "MDX-018\n",
      "Custirsen\n",
      "Technetium Tc-99m ciprofloxacin\n",
      "ACA 125\n",
      "T131\n",
      "ATN-161\n",
      "Epicept NP-1\n",
      "NX-1207\n",
      "Elacytarabine\n",
      "PG-530742\n",
      "KW-7158\n",
      "TAK-428\n",
      "AMD-070\n",
      "NM-702\n",
      "ISIS 113715\n",
      "VX-765\n",
      "LI-301\n",
      "Huperzine-A\n",
      "Piclidenoson\n",
      "Atiprimod\n",
      "Cobiprostone\n",
      "Managlinat dialanetil\n",
      "Budiodarone\n",
      "Mimopezil\n",
      "Telaprevir\n",
      "Pelitinib\n",
      "Mipomersen\n",
      "BMS-488043\n",
      "QR-333\n",
      "Alanosine\n",
      "Brivaracetam\n",
      "Naronapride\n",
      "INO-1001\n",
      "Regrelor\n",
      "Delcasertib\n",
      "Naluzotan\n",
      "PBT-1033\n",
      "Motesanib\n",
      "TRU-015\n",
      "Verubulin\n",
      "Facinicline\n",
      "Bedoradrine\n",
      "PRX-03140\n",
      "Beclanorsen\n",
      "PRX-08066\n",
      "MKC-1\n",
      "Apilimod\n",
      "CTCE-9908\n",
      "Retaspimycin\n",
      "Sodium stibogluconate\n",
      "ALT-2074\n",
      "Glypromate\n",
      "DDP-225\n",
      "KP-1461\n",
      "Larazotide\n",
      "OT-551\n",
      "VTP-201227\n",
      "IRX-5183\n",
      "faropenem medoxomil\n",
      "D-JNKI-1\n",
      "NP-50301\n",
      "Levoketoconazole\n",
      "Palifosfamide\n",
      "Apremilast\n",
      "Sotirimod\n",
      "Iodofiltic acid I-123\n",
      "Sivifene\n",
      "BL-1020\n",
      "CRx-119\n",
      "NPS-2143\n",
      "ALS-08\n",
      "13-deoxydoxorubicin\n",
      "GTS-21\n",
      "Gantacurium Chloride\n",
      "AZD-9684\n",
      "LY-517717\n",
      "Flovagatran\n",
      "Elesclomol\n",
      "CGC-11047\n",
      "ALKS 29\n",
      "PMI-001\n",
      "Strontium malonate\n",
      "Cefilavancin\n",
      "MIV-701\n",
      "Varespladib methyl\n",
      "Vapitadine\n",
      "RPI-78M\n",
      "AGS-005\n",
      "AGS-004\n",
      "CRx-139\n",
      "PF-03187207\n",
      "R-851\n",
      "MPI-674\n",
      "AVE-1625\n",
      "RP01\n",
      "ALKS 27\n",
      "VSF-173\n",
      "IPH 1101\n",
      "BF-37\n",
      "PAC-113\n",
      "DNB-001\n",
      "ATX-201\n",
      "ACP-104\n",
      "Andrographolide\n",
      "Alkaline Phosphatase\n",
      "LCP-AtorFen\n",
      "LLL-3348\n",
      "Rabeximod\n",
      "CRx-401\n",
      "Col-118\n",
      "Oglufanide\n",
      "ATX-101\n",
      "LGD-1550\n",
      "Irofulven\n",
      "MX6\n",
      "SR 140333\n",
      "Perflubron\n",
      "Arylacenamide\n",
      "YKP-10A\n",
      "Daglutril\n",
      "TNX-901\n",
      "NOX-100\n",
      "Alethine\n",
      "GTI 2040\n",
      "ISIS 14803\n",
      "Prasterone sulfate\n",
      "NS-2359\n",
      "Cositecan\n",
      "PI-88\n",
      "99mTc-glucarate\n",
      "Abiraterone\n",
      "GPI-1485\n",
      "Laromustine\n",
      "DP-b99\n",
      "DP-VPA\n",
      "CNS-5161\n",
      "NCX 1015\n",
      "Prolease-r-hFSH\n",
      "LU-31130\n",
      "Trestolone\n",
      "ING-1\n",
      "PPI-1019\n",
      "lymphotoxin beta receptor\n",
      "OC-1012\n",
      "NS-3728\n",
      "OSI-7836\n",
      "OPC-51803\n",
      "BG-777\n",
      "AGI-1096\n",
      "AI-128\n",
      "AI-850\n",
      "trans NV-04\n",
      "NV-07a\n",
      "Mito-4509\n",
      "NCX 950\n",
      "Biomed 101\n",
      "CLX-0921\n",
      "Rivanicline\n",
      "CPD 923\n",
      "PI-166\n",
      "PEG-Infergen\n",
      "Tasquinimod\n",
      "PPI-2458\n",
      "VIT-100\n",
      "ETC-1001\n",
      "Ciluprevir\n",
      "Ethyl pyruvate\n",
      "UC-781\n",
      "AVI-4020\n",
      "AEOL 10150\n",
      "PDE4\n",
      "MBT-0312\n",
      "EHT 0202\n",
      "CHF 4227\n",
      "HCV-086\n",
      "Seletracetam\n",
      "NV-18\n",
      "TAFA-93\n",
      "MEM 1414\n",
      "VEGF-AS\n",
      "GT 389-255\n",
      "Sirna-027\n",
      "rhIGFBP-3\n",
      "CERE-110\n",
      "IT-101\n",
      "KOS-1584\n",
      "BLX-883\n",
      "TD-2749\n",
      "RUS 3108\n",
      "REN-850\n",
      "OSI-930\n",
      "LS11\n",
      "DDP-200\n",
      "RTA 744\n",
      "NLX-P101\n",
      "Dovitinib\n",
      "GPI-0100\n",
      "SB-559448\n",
      "Pegdinetanib\n",
      "Denibulin\n",
      "CVT-6883\n",
      "Edonerpic\n",
      "MK-0354\n",
      "Resatorvid\n",
      "Varlitinib\n",
      "MDX-1303\n",
      "Contulakin-G\n",
      "EVT-101\n",
      "ENMD-1198\n",
      "PPL-100\n",
      "TAS-108\n",
      "ANZ-100\n",
      "PR-104\n",
      "SNS-032\n",
      "Archexin\n",
      "Inosine 5'-sulfate\n",
      "Transcrocetinate\n",
      "Bardoxolone methyl\n",
      "RAF-265\n",
      "Obeticholic acid\n",
      "Plinabulin\n",
      "PRX-07034\n",
      "Adomiparin\n",
      "Aldoxorubicin\n",
      "Cariprazine\n",
      "AV-412\n",
      "PA-1050040\n",
      "Filanesib\n",
      "ZEN-012\n",
      "XTL-6865\n",
      "AZD-8330\n",
      "CAM-2029\n",
      "KAI-1455\n",
      "XMT-1001\n",
      "SNX-5422\n",
      "DTS-201\n",
      "CTS-21166\n",
      "Linsitinib\n",
      "Lumateperone\n",
      "ABT-869\n",
      "Caplacizumab\n",
      "PX-478\n",
      "Tapinarof\n",
      "Friulimicin B\n",
      "ICA-105665\n",
      "Bradanicline\n",
      "Evofosfamide\n",
      "ABT-560\n",
      "Apatorsen\n",
      "NXN-188\n",
      "GSK-923295\n",
      "PRLX 93936\n",
      "VX-148\n",
      "Eldelumab\n",
      "1alpha,24S-Dihydroxyvitamin D2\n",
      "Cenobamate\n",
      "L-aminocarnityl-succinyl-leucyl-argininal-diethylacetal\n",
      "KRP-104\n",
      "SVV-001\n",
      "SNS-314\n",
      "KX-01\n",
      "IRL-1620\n",
      "SUVN-502\n",
      "Sertindole\n",
      "Spiramycin\n",
      "Sulfathiazole\n",
      "Mianserin\n",
      "Teicoplanin\n",
      "Sulfadimethoxine\n",
      "Acetylcysteine\n",
      "Nylidrin\n",
      "Pizotifen\n",
      "Pentaerythritol Tetranitrate\n",
      "Rimonabant\n",
      "Tesofensine\n",
      "Istaroxime\n",
      "Rubitecan\n",
      "Garenoxacin\n",
      "Opebacan\n",
      "Plevitrexed\n",
      "Fosdevirine\n",
      "Indibulin\n",
      "Noscapine\n",
      "Romidepsin\n",
      "Glufosfamide\n",
      "Talotrexin\n",
      "Darinaparsin\n",
      "Talabostat\n",
      "Forodesine\n",
      "Valtorcitabine\n",
      "Ispinesib\n",
      "Solabegron\n",
      "Zosuquidar\n",
      "Pixantrone\n",
      "Elocalcitol\n",
      "Seliciclib\n",
      "Icatibant\n",
      "Bimosiamose\n",
      "Alovudine\n",
      "Atrasentan\n",
      "Tedisamil\n",
      "Rufinamide\n",
      "Lasofoxifene\n",
      "Alogliptin\n",
      "Tapentadol\n",
      "Sugammadex\n",
      "Silodosin\n",
      "Prasugrel\n",
      "Eltrombopag\n",
      "Doripenem\n",
      "Tolvaptan\n",
      "Regadenoson\n",
      "Ferumoxytol\n",
      "Asenapine\n",
      "Vernakalant\n",
      "Lacosamide\n",
      "Dalbavancin\n",
      "Alicaforsen\n",
      "Rivaroxaban\n",
      "Ocaperidone\n",
      "Nalmefene\n",
      "Caldaret\n",
      "Ridaforolimus\n",
      "Maribavir\n",
      "Vadimezan\n",
      "Elvucitabine\n",
      "Avanafil\n",
      "Tariquidar\n",
      "Eflornithine\n",
      "Exisulind\n",
      "CX516\n",
      "Amelubant\n",
      "Arzoxifene\n",
      "Fluasterone\n",
      "Dersalazine\n",
      "Thioctic acid tromethamine\n",
      "Incadronic acid\n",
      "Bimoclomol\n",
      "Aviptadil\n",
      "Hexaminolevulinate\n",
      "Droxidopa\n",
      "Amrubicin\n",
      "Tolperisone\n",
      "Lonidamine\n",
      "Udenafil\n",
      "Sitaxentan\n",
      "MAHDL01\n",
      "Maxacalcitol\n",
      "Alvimopan\n",
      "Tanomastat\n",
      "Senicapoc\n",
      "Torcetrapib\n",
      "Levocetirizine\n",
      "Ziconotide\n",
      "Temsirolimus\n",
      "Amisulpride\n",
      "Simeprevir\n",
      "Dapagliflozin\n",
      "Pegnivacogin\n",
      "Pramiconazole\n",
      "LX-2931\n",
      "Glesatinib\n",
      "Onalespib\n",
      "Apoptone\n",
      "Refametinib\n",
      "Darapladib\n",
      "Pegpleranib\n",
      "Methoxyamine\n",
      "4-O-Demethylpenclomedine\n",
      "Tucidinostat\n",
      "Saxagliptin\n",
      "Elsiglutide\n",
      "Fiboflapon\n",
      "Tezampanel\n",
      "Iclaprim\n",
      "Lucatumumab\n",
      "Becatecarin\n",
      "Sapacitabine\n",
      "Relacatib\n",
      "Alamifovir\n",
      "Indisulam\n",
      "CHGN111\n",
      "Xaliproden\n",
      "Abafungin\n",
      "Nicaraven\n",
      "Vitespen\n",
      "Bazedoxifene\n",
      "Telavancin\n",
      "Ambrisentan\n",
      "Idraparinux\n",
      "Taribavirin\n",
      "Doxercalciferol\n",
      "Oxymetholone\n",
      "Armodafinil\n",
      "Etravirine\n",
      "Calfactant\n",
      "Cethromycin\n",
      "Annamycin\n",
      "Declopramide\n",
      "Ticalopride\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Talnetant\n",
      "Evernimicin\n",
      "Tezacitabine\n",
      "Repifermin\n",
      "Tarazepide\n",
      "Semaxanib\n",
      "Tifacogin\n",
      "Tyloxapol\n",
      "Ravuconazole\n",
      "Cangrelor\n",
      "Avasimibe\n",
      "Dexanabinol\n",
      "Diethylnorspermine\n",
      "Dotarizine\n",
      "Lonafarnib\n",
      "Ilodecakin\n",
      "Aprinocarsen\n",
      "Mirostipen\n",
      "Sarizotan\n",
      "Meclinertant\n",
      "Tecastemizole\n",
      "Remacemide\n",
      "Enrasentan\n",
      "Squalamine\n",
      "Cariporide\n",
      "Lestaurtinib\n",
      "clomethiazole\n",
      "Naxifylline\n",
      "Fradafiban\n",
      "Sumanirole\n",
      "Porfiromycin\n",
      "Propentofylline\n",
      "Prucalopride\n",
      "Manitimus\n",
      "ALGRX 1207\n",
      "Ropidoxuridine\n",
      "Enzastaurin\n",
      "Velafermin\n",
      "Sufugolix\n",
      "S-8510\n",
      "Repinotan\n",
      "Muraglitazar\n",
      "Deramciclane\n",
      "Resiniferatoxin\n",
      "Edaglitazone\n",
      "Ertiprotafib\n",
      "Levovirin\n",
      "Ganstigmine\n",
      "Tramiprosate\n",
      "Ocinaplon\n",
      "Resiquimod\n",
      "Pafuramidine\n",
      "Ragaglitazar\n",
      "Etilevodopa\n",
      "Tesaglitazar\n",
      "Robalzotan\n",
      "Astaxanthin\n",
      "Minodronic acid\n",
      "Labradimil\n",
      "Gaboxadol\n",
      "Siramesine\n",
      "Edifoligide\n",
      "Tezosentan\n",
      "Lanimostim\n",
      "Emfilermin\n",
      "alpha-Hydroxy glycineamide\n",
      "Rebimastat\n",
      "Valomaciclovir\n",
      "Tonabersat\n",
      "Adipiplon\n",
      "Celgosivir\n",
      "Bevirimat\n",
      "Dextofisopam\n",
      "Fipamezole\n",
      "Cetilistat\n",
      "Mitemcinal\n",
      "Triphendiol\n",
      "Pazopanib\n",
      "Ceftaroline fosamil\n",
      "Agomelatine\n",
      "Midostaurin\n",
      "Brostallicin\n",
      "Nemonoxacin\n",
      "Panobinostat\n",
      "Ilepatril\n",
      "Apixaban\n",
      "Tafenoquine\n",
      "Odiparcil\n",
      "Omiganan\n",
      "Peramivir\n",
      "Bosutinib\n",
      "Amdoxovir\n",
      "Aplindore\n",
      "Flupirtine\n",
      "Taranabant\n",
      "Vipadenant\n",
      "Axitinib\n",
      "Zibotentan\n",
      "Anacetrapib\n",
      "Casopitant\n",
      "Otamixaban\n",
      "Isavuconazonium\n",
      "Dalfampridine\n",
      "Quarfloxin\n",
      "Fispemifene\n",
      "Perifosine\n",
      "Anamorelin\n",
      "Priralfinamide\n",
      "Vicriviroc\n",
      "Safinamide\n",
      "TAS-106\n",
      "Valrocemide\n",
      "Rostaporfin\n",
      "Saredutant\n",
      "Pasireotide\n",
      "Lixivaptan\n",
      "prGCD\n",
      "Arverapamil\n",
      "Odanacatib\n",
      "Almorexant\n",
      "Clazosentan\n",
      "Esmirtazapine\n",
      "Amediplase\n",
      "Asoprisnil\n",
      "Naproxcinod\n",
      "Clevudine\n",
      "Vilazodone\n",
      "Laquinimod\n",
      "Ethanolamine Oleate\n",
      "Nitrous oxide\n",
      "Mepyramine\n",
      "Mevastatin\n",
      "Xylometazoline\n",
      "Dabigatran etexilate\n",
      "Arbekacin\n",
      "Artemether\n",
      "Betahistine\n",
      "Degarelix\n",
      "Desvenlafaxine\n",
      "Dexmethylphenidate\n",
      "Fesoterodine\n",
      "Gadobutrol\n",
      "Iobenguane\n",
      "Gadofosveset trisodium\n",
      "Isometheptene\n",
      "Levonordefrin\n",
      "Lumefantrine\n",
      "Methacholine\n",
      "Methyltestosterone\n",
      "Naphazoline\n",
      "Nilvadipine\n",
      "Norelgestromin\n",
      "Propylhexedrine\n",
      "Potassium Iodide\n",
      "Fospropofol\n",
      "Fosaprepitant\n",
      "Stanozolol\n",
      "Gimatecan\n",
      "Aluminum hydroxide\n",
      "Calcium Carbonate\n",
      "Lornoxicam\n",
      "Bufuralol\n",
      "Sparteine\n",
      "Aniline\n",
      "Sulfaphenazole\n",
      "Gestodene\n",
      "Seproxetine\n",
      "beta-Naphthoflavone\n",
      "Bafilomycin A1\n",
      "Bafilomycin B1\n",
      "Enclomiphene\n",
      "Aceclofenac\n",
      "Zaltoprofen\n",
      "Ketobemidone\n",
      "Seratrodast\n",
      "BW-A 58C\n",
      "Gavestinel\n",
      "Ambroxol\n",
      "ginkgolide-A\n",
      "ginkgolide-B\n",
      "ginkgolide-C\n",
      "ginkgolide-J\n",
      "ginkgolide-M\n",
      "Ginsenoside C\n",
      "ginsenoside Rb1\n",
      "Ginsenoside Rg1\n",
      "Drotaverine\n",
      "Danaparoid\n",
      "Beta carotene\n",
      "Glycine betaine\n",
      "Manganese\n",
      "Pinacidil\n",
      "Saralasin\n",
      "Tetryzoline\n",
      "Alcaftadine\n",
      "Ammonium chloride\n",
      "Ammonium lactate\n",
      "Bendamustine\n",
      "Benzyl alcohol\n",
      "Besifloxacin\n",
      "Cabazitaxel\n",
      "Capsaicin\n",
      "Carglumic Acid\n",
      "Sodium cellulose phosphate\n",
      "Chenodeoxycholic acid\n",
      "Cupric sulfate\n",
      "Dalteparin\n",
      "Desoxycorticosterone acetate\n",
      "Difluprednate\n",
      "Dimercaprol\n",
      "Prussian blue\n",
      "Gallium citrate Ga 67\n",
      "Ganirelix\n",
      "Halcinonide\n",
      "Hexocyclium\n",
      "Histrelin\n",
      "Hydroxyprogesterone caproate\n",
      "Lanreotide\n",
      "Lanthanum carbonate\n",
      "Levopropoxyphene\n",
      "Lodoxamide\n",
      "Mafenide\n",
      "Mangafodipir\n",
      "Mebutamate\n",
      "Methenamine\n",
      "Methylnaltrexone\n",
      "Monoctanoin\n",
      "Nepafenac\n",
      "Niclosamide\n",
      "Nonoxynol-9\n",
      "Pentetate calcium trisodium\n",
      "Pentetate zinc trisodium\n",
      "Phenyl aminosalicylate\n",
      "Plerixafor\n",
      "Plicamycin\n",
      "Polidocanol\n",
      "Povidone-iodine\n",
      "Pralatrexate\n",
      "Protokylol\n",
      "Pyrithione zinc\n",
      "Pyrvinium\n",
      "Raltegravir\n",
      "Phenylbutyric acid\n",
      "Sulconazole\n",
      "Sulfameter\n",
      "Tinzaparin\n",
      "Tiopronin\n",
      "Triethylenetetramine\n",
      "Triptorelin\n",
      "Unoprostone\n",
      "Viomycin\n",
      "5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole\n",
      "4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID\n",
      "(1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID)\n",
      "2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE\n",
      "2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL\n",
      "1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE\n",
      "N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide\n",
      "(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID\n",
      "N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide\n",
      "(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide\n",
      "methyl L-phenylalaninate\n",
      "N-(ethoxycarbonyl)-L-leucine\n",
      "diethyl [(1R)-1,5-diaminopentyl]boronate\n",
      "D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-prolinamide\n",
      "(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one\n",
      "2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE\n",
      "4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE\n",
      "(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide\n",
      "5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine\n",
      "1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine\n",
      "1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine\n",
      "(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide\n",
      "N-(pyridin-3-ylmethyl)aniline\n",
      "4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE\n",
      "N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide\n",
      "6-fluoro-2-(2-hydroxy-3-isobutoxy-phenyl)-1H-benzoimidazole-5-carboxamidine\n",
      "6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE\n",
      "N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE\n",
      "N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide\n",
      "N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE\n",
      "2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione\n",
      "6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE\n",
      "2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID\n",
      "2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID\n",
      "6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID\n",
      "6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID\n",
      "3,6,9,12,15,18-HEXAOXAICOSANE\n",
      "N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide\n",
      "1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE\n",
      "17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE\n",
      "17-METHYL-17-ALPHA-DIHYDROEQUILENIN\n",
      "1-((2-HYDROXYETHOXY)METHYL)-5-(PHENYLTHIO)PYRIMIDINE-2,4(1H,3H)-DIONE\n",
      "1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE\n",
      "(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL\n",
      "3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE\n",
      "N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE\n",
      "N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE\n",
      "1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide\n",
      "5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE\n",
      "(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE\n",
      "(1Z)-2-HYDROXY-3-OXOHEX-1-EN-1-YL DIHYDROGEN PHOSPHATE\n",
      "1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea\n",
      "1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea\n",
      "4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE\n",
      "3-[({(1E)-[2-(trifluoromethyl)phenyl]methylidene}amino)oxy]propanoic acid\n",
      "N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL\n",
      "[(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid\n",
      "(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE\n",
      "3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one\n",
      "(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE\n",
      "5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE\n",
      "(5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide\n",
      "1-DECANE-SULFONIC-ACID\n",
      "1-DODECANOL\n",
      "1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide\n",
      "3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol\n",
      "4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol\n",
      "N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE\n",
      "1-[4-(hydroxymethyl)phenyl]guanidine\n",
      "2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL\n",
      "4-(1-methyl-1-phenylethyl)phenol\n",
      "(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid\n",
      "(5S,6S)-6-[(R)ACETOXYETH-2-YL]-PENEM-3-CARBOXYLATEPROPANE\n",
      "(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid\n",
      "2-AMINO-4-HYDROXYPYRIMIDINE-5-CARBOXYLIC ACID ETHYL ESTER\n",
      "2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID\n",
      "(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID\n",
      "1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide\n",
      "[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE\n",
      "D-leucyl-N-(3-chlorobenzyl)-L-prolinamide\n",
      "UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE\n",
      "(2R,3R)-3-{[3,5-BIS(TRIFLUOROMETHYL)PHENYL]AMINO}-2-CYANO-3-THIOXOPROPANAMIDE\n",
      "1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE\n",
      "naphthalene-1,2,4,5,7-pentol\n",
      "N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE\n",
      "(4-fluorophenyl)(pyridin-4-yl)methanone\n",
      "2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE\n",
      "D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide\n",
      "Eribaxaban\n",
      "(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID\n",
      "2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid\n",
      "2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE\n",
      "(2R)-2-benzyl-3-nitropropanoic acid\n",
      "3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE\n",
      "(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid\n",
      "[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE\n",
      "(2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID\n",
      "1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide\n",
      "N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide\n",
      "(1-HYDROXYNONANE-1,1-DIYL)BIS(PHOSPHONIC ACID)\n",
      "10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine\n",
      "N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide\n",
      "(1R)-3-chloro-1-phenylpropan-1-ol\n",
      "2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID\n",
      "N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide\n",
      "4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL\n",
      "4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide\n",
      "N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE\n",
      "N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide\n",
      "(Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide\n",
      "N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide\n",
      "(3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol\n",
      "N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide\n",
      "N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide\n",
      "(2S,3S)-3-(4-fluorophenyl)-2,3-dihydroxypropanoic acid\n",
      "1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide\n",
      "2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE\n",
      "N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]naphthalene-2-carbohydrazide\n",
      "4-chloro-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide\n",
      "(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid\n",
      "(2S)-2-HYDROXY-2H-CHROMENE-2-CARBOXYLIC ACID\n",
      "2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE\n",
      "2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate\n",
      "3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid\n",
      "N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE\n",
      "4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL\n",
      "5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE\n",
      "(2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine\n",
      "N-[(1R,2R,3E)-2-hydroxy-1-(hydroxymethyl)heptadec-3-en-1-yl]acetamide\n",
      "5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide\n",
      "(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone\n",
      "3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide\n",
      "5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE\n",
      "Hexylphosphonic acid (R)-2-methyl-3-phenylpropyl ester\n",
      "Hexylphosphonic acid (S)-2-methyl-3-phenylpropyl ester\n",
      "6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE\n",
      "1,1'-HEXANE-1,6-DIYLBIS(1H-IMIDAZOLE)\n",
      "2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide\n",
      "2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE\n",
      "N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA\n",
      "7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile\n",
      "4,4'-PROPANE-2,2-DIYLDIPHENOL\n",
      "5-hydroxy-4-(7-methoxy-1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-2-(3-methylbutyl)-6-phenylpyridazin-3(2H)-one\n",
      "1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA\n",
      "(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine\n",
      "N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]-4-methoxybenzohydrazide\n",
      "5-(dodecylthio)-1H-1,2,3-triazole-4-carboxylic acid\n",
      "(2S)-2-(1H-indol-3-yl)hexanoic acid\n",
      "(2S)-2-(1H-indol-3-yl)pentanoic acid\n",
      "(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid\n",
      "(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol\n",
      "(1R,2R,3R,4S,5R)-4-(BENZYLAMINO)-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL\n",
      "2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid\n",
      "2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE\n",
      "2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE\n",
      "2-HYDROXY-5-{[(1E)-2-PHENYLETHYLIDENE]AMINO}-L-TYROSINE\n",
      "{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID\n",
      "4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID\n",
      "N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide\n",
      "(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone\n",
      "(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine\n",
      "(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine\n",
      "N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide\n",
      "D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide\n",
      "2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide\n",
      "[(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid\n",
      "N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide\n",
      "N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide\n",
      "(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine\n",
      "4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile\n",
      "(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine\n",
      "2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide\n",
      "D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide\n",
      "9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE\n",
      "(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine\n",
      "4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE\n",
      "2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL\n",
      "N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE\n",
      "(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE\n",
      "6-AMINO-3,7-DIHYDRO-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE\n",
      "TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE\n",
      "2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole\n",
      "(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine\n",
      "(3R)-8-(dioxidosulfanyl)-3-methyl-1,2,3,4-tetrahydroquinoline\n",
      "(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one\n",
      "5-ETHYL-3-[(2-METHOXYETHYL)METHYLAMINO]-6-METHYL-4-(3-METHYLBENZYL)PYRIDIN-2(1H)-ONE\n",
      "N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE\n",
      "N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide\n",
      "(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine\n",
      "3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate\n",
      "(1R)-2-{[AMINO(IMINO)METHYL]AMINO}-1-{4-[(4R)-4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL]PHENYL}ETHYL NICOTINATE\n",
      "2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE\n",
      "3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE\n",
      "(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE\n",
      "D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide\n",
      "(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID\n",
      "4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE\n",
      "(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID\n",
      "3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid\n",
      "2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL\n",
      "5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE\n",
      "2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID\n",
      "(2E)-3-{3-[(5-ETHYL-3-IODO-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY]PHENYL}ACRYLONITRILE\n",
      "(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol\n",
      "(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL\n",
      "2-(cyclohexylamino)benzoic acid\n",
      "(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide\n",
      "2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide\n",
      "N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide\n",
      "7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide\n",
      "7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide\n",
      "3-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide\n",
      "(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol\n",
      "2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide\n",
      "2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID\n",
      "N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide\n",
      "(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine\n",
      "5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide\n",
      "3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER\n",
      "5'-S-ethyl-5'-thioadenosine\n",
      "2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID\n",
      "(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL\n",
      "2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione\n",
      "2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide\n",
      "(3S)-1-(2-hydroxyphenyl)-5-oxopyrrolidine-3-carboxylic acid\n",
      "5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione\n",
      "N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE\n",
      "3-(INDOL-3-YL) LACTATE\n",
      "1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL\n",
      "N-{3-[4-hydroxy-1-(3-methylbutyl)-2-oxo-1,2-dihydropyrrolo[1,2-b]pyridazin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl}methanesulfonamide\n",
      "{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID\n",
      "(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE\n",
      "5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine\n",
      "2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE\n",
      "(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE\n",
      "(4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID\n",
      "3-Hydroxyhippuric acid\n",
      "(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid\n",
      "(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENETHYL)GUANIDINE\n",
      "(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE\n",
      "5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one\n",
      "6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER\n",
      "3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE\n",
      "6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE\n",
      "(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENYL)GUANIDINE\n",
      "(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE\n",
      "3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol\n",
      "N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE\n",
      "(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE\n",
      "1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL\n",
      "beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide\n",
      "N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide\n",
      "2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID\n",
      "4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL\n",
      "4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL\n",
      "(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide\n",
      "N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide\n",
      "(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE\n",
      "(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide\n",
      "(2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE\n",
      "{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID\n",
      "1-(2,2'-bithiophen-5-yl)methanamine\n",
      "(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide\n",
      "6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE\n",
      "4-tert-butyl-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide\n",
      "4-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide\n",
      "N-[4-(benzyloxy)phenyl]glycinamide\n",
      "4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL\n",
      "PD-0325901\n",
      "(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid\n",
      "2-(4-METHYLPHENOXY)ETHYLPHOSPHINATE\n",
      "4-amino-N-[4-(benzyloxy)phenyl]butanamide\n",
      "2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE\n",
      "4-(DIMETHYLAMINO)BUTYL IMIDOTHIOCARBAMATE\n",
      "(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE\n",
      "4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID\n",
      "(2E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid\n",
      "4-(4-FLUOROBENZYL)PIPERIDINE\n",
      "(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid\n",
      "N-[(4-HYDROXY-8-IODOISOQUINOLIN-3-YL)CARBONYL]GLYCINE\n",
      "(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE\n",
      "4-[(METHYLSULFONYL)AMINO]BENZOIC ACID\n",
      "N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide\n",
      "1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE\n",
      "5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE\n",
      "Hymecromone\n",
      "1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL\n",
      "N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE\n",
      "4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE\n",
      "1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine\n",
      "N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE\n",
      "(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE\n",
      "4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid\n",
      "O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE\n",
      "{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID\n",
      "N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE\n",
      "(2R)-1-(2,6-dimethylphenoxy)propan-2-amine\n",
      "4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID\n",
      "(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide\n",
      "1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA\n",
      "D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide\n",
      "5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE\n",
      "(2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE\n",
      "(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(R)-HYDROXY[(1R)-2-METHYL-1-{[(3-PHENYLPROPYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID\n",
      "(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE\n",
      "Neflamapimod\n",
      "3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid\n",
      "5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine\n",
      "5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine\n",
      "5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine\n",
      "D-phenylalanyl-N-benzyl-L-prolinamide\n",
      "5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine\n",
      "(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE\n",
      "2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE\n",
      "methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate\n",
      "(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one\n",
      "(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one\n",
      "4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME\n",
      "4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one\n",
      "N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide\n",
      "6-methyl-5-[3-methyl-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine\n",
      "(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE\n",
      "(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE\n",
      "(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione\n",
      "(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE\n",
      "5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE\n",
      "6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one\n",
      "N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE\n",
      "5-phenyl-1H-indazol-3-amine\n",
      "4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide\n",
      "5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE\n",
      "N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine\n",
      "N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE\n",
      "5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE\n",
      "[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile\n",
      "5R-(3,4-DICHLOROPHENYLMETHYL)-3-(2-THIOPHENESULFONYLAMINO)-4-OXO-2-THIONOTHIAZOLIDINE\n",
      "5'-FLUORO-2',5'-DIDEOXYADENOSINE\n",
      "5-(2-hydroxyethyl)nonane-1,9-diol\n",
      "(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid\n",
      "7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE\n",
      "6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE\n",
      "N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide\n",
      "5-aminonaphthalene-1-sulfonic acid\n",
      "(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID\n",
      "5-PENTYL-2-PHENOXYPHENOL\n",
      "3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide\n",
      "5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide\n",
      "4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide\n",
      "(2S)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-[(S)-HYDROXY(3-PHENYLPROPYL)PHOSPHORYL]PROPANOIC ACID\n",
      "N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide\n",
      "6-(cyclohexylsulfanyl)-1-(ethoxymethyl)-5-(1-methylethyl)pyrimidine-2,4(1H,3H)-dione\n",
      "2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID\n",
      "4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE\n",
      "6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE\n",
      "(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE\n",
      "(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid\n",
      "3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide\n",
      "(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE\n",
      "(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine\n",
      "2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide\n",
      "4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL\n",
      "N-methyl-1-(2-thiophen-2-ylphenyl)methanamine\n",
      "4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID\n",
      "5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE\n",
      "(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID\n",
      "(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID\n",
      "(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid\n",
      "6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE\n",
      "6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE\n",
      "(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE\n",
      "N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE\n",
      "6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE\n",
      "2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE\n",
      "(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid\n",
      "(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid\n",
      "3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine\n",
      "(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE\n",
      "N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE\n",
      "(5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL\n",
      "2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID\n",
      "(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE\n",
      "N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide\n",
      "6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE\n",
      "BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE\n",
      "N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE\n",
      "(2,2-DIPHOSPHONOETHYL)(DODECYL)DIMETHYLPHOSPHONIUM\n",
      "(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE\n",
      "METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE\n",
      "N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE\n",
      "N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE\n",
      "N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE\n",
      "4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE\n",
      "1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA\n",
      "3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE\n",
      "3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE\n",
      "N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE\n",
      "Veliparib\n",
      "N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan\n",
      "3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione\n",
      "N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE\n",
      "3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL\n",
      "{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone\n",
      "Nesbuvir\n",
      "7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile\n",
      "3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid\n",
      "7-carboxy-5-hydroxy-12,13-dihydro-6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole\n",
      "(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile\n",
      "(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE\n",
      "5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE\n",
      "6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE\n",
      "(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE\n",
      "[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA\n",
      "7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE\n",
      "N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine\n",
      "N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE\n",
      "N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE\n",
      "3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide\n",
      "N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine\n",
      "N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE\n",
      "N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE\n",
      "3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE\n",
      "4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione\n",
      "(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol\n",
      "1-(4-thiophen-2-ylphenyl)methanamine\n",
      "N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline\n",
      "THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE\n",
      "1-{[N-(1-IMINO-GUANIDINO-METHYL)]SULFANYLMETHYL}-3-TRIFLUOROMETHYL-BENZENE\n",
      "[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid\n",
      "(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE\n",
      "3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID\n",
      "8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one\n",
      "2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine\n",
      "2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE\n",
      "(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID\n",
      "N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE\n",
      "4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one\n",
      "N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE\n",
      "1-[(2-AMINO-4-CHLORO-5-METHYLPHENYL)SULFONYL]-L-PROLINE\n",
      "N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide\n",
      "3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)quinolin-2(1H)-one\n",
      "5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE\n",
      "2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE\n",
      "2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE\n",
      "N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE\n",
      "5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE\n",
      "N~3~-BENZYLPYRIDINE-2,3-DIAMINE\n",
      "3-({[(1Z)-(2-methoxyphenyl)methylidene]amino}oxy)propanoic acid\n",
      "9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid\n",
      "N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE\n",
      "(3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID\n",
      "BMS-564929\n",
      "2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL\n",
      "N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide\n",
      "5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID\n",
      "(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE\n",
      "5-amino-1-(4-chlorophenyl)-1H-pyrazole-4-carbonitrile\n",
      "4-(2-amino-1,3-thiazol-4-yl)phenol\n",
      "benzyl (2-oxopropyl)carbamate\n",
      "3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid\n",
      "2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID\n",
      "(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE\n",
      "5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE\n",
      "3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID\n",
      "4-METHYL-PENTANOIC ACID {1-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYLCARBAMOYL]-2-METHYL-PROPYL}-AMIDE\n",
      "2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine\n",
      "9H-CARBAZOLE\n",
      "(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid\n",
      "N~3~-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE\n",
      "5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID\n",
      "5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID\n",
      "ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE\n",
      "N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide\n",
      "5-(2-CHLOROBENZYL)-2-FUROIC ACID\n",
      "5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID\n",
      "(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one\n",
      "18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE\n",
      "2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE\n",
      "5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID\n",
      "1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA\n",
      "5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide\n",
      "N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide\n",
      "(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one\n",
      "N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE\n",
      "6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE\n",
      "4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID\n",
      "2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE\n",
      "2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID\n",
      "2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID\n",
      "3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE\n",
      "N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE\n",
      "6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide\n",
      "(2-ACETYL-5-METHYLANILINO)(2,6-DIBROMOPHENYL)ACETAMIDE\n",
      "METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE\n",
      "1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID\n",
      "trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium\n",
      "2-(4-NITROPHENYL)ACETIC ACID\n",
      "ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE\n",
      "N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE\n",
      "N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE\n",
      "3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL\n",
      "4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL\n",
      "4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE\n",
      "5-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENOXY]-2-NITROBENZOIC ACID\n",
      "(3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione\n",
      "N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine\n",
      "octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside\n",
      "1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone\n",
      "4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE\n",
      "3,6,9,12,15-PENTAOXAHEPTADECAN-1-OL\n",
      "4-(2-aminoethyl)-2-cyclohexylphenol\n",
      "4-(2-aminoethyl)-2-ethylphenol\n",
      "4-(2-Aminoethyl)Benzenesulfonyl Fluoride\n",
      "Brefeldin A\n",
      "(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE\n",
      "(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide\n",
      "O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE\n",
      "Apigenin\n",
      "4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL\n",
      "2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM\n",
      "3-(heptyloxy)benzoic acid\n",
      "(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE\n",
      "4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL\n",
      "2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide\n",
      "3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide\n",
      "1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea\n",
      "1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea\n",
      "THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)\n",
      "6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE\n",
      "NAPHTHALEN-2-YL-3-ALANINE\n",
      "2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER\n",
      "(3Z,5S,6R,7S,8S,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol\n",
      "4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE\n",
      "N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide\n",
      "(3Z,5S,6R,7S,8R,8aS)-3-(octylimino)hexahydro[1,3]thiazolo[3,4-a]pyridine-5,6,7,8-tetrol\n",
      "3-(10-methyl-9-anthryl)propanoic acid\n",
      "ANDROSTA-1,4-DIENE-3,17-DIONE\n",
      "Anisomycin\n",
      "5-BETA-ANDROSTANE-3,17-DIONE\n",
      "5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID)\n",
      "N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE\n",
      "4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL\n",
      "(2S)-2-({6-[(3-amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methylbutan-1-ol\n",
      "1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)\n",
      "S-Atrolactic Acid\n",
      "N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine\n",
      "N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE\n",
      "1-ACETYL-2-CARBOXYPIPERIDINE\n",
      "3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE\n",
      "3-(BUTYLSULPHONYL)-PROPANOIC ACID\n",
      "ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE\n",
      "N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE\n",
      "2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE\n",
      "(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE\n",
      "2-CHLORO-4-ISOPROPYLAMINO-6-ETHYLAMINO -1,3,5-TRIAZINE\n",
      "2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE\n",
      "AUROVERTIN B\n",
      "4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid\n",
      "1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid\n",
      "(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide\n",
      "2-[(CYCLOPROPYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE\n",
      "1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE\n",
      "METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE\n",
      "Azapropazone\n",
      "4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE\n",
      "(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID\n",
      "1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE\n",
      "(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE\n",
      "5-(2-METHOXYPHENYL)-2-FUROIC ACID\n",
      "5-(2-NITROPHENYL)-2-FUROIC ACID\n",
      "(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID\n",
      "[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID\n",
      "PHENYLALANINE BORONIC ACID\n",
      "1-biphenyl-2-ylmethanamine\n",
      "5'-S-[2-(decylamino)ethyl]-5'-thioadenosine\n",
      "(5S)-1-benzyl-3-(1,1-dioxido-1,2-benzisothiazol-3-yl)-4-hydroxy-5-(1-methylethyl)-1,5-dihydro-2H-pyrrol-2-one\n",
      "4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine\n",
      "(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE\n",
      "bis(4-nitrophenyl) hydrogen phosphate\n",
      "S-23\n",
      "(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid\n",
      "4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile\n",
      "(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide\n",
      "(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide\n",
      "tripotassium (1R)-4-biphenyl-4-yl-1-phosphonatobutane-1-sulfonate\n",
      "Sobetirome\n",
      "[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)\n",
      "2-[(2-methoxy-5-methylphenoxy)methyl]pyridine\n",
      "4-[(5-methoxy-2-methylphenoxy)methyl]pyridine\n",
      "2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid\n",
      "(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one\n",
      "(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one\n",
      "[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate\n",
      "(TERT-BUTYLOXYCARBONYL)-ALANYL-AMINO ETHYL-FORMAMIDE\n",
      "HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE\n",
      "1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE\n",
      "N-(1-PHENYL-PROPYL)-FORMAMIDE\n",
      "1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE\n",
      "1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE\n",
      "4-TERT-BUTYLBENZENESULFONIC ACID\n",
      "3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID\n",
      "(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide\n",
      "6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE\n",
      "N'-[(1E)-(3,5-DIBROMO-2,4-DIHYDROXYPHENYL)METHYLENE]NICOTINOHYDRAZIDE\n",
      "N-(biphenyl-4-ylsulfonyl)-D-leucine\n",
      "5beta-dihydrotestosterone\n",
      "(2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid\n",
      "N-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDE\n",
      "(R)-minalrestat\n",
      "1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA\n",
      "2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one\n",
      "2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE\n",
      "(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE\n",
      "N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide\n",
      "3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione\n",
      "3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE\n",
      "3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione\n",
      "4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE\n",
      "2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE\n",
      "3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE\n",
      "(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE\n",
      "(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(butylsulfanyl)methyl]pyrrolidin-3-ol\n",
      "1(R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID\n",
      "(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile\n",
      "(1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID\n",
      "4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide\n",
      "(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one\n",
      "(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one\n",
      "(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one\n",
      "5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE\n",
      "(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE\n",
      "(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER\n",
      "3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE\n",
      "N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE\n",
      "Felbinac\n",
      "1,1'-BIPHENYL-3,4-DIOL\n",
      "(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL\n",
      "4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN\n",
      "tert-butyl [(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]carbamate\n",
      "(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE\n",
      "1,1'-BIPHENYL-2-SULFINIC ACID\n",
      "(2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid\n",
      "4,4'-cyclohexane-1,1-diyldiphenol\n",
      "3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline\n",
      "(6-METHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL)METHYLPHOSPHINATE\n",
      "{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE\n",
      "4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium\n",
      "2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL\n",
      "5-amino-2,4,6-tribromobenzene-1,3-dicarboxylic acid\n",
      "BROMAMPHENICOL\n",
      "(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE\n",
      "(3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONIABICYCLO[3.2.1]OCTANE\n",
      "5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE\n",
      "1,3-DIPHENYLUREA\n",
      "5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL\n",
      "4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID\n",
      "N-(4-{[amino(imino)methyl]amino}butyl)-2,4'-bi-1,3-thiazole-4-carboxamide\n",
      "(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one\n",
      "(2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol\n",
      "4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol\n",
      "(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE\n",
      "(2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol\n",
      "N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin-3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide\n",
      "L-BENZYLSUCCINIC ACID\n",
      "2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione\n",
      "4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE\n",
      "difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron\n",
      "3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid\n",
      "4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile\n",
      "7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE\n",
      "7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE\n",
      "3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one\n",
      "1-(2-{[(6-AMINO-2-METHYLPYRIDIN-3-YL)METHYL]AMINO}ETHYL)-6-CHLORO-3-[(2,2-DIFLUORO-2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL\n",
      "(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid\n",
      "3-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPIONIC\n",
      "(2R)-2-ETHYL-1-HEXANESULFONIC ACID\n",
      "(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one\n",
      "N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE\n",
      "6-CHLORO-1-(2-{[(5-CHLORO-1-BENZOTHIEN-3-YL)METHYL]AMINO}ETHYL)-3-[(2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL\n",
      "N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE\n",
      "N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine\n",
      "3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine\n",
      "N-[4-({[5-(DIMETHYLAMINO)-1-NAPHTHYL]SULFONYL}AMINO)BUTYL]-3-SULFANYLPROPANAMIDE\n",
      "N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE\n",
      "3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one\n",
      "2-IMINO-5-(1-PYRIDIN-2-YL-METH-(E)-YLIDENE)-1,3-THIAZOLIDIN-4-ONE\n",
      "(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol\n",
      "4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE\n",
      "N-hexanoyl-L-homoserine\n",
      "4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE\n",
      "4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE\n",
      "2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one\n",
      "N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide\n",
      "N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide\n",
      "4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE\n",
      "4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID\n",
      "4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE\n",
      "4-(dihydroxyboranyl)-2-({[4-(phenylsulfonyl)thiophen-2-yl]sulfonyl}amino)benzoic acid\n",
      "5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOBUTYL-HEXANOIC ACID\n",
      "(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol\n",
      "N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE\n",
      "N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE\n",
      "[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid\n",
      "5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID\n",
      "2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE\n",
      "2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE\n",
      "2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE\n",
      "(2S)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile\n",
      "(2R)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile\n",
      "9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONANAMIDE\n",
      "Hydroxy(oxo)(2-{(1S)-2,2,2-trifluoro-1-[2-(trimethylarsonio)ethoxy]ethyl}phenyl)ammonium\n",
      "N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE\n",
      "(5BETA)-PREGNANE-3,20-DIONE\n",
      "2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE\n",
      "(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide\n",
      "N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide\n",
      "(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide\n",
      "N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE\n",
      "1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine\n",
      "6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one\n",
      "Chloramphenicol succinate\n",
      "(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL\n",
      "(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE\n",
      "CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE\n",
      "3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID\n",
      "N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE\n",
      "3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate\n",
      "(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol\n",
      "2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE\n",
      "2,4-DIAMINO-1,5-DIPHENYL-3-HYDROXYPENTANE\n",
      "6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE\n",
      "3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE\n",
      "BIS-1,2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE\n",
      "BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBONYL}-PIPERAZINE\n",
      "5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOPROPYL-HEXANOIC ACID\n",
      "N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE\n",
      "(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE\n",
      "N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine\n",
      "5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine\n",
      "5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE\n",
      "N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE\n",
      "3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID\n",
      "N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE\n",
      "S-[3-(3,4-DICHLOROPHENYL)-3-OXOPROPYL]-L-CYSTEINE\n",
      "N1-CYCLOPENTYL-N2-(THIAZOL-2-YL)OXALAMIDE\n",
      "(1R)-2-METHYL-1-(PHENYLMETHYL)PROPYL[(1S)-1-FORMYLPENTYL]CARBAMATE\n",
      "1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE\n",
      "4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL\n",
      "(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE\n",
      "(17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate\n",
      "CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL\n",
      "2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE\n",
      "[(2-AMINO-ALPHA-METHOXYIMINO-4-THIAZOLYLACETYL)AMINO]METHYLBORONIC ACID\n",
      "4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol\n",
      "S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE\n",
      "N-hexanoyl-L-homocysteine\n",
      "(6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO[4,5,6-CD]INDOL-11-ONE\n",
      "2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE\n",
      "6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE\n",
      "4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE\n",
      "N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide\n",
      "N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE\n",
      "NAPHTHALENE-1,2-DIOL\n",
      "DECANE-1-THIOL\n",
      "6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE\n",
      "3-phenyl-5-(1H-pyrazol-3-yl)isoxazole\n",
      "PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE\n",
      "Tranilast\n",
      "4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid\n",
      "N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE\n",
      "2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE\n",
      "N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide\n",
      "2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE\n",
      "(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE\n",
      "1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA\n",
      "4,4'-DIPYRIDYL DISULFIDE\n",
      "1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide\n",
      "4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide\n",
      "4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide\n",
      "(2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE\n",
      "6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one\n",
      "N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE\n",
      "N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE\n",
      "N-DODECYL-N,N-DIMETHYLGLYCINATE\n",
      "5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide\n",
      "octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside\n",
      "(2,6-DIMETHYL-PHENOXY)-ACETIC ACID\n",
      "bis(4-hydroxyphenyl)methanone\n",
      "5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE\n",
      "Dibromotyrosine\n",
      "(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL\n",
      "3-(7-DIAMINOMETHYL-NAPHTHALEN-2-YL)-PROPIONIC ACID ETHYL ESTER\n",
      "2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione\n",
      "DECYL(DIMETHYL)PHOSPHINE OXIDE\n",
      "5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine\n",
      "5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine\n",
      "5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine\n",
      "SEBACIC ACID\n",
      "UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE\n",
      "(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL\n",
      "(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL\n",
      "(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol\n",
      "DECYL FORMATE\n",
      "N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE\n",
      "1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE\n",
      "N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE\n",
      "(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC\n",
      "3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE\n",
      "PHOSPHONIC ACID 2-DODECANOYLAMINO-HEXYL ESTER PROPYL ESTER\n",
      "AC-(D)PHE-PRO-BOROLYS-OH\n",
      "AC-(D)PHE-PRO-BOROHOMOLYS-OH\n",
      "AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH\n",
      "1,6-DIHYDROXY NAPHTHALENE\n",
      "N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE\n",
      "2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID\n",
      "5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE\n",
      "N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide\n",
      "(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE\n",
      "2-((3',5'-DIMETHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID\n",
      "3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)-2-METHYL-PROPIONIC ACID\n",
      "2,3-DIMETHYL-1,4-NAPHTHOQUINONE\n",
      "4-METHYL-N-METHYL-N-(2-PHENYL-2H-PYRAZOL-3-YL)BENZENESULFONAMIDE\n",
      "2-[1-METHYLHEXYL]-4,6-DINITROPHENOL\n",
      "TRANS-2-(DIMETHYLPHENYLSILYL)-PIPERIDINE-N-OXIDE\n",
      "DEAMINO-METHYL-PHENYLALANINE\n",
      "O,O-DIETHYL HYDROGEN THIOPHOSPHATE\n",
      "(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID\n",
      "3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one\n",
      "2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one\n",
      "(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL\n",
      "(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid\n",
      "[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID\n",
      "DODECANESULFONATE ION\n",
      "N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine\n",
      "5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID\n",
      "4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE\n",
      "4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE\n",
      "4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE\n",
      "4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE\n",
      "METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE\n",
      "2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid\n",
      "1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine\n",
      "N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide\n",
      "2,5-dichloro-N-(3,5-dibromo-4-hydroxyphenyl)benzamide\n",
      "N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide\n",
      "methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate\n",
      "1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine\n",
      "3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine\n",
      "3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN\n",
      "1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE\n",
      "(16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL\n",
      "(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE\n",
      "6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE\n",
      "1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE\n",
      "2-Hydroxyestradiol\n",
      "(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL\n",
      "3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL\n",
      "PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE\n",
      "(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol\n",
      "3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL\n",
      "(1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid\n",
      "6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID\n",
      "Emodin\n",
      "(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL\n",
      "(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE\n",
      "3-(4-HYDROXY-PHENYL)PYRUVIC ACID\n",
      "[(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid\n",
      "Epibatidine\n",
      "DIETHYL 4-METHOXYPHENYL PHOSPHATE\n",
      "3-(4-NITRO-PHENOXY)-PROPAN-1-OL\n",
      "3-(5-methoxy-1H-indol-3-yl)propanoic acid\n",
      "Indeglitazar\n",
      "2-tert-butylbenzene-1,4-diol\n",
      "2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE\n",
      "3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide\n",
      "5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE\n",
      "4-[(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYL]PHENOL\n",
      "2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE\n",
      "1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE\n",
      "N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide\n",
      "N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide\n",
      "(2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide\n",
      "(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide\n",
      "N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide\n",
      "(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE\n",
      "(7R,12R,13R)-13-formyl-12,14-dihydroxy-3,5,7-trimethyltetradeca-2,4-dienoic acid\n",
      "4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE\n",
      "N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE\n",
      "S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE\n",
      "Z-Val-Ala-Asp fluoromethyl ketone\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE\n",
      "3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID\n",
      "(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE\n",
      "2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE\n",
      "2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE\n",
      "(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol\n",
      "(2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol\n",
      "3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID\n",
      "N-({(1R)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-L-glutamic acid\n",
      "(2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol\n",
      "1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL\n",
      "(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one\n",
      "5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID\n",
      "5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID\n",
      "3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid\n",
      "(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol\n",
      "4-(N-ACETYLAMINO)-3-[N-(2-ETHYLBUTANOYLAMINO)]BENZOIC ACID\n",
      "(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE\n",
      "FLUORESCIN\n",
      "METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE\n",
      "(2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME}\n",
      "Ferulic acid\n",
      "(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE\n",
      "S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE\n",
      "5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID\n",
      "[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID\n",
      "(1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid\n",
      "5-FLUOROINDOLE PROPANOL PHOSPHATE\n",
      "3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE\n",
      "Flavone\n",
      "FAMOXADONE\n",
      "N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE\n",
      "FARNESYL DIPHOSPHATE\n",
      "N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-NITRILOMETHYL-PYRIDYL]-THIOUREA\n",
      "4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE\n",
      "1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE\n",
      "[4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETIC ACID\n",
      "1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE\n",
      "1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE\n",
      "5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE\n",
      "(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE\n",
      "1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea\n",
      "N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE\n",
      "4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE\n",
      "(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE\n",
      "(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE\n",
      "5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE\n",
      "3,7,3',4'-TETRAHYDROXYFLAVONE\n",
      "(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE\n",
      "N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-CHLORO-PYRIDYL]-THIOUREA\n",
      "(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE\n",
      "N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE\n",
      "N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide\n",
      "3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE\n",
      "2-phenyl-1H-imidazole-4-carboxylic acid\n",
      "5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE\n",
      "3-CHLORO-2,2-DIMETHYL-N-[4-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE\n",
      "(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID\n",
      "(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL\n",
      "(1S,2R)-2-[(2,5-difluorophenyl)carbamoyl]cyclopropanecarboxylic acid\n",
      "4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE\n",
      "3-(4-HYDROXYPHENYL)-1-(2,4,6-TRIHYDROXYPHENYL)PROPAN-1-ONE\n",
      "N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide\n",
      "N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide\n",
      "GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE\n",
      "GIBBERELLIN A3\n",
      "GIBBERELLIN A4\n",
      "N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID\n",
      "1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea\n",
      "(2E)-3-(2,4-DICHLOROPHENYL)-N-HYDROXYACRYLAMIDE\n",
      "(2E)-3-(4-CHLOROPHENYL)-N-HYDROXYACRYLAMIDE\n",
      "6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL\n",
      "(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate\n",
      "(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid\n",
      "4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one\n",
      "(3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid\n",
      "2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide\n",
      "4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID\n",
      "4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE\n",
      "(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE\n",
      "2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE\n",
      "4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde\n",
      "N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide\n",
      "N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide\n",
      "N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide\n",
      "1-DECYL-3-TRIFLUORO ETHYL-SN-GLYCERO-2-PHOSPHOMETHANOL\n",
      "[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid\n",
      "(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE\n",
      "N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE\n",
      "(E)-[4-(3,5-difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol\n",
      "Geranylgeranyl diphosphate\n",
      "(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid\n",
      "5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE\n",
      "6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE\n",
      "2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide\n",
      "1S,3AS,8AS-TRIMETHYL-1-OXIDO-1,2,3,3A,8,8A-HEXAHYDROPYRROLO[2,3-B]INDOL-5-YL 2-ETHYLPHENYLCARBAMATE\n",
      "6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE\n",
      "5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide\n",
      "S-NONYL-CYSTEINE\n",
      "(1R,2S)-2-(5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)cyclohexanecarboxylic acid\n",
      "(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE\n",
      "1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID\n",
      "[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE\n",
      "N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE\n",
      "(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE\n",
      "6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE\n",
      "(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine\n",
      "(2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine\n",
      "4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE\n",
      "(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE\n",
      "(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide\n",
      "7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE\n",
      "2-chloro-5-nitro-N-phenylbenzamide\n",
      "4-[(CYCLOPROPYLETHYNYL)OXY]-6-FLUORO-3-ISOPROPYLQUINOLIN-2(1H)-ONE\n",
      "3-(1H-tetrazol-5-ylamino)cyclohex-2-en-1-one\n",
      "(5S)-2-(cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one\n",
      "6-CHLORO-4-(CYCLOHEXYLOXY)-3-PROPYLQUINOLIN-2(1H)-ONE\n",
      "6-CHLORO-4-(CYCLOHEXYLSULFANYL)-3-PROPYLQUINOLIN-2(1H)-ONE\n",
      "6-CHLORO-4-(CYCLOHEXYLSULFINYL)-3-PROPYLQUINOLIN-2(1H)-ONE\n",
      "(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID\n",
      "6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE\n",
      "5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide\n",
      "(1-HYDROXYDODECANE-1,1-DIYL)BIS(PHOSPHONIC ACID)\n",
      "(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one\n",
      "5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide\n",
      "(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE\n",
      "8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE\n",
      "N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE\n",
      "N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide\n",
      "2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID\n",
      "N-{[2-({[1-(4-CARBOXYBUTANOYL)AMINO]-2-PHENYLETHYL}-HYDROXYPHOSPHINYL)OXY]ACETYL}-2-PHENYLETHYLAMINE\n",
      "4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID\n",
      "(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE\n",
      "ISOPROPYL (2S)-2-ETHYL-7-FLUORO-3-OXO-3,4-DIHYDROQUINOXALINE-1(2H)-CARBOXYLATE\n",
      "Talviraline\n",
      "(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)BENZYL)GUANIDINE\n",
      "3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER\n",
      "(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol\n",
      "4-(2-HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID\n",
      "4-{[(14beta,17alpha)-3-hydroxyestra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid\n",
      "1-(2-HYDROXYETHYLOXYMETHYL)-6-PHENYL THIOTHYMINE\n",
      "PHENYL[1-(N-SUCCINYLAMINO)PENTYL]PHOSPHONATE\n",
      "4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID\n",
      "ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID\n",
      "(2S)-hydroxy(4-hydroxyphenyl)ethanoic acid\n",
      "1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE\n",
      "2-(BUTYRYLOXY)-1-{[(TETRAHYDROXYPHOSPHORANYL)OXY]METHYL}ETHYL BUTYRATE\n",
      "(2S) N-acetyl-L-alanyl-αL-phenylalanyl-chloroethylketone\n",
      "3-FORMYL-2-HYDROXY-5-METHYL-HEXANOIC ACID HYDROXYAMIDE\n",
      "5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE\n",
      "TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE\n",
      "3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE\n",
      "(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione\n",
      "[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL\n",
      "(2S)-2-HYDROXYOCTANOIC ACID\n",
      "7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN\n",
      "(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL\n",
      "(2S)-2-amino-3-phenylpropane-1,1-diol\n",
      "(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE\n",
      "2-OXOHEPTYLPHOSPHONIC ACID\n",
      "HOMOPHENYLALANINYLMETHANE\n",
      "2-hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid\n",
      "(2E,4E)-2-Hydroxy-6-oxo-6-phenyl-2,4-hexadienoic acid\n",
      "3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID\n",
      "4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE\n",
      "2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE\n",
      "7-METHOXY-1-METHYL-9H-BETA-CARBOLINE\n",
      "N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide\n",
      "2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide\n",
      "N-oxo-2-(phenylsulfonylamino)ethanamide\n",
      "octyl alpha-L-altropyranoside\n",
      "octyl beta-D-galactopyranoside\n",
      "4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID\n",
      "N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE\n",
      "3-[(4-Carboxy-2-hydroxyphenyl)sulfamoyl]-2-thiophenecarboxylic acid\n",
      "N-(2-OXOTETRAHYDROFURAN-3-YL)OCTANAMIDE\n",
      "N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE\n",
      "(3R)-3-HYDROXYDODECANOIC ACID\n",
      "Hexestrol\n",
      "dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate\n",
      "Erteberel\n",
      "[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE\n",
      "5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile\n",
      "N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine\n",
      "2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine\n",
      "5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-chroman-5-yl]methyl]pyrimidine-2,4-diamine\n",
      "N-(3-MERCAPTOPROPANOYL)-D-ALANINE\n",
      "9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE\n",
      "PH-797804\n",
      "2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine\n",
      "2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol\n",
      "N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE\n",
      "5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid\n",
      "N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide\n",
      "ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE\n",
      "({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID\n",
      "1H-INDOL-3-YLACETIC ACID\n",
      "N-[1H-INDOL-3-YL-ACETYL]ASPARTIC ACID\n",
      "N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID\n",
      "N-[1H-INDOL-3-YL-ACETYL]VALINE ACID\n",
      "3-isobutyl-1-methyl-7H-xanthine\n",
      "(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE\n",
      "[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER\n",
      "METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE\n",
      "(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID\n",
      "3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE\n",
      "5-ACETAMIDO-5,6-DIHYDRO-4-HYDROXY-6-ISOBUTOXY-4H-PYRAN-2-CARBOXYLIC ACID\n",
      "1-(4-CYANO-PHENYL)-3-[2-(2,6-DICHLORO-PHENYL)-1-IMINO-ETHYL]-THIOUREA\n",
      "METHYL N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINATE\n",
      "N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE\n",
      "(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE\n",
      "6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile\n",
      "[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile\n",
      "9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE\n",
      "N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA\n",
      "3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol\n",
      "5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide\n",
      "5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE\n",
      "1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE\n",
      "N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE\n",
      "1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE\n",
      "2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID\n",
      "3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID\n",
      "3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID\n",
      "2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID\n",
      "(2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID\n",
      "2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide\n",
      "2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol\n",
      "1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID\n",
      "2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide\n",
      "+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE\n",
      "[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID\n",
      "[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER\n",
      "2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE\n",
      "2-(ACETYL-HYDROXY-AMINO)-4-METHYL-PENTANOIC ACID METHYL ESTER\n",
      "(RP,SP)-O-(2R)-(1-PHENOXYBUT-2-YL)-METHYLPHOSPHONIC ACID CHLORIDE\n",
      "N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE\n",
      "3-SULFOOXY-1H-INDOLE\n",
      "N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE\n",
      "N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE\n",
      "N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE\n",
      "5-(2-methylpiperazine-1-sulfonyl)isoquinoline\n",
      "N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE\n",
      "{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID\n",
      "2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE\n",
      "5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID\n",
      "ISOTHIAZOLIDINONE ANALOG\n",
      "(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol\n",
      "4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide\n",
      "N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine\n",
      "(2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID\n",
      "5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine\n",
      "5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE\n",
      "(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime\n",
      "(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime\n",
      "(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE\n",
      "(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE\n",
      "(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE\n",
      "(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime\n",
      "4-(6-CHLORO-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL) BUTYL PHOSPHATE\n",
      "3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE\n",
      "N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE\n",
      "N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine\n",
      "(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL\n",
      "5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide\n",
      "(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile\n",
      "N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine\n",
      "1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE\n",
      "N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE\n",
      "2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide\n",
      "1-(3-chloro-4-methylphenyl)-3-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)thio]ethyl}urea\n",
      "BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE\n",
      "N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide\n",
      "3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide\n",
      "N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE\n",
      "N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE\n",
      "(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE\n",
      "(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE\n",
      "1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE\n",
      "6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one\n",
      "(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide\n",
      "L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide\n",
      "(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE\n",
      "N-[(2R)-2-benzyl-4-(hydroxyamino)-4-oxobutanoyl]-L-alanine\n",
      "3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID\n",
      "N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine\n",
      "1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA\n",
      "(1S,6R)-3-{[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]CARBONYL}-6-(2,4,5-TRIFLUOROPHENYL)CYCLOHEX-3-EN-1-AMINE\n",
      "4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL\n",
      "2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide\n",
      "4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol\n",
      "4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL\n",
      "7,8-dihydroxy-4-phenyl-2H-chromen-2-one\n",
      "5-phenyl-2-keto-valeric acid\n",
      "(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE\n",
      "1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine\n",
      "1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine\n",
      "1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine\n",
      "N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine\n",
      "N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine\n",
      "N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine\n",
      "4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one\n",
      "(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE\n",
      "4-(2-AMINOPHENYL)-4-OXOBUTANOIC ACID\n",
      "4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE\n",
      "3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE\n",
      "1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE\n",
      "N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA\n",
      "2-(1H-pyrazol-3-yl)-1H-benzimidazole\n",
      "N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE\n",
      "4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM\n",
      "N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-\n",
      "4-AMINO-5-(2-METHYLPHENYL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOLE-3-THIONE\n",
      "2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE\n",
      "(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine\n",
      "4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE\n",
      "(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE\n",
      "3-(3-methylbut-2-en-1-yl)-3H-purin-6-amine\n",
      "4-(2-amino-1,3-thiazol-4-yl)pyrimidin-2-amine\n",
      "4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine\n",
      "2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID\n",
      "{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid\n",
      "AMG-208\n",
      "LATRUNCULIN B\n",
      "3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO-FURAN-3-YL)-AMIDE\n",
      "N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE\n",
      "2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide\n",
      "IDD594\n",
      "1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE\n",
      "N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine\n",
      "4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE\n",
      "2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile\n",
      "LGD-2226\n",
      "(3Z,5S,6R,7S,8R,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol\n",
      "3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE\n",
      "3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide\n",
      "3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE\n",
      "(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE\n",
      "3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA\n",
      "8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM\n",
      "2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE\n",
      "{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid\n",
      "6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine\n",
      "2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol\n",
      "2,6-dibromo-4-[(E)-2-phenylethenyl]phenol\n",
      "3,5-dibromobiphenyl-4-ol\n",
      "2,6-dibromo-4-phenoxyphenol\n",
      "N-(3,5-dibromo-4-hydroxyphenyl)benzamide\n",
      "N-[(6-butoxynaphthalen-2-yl)sulfonyl]-L-glutamic acid\n",
      "N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid\n",
      "N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID\n",
      "N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID\n",
      "(1S,4R,7AR)-4-BUTOXY-1-[(1R)-1-FORMYLPROPYL]-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID\n",
      "(1R,4S,7AS)-1-(1-FORMYLPROP-1-EN-1-YL)-4-METHOXY-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID\n",
      "4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol\n",
      "N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID\n",
      "3-pyridin-4-yl-1H-indazole\n",
      "5-benzyl-1,3-thiazol-2-amine\n",
      "2-aminoethyl naphthalen-1-ylacetate\n",
      "(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine\n",
      "2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide\n",
      "1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)\n",
      "6,8-DIMERCAPTO-OCTANOIC ACID AMIDE\n",
      "(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid\n",
      "N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE\n",
      "N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE\n",
      "3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE\n",
      "4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE\n",
      "3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE\n",
      "1,3,3-trimethyl-2-[(1E,3E)-3-methylpenta-1,3-dien-1-yl]cyclohexene\n",
      "(1S,4R,9S)-5-(trifluoromethyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-9-amine\n",
      "(1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol\n",
      "N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine\n",
      "2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-3-METHYL-BUTYRIC ACID\n",
      "5-hydroxynaphthalene-1-sulfonamide\n",
      "N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide\n",
      "4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide\n",
      "N-phenyl-1H-pyrazole-3-carboxamide\n",
      "4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide\n",
      "(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide\n",
      "{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide\n",
      "5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile\n",
      "5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE\n",
      "4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide\n",
      "4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide\n",
      "5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE\n",
      "6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine\n",
      "6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE\n",
      "7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine\n",
      "4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid\n",
      "1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine\n",
      "1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine\n",
      "4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium\n",
      "(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol\n",
      "{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate\n",
      "(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE\n",
      "3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile\n",
      "N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE\n",
      "3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID\n",
      "ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE\n",
      "2,4-DINITROPHENYL 2-DEOXY-2-FLUORO-BETA-D-MANNOPYRANOSIDE\n",
      "4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE\n",
      "(2S)-2-AMINO-4-(METHYLSULFANYL)-1-(1,3-THIAZOL-2-YL)BUTANE-1,1-DIOL\n",
      "(S)-2-(MERCAPTOMETHYL)-5-PHENYLPENTANOIC ACID\n",
      "Fasudil\n",
      "5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine\n",
      "(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE\n",
      "indane-5-sulfonamide\n",
      "(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile\n",
      "Methylthioninium\n",
      "7-AMINO-4-METHYL-CHROMEN-2-ONE\n",
      "(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide\n",
      "(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE\n",
      "11-MERCAPTOUNDECANOIC ACID\n",
      "(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide\n",
      "5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE\n",
      "5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE\n",
      "(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID\n",
      "(1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE\n",
      "(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID\n",
      "4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine\n",
      "methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate\n",
      "2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE\n",
      "2-((3'-METHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID\n",
      "4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine\n",
      "2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE\n",
      "2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE\n",
      "(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE\n",
      "METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE\n",
      "Emivirine\n",
      "N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide\n",
      "4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid\n",
      "2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE\n",
      "2-(3-NITROPHENYL)ACETIC ACID\n",
      "4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine\n",
      "(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE\n",
      "2-((3',5'-DIMETHOXY-4'-HYDROXYPHENYL)AZO)BENZOIC ACID\n",
      "(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime\n",
      "[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE\n",
      "N-[(BENZYLOXY)CARBONYL]-L-CYSTEINYLGLYCINE\n",
      "(1R)-menthyl hexyl phosphonate group\n",
      "(1S)-menthyl hexyl phosphonate group\n",
      "4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE\n",
      "7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE\n",
      "3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE\n",
      "4-(1,3-BENZOXAZOL-2-YL)-2,6-DIMETHYLPHENOL\n",
      "4-(1,3-BENZOXAZOL-2-YL)-2,6-DIBROMOPHENOL\n",
      "2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE\n",
      "2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE\n",
      "2-(4-DIMETHYLAMINOPHENYL)DIAZENYLBENZOIC ACID\n",
      "2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE\n",
      "5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide\n",
      "1-[2-(3-ACETYL-2-HYDROXY-6-METHOXY-PHENYL)-CYCLOPROPYL]-3-(5-CYANO-PYRIDIN-2-YL)-THIOUREA\n",
      "1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE\n",
      "4-(1H-IMIDAZOL-1-YL)PHENOL\n",
      "2-T-BUTYLAMINO-4-ETHYLAMINO-6-METHYLTHIO-S-TRIAZINE\n",
      "2-((3'-TERTBUTYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID\n",
      "S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate\n",
      "HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM\n",
      "4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE\n",
      "(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid\n",
      "N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE\n",
      "METHOXYUNDECYLPHOSPHINIC ACID\n",
      "N-{(1S,2R)-1-BENZYL-3-[(CYCLOPROPYLMETHYL)(2-FURYLSULFONYL)AMINO]-2-HYDROXYPROPYL}-N'-METHYLSUCCINAMIDE\n",
      "(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL\n",
      "Myxopyronin B\n",
      "1-(1-HYDROXY-2,2,6,6-TETRAMETHYLPIPERIDIN-4-YL)PYRROLIDINE-2,5-DIONE\n",
      "5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one\n",
      "[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID\n",
      "5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE\n",
      "Myristic acid\n",
      "[5-(5-Amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-6-hydroxy-3'-nitro-3-biphenylyl]acetic acid\n",
      "6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE\n",
      "5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine\n",
      "N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide\n",
      "(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one\n",
      "2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate)\n",
      "5-AMINO-NAPHTALENE-2-MONOSULFONATE\n",
      "(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE\n",
      "N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE\n",
      "4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE\n",
      "N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide\n",
      "(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE\n",
      "1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE\n",
      "(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE\n",
      "6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE\n",
      "3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE\n",
      "3,6,9,12,15-PENTAOXATRICOSAN-1-OL\n",
      "(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE\n",
      "4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID\n",
      "2-((4'-HYDROXYNAPHTHYL)-AZO)BENZOIC ACID\n",
      "NAM NAPTHYLAMINOALANINE\n",
      "2-NAPHTHALENESULFONIC ACID\n",
      "(3AR,5R,6S,7R,7AR)-5-(HYDROXYMETHYL)-2-PROPYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D][1,3]THIAZOLE-6,7-DIOL\n",
      "N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE\n",
      "4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID\n",
      "6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID\n",
      "7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID\n",
      "(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-N-octyl-6-oxa-8-azabicyclo[3.2.1]octane-8-carbothioamide\n",
      "2-hydroxy-7-methoxy-5-methyl-naphthalene-1-carboxylic acid meso-2,5-dihydroxy-cyclopent-3-enyl ester\n",
      "2,6-dicarboxynaphthalene\n",
      "N-(carboxycarbonyl)-D-phenylalanine\n",
      "(1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene\n",
      "2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL\n",
      "Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate\n",
      "6-amino-4-(2-phenylethyl)-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one\n",
      "6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE\n",
      "N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE\n",
      "N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID\n",
      "(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID\n",
      "4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION\n",
      "6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE\n",
      "N-DODECANOYL-L-TYROSINE\n",
      "trifluoro-[hydroxy-[hydroxy-[2-(N-methyl-2-nitro-anilino)ethoxy]phosphoryl]oxy-phosphoryl]oxy-beryllium(1-)\n",
      "2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE\n",
      "1-(2-CYCLOPROPYLETHYL)-3-(1,1-DIOXIDO-2H-1,2,4-BENZOTHIADIAZIN-3-YL)-6-FLUORO-4-HYDROXYQUINOLIN-2(1H)-ONE\n",
      "3-{ISOPROPYL[(TRANS-4-METHYLCYCLOHEXYL)CARBONYL]AMINO}-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID\n",
      "(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE\n",
      "O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-bromophenyl)thiocarbamate\n",
      "O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-chlorophenyl)thiocarbamate\n",
      "(2R,3R,4R,5S)-2-(HYDROXYMETHYL)-1-NONYLPIPERIDINE-3,4,5-TRIOL\n",
      "O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-iodophenyl)thiocarbamate\n",
      "(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol\n",
      "NAPHTHYLOXYACETIC ACID\n",
      "(1R,2R)-N-(2-AMINOETHYL)-2-{[(4-METHOXYPHENYL)SULFONYL]METHYL}CYCLOHEXANECARBOXAMIDE\n",
      "CYCLOHEXYL-NORSTATINE\n",
      "N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE\n",
      "N-(3-AMINOPROPYL)-2-NITROBENZENAMINE\n",
      "(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE\n",
      "(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE\n",
      "2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID\n",
      "4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION\n",
      "5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID\n",
      "ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE\n",
      "4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid\n",
      "1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine\n",
      "N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE\n",
      "3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid\n",
      "(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide\n",
      "(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide\n",
      "(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide\n",
      "3-[(3-Nitrophenyl)sulfamoyl]-2-thiophenecarboxylic acid\n",
      "2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE\n",
      "SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER\n",
      "3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL\n",
      "N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide\n",
      "6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE\n",
      "nocodazole\n",
      "(2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE\n",
      "2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE\n",
      "4-amino-7,7-dimethyl-7,8-dihydroquinazolin-5(6H)-one\n",
      "5-methyl-6-phenylquinazoline-2,4-diamine\n",
      "6-(2-phenoxyethoxy)-1,3,5-triazine-2,4-diamine\n",
      "2'-HYDROXY-1,1'-BIPHENYL-2-SULFINIC ACID\n",
      "DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE\n",
      "(1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol\n",
      "2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID\n",
      "3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE\n",
      "N-3-OXO-DODECANOYL-L-HOMOSERINE LACTONE\n",
      "2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE\n",
      "2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE\n",
      "2-(3,6-DIHYDROXYPHENYL)ACETIC ACID\n",
      "PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID\n",
      "Sulthiame\n",
      "METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE\n",
      "N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine\n",
      "9-(2-carboxyethyl)-10-methylanthracene endoperoxide\n",
      "4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME\n",
      "3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME\n",
      "4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME\n",
      "2-Methyl-2-propanyl [(1R)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate\n",
      "2-Methyl-2-propanyl [(1S)-2-methyl-1-(1,3,4-oxadiazol-2-yl)propyl]carbamate\n",
      "19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one\n",
      "6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE\n",
      "N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE\n",
      "4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide\n",
      "S-PALMITOYL-L-CYSTEINE\n",
      "4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide\n",
      "4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE\n",
      "(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE\n",
      "4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile\n",
      "N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE\n",
      "N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide\n",
      "5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE\n",
      "N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide\n",
      "6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine\n",
      "2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE\n",
      "2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE\n",
      "1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid\n",
      "4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol\n",
      "1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE\n",
      "2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE\n",
      "2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE\n",
      "2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE\n",
      "2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide\n",
      "N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE\n",
      "1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine\n",
      "1-{[(1E)-(3-HYDROXY-2-METHYL-5-{[(TRIHYDROXY-LAMBDA^5^-PHOSPHANYL)OXY]METHYL}PYRIDIN-4-YL)METHYLIDENE]AMINO}UNDECAN-2-ONE\n",
      "8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide\n",
      "3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid\n",
      "(R)-2-(FORMYLOXY)-3-(PHOSPHONOOXY)PROPYL PENTANOATE\n",
      "OCTANE-1,3,5,7-TETRACARBOXYLIC ACID\n",
      "1-(biphenyl-4-ylmethyl)-1H-imidazole\n",
      "S-(4-BROMOBENZYL)CYSTEINE\n",
      "PARA-(BENZOYL)-PHENYLALANINE\n",
      "1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA\n",
      "4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL\n",
      "(3S)-3-Amino-1-chloro-4-phenyl-2-butanone\n",
      "PCNOTAXIME Group\n",
      "(2R)-3-(phosphonooxy)propane-1,2-diyl diheptanoate\n",
      "N-[4-(4-nitrophenylphospho)butanoyl]-D-alanine\n",
      "4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID\n",
      "6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one\n",
      "Gosogliptin\n",
      "4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole\n",
      "2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline\n",
      "4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid\n",
      "2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline\n",
      "2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline\n",
      "5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE\n",
      "6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE\n",
      "(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE\n",
      "6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE\n",
      "2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL\n",
      "2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL\n",
      "PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE\n",
      "2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE\n",
      "4-{[(Z)-(5-OXO-2-PHENYL-1,3-OXAZOL-4(5H)-YLIDENE)METHYL]AMINO}BUTANOIC ACID\n",
      "6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID\n",
      "2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine\n",
      "PICEATANNOL\n",
      "4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid\n",
      "(2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID\n",
      "2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID\n",
      "METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID\n",
      "S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEXANETHIOATE\n",
      "S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEPTANETHIOATE\n",
      "[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE\n",
      "PLATENSIMYCIN\n",
      "(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl 2,2-dimethylpropanoate\n",
      "4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE\n",
      "PARA-NITROBENZYL GLUTARYL GLYCINIC ACID\n",
      "N-[4-(4-nitrophenylphospho)butanoyl]-L-alanine\n",
      "6-{4-[HYDROXY-(4-NITRO-PHENOXY)-PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID\n",
      "METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER\n",
      "6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE\n",
      "(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE\n",
      "(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate\n",
      "(1S)-1-(PHENOXYMETHYL)PROPYL METHYLPHOSPHONOCHLORIDOATE\n",
      "1-{[1-(2-AMINO-3-PHENYL-PROPIONYL)-PYRROLIDINE-2-CARBONYL]-AMINO}-2-(3-CYANO-PHENYL)-ETHANEBORONIC ACID\n",
      "PIPERIDINE-2-CARBOXYLIC ACID TERT-BUTYLAMIDE\n",
      "[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE\n",
      "[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE\n",
      "[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE\n",
      "THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE\n",
      "PREPHENIC ACID\n",
      "3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL\n",
      "N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide\n",
      "PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE\n",
      "[(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID\n",
      "THYMIDINE-5'-THIOPHOSPHATE\n",
      "phenyl ethenesulfonate\n",
      "2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID\n",
      "(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid\n",
      "8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-\n",
      "Puromycin\n",
      "(2E,4R,5S)-2,3,4,5-TETRAHYDROXY-6-(PALMITOYLOXY)HEX-2-ENOIC ACID\n",
      "Parecoxib\n",
      "N-1,10-phenanthrolin-5-ylacetamide\n",
      "6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE\n",
      "4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol\n",
      "2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol\n",
      "3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile\n",
      "(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE\n",
      "3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile\n",
      "3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL\n",
      "(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol\n",
      "2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid\n",
      "N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine\n",
      "N-(QUINOLIN-8-YL)METHANESULFONAMIDE\n",
      "2-NONYL-4-HYDROXYQUINOLINE N-OXIDE\n",
      "N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE\n",
      "Ro 12-7310\n",
      "S-[(1-Hydroxy-2,2,5,5-tetramethyl-4-phenyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate\n",
      "4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE\n",
      "(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE\n",
      "3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile\n",
      "3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile\n",
      "3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL\n",
      "N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE\n",
      "(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol\n",
      "METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE\n",
      "2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE\n",
      "5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol\n",
      "6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID\n",
      "tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate\n",
      "3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole\n",
      "1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine\n",
      "(R)-Fluoxetine\n",
      "5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole\n",
      "3-(CARBOXYAMIDE(2-CARBOXYAMIDE-2-TERTBUTYLETHYL))PENTAN\n",
      "[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl hydrogen hex-5-enylphosphonate\n",
      "3-AMINO-AZACYCLOTRIDECAN-2-ONE\n",
      "N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide\n",
      "N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide\n",
      "4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN\n",
      "4-METHYL-N-{(5E)-5-[(5-METHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}BENZENESULFONAMIDE\n",
      "[[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER\n",
      "4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE\n",
      "(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID\n",
      "Efaproxiral\n",
      "3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE\n",
      "4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE\n",
      "N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE\n",
      "CTS-1027\n",
      "N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE\n",
      "(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID\n",
      "5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID\n",
      "S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate\n",
      "4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE\n",
      "(R)-warfarin\n",
      "(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate\n",
      "(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate\n",
      "N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide\n",
      "(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol\n",
      "DIETHYL PROPANE-1,3-DIYLBISCARBAMATE\n",
      "Capravirine\n",
      "(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol\n",
      "6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM\n",
      "methyl 4-bromo-N-[8-(hydroxyamino)-8-oxooctanoyl]-L-phenylalaninate\n",
      "N-{(2S)-3-[(1R)-1-aminoethyl](hydroxy)phosphoryl-2-benzylpropanoyl}-L-phenylalanine\n",
      "N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID\n",
      "N-BENZOYL-D-ALANINE\n",
      "1-[6-(2-CHLORO-4-METHYXYPHENOXY)-HEXYL]-IMIDAZOLE\n",
      "5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE\n",
      "6-amino-2-methyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one\n",
      "6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one\n",
      "[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID\n",
      "6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one\n",
      "(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE\n",
      "(S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE]\n",
      "(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one\n",
      "N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine\n",
      "(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE\n",
      "4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE\n",
      "4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE\n",
      "[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL\n",
      "2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE\n",
      "CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE\n",
      "1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE\n",
      "2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE\n",
      "(6E,11E)-HEPTADECA-6,11-DIENE-9,9-DIYLBIS(PHOSPHONIC ACID)\n",
      "7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE\n",
      "5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine\n",
      "6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine\n",
      "3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine\n",
      "5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine\n",
      "3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine\n",
      "3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine\n",
      "3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine\n",
      "N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine\n",
      "3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine\n",
      "2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER\n",
      "[(3S)-9-hydroxy-1-methyl-10-oxo-4,10-dihydro-3H-benzo[g]isochromen-3-yl]acetic acid\n",
      "3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione\n",
      "1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE\n",
      "(S)-Fluoxetine\n",
      "(1R)-1-PHENYLETHYL 4-(ACETYLAMINO)BENZYLPHOSPHONATE\n",
      "4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE\n",
      "PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE\n",
      "[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl hydrogen hex-5-enylphosphonate\n",
      "(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER\n",
      "7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline\n",
      "(1R)-1-(2-THIENYLACETYLAMINO)-1-(3-CARBOXYPHENYL)METHYLBORONIC ACID\n",
      "(1R)-1-(2-thienylacetylamino)-1-phenylmethylboronic acid\n",
      "(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime\n",
      "N-(3-carboxypropanoyl)-L-norvaline\n",
      "1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline\n",
      "5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID\n",
      "2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide\n",
      "2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL\n",
      "N-[(2S,4S,6R)-2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo-4lambda~4~-thia-1-azabicyclo[3.2.0]hept-6-yl]-2-phenylacetamide\n",
      "3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE\n",
      "BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE\n",
      "4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID\n",
      "(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide\n",
      "L-1-naphthyl-2-acetamido-ethane boronic acid\n",
      "D-1-naphthyl-2-acetamido-ethane boronic acid\n",
      "(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE\n",
      "3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE\n",
      "4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID\n",
      "4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID\n",
      "4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE\n",
      "3-[(4-CHLOROANILINO)SULFONYL]THIOPHENE-2-CARBOXYLIC ACID\n",
      "(5R)-2-SULFANYL-5-[4-(TRIFLUOROMETHYL)BENZYL]-1,3-THIAZOL-4-ONE\n",
      "2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM\n",
      "1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE\n",
      "3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE\n",
      "4-[(5-bromopyridin-2-yl)amino]-4-oxobutanoic acid\n",
      "4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}aniline\n",
      "4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline\n",
      "4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid\n",
      "N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide\n",
      "2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide\n",
      "6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline\n",
      "S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] hexanethioate\n",
      "S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] octanethioate\n",
      "SINAPINATE\n",
      "2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE\n",
      "SYRINGATE\n",
      "1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE\n",
      "5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE\n",
      "1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE\n",
      "TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE\n",
      "4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL\n",
      "5'-deoxy-5'-piperidin-1-ylthymidine\n",
      "6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine\n",
      "4-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE\n",
      "N-[(4-methoxyphenyl)sulfonyl]-D-alanine\n",
      "5-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE\n",
      "tributylstannanyl\n",
      "3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one\n",
      "N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-4-methylbenzenesulfonamide\n",
      "Triclosan\n",
      "6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL\n",
      "(3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN-3-OL\n",
      "(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE\n",
      "4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE\n",
      "(2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide\n",
      "N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE\n",
      "2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL\n",
      "1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE\n",
      "2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL\n",
      "3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE\n",
      "2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM\n",
      "4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE\n",
      "3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER\n",
      "Testosterone succinate\n",
      "{(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide\n",
      "Thiamphenicol\n",
      "4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL\n",
      "2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)-METHYL]-5-METHYLENE-5,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID\n",
      "BENZOTHIAZOLE\n",
      "Thiorphan\n",
      "(5R)-4-HYDROXY-3,5-DIMETHYL-5-[(1E,3E)-2-METHYLPENTA-1,3-DIENYL]THIOPHEN-2(5H)-ONE\n",
      "(5R)-5-[(1E)-BUTA-1,3-DIENYL]-4-HYDROXY-3,5-DIMETHYLTHIOPHEN-2(5H)-ONE\n",
      "N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE\n",
      "N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE\n",
      "1,3,5-BENZENETRICARBOXYLIC ACID\n",
      "TNP-470\n",
      "6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL\n",
      "N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID\n",
      "2-Hydroxybenzalpyruvate\n",
      "4-(2-METHOXYPHENYL)-2-OXOBUT-3-ENOIC ACID\n",
      "2-AMINO-3-(1-HYDROPEROXY-1H-INDOL-3-YL)PROPAN-1-OL\n",
      "Dapivirine\n",
      "(2S,3S)-3-FORMYL-2-({[(4-METHYLPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID\n",
      "(2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID\n",
      "(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine\n",
      "2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER\n",
      "{1-[2-(1-FORMYL-PROPYL)-3-METHANESULFONYLAMINO-PYRROLIDINE-1-CARBONYL]-2-METHYL-PROPYL}-CARBAMIC ACID TERT-BUTYL ESTER\n",
      "6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE\n",
      "TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL\n",
      "TRAZEOLIDE\n",
      "(1R,3S,5S,8R)-8-Hydroxy-2-oxabicyclo[3.3.1]non-6-ene-3,5-dicarboxylic acid\n",
      "(1S)-1-AMINO-2-(1H-INDOL-3-YL)ETHANOL\n",
      "3'-THIO-THYMIDINE-5'-PHOSPHATE\n",
      "2-(1H-INDOL-3-YL)ACETAMIDE\n",
      "2-(1H-INDOL-3-YL)ETHANAMINE\n",
      "TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL\n",
      "9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE\n",
      "5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide\n",
      "2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID\n",
      "ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE\n",
      "2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide\n",
      "1,2,5,8-tetrahydroxyanthracene-9,10-dione\n",
      "1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione\n",
      "3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE\n",
      "4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE\n",
      "({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER\n",
      "6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE\n",
      "5-imino-4-(3-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine\n",
      "4-(4-fluoro-phenylazo)-5-imino-5H-pyrazol-3-ylamine\n",
      "3-(5-amino-3-imino-3H-pyrazol-4-ylazo)-benzoic acid\n",
      "METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE\n",
      "METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE\n",
      "5-IMINO-4-(2-TRIFLUOROMETHYL-PHENYLAZO)-5H-PYRAZOL-3-YLAMINE\n",
      "4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE\n",
      "4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE\n",
      "(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE\n",
      "(5Z)-7-{(1R,4S,5R,6R)-6-[(1E)-1-Octen-1-yl]-2,3-diazabicyclo[2.2.1]hept-2-en-5-yl}-5-heptenoic acid\n",
      "(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE\n",
      "N-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE\n",
      "(4-ETHYLPHENYL)SULFAMIC ACID\n",
      "N-{3-[(E)-(tert-butoxyimino)methyl]-4-chlorophenyl}-2-methylfuran-3-carbimidothioic acid\n",
      "1-METHYL ETHYL 2-CHLORO-5-[[[(1-METHYLETHOXY)THIOOXO]METHYL]AMINO]-BENZOATE\n",
      "1-METHYL ETHYL 1-CHLORO-5-[[(5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL]AMINO]BENZOATE\n",
      "REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE\n",
      "O-DECYL HYDROGEN THIOCARBONATE\n",
      "1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine\n",
      "5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE\n",
      "FG-2216\n",
      "undecan-2-one\n",
      "UBIQUINONE-1\n",
      "UBIQUINONE-2\n",
      "ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate\n",
      "D-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid\n",
      "L-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid\n",
      "9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol\n",
      "3-(4-nitrophenyl)-1H-pyrazole\n",
      "4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide\n",
      "1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL\n",
      "1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine\n",
      "2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE\n",
      "2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID\n",
      "12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one\n",
      "[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate\n",
      "6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE\n",
      "(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID\n",
      "4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine\n",
      "N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine\n",
      "2,3-diphenyl-1H-indole-7-carboxylic acid\n",
      "(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE\n",
      "Methyl vanillate\n",
      "11-[(MERCAPTOCARBONYL)OXY]UNDECANOIC ACID\n",
      "2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL\n",
      "2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL\n",
      "2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL\n",
      "[(2S)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-2-yl]acetic acid\n",
      "4-(3-ethylthiophen-2-yl)benzene-1,2-diol\n",
      "5-(5-(6-CHLORO-4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE\n",
      "5-(5-(4-(4,5-dihydro-2-oxazoly)phenoxy)pentyl)-3-methyl osoxazole\n",
      "5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole\n",
      "5-(7-(6-chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole\n",
      "5-(5-(2,6-DICHLORO-4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE\n",
      "5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole\n",
      "(S)-5-(7-(4-(4-Ethyl-4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methylisoxazole\n",
      "5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole\n",
      "3-Methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)-1,2-oxazole\n",
      "5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole\n",
      "5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide\n",
      "3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE\n",
      "2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid\n",
      "NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE\n",
      "(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE\n",
      "6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE\n",
      "R,S-Warfarin alcohol\n",
      "S,R-Warfarin alcohol\n",
      "(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL\n",
      "1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one\n",
      "2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione\n",
      "CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE\n",
      "5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine\n",
      "1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)\n",
      "2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE\n",
      "6-methoxy-9-methyl[1,3]dioxolo[4,5-h]quinolin-8(9H)-one\n",
      "4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE\n",
      "1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE\n",
      "(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one\n",
      "4-(DIMETHYLAMINO)BENZOIC ACID\n",
      "3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE\n",
      "1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE\n",
      "N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE\n",
      "N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide\n",
      "4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE\n",
      "(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE\n",
      "N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide\n",
      "(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE\n",
      "5-(2-chlorophenyl)furan-2-carbohydrazide\n",
      "IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE\n",
      "[(3R,4S,5S,7R)-4,8-DIHYDROXY-3,5,7-TRIMETHYL-2-OXOOCTYL]PHOSPHONIC ACID\n",
      "(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid\n",
      "(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione\n",
      "O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID\n",
      "[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE\n",
      "6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE\n",
      "L-PROLINE, 1-[(2S)-3-MERCAPTO-2-METHYL-1-OXOPROPYL]-4-(PHENYLTHIO)-, 4S\n",
      "2-(4-METHOXYPHENYL)ACETAMIDE\n",
      "N-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE\n",
      "4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol\n",
      "(5R)-2-[(2-fluorophenyl)amino]-5-(1-methylethyl)-1,3-thiazol-4(5H)-one\n",
      "3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID\n",
      "RALOXIFENE CORE\n",
      "1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine\n",
      "Nα-[(Benzyloxy)carbonyl]-N-[(2S)-4-fluoro-3-oxo-2-butanyl]-L-tyrosinamide\n",
      "N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE\n",
      "5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE\n",
      "[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone\n",
      "2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol\n",
      "6-MORPHOLIN-4-YL-9H-PURINE\n",
      "1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE\n",
      "4-(2-AMINOETHYL)BENZENESULFONAMIDE\n",
      "(4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid\n",
      "2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID\n",
      "4-METHYL-2H-CHROMEN-2-ONE\n",
      "4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine\n",
      "4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine\n",
      "3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE\n",
      "2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE\n",
      "1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID\n",
      "1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE\n",
      "Diloxanide\n",
      "Ethyl biscoumacetate\n",
      "Azidocillin\n",
      "Pipazethate\n",
      "Salicylamide\n",
      "Sulfamoxole\n",
      "Antazoline\n",
      "Chloropyramine\n",
      "Dimetindene\n",
      "Isothipendyl\n",
      "Tymazoline\n",
      "Nandrolone decanoate\n",
      "Metiamide\n",
      "Roxatidine acetate\n",
      "Bopindolol\n",
      "Bupranolol\n",
      "Dichloroacetic Acid\n",
      "Cinitapride\n",
      "Tofisopam\n",
      "Nadroparin\n",
      "Triflusal\n",
      "Lurasidone\n",
      "Ticagrelor\n",
      "Hyaluronic acid\n",
      "Tafluprost\n",
      "Ivacaftor\n",
      "Azilsartan medoxomil\n",
      "Spinosad\n",
      "Ioflupane I-123\n",
      "Deferiprone\n",
      "Lomitapide\n",
      "Vismodegib\n",
      "Dehydroascorbic Acid\n",
      "2-deoxyglucose\n",
      "Tauroursodeoxycholic acid\n",
      "Spaglumic Acid\n",
      "Temocapril\n",
      "Tetraethylammonium\n",
      "Agmatine\n",
      "Serotonin\n",
      "Tyramine\n",
      "Acetylcarnitine\n",
      "GS 0573\n",
      "Uric Acid\n",
      "Oxogluric acid\n",
      "Ellagic Acid\n",
      "Hydroxyproline\n",
      "Guvacine\n",
      "Leukotriene C4\n",
      "DADLE\n",
      "Pitavastatin\n",
      "DPDPE\n",
      "Cholecystokinin\n",
      "Rilpivirine\n",
      "Crizotinib\n",
      "Ulipristal\n",
      "Fingolimod\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Tesamorelin\n",
      "Eribulin\n",
      "Gabapentin Enacarbil\n",
      "Boceprevir\n",
      "Fidaxomicin\n",
      "Cabozantinib\n",
      "Ruxolitinib\n",
      "Aminopterin\n",
      "Teriflunomide\n",
      "Vemurafenib\n",
      "Linagliptin\n",
      "Perampanel\n",
      "Gadoxetic acid\n",
      "Icosapent ethyl\n",
      "Carfilzomib\n",
      "Linaclotide\n",
      "Arbaclofen\n",
      "Arbaclofen Placarbil\n",
      "Mirabegron\n",
      "Tofacitinib\n",
      "Regorafenib\n",
      "Aclidinium\n",
      "Enzalutamide\n",
      "Ponatinib\n",
      "Bedaquiline\n",
      "Formestane\n",
      "Fluticasone furoate\n",
      "Canagliflozin\n",
      "Dimethyl fumarate\n",
      "Glycerol Phenylbutyrate\n",
      "Pomalidomide\n",
      "Trametinib\n",
      "Dabrafenib\n",
      "Radium Ra 223 Dichloride\n",
      "Aleglitazar\n",
      "Afatinib\n",
      "Ferric Carboxymaltose\n",
      "Levomilnacipran\n",
      "(4R)-limonene\n",
      "Perospirone\n",
      "Amfecloral\n",
      "Adrafinil\n",
      "Acediasulfone\n",
      "Amperozide\n",
      "Arsthinol\n",
      "Dolutegravir\n",
      "Riociguat\n",
      "Macitentan\n",
      "Luliconazole\n",
      "Sofosbuvir\n",
      "Chlorcyclizine\n",
      "TAS-102\n",
      "Magaldrate\n",
      "Letosteine\n",
      "Kebuzone\n",
      "Isoxsuprine\n",
      "Isoxicam\n",
      "Isoconazole\n",
      "Isoaminile\n",
      "Iotroxic acid\n",
      "Iopanoic acid\n",
      "Iopamidol\n",
      "Iodamide\n",
      "Inositol nicotinate\n",
      "Indoramin\n",
      "Indoprofen\n",
      "Indenolol\n",
      "Indalpine\n",
      "Ifenprodil\n",
      "Ibuproxam\n",
      "Hydroxydione\n",
      "Hexoprenaline\n",
      "Hexetidine\n",
      "Hexamethonium\n",
      "Azosemide\n",
      "Glibornuride\n",
      "Gemeprost\n",
      "Fusafungine\n",
      "Fursultiamine\n",
      "Dimetotiazine\n",
      "Fominoben\n",
      "Flurothyl\n",
      "Fluprednidene\n",
      "Fluocortolone\n",
      "Flumequine\n",
      "Fluclorolone acetonide\n",
      "Flubendazole\n",
      "Florantyrone\n",
      "Floctafenine\n",
      "Fentonium\n",
      "Fenspiride\n",
      "Fendiline\n",
      "Fenbufen\n",
      "Etozoline\n",
      "Etofibrate\n",
      "Etofenamate\n",
      "Etilefrine\n",
      "Etifoxine\n",
      "Etidocaine\n",
      "Ethoheptazine\n",
      "Etamivan\n",
      "Eprazinone\n",
      "Epirizole\n",
      "Eperisone\n",
      "Enviomycin\n",
      "Ditazole\n",
      "Diosmin\n",
      "Dimetacrine\n",
      "Dexetimide\n",
      "Demexiptiline\n",
      "Cyclopentamine\n",
      "Cyamemazine\n",
      "Barbexaclone\n",
      "Cloperastine\n",
      "Clocapramine\n",
      "Clobutinol\n",
      "Clinofibrate\n",
      "Chlorphenoxamine\n",
      "Cephaloridine\n",
      "Articaine\n",
      "Carmofur\n",
      "Beclamide\n",
      "Carbazochrome\n",
      "Befunolol\n",
      "Captodiame\n",
      "Canrenoic acid\n",
      "Butriptyline\n",
      "Brotizolam\n",
      "Bromopride\n",
      "Bromhexine\n",
      "Bisacodyl\n",
      "Benzoctamine\n",
      "Benfluorex\n",
      "Benactyzine\n",
      "Aliskiren\n",
      "Ledipasvir\n",
      "Cytisine\n",
      "Vorapaxar\n",
      "Miltefosine\n",
      "Suvorexant\n",
      "Empagliflozin\n",
      "Eliglustat\n",
      "Efinaconazole\n",
      "Tavaborole\n",
      "Tedizolid Phosphate\n",
      "Finafloxacin\n",
      "Netupitant\n",
      "Naloxegol\n",
      "Ceftolozane\n",
      "Ibrutinib\n",
      "Idelalisib\n",
      "Acipimox\n",
      "Amorolfine\n",
      "Atosiban\n",
      "Avibactam\n",
      "Cannabidiol\n",
      "Cefminox\n",
      "Ceritinib\n",
      "Ciprofibrate\n",
      "Cobicistat\n",
      "Corticorelin ovine triflutate\n",
      "Vortioxetine\n",
      "Trimetazidine\n",
      "Tibolone\n",
      "Tasimelteon\n",
      "Sodium oxybate\n",
      "Palbociclib\n",
      "Olaparib\n",
      "Edoxaban\n",
      "Umeclidinium\n",
      "Lenvatinib\n",
      "Nintedanib\n",
      "Olodaterol\n",
      "Idebenone\n",
      "Vilanterol\n",
      "Ivabradine\n",
      "Benzydamine\n",
      "Tetracaine\n",
      "Eugenol\n",
      "Potassium alum\n",
      "Amylocaine\n",
      "Trimebutine\n",
      "Pinaverium\n",
      "Tixocortol\n",
      "Xanthinol\n",
      "Chlortetracycline\n",
      "Podophyllin\n",
      "Difluocortolone\n",
      "Benzoyl peroxide\n",
      "Quinagolide\n",
      "Somatostatin\n",
      "Thyroid, porcine\n",
      "Elvitegravir\n",
      "Daclatasvir\n",
      "Magnesium hydroxide\n",
      "Hydroxyethyl Starch\n",
      "Coenzyme M\n",
      "Pentastarch\n",
      "Nitrous acid\n",
      "Colfosceril palmitate\n",
      "Diiodohydroxyquinoline\n",
      "Calcium carbimide\n",
      "Paraldehyde\n",
      "Stiripentol\n",
      "Eslicarbazepine acetate\n",
      "Zucapsaicin\n",
      "Aurothioglucose\n",
      "Dienogest\n",
      "Medrogestone\n",
      "Potassium Citrate\n",
      "Brexpiprazole\n",
      "Chromic chloride\n",
      "Copper\n",
      "Cupric Chloride\n",
      "Gadoteric acid\n",
      "Iothalamic acid\n",
      "Ioversol\n",
      "Ioxilan\n",
      "Isosulfan blue\n",
      "Technetium Tc-99m mebrofenin\n",
      "Technetium Tc-99m medronate\n",
      "Technetium Tc-99m oxidronate\n",
      "Oxygen\n",
      "Sincalide\n",
      "Sonidegib\n",
      "Uridine triacetate\n",
      "Water\n",
      "Iron saccharate\n",
      "Ferric pyrophosphate\n",
      "Florbetaben (18F)\n",
      "Florbetapir (18F)\n",
      "Flutemetamol (18F)\n",
      "Nitrogen\n",
      "Sodium Chloride\n",
      "Sodium Citrate\n",
      "Helium\n",
      "Iopromide\n",
      "Carbon dioxide\n",
      "Trypan blue\n",
      "Technetium Tc-99m tetrofosmin\n",
      "Technetium Tc-99m sestamibi\n",
      "Technetium Tc-99m exametazime\n",
      "Technetium Tc-99m disofenin\n",
      "Technetium Tc-99m pyrophosphate\n",
      "Etizolam\n",
      "Dosulepin\n",
      "4-Phenylfentanyl\n",
      "3-Allylfentanyl\n",
      "β-Hydroxythiofentanyl\n",
      "β-Methylfentanyl\n",
      "Brifentanil\n",
      "Butyrfentanyl\n",
      "Lofentanil\n",
      "Mirfentanil\n",
      "p-Fluorofentanyl\n",
      "Phenaridine\n",
      "R-30490\n",
      "Thienylfentanyl\n",
      "Trefentanil\n",
      "Benzylfentanyl\n",
      "Dasabuvir\n",
      "Edivoxetine\n",
      "Viloxazine\n",
      "Nisoxetine\n",
      "Lortalamine\n",
      "Amedalin\n",
      "Daledalin\n",
      "Talopram\n",
      "Talsupram\n",
      "Tandamine\n",
      "CP-39,332\n",
      "Etoperidone\n",
      "Lorpiprazole\n",
      "Lubazodone\n",
      "Mepiprazole\n",
      "Lobeglitazone\n",
      "Netoglitazone\n",
      "Rivoglitazone\n",
      "Ciglitazone\n",
      "Cirazoline\n",
      "Synephrine\n",
      "Arotinolol\n",
      "Moxisylyte\n",
      "Trimazosin\n",
      "AS-8112\n",
      "Pholcodine\n",
      "Piracetam\n",
      "Limaprost\n",
      "Loxoprofen\n",
      "Dexibuprofen\n",
      "Dexketoprofen\n",
      "Droxicam\n",
      "Tolfenamic Acid\n",
      "Firocoxib\n",
      "Clonixin\n",
      "Bisoxatin\n",
      "Nicorandil\n",
      "Polaprezinc\n",
      "Blonanserin\n",
      "Melperone\n",
      "Zotepine\n",
      "RP5063\n",
      "Barnidipine\n",
      "Aranidipine\n",
      "Azelnidipine\n",
      "Benidipine\n",
      "Cilnidipine\n",
      "Cronidipine\n",
      "Darodipine\n",
      "Efonidipine\n",
      "Lacidipine\n",
      "Levamlodipine\n",
      "Manidipine\n",
      "Niguldipine\n",
      "Niludipine\n",
      "Methylene blue\n",
      "Moxonidine\n",
      "Hydracarbazine\n",
      "Pirlindole\n",
      "Toloxatone\n",
      "Benmoxin\n",
      "Iproclozide\n",
      "Mebanazine\n",
      "Octamoxin\n",
      "Pheniprazine\n",
      "Phenoxypropazine\n",
      "Pivhydrazine\n",
      "Safrazine\n",
      "Caroxazone\n",
      "Dextran\n",
      "Tegafur\n",
      "Gimeracil\n",
      "Bemiparin\n",
      "Reviparin\n",
      "Parnaparin\n",
      "Certoparin\n",
      "Imidafenacin\n",
      "Patiromer\n",
      "Lixisenatide\n",
      "Technetium Tc-99m tilmanocept\n",
      "Strontium ranelate\n",
      "Picosulfuric acid\n",
      "Phenylacetic acid\n",
      "Ubidecarenone\n",
      "Cimetropium\n",
      "Eluxadoline\n",
      "Doxofylline\n",
      "Artesunate\n",
      "Bismuth Subcitrate\n",
      "Sodium aurothiomalate\n",
      "Choline C 11\n",
      "Activated charcoal\n",
      "Fimasartan\n",
      "Lumacaftor\n",
      "Magnesium Trisilicate\n",
      "Molsidomine\n",
      "Trapidil\n",
      "Imolamine\n",
      "Morniflumate\n",
      "Pipamperone\n",
      "Polyethylene glycol\n",
      "Propacetamol\n",
      "Tianeptine\n",
      "Ramosetron\n",
      "Rolapitant\n",
      "Sacubitril\n",
      "Iodide I-131\n",
      "Talniflumate\n",
      "Ombitasvir\n",
      "Paritaprevir\n",
      "Silibinin A\n",
      "Tenofovir alafenamide\n",
      "Butylscopolamine\n",
      "Chondroitin sulfate\n",
      "Setiptiline\n",
      "Aptazapine\n",
      "Metralindole\n",
      "Oxaprotiline\n",
      "Solithromycin\n",
      "Kitasamycin\n",
      "Polycarbophil calcium\n",
      "Ioxaglic acid\n",
      "Technetium Tc-99m pertechnetate\n",
      "Xenon-133\n",
      "Thallous Chloride\n",
      "Synthetic Conjugated Estrogens, A\n",
      "Synthetic Conjugated Estrogens, B\n",
      "Carbenicillin indanyl\n",
      "Procaine benzylpenicillin\n",
      "Zinc oxide\n",
      "Zinc sulfate\n",
      "Benzathine benzylpenicillin\n",
      "Sulbactam\n",
      "Sodium fluoride\n",
      "Ammonia N-13\n",
      "Tegafur-uracil\n",
      "Vayarin\n",
      "Osimertinib\n",
      "Kappadione\n",
      "Iopodic acid\n",
      "Alatrofloxacin\n",
      "Technetium Tc-99m nofetumomab merpentan\n",
      "Medical air\n",
      "Mersalyl\n",
      "Tyropanoic acid\n",
      "Glucose\n",
      "Propoxycaine\n",
      "Tipiracil\n",
      "Invert sugar\n",
      "Pramocaine\n",
      "Metrizoic acid\n",
      "Acetrizoic acid\n",
      "beta-Propiolactone\n",
      "Piperonyl butoxide\n",
      "Levobetaxolol\n",
      "Hydroxyamphetamine\n",
      "Sulfur\n",
      "Sulfabenzamide\n",
      "Dexpanthenol\n",
      "Rauwolfia serpentina root\n",
      "Procaine merethoxylline\n",
      "Propyliodone\n",
      "Polyestradiol phosphate\n",
      "Norethynodrel\n",
      "Tannic acid\n",
      "Indocyanine green\n",
      "Chymotrypsin\n",
      "Lapyrium\n",
      "Fluprednisolone\n",
      "Sutilains\n",
      "Estrogens, esterified\n",
      "Meprednisone\n",
      "Norgestrel\n",
      "Amino acids\n",
      "Phosphoric acid\n",
      "Sodium acetate\n",
      "Propoxyphene napsylate\n",
      "Technetium Tc-99m sulfur colloid\n",
      "Sodium fluoride F-18\n",
      "Isosorbide\n",
      "Iocetamic acid\n",
      "Magnesium chloride\n",
      "Magnesium acetate tetrahydrate\n",
      "Monopotassium phosphate\n",
      "Dipotassium phosphate\n",
      "Potassium perchlorate\n",
      "Xylose\n",
      "Iodide I-123\n",
      "Protirelin\n",
      "Soybean oil\n",
      "Indium In-111 pentetate\n",
      "Safflower oil\n",
      "Sodium phosphate\n",
      "Tartaric acid\n",
      "Sodium carbonate\n",
      "Glycerin\n",
      "Sodium sulfate\n",
      "Indium In-111 oxyquinoline\n",
      "Enalaprilat\n",
      "Rubidium chloride Rb-82\n",
      "Magnesium carbonate\n",
      "Sodium monofluorophosphate\n",
      "Iotrolan\n",
      "Acrivastine\n",
      "Indium In-111 chloride\n",
      "Cetyl alcohol\n",
      "Avobenzone\n",
      "Octinoxate\n",
      "Strontium chloride Sr-89\n",
      "Thiosulfuric acid\n",
      "Fludeoxyglucose F-18\n",
      "Urea C-13\n",
      "Talc\n",
      "Simethicone\n",
      "Urea C-14\n",
      "Mequinol\n",
      "Sodium ferric gluconate complex\n",
      "Hydroquinone\n",
      "Ecamsule\n",
      "Octocrylene\n",
      "Titanium dioxide\n",
      "Iodine povacrylex\n",
      "Omega-3-acid ethyl esters\n",
      "Methyl salicylate\n",
      "Iobenguane sulfate I-123\n",
      "Desoxyribonuclease\n",
      "Thonzonium\n",
      "Dexchlorpheniramine maleate\n",
      "Sodium glycerophosphate\n",
      "Choline C-11\n",
      "Olive oil\n",
      "Omega-3-carboxylic acids\n",
      "Ixazomib\n",
      "Levmetamfetamine\n",
      "Mineral oil\n",
      "Petrolatum\n",
      "Carboxymethylcellulose\n",
      "Polyvinyl alcohol\n",
      "Povidone\n",
      "Octisalate\n",
      "Polysorbate 80\n",
      "Homosalate\n",
      "Selenic acid\n",
      "Phenyl salicylate\n",
      "Hydrofluoric acid\n",
      "Cetylpyridinium\n",
      "Dimethicone\n",
      "Hypromellose\n",
      "Dextran 70\n",
      "Polyethylene glycol 400\n",
      "Trolamine salicylate\n",
      "Silver nitrate\n",
      "Aluminum chloride\n",
      "Coal tar\n",
      "Resorcinol\n",
      "Cocoa butter\n",
      "Pyrethrum extract\n",
      "Shark liver oil\n",
      "Docusate\n",
      "Potassium nitrate\n",
      "Hydrogen peroxide\n",
      "Stannous fluoride\n",
      "Calcium Citrate\n",
      "Vitamin D\n",
      "Meradimate\n",
      "Potassium bicarbonate\n",
      "Allantoin\n",
      "N-acetyltyrosine\n",
      "Sulfur hexafluoride\n",
      "Benzalkonium\n",
      "Pamabrom\n",
      "Potassium bitartrate\n",
      "Aluminum sesquichlorohydrate\n",
      "Chlorine\n",
      "Magnesium citrate\n",
      "Witch hazel\n",
      "Lanolin\n",
      "Castor oil\n",
      "Eucalyptus oil\n",
      "Ensulizole\n",
      "Aluminum zirconium trichlorohydrex gly\n",
      "Undecylenate\n",
      "Ammonia\n",
      "Sodium iodide\n",
      "Turpentine\n",
      "Chloroxylenol\n",
      "Dextran 40\n",
      "Hypochlorite\n",
      "Racepinephrine\n",
      "Benzethonium\n",
      "Calcium gluconate\n",
      "Selenious acid\n",
      "Ammonium molybdate\n",
      "Carbamide peroxide\n",
      "Opium\n",
      "Silicon dioxide\n",
      "Omega-3 fatty acids\n",
      "Cupric oxide\n",
      "Selenium\n",
      "Chromium\n",
      "Molybdenum\n",
      "Chromium Cr-51\n",
      "Manganese gluconate\n",
      "Selenomethionine\n",
      "Cresol\n",
      "Oxyquinoline\n",
      "Aluminum zirconium pentachlorohydrate\n",
      "Butamben\n",
      "Aluminum zirconium tetrachlorohydrex gly\n",
      "Barium sulfate\n",
      "Sodium hydroxide\n",
      "Trichloroacetate\n",
      "Potassium hydroxide\n",
      "Zinc citrate\n",
      "Triclocarban\n",
      "Pyrantel\n",
      "Anthralin\n",
      "Pectin\n",
      "Sodium sulfide\n",
      "Phenyltoloxamine\n",
      "Polyethylene glycol 300\n",
      "Picrate\n",
      "Bicisate\n",
      "Rosin\n",
      "Calcium threonate\n",
      "Ferrous asparto glycinate\n",
      "Ferric sulfate\n",
      "Sesame oil\n",
      "Zinc picolinate\n",
      "Zeaxanthin\n",
      "Polysorbate 20\n",
      "Exametazime\n",
      "Tetrofosmin\n",
      "Homatropine\n",
      "Rose bengal\n",
      "Light green SF yellowish\n",
      "Oftasceine\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Sulisobenzone\n",
      "Pentoxyverine\n",
      "Magnesium glycinate\n",
      "Pantethine\n",
      "Cobamamide\n",
      "Papain\n",
      "Xylitol\n",
      "Peppermint oil\n",
      "Sage oil\n",
      "Aluminum zirconium octachlorohydrex gly\n",
      "N-alkyl ethylbenzyl dimethyl ammonium (c12-c14)\n",
      "Boron\n",
      "Alcloxa\n",
      "Bemotrizinol\n",
      "Aluminum chlorohydrex propylene glycol\n",
      "Iron protein succinylate\n",
      "Ferrous bisglycinate\n",
      "Potassium dichromate\n",
      "Arbutin\n",
      "Tea tree oil\n",
      "Enzacamene\n",
      "Octacosanol\n",
      "Benzoin\n",
      "Methyl cellulose\n",
      "Lycopene\n",
      "Poliglusam\n",
      "Thonzylamine\n",
      "Trypsin\n",
      "Borage oil\n",
      "Aluminum sulfate\n",
      "Dextran 75\n",
      "Gelatin\n",
      "Ethyl macadamiate\n",
      "Cyclomethicone 5\n",
      "Copper gluconate\n",
      "Zinc gluconate\n",
      "Tocopherol\n",
      "Poloxamer 407\n",
      "Xanthan gum\n",
      "Hexylresorcinol\n",
      "Chromium picolinate\n",
      "Levomefolic acid\n",
      "Fluoride ion\n",
      "Ceramide 3\n",
      "Diosmetin\n",
      "Diacetyl benzoyl lathyrol\n",
      "Atractylodes japonica root\n",
      "Polydatin\n",
      "Calcium glycerophosphate\n",
      "Sea salt\n",
      "Protocatechualdehyde\n",
      "Atractylodes japonica root oil\n",
      "Methyl undecenoyl leucinate\n",
      "Pine needle oil (pinus mugo)\n",
      "Aluminum zirconium pentachlorohydrex gly\n",
      "Brilliant green\n",
      "Docosahexaenoate\n",
      "Rice bran oil\n",
      "Trichophyton verrucosum\n",
      "Prezatide\n",
      "Thioredoxin\n",
      "Vanillyl butyl ether\n",
      "Thrombin\n",
      "Curcuma aromatica root oil\n",
      "Hydrogenated soybean oil\n",
      "Phenoxyethanol\n",
      "Methscopolamine\n",
      "Cod liver oil\n",
      "Glycol salicylate\n",
      "Boric acid\n",
      "Dipyrithione\n",
      "C11-12 isoparaffin\n",
      "Poloxamer 188\n",
      "Kinetin\n",
      "Zeatin\n",
      "Clove oil\n",
      "Ubiquinol\n",
      "Ichthammol\n",
      "Aluminum oxide\n",
      "Silanol\n",
      "Rubidium\n",
      "Calcium Phosphate\n",
      "Cetyl ethylhexanoate\n",
      "Cocamidopropyl betaine\n",
      "Ascorbyl phosphate\n",
      "Propolis wax\n",
      "Polyquaternium-10 (400 cps at 2%)\n",
      "Linseed oil\n",
      "Evening primrose oil\n",
      "Guaiacol\n",
      "Lactobacillus plantarum\n",
      "Selexipag\n",
      "Alectinib\n",
      "Pidotimod\n",
      "Sennosides\n",
      "Roquinimex\n",
      "Cefroxadine\n",
      "Alfaxalone\n",
      "Azaperone\n",
      "Chlorobutanol\n",
      "Diclazuril\n",
      "Emodepside\n",
      "Fenprostalene\n",
      "Imidacloprid\n",
      "Moxidectin\n",
      "Oxfendazole\n",
      "Poloxalene\n",
      "Prostalene\n",
      "Rotenone\n",
      "Squalene\n",
      "Tilmicosin\n",
      "Atipamezole\n",
      "Balsam of Peru\n",
      "Sarafloxacin\n",
      "Deslorelin\n",
      "Dihydrostreptomycin\n",
      "Masitinib\n",
      "Toluene\n",
      "Lesinurad\n",
      "Aminacrine\n",
      "Bicuculline\n",
      "Padimate O\n",
      "Aluminum chlorohydrate\n",
      "Elbasvir\n",
      "Grazoprevir\n",
      "Indigotindisulfonic Acid\n",
      "Light Mineral Oil\n",
      "Venetoclax\n",
      "Thiocolchicoside\n",
      "Cetalkonium\n",
      "Asunaprevir\n",
      "Carbon monoxide\n",
      "Neon\n",
      "Thimerosal\n",
      "Bilastine\n",
      "Nitrocefin\n",
      "Isatoic anhydride\n",
      "Domiphen\n",
      "Levoleucovorin\n",
      "Starch, corn\n",
      "Hydroxyethyl cellulose\n",
      "Myrrh\n",
      "Normethadone\n",
      "Oxilofrine\n",
      "Lifitegrast\n",
      "Velpatasvir\n",
      "Rupatadine\n",
      "Pirarubicin\n",
      "Aclarubicin\n",
      "Zorubicin\n",
      "Gestrinone\n",
      "Neridronic Acid\n",
      "Dehydrocholic acid\n",
      "Candoxatrilat\n",
      "Perflenapent\n",
      "Depreotide\n",
      "Laropiprant\n",
      "Temoporfin\n",
      "Opicapone\n",
      "Isavuconazole\n",
      "Colestilan chloride\n",
      "Tocofersolan\n",
      "Nomegestrol\n",
      "Delamanid\n",
      "Artenimol\n",
      "Amifampridine\n",
      "Vinflunine\n",
      "Pitolisant\n",
      "Tafamidis\n",
      "PF-4191834\n",
      "Incyclinide\n",
      "Afuresertib\n",
      "Lersivirine\n",
      "HT-0712\n",
      "Dactolisib\n",
      "Tucatinib\n",
      "Bremelanotide\n",
      "T-2000\n",
      "Evacetrapib\n",
      "Rebamipide\n",
      "QAV-680\n",
      "Indium\n",
      "Latanoprostene Bunod\n",
      "Rabusertib\n",
      "Pictilisib\n",
      "Psilocybine\n",
      "BMS-690514\n",
      "Buparlisib\n",
      "2'-cyano-2'-deoxy-1-(beta-D-arabinofuranosyl)cytosine\n",
      "Ortataxel\n",
      "SP-8203\n",
      "AZD-4877\n",
      "Curcumin\n",
      "Pyridoxamine\n",
      "Equol\n",
      "Mosapride\n",
      "Galidesivir\n",
      "Triheptanoin\n",
      "Treosulfan\n",
      "Fruquintinib\n",
      "Tofimilast\n",
      "Daprodustat\n",
      "PF-06282999\n",
      "APR-246\n",
      "Iferanserin\n",
      "E-6201\n",
      "2-chloroethyl-3-sarcosinamide-1-nitrosourea\n",
      "Selumetinib\n",
      "Naldemedine\n",
      "AZD-2624\n",
      "Voclosporin\n",
      "Ilorasertib\n",
      "Carnosine\n",
      "Racecadotril\n",
      "Pacritinib\n",
      "Ipragliflozin\n",
      "Tropisetron\n",
      "Setmelanotide\n",
      "Amenamevir\n",
      "Antineoplaston A10\n",
      "Acalabrutinib\n",
      "Adomeglivant\n",
      "Iomeprol\n",
      "Raxatrigine\n",
      "Olaptesed Pegol\n",
      "Peficitinib\n",
      "Acetyl hexapeptide-8\n",
      "Trigonellamide\n",
      "Navarixin\n",
      "Tezacaftor\n",
      "Ruzasvir\n",
      "Misonidazole\n",
      "Epacadostat\n",
      "Encorafenib\n",
      "UK-390957\n",
      "Angiotensin 1-7\n",
      "Mitoglitazone\n",
      "Dutogliptin\n",
      "Bombesin\n",
      "Latrepirdine\n",
      "Encenicline\n",
      "Fondaparinux\n",
      "GSK-2330672\n",
      "Ribociclib\n",
      "Depatuxizumab mafodotin\n",
      "Lasmiditan\n",
      "Fedovapagon\n",
      "Galactose\n",
      "PF-00489791\n",
      "Icotinib\n",
      "Rilmenidine\n",
      "Vonoprazan\n",
      "MK-1775\n",
      "Famitinib\n",
      "Ebastine\n",
      "Ipatasertib\n",
      "Epetraborole\n",
      "Otenabant\n",
      "Barasertib\n",
      "Benfotiamine\n",
      "(R)-Praziquantel\n",
      "Clobetasol\n",
      "Cabotegravir\n",
      "Bryostatin 1\n",
      "Rifamycin\n",
      "Tetrahydrocannabivarin\n",
      "Istradefylline\n",
      "Cenicriviroc\n",
      "Pevonedistat\n",
      "Talazoparib\n",
      "Tenapanor\n",
      "Marizomib\n",
      "Momelotinib\n",
      "Spebrutinib\n",
      "PF-04991532\n",
      "AZD-1305\n",
      "O-(2,4-dichlorophenyl)-O-methyl-isopropylphosphoramidothioate\n",
      "Funapide\n",
      "Talinolol\n",
      "Pilaralisib\n",
      "BMS-903452\n",
      "Pazufloxacin\n",
      "PF-03758309\n",
      "Danusertib\n",
      "Danoprevir\n",
      "Allicin\n",
      "Tosedostat\n",
      "Birinapant\n",
      "Imidapril\n",
      "NRX-1074\n",
      "Anisodamine\n",
      "Pefcalcitol\n",
      "Ralimetinib\n",
      "Hyodeoxycholic Acid\n",
      "Radafaxine\n",
      "Capmatinib\n",
      "Mirodenafil\n",
      "Niraparib\n",
      "Berzosertib\n",
      "GSK-2636771\n",
      "Fostemsavir\n",
      "Aceneuramic acid\n",
      "Tanzisertib\n",
      "Bictegravir\n",
      "Tivozanib\n",
      "Rapastinel\n",
      "AZD-5672\n",
      "Saracatinib\n",
      "VTP-194204\n",
      "Dexmecamylamine\n",
      "Faldaprevir\n",
      "Artefenomel\n",
      "Etarfolatide\n",
      "Arhalofenate\n",
      "Talaporfin\n",
      "Mipsagargin\n",
      "PF-03882845\n",
      "Tilarginine\n",
      "Omecamtiv Mecarbil\n",
      "Baricitinib\n",
      "Retosiban\n",
      "ASP-4058\n",
      "Nifurtimox\n",
      "Danegaptide\n",
      "TMC-647055\n",
      "Esketamine\n",
      "Tofogliflozin\n",
      "Mirogabalin\n",
      "Ertugliflozin\n",
      "Neratinib\n",
      "Ruboxistaurin\n",
      "Mocetinostat\n",
      "Dinitrochlorobenzene\n",
      "Crenolanib\n",
      "Basimglurant\n",
      "Indium In-111 pentetreotide\n",
      "Sapanisertib\n",
      "Osilodrostat\n",
      "Revamilast\n",
      "PZ-128\n",
      "Entinostat\n",
      "Angiotensin II\n",
      "PF-04958242\n",
      "Pritelivir\n",
      "Lucitanib\n",
      "Creatinine\n",
      "Cadazolid\n",
      "Mannose 6-phosphate\n",
      "Bafetinib\n",
      "Tegobuvir\n",
      "Relugolix\n",
      "Revefenacin\n",
      "Leukotriene D4\n",
      "Allopregnanolone\n",
      "Aramchol\n",
      "Litronesib\n",
      "Alvelestat\n",
      "Preladenant\n",
      "Brivanib alaninate\n",
      "JNJ-39393406\n",
      "Etiracetam\n",
      "Valspodar\n",
      "RG-4733\n",
      "PF-00610355\n",
      "ZD-6126\n",
      "Verinurad\n",
      "Crocin\n",
      "3,3'-diindolylmethane\n",
      "Alanyl Glutamine\n",
      "Basmisanil\n",
      "Filibuvir\n",
      "Dusquetide\n",
      "Acridine Carboxamide\n",
      "AUY922\n",
      "BPC-157\n",
      "SB-705498\n",
      "Anlotinib\n",
      "Infigratinib\n",
      "Laninamivir octanoate\n",
      "Lanicemine\n",
      "Cilengitide\n",
      "CUDC-907\n",
      "Prulifloxacin\n",
      "Avagacestat\n",
      "Efatutazone\n",
      "Gedatolisib\n",
      "2,4-thiazolidinedione\n",
      "MK-8776\n",
      "OC-459\n",
      "Apalutamide\n",
      "Gisadenafil\n",
      "GW842166\n",
      "Flumatinib\n",
      "Sutezolid\n",
      "Acyline\n",
      "Rociletinib\n",
      "Varespladib\n",
      "MK-0249\n",
      "Galunisertib\n",
      "Lanopepden\n",
      "LY-2090314\n",
      "Valbenazine\n",
      "Indium In-111\n",
      "Vatiquinone\n",
      "Guadecitabine\n",
      "6-O-benzylguanine\n",
      "Lesogaberan\n",
      "Deflazacort\n",
      "Danirixin\n",
      "Decoglurant\n",
      "Safingol\n",
      "Vistusertib\n",
      "Lodenafil Carbonate\n",
      "Vaniprevir\n",
      "Abametapir\n",
      "Riboprine\n",
      "Epelsiban\n",
      "Flomoxef\n",
      "Bempedoic acid\n",
      "Kynurenic Acid\n",
      "Difelikefalin\n",
      "Henagliflozin\n",
      "Triapine\n",
      "Tasisulam\n",
      "Selinexor\n",
      "Delafloxacin\n",
      "Ingavirin\n",
      "AZD-1981\n",
      "Pridopidine\n",
      "Lapachone\n",
      "Vestipitant\n",
      "Teneligliptin\n",
      "Lemborexant\n",
      "Duvelisib\n",
      "PF-04447943\n",
      "Lomibuvir\n",
      "Delanzomib\n",
      "Idalopirdine\n",
      "Brivanib\n",
      "Carboxyamidotriazole\n",
      "AZD-1236\n",
      "GSK-1059615\n",
      "Dacomitinib\n",
      "Ilaprazole\n",
      "SJG-136\n",
      "BMS-986094\n",
      "Binimetinib\n",
      "MK-7145\n",
      "Uprosertib\n",
      "Burixafor\n",
      "Vilaprisan\n",
      "Tesevatinib\n",
      "PF-04691502\n",
      "TAK-448\n",
      "Golvatinib\n",
      "Glasdegib\n",
      "Elagolix\n",
      "Carbon Black\n",
      "Elamipretide\n",
      "GDC-0623\n",
      "Letaxaban\n",
      "Dapaconazole\n",
      "Entrectinib\n",
      "GSK-2018682\n",
      "Benznidazole\n",
      "MK-0812\n",
      "Oprozomib\n",
      "Omarigliptin\n",
      "PF-03463275\n",
      "Diacerein\n",
      "Avatrombopag\n",
      "Thymopentin\n",
      "Sorivudine\n",
      "Vosaroxin\n",
      "Apabetalone\n",
      "Abemaciclib\n",
      "AZD-4818\n",
      "Briciclib\n",
      "Nirogacestat\n",
      "BMS-906024\n",
      "Isoflavone\n",
      "Prexasertib\n",
      "GW-406381\n",
      "Fostamatinib\n",
      "Fevipiprant\n",
      "PF-04457845\n",
      "Axelopran\n",
      "Alpelisib\n",
      "Ponesimod\n",
      "Ozagrel\n",
      "Tesetaxel\n",
      "Tecovirimat\n",
      "Dinaciclib\n",
      "Evatanepag\n",
      "PF-04418948\n",
      "Triptolide\n",
      "Voxilaprevir\n",
      "Serdemetan\n",
      "Broxuridine\n",
      "Chlorogenic Acid\n",
      "Fluorescein lisicol\n",
      "Ammonio methacrylate copolymer type A\n",
      "Atagabalin\n",
      "Sarecycline\n",
      "Naquotinib\n",
      "Vedroprevir\n",
      "Epicatechin\n",
      "2-octyl cyanoacrylate\n",
      "Mapracorat\n",
      "Ibodutant\n",
      "Sepetaprost\n",
      "MK-0893\n",
      "Mericitabine\n",
      "Atopaxar\n",
      "Ganetespib\n",
      "Savolitinib\n",
      "Dasolampanel etibutil\n",
      "LY-3039478\n",
      "Setrobuvir\n",
      "Icariin\n",
      "BQ-123\n",
      "MK-0767\n",
      "ORM-12741\n",
      "Recoflavone\n",
      "JNJ-40411813\n",
      "RRx-001\n",
      "Pardoprunox\n",
      "Volasertib\n",
      "CERC-301\n",
      "BMS-777607\n",
      "Radalbuvir\n",
      "Orteronel\n",
      "BMS-394136\n",
      "T-900607\n",
      "Sovaprevir\n",
      "Letermovir\n",
      "Vabicaserin\n",
      "Orantinib\n",
      "Albaconazole\n",
      "Censavudine\n",
      "Surotomycin\n",
      "Enobosarm\n",
      "Gefarnate\n",
      "Ritobegron\n",
      "Anecortave\n",
      "Vesnarinone\n",
      "Mafosfamide\n",
      "ADP-597\n",
      "LCL-161\n",
      "Oxitropium\n",
      "Vanillyl alcohol\n",
      "TT-232\n",
      "Gadolinium\n",
      "Naftopidil\n",
      "Tetrahydropalmatine\n",
      "Semapimod\n",
      "Telotristat ethyl\n",
      "PF-05175157\n",
      "Mannitol busulfan\n",
      "L-Baclofen\n",
      "UK-396,082\n",
      "Abediterol\n",
      "CC-220\n",
      "Imagabalin\n",
      "PF-06305591\n",
      "Vaborbactam\n",
      "Taselisib\n",
      "CPI-613\n",
      "m-Chlorophenylpiperazine\n",
      "MK-212\n",
      "Zuretinol acetate\n",
      "CE-224535\n",
      "Poziotinib\n",
      "AZD-9164\n",
      "Epigallocatechin Gallate\n",
      "Mitometh\n",
      "Avoralstat\n",
      "Entospletinib\n",
      "Figopitant\n",
      "Cinepazide\n",
      "Namitecan\n",
      "Dianicline\n",
      "Bradykinin\n",
      "Sultamicillin\n",
      "Ulimorelin\n",
      "Tideglusib\n",
      "Lorlatinib\n",
      "Vinpocetine\n",
      "BLXA4\n",
      "Gepotidacin\n",
      "Elubrixin\n",
      "GSK-256066\n",
      "PF-03715455\n",
      "Alisporivir\n",
      "Dilmapimod\n",
      "Gilteritinib\n",
      "Rezatomidine\n",
      "BMS-275183\n",
      "AZD-0328\n",
      "Rigosertib\n",
      "Erdafitinib\n",
      "Menatetrenone\n",
      "S-3304\n",
      "Pelubiprofen\n",
      "Brincidofovir\n",
      "Citicoline\n",
      "Itacitinib\n",
      "Napabucasin\n",
      "Cordycepin\n",
      "Filorexant\n",
      "Bucillamine\n",
      "Deutetrabenazine\n",
      "HX-1171\n",
      "Sarpogrelate\n",
      "Presatovir\n",
      "LY-3023414\n",
      "MK-0557\n",
      "Veledimex\n",
      "Nimorazole\n",
      "Diphencyprone\n",
      "CUDC-101\n",
      "Tricaprylin\n",
      "Eplivanserin\n",
      "Telinavir\n",
      "Secoisolariciresinol\n",
      "Apitolisib\n",
      "Dalcetrapib\n",
      "Sapitinib\n",
      "Gepirone\n",
      "Exatecan\n",
      "SRT-2104\n",
      "Abacavir hydroxyacetate\n",
      "Zicronapine\n",
      "Faropenem\n",
      "Obatoclax\n",
      "Emeramide\n",
      "Ajulemic acid\n",
      "Atamestane\n",
      "VP-14637\n",
      "CP-866087\n",
      "Auriclosene\n",
      "Fosdagrocorat\n",
      "TRV-120027\n",
      "Tivantinib\n",
      "PF-03654746\n",
      "Tozadenant\n",
      "Terbogrel\n",
      "N-6022\n",
      "Verdinexor\n",
      "Iron isomaltoside 1000\n",
      "Tirasemtiv\n",
      "AZD-6280\n",
      "PSI-697\n",
      "Landiolol\n",
      "Luseogliflozin\n",
      "Bergapten\n",
      "AZD-5363\n",
      "GSK-424887\n",
      "ORG-25935\n",
      "Canrenone\n",
      "Lurtotecan\n",
      "Squaric Acid Dibutyl Ester\n",
      "Oxothiazolidinecarboxylic acid\n",
      "Beclabuvir\n",
      "Terameprocol\n",
      "Tetulomab tetraxetan Lu-177\n",
      "Telcagepant\n",
      "Cerlapirdine\n",
      "Bunazosin\n",
      "Temefos\n",
      "KRN-7000\n",
      "Iguratimod\n",
      "BMS-214662\n",
      "Estetrol\n",
      "Bexagliflozin\n",
      "GW-274150\n",
      "MK-0777\n",
      "Balicatib\n",
      "TAK-733\n",
      "AZD-7762\n",
      "Edaravone\n",
      "CP-601927\n",
      "Triclabendazole\n",
      "AZD-4547\n",
      "Tulobuterol\n",
      "Moxaverine\n",
      "PG-701\n",
      "GDC-0810\n",
      "ABT-751\n",
      "Vadadustat\n",
      "Platinum\n",
      "CG-200745\n",
      "Radiprodil\n",
      "CRS-3123\n",
      "Begacestat\n",
      "Atevirdine\n",
      "Fexinidazole\n",
      "Epofolate\n",
      "Brigatinib\n",
      "Carmegliptin\n",
      "PF-06273340\n",
      "Losmapimod\n",
      "ORE-1001\n",
      "Vidupiprant\n",
      "Ecopipam\n",
      "Seviteronel\n",
      "Apomine\n",
      "Polihexanide\n",
      "Propiverine\n",
      "OBP-801\n",
      "AZD-5423\n",
      "Defactinib\n",
      "Balapiravir\n",
      "LY-2608204\n",
      "Verubecestat\n",
      "Simendan\n",
      "Talsaclidine\n",
      "Piromelatine\n",
      "Darexaban\n",
      "Puerarin\n",
      "Tacedinaline\n",
      "Barusiban\n",
      "Nefopam\n",
      "Evodenoson\n",
      "GLPG-0187\n",
      "5-(hydroxymethyl)-2-furaldehyde\n",
      "Bavisant\n",
      "P-nitrobiphenyl\n",
      "Doravirine\n",
      "CP-724714\n",
      "Motolimod\n",
      "Dasotraline\n",
      "Cipargamin\n",
      "Foretinib\n",
      "Eltanolone\n",
      "GI-181771X\n",
      "Trehalose\n",
      "CP1-1189\n",
      "ORG-25435\n",
      "Dopexamine\n",
      "Chlorproguanil\n",
      "9CUAB30\n",
      "BMS-599626\n",
      "Benzbromarone\n",
      "Palovarotene\n",
      "Ifetroban\n",
      "GW-870086\n",
      "Radotinib\n",
      "Idasanutlin\n",
      "Antroquinonol\n",
      "Salvinorin A\n",
      "Cantharidin\n",
      "Eravacycline\n",
      "Labetuzumab govitecan\n",
      "Rucaparib\n",
      "SPK-843\n",
      "Milataxel\n",
      "GDC-0917\n",
      "N-acetylsulfanilyl chloride\n",
      "Carisbamate\n",
      "Radezolid\n",
      "Navitoclax\n",
      "LY-2456302\n",
      "Temocillin\n",
      "MBX-2982\n",
      "CG-400549\n",
      "5-amino-1,3,4-thiadiazole-2-thiol\n",
      "Rostafuroxin\n",
      "Siagoside\n",
      "Bizelesin\n",
      "Ulodesine\n",
      "Imrecoxib\n",
      "Netazepide\n",
      "BMS-863233\n",
      "Enbucrilate\n",
      "BIIB021\n",
      "PF-03654764\n",
      "Piclozotan\n",
      "Diaminohydroxypropanetetraacetic acid\n",
      "Betrixaban\n",
      "Perzinfotel\n",
      "Selurampanel\n",
      "AZD-3839\n",
      "Sotrastaurin\n",
      "Ipamorelin\n",
      "Siponimod\n",
      "Oglemilast\n",
      "Ricolinostat\n",
      "Relebactam\n",
      "Apricoxib\n",
      "Indirubin\n",
      "GDC-0152\n",
      "Merestinib\n",
      "R-306465\n",
      "Cytochlor\n",
      "AR-67\n",
      "10-hydroxycamptothecin\n",
      "OSI-027\n",
      "Evocalcet\n",
      "Zamicastat\n",
      "MBX-8025\n",
      "Sagopilone\n",
      "Resminostat\n",
      "Fanapanel\n",
      "Eleclazine\n",
      "Esreboxetine\n",
      "DSM-265\n",
      "Naproxen etemesil\n",
      "Polmacoxib\n",
      "Voxtalisib\n",
      "Bromperidol\n",
      "Pumosetrag\n",
      "Samarium\n",
      "Remimazolam\n",
      "Triciribine\n",
      "Lisofylline\n",
      "Iobitridol\n",
      "PF-03635659\n",
      "Sabarubicin\n",
      "R-428\n",
      "Gemigliptin\n",
      "Usistapide\n",
      "Galeterone\n",
      "VTP-27999\n",
      "Anagliptin\n",
      "Saccharin\n",
      "HSD-016\n",
      "Diazepinomicin\n",
      "Sulforaphane\n",
      "Fozivudine Tidoxil\n",
      "MK-3207\n",
      "Liothyronine I-131\n",
      "Bitopertin\n",
      "Orvepitant\n",
      "PAC-14028\n",
      "CI-1040\n",
      "BC-3781\n",
      "CC-401\n",
      "SCH-900271\n",
      "Steviolbioside\n",
      "Tipelukast\n",
      "Vofopitant\n",
      "Filociclovir\n",
      "Ioforminol\n",
      "Verdiperstat\n",
      "Tavilermide\n",
      "Alvespimycin\n",
      "Sonedenoson\n",
      "Theanine\n",
      "Nitroaspirin\n",
      "Derenofylline\n",
      "Nadifloxacin\n",
      "Lifibrol\n",
      "Tempol\n",
      "Propyl Gallate\n",
      "SCY-635\n",
      "Caprylic alcohol\n",
      "Chlorine Dioxide\n",
      "Zalypsis\n",
      "Omadacycline\n",
      "Rimegepant\n",
      "Muscimol\n",
      "Belotecan\n",
      "GLPG-0492\n",
      "Ralinepag\n",
      "Semagacestat\n",
      "Bevenopran\n",
      "Ketanserin\n",
      "Favipiravir\n",
      "TU-100\n",
      "Pf-04531083\n",
      "Dexelvucitabine\n",
      "MK-3118\n",
      "Levodropropizine\n",
      "Taurolidine\n",
      "Lynestrenol\n",
      "Biphenyl dimethyl dicarboxylate\n",
      "CPG-52852\n",
      "Perfluoro tert-butylcyclohexane\n",
      "Piribedil\n",
      "Zabofloxacin\n",
      "Betulinic Acid\n",
      "Barium\n",
      "Acotiamide\n",
      "Copanlisib\n",
      "Tetrahydrouridine\n",
      "Pimonidazole\n",
      "Elobixibat\n",
      "Promestriene\n",
      "Mirvetuximab Soravtansine\n",
      "Fasiglifam\n",
      "Piritramide\n",
      "PD-217014\n",
      "SGI-1776\n",
      "Selepressin\n",
      "Alagebrium\n",
      "Cortexolone 17α-propionate\n",
      "Fedratinib\n",
      "ABT-384\n",
      "JNJ-40346527\n",
      "E-7820\n",
      "Fenamole\n",
      "Atecegatran metoxil\n",
      "E7107\n",
      "Imeglimin\n",
      "Ozone\n",
      "Imiglitazar\n",
      "Verucerfont\n",
      "Omaveloxolone\n",
      "Iofolastat I-123\n",
      "9-aminocamptothecin\n",
      "PF-00446687\n",
      "Raclopride\n",
      "Sarcosine\n",
      "Methyl pyrrolidone\n",
      "Toreforant\n",
      "Mizolastine\n",
      "BI-671800\n",
      "Batefenterol\n",
      "Sofinicline\n",
      "Glyceryl Trierucate\n",
      "Nitrite\n",
      "Lobucavir\n",
      "Oxethazaine\n",
      "Cevipabulin\n",
      "AC-430\n",
      "N-acetylmannosamine\n",
      "Benzodiazepine\n",
      "Nepadutant\n",
      "Oltipraz\n",
      "Lecozotan\n",
      "SAR-405838\n",
      "GSK-356278\n",
      "Samidorphan\n",
      "Indobufen\n",
      "LY-2886721\n",
      "Sparsentan\n",
      "Pyrazoloacridine\n",
      "Taladegib\n",
      "Idazoxan\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Fluocinolone\n",
      "Mebeverine\n",
      "Nelotanserin\n",
      "MK-5108\n",
      "FK-614\n",
      "AEE-788\n",
      "EC-17\n",
      "WNT-974\n",
      "Setipiprant\n",
      "MK-0686\n",
      "Gemcitabine elaidate\n",
      "Abexinostat\n",
      "Decernotinib\n",
      "Camicinal\n",
      "Tonapofylline\n",
      "CC-223\n",
      "Rimacalib\n",
      "Pexacerfont\n",
      "LY-2452473\n",
      "LY-295501\n",
      "Ronopterin\n",
      "AZD-3043\n",
      "Fosbretabulin\n",
      "Lexaptepid Pegol\n",
      "JNJ-37822681\n",
      "Tradipitant\n",
      "Ozarelix\n",
      "Piperine\n",
      "Maltodextrin\n",
      "Ondelopran\n",
      "Anhydrovinblastine\n",
      "Razupenem\n",
      "AZD-1480\n",
      "Indiplon\n",
      "BMS-911543\n",
      "EC-18\n",
      "Apaziquone\n",
      "AZD-9056\n",
      "Combretastatin\n",
      "ABL-001\n",
      "Nafamostat\n",
      "Sonolisib\n",
      "Pentetreotide\n",
      "Sisomicin\n",
      "Etripamil\n",
      "Netivudine\n",
      "Emixustat\n",
      "Ebselen\n",
      "PF-477736\n",
      "Ozanimod\n",
      "Davunetide\n",
      "Reparixin\n",
      "Plazomicin\n",
      "Mizoribine\n",
      "Apocynin\n",
      "BMS-188797\n",
      "ST-101\n",
      "Lupeol\n",
      "Taprenepag\n",
      "Octenidine\n",
      "Evogliptin\n",
      "GSK-1292263\n",
      "Methyl-D9-choline\n",
      "3,5-diiodothyropropionic acid\n",
      "Isopentyl 2-cyanoacrylate\n",
      "Aclerastide\n",
      "JNJ-41443532\n",
      "BMS-184476\n",
      "Aleplasinin\n",
      "Onapristone\n",
      "PU-H71\n",
      "CP-609754\n",
      "Tedatioxetine\n",
      "Olumacostat glasaretil\n",
      "Nelivaptan\n",
      "AZD-2066\n",
      "Givinostat\n",
      "Tocotrienol\n",
      "Nona-arginine\n",
      "Ibipinabant\n",
      "L-deprenyl-D2 C-11\n",
      "Bardoxolone\n",
      "GSK-376501\n",
      "Patidegib\n",
      "JNJ-42396302\n",
      "AFN-1252\n",
      "SJ-733\n",
      "Samatasvir\n",
      "Urapidil\n",
      "Naveglitazar\n",
      "Letrazuril\n",
      "Indantadol\n",
      "Isoquercetin\n",
      "Emapunil\n",
      "Protionamide\n",
      "Metenkefalin\n",
      "4SC-203\n",
      "Rolofylline\n",
      "Beloranib\n",
      "Icaritin\n",
      "ATX-914\n",
      "Lurbinectedin\n",
      "PF-04995274\n",
      "Modufolin\n",
      "Soblidotin\n",
      "Relamorelin\n",
      "WP 1066\n",
      "Intepirdine\n",
      "Salirasib\n",
      "Mubritinib\n",
      "K-134\n",
      "PHA-793887\n",
      "Vesatolimod\n",
      "Azeliragon\n",
      "LY-2584702\n",
      "UK-432097\n",
      "Gusperimus\n",
      "Ritanserin\n",
      "CE-326597\n",
      "Phenethyl Isothiocyanate\n",
      "BMS-582949\n",
      "Methylselenocysteine\n",
      "Solamargine\n",
      "Velusetrag\n",
      "Omipalisib\n",
      "Spiradoline\n",
      "Cenerimod\n",
      "Seletalisib\n",
      "AR-42\n",
      "Sulprostone\n",
      "Tributyrin\n",
      "Perazine\n",
      "LTX-109\n",
      "Pilsicainide\n",
      "Sotagliflozin\n",
      "Nerispirdine\n",
      "MSX-122\n",
      "NB-001\n",
      "Mibampator\n",
      "Turofexorate isopropyl\n",
      "Nivocasan\n",
      "RO-5028442\n",
      "AZD-7295\n",
      "TD-8954\n",
      "Perfosfamide\n",
      "Fenpropidin\n",
      "ASP-3026\n",
      "Dolastatin 10\n",
      "Daporinad\n",
      "Firategrast\n",
      "Dipraglurant\n",
      "Etanidazole\n",
      "Bindarit\n",
      "CC-115\n",
      "DTP-348\n",
      "Amuvatinib\n",
      "Z-160\n",
      "CGI-1842\n",
      "GSK-690693\n",
      "AKN-028\n",
      "LTX-315\n",
      "Butylphthalide\n",
      "N-omega-nitro-L-arginine methyl ester\n",
      "Malic Acid\n",
      "Bucindolol\n",
      "Racivir\n",
      "Iodide\n",
      "Zoptarelin doxorubicin\n",
      "TAK-901\n",
      "Pelitrexol\n",
      "Atreleuton\n",
      "GW-493838\n",
      "Timcodar\n",
      "Rabacfosadine\n",
      "MK-1496\n",
      "ABC-294640\n",
      "Methyl isocyanate\n",
      "Cicletanine\n",
      "Gaxilose\n",
      "Lometrexol\n",
      "Lafutidine\n",
      "Hydroxytyrosol\n",
      "AZD-8055\n",
      "E-6005\n",
      "Somatoprim\n",
      "Rivipansel\n",
      "Higenamine\n",
      "Quinfamide\n",
      "Balaglitazone\n",
      "SCH-486757\n",
      "Benserazide\n",
      "NS-018\n",
      "Furaprevir\n",
      "Norethandrolone\n",
      "Dinoprost\n",
      "Laninamivir\n",
      "Boscalid\n",
      "p-Quaterphenyl\n",
      "CMX-2043\n",
      "MRX-I\n",
      "Relenopride\n",
      "Laniquidar\n",
      "CHF-6001\n",
      "Picropodophyllin\n",
      "Dichloroisoproterenol\n",
      "Daniquidone\n",
      "Ataciguat\n",
      "GSK-1004723\n",
      "Trifarotene\n",
      "BK-MDA\n",
      "AN-2718\n",
      "Palomid 529\n",
      "Radium Ra-223\n",
      "Terpinen-4-ol\n",
      "Zoliflodacin\n",
      "NM-3\n",
      "GSI-136\n",
      "Perflubutane\n",
      "Tecarfarin\n",
      "Lefamulin\n",
      "Indoximod\n",
      "Amithiozone\n",
      "Cebranopadol\n",
      "Gabexate\n",
      "Prednimustine\n",
      "Tandospirone\n",
      "Secnidazole\n",
      "Grapiprant\n",
      "UK-500001\n",
      "Tetrasul\n",
      "Pegvaliase\n",
      "Pirnabine\n",
      "Pegamotecan\n",
      "Oleandrin\n",
      "Reproterol\n",
      "Pyroxamide\n",
      "PF-04217903\n",
      "Etalocib\n",
      "MK-0752\n",
      "DA-6886\n",
      "BMS-908662\n",
      "Apricitabine\n",
      "Timonacic\n",
      "NVP-LEQ-506\n",
      "LY-377604\n",
      "Tantalum\n",
      "Actinium\n",
      "Rimeporide\n",
      "Sivelestat\n",
      "Melarsoprol\n",
      "Etelcalcetide\n",
      "Pradigastat\n",
      "Benperidol\n",
      "Intoplicine\n",
      "Eliprodil\n",
      "Buthionine Sulfoximine\n",
      "Dianhydrogalactitol\n",
      "Quizartinib\n",
      "Mavatrep\n",
      "GS-9256\n",
      "Oxatomide\n",
      "AV-101\n",
      "Omigapil\n",
      "Indole-3-carbinol\n",
      "Ombrabulin\n",
      "Eltoprazine\n",
      "Lavoltidine\n",
      "CF-102\n",
      "GSK-1521498\n",
      "Tazemetostat\n",
      "Ezutromid\n",
      "Velneperit\n",
      "Dihydrexidine\n",
      "MGB-BP-3\n",
      "Raluridine\n",
      "TD-139\n",
      "PSI-352938\n",
      "MK-7622\n",
      "TT-301\n",
      "Irdabisant\n",
      "Fiacitabine\n",
      "Trofosfamide\n",
      "DEBIO-1347\n",
      "ZSTK-474\n",
      "Samarium Sm-153\n",
      "LY-2334737\n",
      "Mannose\n",
      "Emicerfont\n",
      "Nicoboxil\n",
      "Nolatrexed\n",
      "MGL-3196\n",
      "Mitolactol\n",
      "T-62\n",
      "Pinometostat\n",
      "Chlorsulfaquinoxaline\n",
      "Gallopamil\n",
      "Ozenoxacin\n",
      "Crolibulin\n",
      "Cafedrine\n",
      "Theodrenaline\n",
      "GET-73\n",
      "JNJ-39220675\n",
      "Opipramol\n",
      "Fenobam\n",
      "Merotocin\n",
      "RO-4987655\n",
      "Granotapide\n",
      "Remogliflozin etabonate\n",
      "Quercetin-3'-O-phosphate\n",
      "Isoxaflutole\n",
      "Nikkomycin Z\n",
      "Helium He-3\n",
      "ODM-201\n",
      "Lactitol\n",
      "Phloroglucinol\n",
      "Dihydralazine\n",
      "8-cyclopentyl-1,3-dipropylxanthine\n",
      "Doxifluridine\n",
      "Didox\n",
      "PF-03382792\n",
      "Pivagabine\n",
      "Methylprednisone\n",
      "Terizidone\n",
      "Delparantag\n",
      "5-fluoro-2'-deoxycytidine\n",
      "Prothipendyl\n",
      "IOWH-032\n",
      "INCB-9471\n",
      "Leukotriene B4\n",
      "CP-547632\n",
      "CCX-354\n",
      "Lerisetron\n",
      "Silver\n",
      "Falnidamol\n",
      "Mitoguazone\n",
      "DONU\n",
      "Methylinositol\n",
      "Levoglucose\n",
      "Pactimibe\n",
      "Sepranolone\n",
      "Serlopitant\n",
      "Roniciclib\n",
      "Pyronaridine\n",
      "Simenepag isopropyl\n",
      "Pexidartinib\n",
      "Nepicastat\n",
      "CHS-828\n",
      "XL-888\n",
      "Silicon\n",
      "Pigment blue 16\n",
      "Larotaxel\n",
      "Quisinostat\n",
      "VS-5584\n",
      "Penclomedine\n",
      "LY-518674\n",
      "Neosaxitoxin\n",
      "Icosabutate\n",
      "Deoxyspergualin\n",
      "Bleomycin A6\n",
      "Berkelium\n",
      "MIP-1095 I-123\n",
      "Acteoside\n",
      "Brilacidin\n",
      "PF-00217830\n",
      "MK-6186\n",
      "PCI-27483\n",
      "Tinoridine\n",
      "HKI-357\n",
      "Cortivazol\n",
      "Mavoglurant\n",
      "Rebastinib\n",
      "Cibinetide\n",
      "2,2-bis(4-hydroxy-3-tert-butylphenyl)propane\n",
      "Carbendazim\n",
      "4-isothioureidobutyronitrile\n",
      "Diethylhomospermine\n",
      "AQX-1125\n",
      "LFF-571\n",
      "Hypericin\n",
      "LY-2300559\n",
      "Dimiracetam\n",
      "Henatinib\n",
      "Apratastat\n",
      "123I-iodometomidate\n",
      "LY-2874455\n",
      "IPI-493\n",
      "MK-8245\n",
      "Tiapride\n",
      "Ornidazole\n",
      "Tucaresol\n",
      "Biapenem\n",
      "MK-0873\n",
      "2'-fluoro-5-ethylarabinosyluracil\n",
      "Niobium\n",
      "Enecadin\n",
      "Foxy-5\n",
      "AG-24322\n",
      "Ramatroban\n",
      "Glyceryl Trioleate\n",
      "Aminaphthone\n",
      "Gandotinib\n",
      "Odalasvir\n",
      "Fenoverine\n",
      "Gossypol\n",
      "Tocladesine\n",
      "Pentavalent Antimony\n",
      "PAC-1\n",
      "Lobaplatin\n",
      "Tirilazad\n",
      "CH-5132799\n",
      "Upamostat\n",
      "CP-195543\n",
      "ACT-451840\n",
      "Oteseconazole\n",
      "Irsogladine\n",
      "Methanesulfonyl Fluoride\n",
      "PF-03814735\n",
      "CEP-37440\n",
      "MLN8054\n",
      "ME-344\n",
      "Parthenolide\n",
      "Tramazoline\n",
      "LY-2811376\n",
      "Liarozole\n",
      "Rotigaptide\n",
      "9-(N-methyl-L-isoleucine)-cyclosporin A\n",
      "Nimustine\n",
      "Surinabant\n",
      "Creatinolfosfate\n",
      "GDC-0349\n",
      "Macimorelin\n",
      "Menaquinone 7\n",
      "Yttrium Y-90\n",
      "LCB01-0371\n",
      "KOSN-1724\n",
      "CYR-101\n",
      "Nefiracetam\n",
      "Talarozole\n",
      "Pyritinol\n",
      "Riamet\n",
      "SCYX-7158\n",
      "Miridesap\n",
      "AZD-0424\n",
      "Enoxolone\n",
      "Zidebactam\n",
      "Tiropramide\n",
      "Meclocycline\n",
      "TAK-593\n",
      "Pruvanserin\n",
      "JTK-853\n",
      "Gacyclidine\n",
      "1alpha-Hydroxyvitamin D5\n",
      "CT-2584\n",
      "Valnoctamide\n",
      "Biguanide\n",
      "4SC-202\n",
      "AZD-8418\n",
      "GPX-150\n",
      "X-396\n",
      "Resolvin E1\n",
      "Glycovir\n",
      "QGC-001\n",
      "Mephedrone\n",
      "PKI-179\n",
      "Antimony\n",
      "Chromanol\n",
      "JNJ-38877605\n",
      "Amitriptylinoxide\n",
      "Saroglitazar\n",
      "Norflurane\n",
      "Pentafluoropropane\n",
      "Paquinimod\n",
      "GSK-364735\n",
      "Deferitazole\n",
      "Hydroxypropyl tetrahydropyrantriol\n",
      "Trabodenoson\n",
      "OTX-008\n",
      "Troxerutin\n",
      "Lusutrombopag\n",
      "BMS-986115\n",
      "Sizofiran\n",
      "Trimegestone\n",
      "Artemisinin\n",
      "Fluorine F-18\n",
      "AGN-201904\n",
      "Fluindione\n",
      "PM-060184\n",
      "Neladenoson bialanate\n",
      "Levosalbutamol\n",
      "Ambroxol acefyllinate\n",
      "Calcium glubionate\n",
      "Methallenestril\n",
      "Nedaplatin\n",
      "Fluciclovine (18F)\n",
      "Levomenol\n",
      "Parachlorophenol\n",
      "Esculin\n",
      "Inosine pranobex\n",
      "Sodium lauryl sulfoacetate\n",
      "Clobetasone\n",
      "Alphaprodine\n",
      "Terpin hydrate\n",
      "Olmutinib\n",
      "Ripasudil\n",
      "Zofenopril\n",
      "Alclofenac\n",
      "Omega-6 fatty acids\n",
      "Nandrolone\n",
      "Plecanatide\n",
      "Glyceryl 1-oleate\n",
      "Tunicamycin\n",
      "Rhein\n",
      "Rheinanthrone\n",
      "myo-inositol\n",
      "Troleandomycin\n",
      "Gluconic Acid\n",
      "Methylbenactyzium\n",
      "Technetium Tc-99m etifenin\n",
      "Oxabolone cipionate\n",
      "Phosphocreatine\n",
      "Fentiazac\n",
      "Calcium lactate\n",
      "Alaproclate\n",
      "Propatyl nitrate\n",
      "Ferrous sulfate\n",
      "Ethyl chloride\n",
      "Sitafloxacin\n",
      "Wood creosote\n",
      "Bromelains\n",
      "Ipecacuanha\n",
      "Atracurium\n",
      "Propamidine\n",
      "Magnesium pidolate\n",
      "Proscillaridin\n",
      "Alminoprofen\n",
      "Hydrotalcite\n",
      "Trichloroethylene\n",
      "Pheneticillin\n",
      "Bufexamac\n",
      "Deanol\n",
      "Visnadine\n",
      "Magnesium aspartate\n",
      "Vincamine\n",
      "Melitracen\n",
      "Mercurochrome\n",
      "Sulbutiamine\n",
      "Edoxudine\n",
      "Sodium propionate\n",
      "Cisatracurium\n",
      "Nalfurafine\n",
      "Lentinan\n",
      "Bencyclane\n",
      "Policresulen\n",
      "Otilonium\n",
      "Aloxiprin\n",
      "Pranoprofen\n",
      "Alginic acid\n",
      "Metergoline\n",
      "Dobesilic acid\n",
      "Cyclopenthiazide\n",
      "Iodoxamic acid\n",
      "Mesterolone\n",
      "Almasilate\n",
      "Umifenovir\n",
      "Carbaspirin calcium\n",
      "Mifamurtide\n",
      "Potassium gluconate\n",
      "Loprazolam\n",
      "Semustine\n",
      "Montmorillonite\n",
      "Hemoglobin raffimer\n",
      "Propicillin\n",
      "Dexchlorpheniramine\n",
      "Drisapersen\n",
      "Tacalcitol\n",
      "Distigmine\n",
      "Protamine\n",
      "Pristinamycin\n",
      "Sodium tartrate\n",
      "Meglumine antimoniate\n",
      "Guaiacolsulfonate\n",
      "Bioallethrin\n",
      "Trolamine\n",
      "Magnesium gluconate\n",
      "Niperotidine\n",
      "Monoxerutin\n",
      "Mercuric chloride\n",
      "Rufloxacin\n",
      "Xamoterol\n",
      "Acemetacin\n",
      "Magnesium orotate\n",
      "Clopamide\n",
      "Paclitaxel poliglumex\n",
      "Oblimersen\n",
      "Iodoform\n",
      "Potassium permanganate\n",
      "Etofylline nicotinate\n",
      "Cloprednol\n",
      "Etafenone\n",
      "Clofibride\n",
      "Artemotil\n",
      "Anethole trithione\n",
      "Gamolenic acid\n",
      "Dimazole\n",
      "Fosfructose\n",
      "Dehydroemetine\n",
      "Ethynodiol\n",
      "Fluticasone\n",
      "Adefovir\n",
      "2-Methoxy-6-{(E)-[(4-methylphenyl)imino]methyl}phenol\n",
      "Albendazole oxide\n",
      "Lormetazepam\n",
      "Fenofibric acid\n",
      "Enasidenib\n",
      "Harmaline\n",
      "Brofaromine\n",
      "Iniparib\n",
      "Pibrentasvir\n",
      "Glecaprevir\n",
      "Methyl nicotinate\n",
      "Ferric subsulfate\n",
      "Amylmetacresol\n",
      "Bismuth Subgallate\n",
      "Valproate bismuth\n",
      "Phloxine B\n",
      "Coumermycin A1\n",
      "Volixibat\n",
      "Toyocamycin\n",
      "Deoxyepinephrine\n",
      "Diclofop-methyl\n",
      "Candesartan\n",
      "Valopicitabine\n",
      "2'-C-methylcytidine\n",
      "Dotatate gallium Ga-68\n",
      "anle138b\n",
      "Semaglutide\n",
      "Relcovaptan\n",
      "Ulixertinib\n",
      "Netarsudil\n",
      "Ligandrol\n",
      "AC-262536\n",
      "JNJ-28330835\n",
      "LGD-3303\n",
      "S-40503\n",
      "RAD-140\n",
      "2,5-Dimethoxy-4-ethylthioamphetamine\n",
      "Piperaquine\n",
      "Testosterone cypionate\n",
      "Testosterone enanthate\n",
      "Testosterone undecanoate\n",
      "Testosterone 17-enanthate 3-benzilic acid hydrazone\n",
      "N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine\n",
      "Ferric cation\n",
      "WIN 55212-2\n",
      "Stanolone acetate\n",
      "Estradiol acetate\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Estradiol benzoate\n",
      "Estradiol cypionate\n",
      "Estradiol dienanthate\n",
      "Estradiol valerate\n",
      "J147\n",
      "Trestolone acetate\n",
      "Medium-chain triglycerides\n",
      "Bronopol\n",
      "Fish oil\n",
      "Calcium saccharate\n",
      "1,2-dichlorobenzene\n",
      "Peanut oil\n",
      "Isopropyl myristate\n",
      "Patent Blue V\n",
      "Quaternium-24\n",
      "Dioctyldimonium\n",
      "Vanadium\n",
      "Racemethionine\n",
      "Passiflora incarnata flower\n",
      "Cimicifuga racemosa\n",
      "Potassium carbonate\n",
      "Selisistat\n",
      "Copper Cu-64\n",
      "Nomegestrol acetate\n",
      "Lutetium Lu-177\n",
      "5,7,2′-trihydroxy-6,8-dimethoxyflavone\n",
      "Cyclopropane\n",
      "Lutetium Lu 177 dotatate\n",
      "Strontium chloride\n",
      "SB-269970\n",
      "Epitizide\n",
      "Dipropyl-4-hydroxytryptamine\n",
      "Pipequaline\n",
      "MRK-409\n",
      "Ferric pyrophosphate citrate\n",
      "Magnesium acetate\n",
      "Baloxavir marboxil\n",
      "Tetraglyme\n",
      "alpha-Tocopherol succinate\n",
      "D-alpha-Tocopherol acetate\n",
      "alpha-Tocopherol acetate\n"
     ]
    }
   ],
   "source": [
    "# Takes around 10 minutes to run.\n",
    "i=-1\n",
    "#iterate over drug entries to extract information\n",
    "for drug in obj.drugbank.drug:\n",
    "    \n",
    "    #print(drug)\n",
    "    drug_type = str(drug[\"type\"])\n",
    "    \n",
    "    # select for small molecule drugs\n",
    "    if drug_type in [\"small molecule\", \"Small Molecule\", \"Small molecule\"]:\n",
    "        i=i+1\n",
    "        print(drug.name.cdata)\n",
    "        \n",
    "        # Select drugs that are in approved group\n",
    "        \n",
    "        drug_groups = []\n",
    "        for group in drug.groups.group:\n",
    "            group_label = group.cdata\n",
    "            drug_groups.append(group_label) \n",
    "\n",
    "        # If drug does not belong to \"approved\" group skip\n",
    "        if \"approved\" not in  drug_groups:\n",
    "            continue\n",
    "\n",
    "        # Check if there is any product data and skip otherwise\n",
    "        if len(drug.products) == 0:\n",
    "            continue\n",
    "            \n",
    "        # Skip drugs that don't have product strength listed (such as topical drug \"DB00027\")\n",
    "        strength_info = \"\"\n",
    "        for product in drug.products.product:\n",
    "            strength_info = strength_info + product.strength.cdata\n",
    "        if len(strength_info) == 0:\n",
    "            continue    \n",
    "        \n",
    "        # Annotate drugs that belong to kinase inibitor drug category\n",
    "        \n",
    "        # Check if category information is available\n",
    "        if len(drug.categories) == 0:\n",
    "            df_drugbank_sm.loc[i, \"kinase inhibitor category\"] = \"unknown\"\n",
    "        else:\n",
    "            # Collect all category labels in a set\n",
    "            category_set = set()\n",
    "        \n",
    "            for category in drug.categories.category:\n",
    "                category_label = category.category.cdata\n",
    "                #print(category_label)\n",
    "                category_set.add(category_label)\n",
    "            \n",
    "            drug_category = []\n",
    "            # Record \"True\" in the database if it belongs to \"Kinase Inhibitor\" category\n",
    "            if \"Kinase Inhibitor\" in category_set:\n",
    "                drug_category.append(\"Kinase Inhibitor\")\n",
    "            if \"Protein Kinase Inhibitors\" in category_set:\n",
    "                drug_category.append(\"Protein Kinase Inhibitor\")\n",
    "            \n",
    "            if len(drug_category) >= 1:  # This is a kinase inhibitor\n",
    "                df_drugbank_sm.loc[i, \"kinase inhibitor category\"] = \"True\"\n",
    "            else:\n",
    "                df_drugbank_sm.loc[i, \"kinase inhibitor category\"] = \"False\"\n",
    "            \n",
    "        #Get drugbank_id\n",
    "        for id in drug.drugbank_id:\n",
    "            if str(id[\"primary\"])==\"true\":\n",
    "                df_drugbank_sm.loc[i, \"drugbank_id\"]=id.cdata\n",
    "\n",
    "        #Drug name\n",
    "        df_drugbank_sm.loc[i,\"name\"]=drug.name.cdata\n",
    "\n",
    "        #Drug CAS\n",
    "        df_drugbank_sm.loc[i, \"cas\"]=drug.cas_number.cdata\n",
    "\n",
    "        # Drug group    \n",
    "        df_drugbank_sm.loc[i, \"group\"] = drug_groups\n",
    "\n",
    "        #Get SMILES, logP, Solubility\n",
    "        #Skip drugs with no structure. (\"DB00386\",\"DB00407\",\"DB00702\",\"DB00785\",\"DB00840\",\n",
    "        #                                            \"DB00893\",\"DB00930\",\"DB00965\", \"DB01109\",\"DB01266\",\n",
    "        #                                           \"DB01323\", \"DB01341\"...)\n",
    "        if len(drug.calculated_properties.cdata)==0: #If there is no calculated properties\n",
    "            continue\n",
    "        else:\n",
    "            for property in drug.calculated_properties.property:\n",
    "                if property.kind.cdata == \"SMILES\":\n",
    "                    df_drugbank_sm.loc[i, \"smiles\"]=property.value.cdata\n",
    "\n",
    "                if property.kind.cdata == \"Water Solubility\":\n",
    "                    solubility_value, solubility_unit = property.value.cdata.split(\" \") \n",
    "                    df_drugbank_sm.loc[i, \"ALOGPS solubility value\"] = float(solubility_value)\n",
    "                    df_drugbank_sm.loc[i, \"ALOGPS solubility unit\"] = solubility_unit\n",
    "\n",
    "        # Dosage strength \n",
    "\n",
    "        # Save dosage information of all products in df_strength\n",
    "        df_strength = pd.DataFrame(columns=[\"value\", \"unit\", \"route\", \"form\"])\n",
    "\n",
    "        for p_i, product in enumerate(drug.products.product):\n",
    "\n",
    "            # check if strength information is available and skip otherwise \n",
    "            if len(product.strength.cdata) == 0:\n",
    "                continue\n",
    "\n",
    "            # split the value and unit of dosage strength\n",
    "            try:\n",
    "                try:\n",
    "                    strength_value, strength_unit = product.strength.cdata.split(\" \")\n",
    "                except ValueError:    \n",
    "                    strength_value, strength_unit, extra = product.strength.cdata.split(\" \")\n",
    "                    strength_unit = strength_unit + extra\n",
    "            except ValueError: \n",
    "                strength_value, strength_unit, ext1, ext2, ext3 = product.strength.cdata.split(\" \")\n",
    "                strength_unit = strength_unit + ext1 + ext2 + ext3\n",
    "\n",
    "            df_strength.loc[p_i, \"value\"] = float(strength_value)\n",
    "            df_strength.loc[p_i, \"unit\"] = strength_unit\n",
    "            df_strength.loc[p_i, \"form\"] = product.dosage_form.cdata\n",
    "            df_strength.loc[p_i, \"route\"] = product.route.cdata\n",
    "\n",
    "        # Sort df_strength based on value column, ascending\n",
    "        df_strength_sorted = df_strength.sort_values(\"value\")\n",
    "        df_strength_sorted= df_strength_sorted.reset_index(drop=True)\n",
    "\n",
    "        # Save the info related to the minimum dosage strength to df_drugbank_sm\n",
    "        df_drugbank_sm.loc[i, \"min dosage strength value\"] = df_strength_sorted.loc[0, \"value\"]\n",
    "        df_drugbank_sm.loc[i, \"min dosage strength unit\"] = df_strength_sorted.loc[0, \"unit\"]\n",
    "        df_drugbank_sm.loc[i, \"route\"] = df_strength_sorted.loc[0, \"route\"]\n",
    "        df_drugbank_sm.loc[i, \"form\"] = df_strength_sorted.loc[0, \"form\"] \n",
    "\n",
    "        # Sort df_strength based on value column, descending\n",
    "        df_strength_sorted = df_strength.sort_values(\"value\", ascending=False)\n",
    "        df_strength_sorted= df_strength_sorted.reset_index(drop=True)\n",
    "\n",
    "        # Save the info related to the max dosage strength to df_drugbank_sm\n",
    "        df_drugbank_sm.loc[i, \"max dosage strength value\"] = df_strength_sorted.loc[0, \"value\"]\n",
    "        df_drugbank_sm.loc[i, \"max dosage strength unit\"] = df_strength_sorted.loc[0, \"unit\"]\n",
    "\n",
    "   # if i == 500:\n",
    "   #     break\n",
    "\n",
    "df_drugbank_sm = df_drugbank_sm.reset_index(drop=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 90,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(1724, 14)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugbank_id</th>\n",
       "      <th>name</th>\n",
       "      <th>min dosage strength value</th>\n",
       "      <th>min dosage strength unit</th>\n",
       "      <th>max dosage strength value</th>\n",
       "      <th>max dosage strength unit</th>\n",
       "      <th>route</th>\n",
       "      <th>form</th>\n",
       "      <th>group</th>\n",
       "      <th>kinase inhibitor category</th>\n",
       "      <th>cas</th>\n",
       "      <th>smiles</th>\n",
       "      <th>ALOGPS solubility value</th>\n",
       "      <th>ALOGPS solubility unit</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>DB00006</td>\n",
       "      <td>Bivalirudin</td>\n",
       "      <td>250</td>\n",
       "      <td>mg</td>\n",
       "      <td>500</td>\n",
       "      <td>mg/100mL</td>\n",
       "      <td>Intravenous</td>\n",
       "      <td>Powder, for solution</td>\n",
       "      <td>[approved, investigational]</td>\n",
       "      <td>False</td>\n",
       "      <td>128270-60-0</td>\n",
       "      <td>CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@...</td>\n",
       "      <td>0.0464</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>DB00014</td>\n",
       "      <td>Goserelin</td>\n",
       "      <td>3.6</td>\n",
       "      <td>mg/1</td>\n",
       "      <td>10.8</td>\n",
       "      <td>mg/1</td>\n",
       "      <td>Subcutaneous</td>\n",
       "      <td>Implant</td>\n",
       "      <td>[approved]</td>\n",
       "      <td>False</td>\n",
       "      <td>65807-02-5</td>\n",
       "      <td>CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H...</td>\n",
       "      <td>0.0283</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>DB00035</td>\n",
       "      <td>Desmopressin</td>\n",
       "      <td>0.1</td>\n",
       "      <td>mg/1</td>\n",
       "      <td>240</td>\n",
       "      <td>mcg</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Tablet</td>\n",
       "      <td>[approved]</td>\n",
       "      <td>False</td>\n",
       "      <td>16679-58-6</td>\n",
       "      <td>NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)...</td>\n",
       "      <td>0.11</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>DB00050</td>\n",
       "      <td>Cetrorelix</td>\n",
       "      <td>0.25</td>\n",
       "      <td>mg</td>\n",
       "      <td>3</td>\n",
       "      <td>mg</td>\n",
       "      <td>Subcutaneous</td>\n",
       "      <td>Injection, powder, for solution</td>\n",
       "      <td>[approved, investigational]</td>\n",
       "      <td>False</td>\n",
       "      <td>120287-85-6</td>\n",
       "      <td>CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H...</td>\n",
       "      <td>0.00694</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>DB00067</td>\n",
       "      <td>Vasopressin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[approved]</td>\n",
       "      <td>False</td>\n",
       "      <td>11000-17-2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>DB00080</td>\n",
       "      <td>Daptomycin</td>\n",
       "      <td>350</td>\n",
       "      <td>mg/7mL</td>\n",
       "      <td>500</td>\n",
       "      <td>mg</td>\n",
       "      <td>Intravenous</td>\n",
       "      <td>Injection, powder, lyophilized, for solution</td>\n",
       "      <td>[approved, investigational]</td>\n",
       "      <td>False</td>\n",
       "      <td>103060-53-3</td>\n",
       "      <td>CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)...</td>\n",
       "      <td>0.0173</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>DB00091</td>\n",
       "      <td>Cyclosporine</td>\n",
       "      <td>0.0005</td>\n",
       "      <td>g/100mL</td>\n",
       "      <td>100</td>\n",
       "      <td>mg</td>\n",
       "      <td>Ophthalmic</td>\n",
       "      <td>Liquid</td>\n",
       "      <td>[approved, investigational, vet_approved]</td>\n",
       "      <td>False</td>\n",
       "      <td>59865-13-3</td>\n",
       "      <td>CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\\C=C\\C)N...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>DB00104</td>\n",
       "      <td>Octreotide</td>\n",
       "      <td>10</td>\n",
       "      <td>mg</td>\n",
       "      <td>1000</td>\n",
       "      <td>ug/mL</td>\n",
       "      <td>Intramuscular</td>\n",
       "      <td>Powder</td>\n",
       "      <td>[approved, investigational]</td>\n",
       "      <td>False</td>\n",
       "      <td>83150-76-9</td>\n",
       "      <td>[H][C@]1(NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CN...</td>\n",
       "      <td>0.0122</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>DB00115</td>\n",
       "      <td>Cyanocobalamin</td>\n",
       "      <td>0.025</td>\n",
       "      <td>mg</td>\n",
       "      <td>1000</td>\n",
       "      <td>mcg</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Tablet</td>\n",
       "      <td>[approved, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>68-19-9</td>\n",
       "      <td>[C@H]1([C@@H]2[C@H]([C@@H](N3C4=CC(=C(C)C=C4[N...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>DB00121</td>\n",
       "      <td>Biotin</td>\n",
       "      <td>0.002</td>\n",
       "      <td>mL/mL</td>\n",
       "      <td>500</td>\n",
       "      <td>mcg</td>\n",
       "      <td>Topical</td>\n",
       "      <td>Liquid</td>\n",
       "      <td>[approved, investigational, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>58-85-5</td>\n",
       "      <td>[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2</td>\n",
       "      <td>1.22</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>DB00122</td>\n",
       "      <td>Choline</td>\n",
       "      <td>100</td>\n",
       "      <td>mg</td>\n",
       "      <td>500</td>\n",
       "      <td>mg</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Tablet</td>\n",
       "      <td>[approved, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>62-49-7</td>\n",
       "      <td>C[N+](C)(C)CCO</td>\n",
       "      <td>3.61</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>DB00125</td>\n",
       "      <td>L-Arginine</td>\n",
       "      <td>10</td>\n",
       "      <td>g/100mL</td>\n",
       "      <td>250</td>\n",
       "      <td>mg</td>\n",
       "      <td>Intravenous</td>\n",
       "      <td>Injection, solution</td>\n",
       "      <td>[approved, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>74-79-3</td>\n",
       "      <td>N[C@@H](CCCNC(N)=N)C(O)=O</td>\n",
       "      <td>2.28</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>DB00126</td>\n",
       "      <td>Vitamin C</td>\n",
       "      <td>0.3</td>\n",
       "      <td>mg</td>\n",
       "      <td>1250</td>\n",
       "      <td>mg</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Solution</td>\n",
       "      <td>[approved, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>50-81-7</td>\n",
       "      <td>[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO</td>\n",
       "      <td>245</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>DB00130</td>\n",
       "      <td>L-Glutamine</td>\n",
       "      <td>5</td>\n",
       "      <td>g/1</td>\n",
       "      <td>5</td>\n",
       "      <td>g/1</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Powder, for solution</td>\n",
       "      <td>[approved, investigational, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>56-85-9</td>\n",
       "      <td>N[C@@H](CCC(N)=O)C(O)=O</td>\n",
       "      <td>97.8</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>DB00136</td>\n",
       "      <td>Calcitriol</td>\n",
       "      <td>0.25</td>\n",
       "      <td>ug/1</td>\n",
       "      <td>3</td>\n",
       "      <td>ug/g</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Capsule, liquid filled</td>\n",
       "      <td>[approved, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>32222-06-3</td>\n",
       "      <td>C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\\C(...</td>\n",
       "      <td>0.00667</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>DB00137</td>\n",
       "      <td>Lutein</td>\n",
       "      <td>20</td>\n",
       "      <td>g/100g</td>\n",
       "      <td>20</td>\n",
       "      <td>g/100g</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Capsule</td>\n",
       "      <td>[approved, investigational, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>127-40-2</td>\n",
       "      <td>C\\C(\\C=C\\C=C(/C)\\C=C\\[C@H]1C(C)=C[C@H](O)CC1(C...</td>\n",
       "      <td>0.000732</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>DB00140</td>\n",
       "      <td>Riboflavin</td>\n",
       "      <td>1.46</td>\n",
       "      <td>mg/mL</td>\n",
       "      <td>200</td>\n",
       "      <td>mg</td>\n",
       "      <td>Ophthalmic</td>\n",
       "      <td>Solution / drops</td>\n",
       "      <td>[approved, investigational, nutraceutical, vet...</td>\n",
       "      <td>False</td>\n",
       "      <td>83-88-5</td>\n",
       "      <td>CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO)C3=N...</td>\n",
       "      <td>0.657</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>DB00142</td>\n",
       "      <td>Glutamic Acid</td>\n",
       "      <td>325</td>\n",
       "      <td>mg</td>\n",
       "      <td>325</td>\n",
       "      <td>mg</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Capsule</td>\n",
       "      <td>[approved, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>56-86-0</td>\n",
       "      <td>N[C@@H](CCC(O)=O)C(O)=O</td>\n",
       "      <td>80.6</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>DB00145</td>\n",
       "      <td>Glycine</td>\n",
       "      <td>1.5</td>\n",
       "      <td>g/100mL</td>\n",
       "      <td>15</td>\n",
       "      <td>mg</td>\n",
       "      <td>Irrigation</td>\n",
       "      <td>Solution</td>\n",
       "      <td>[approved, nutraceutical, vet_approved]</td>\n",
       "      <td>False</td>\n",
       "      <td>56-40-6</td>\n",
       "      <td>NCC(O)=O</td>\n",
       "      <td>552</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>DB00146</td>\n",
       "      <td>Calcidiol</td>\n",
       "      <td>30</td>\n",
       "      <td>ug/1</td>\n",
       "      <td>30</td>\n",
       "      <td>ug/1</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Capsule, extended release</td>\n",
       "      <td>[approved, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>19356-17-3</td>\n",
       "      <td>C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\\C(...</td>\n",
       "      <td>0.0022</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   drugbank_id            name min dosage strength value  \\\n",
       "0      DB00006     Bivalirudin                       250   \n",
       "1      DB00014       Goserelin                       3.6   \n",
       "2      DB00035    Desmopressin                       0.1   \n",
       "3      DB00050      Cetrorelix                      0.25   \n",
       "4      DB00067     Vasopressin                       NaN   \n",
       "5      DB00080      Daptomycin                       350   \n",
       "6      DB00091    Cyclosporine                    0.0005   \n",
       "7      DB00104      Octreotide                        10   \n",
       "8      DB00115  Cyanocobalamin                     0.025   \n",
       "9      DB00121          Biotin                     0.002   \n",
       "10     DB00122         Choline                       100   \n",
       "11     DB00125      L-Arginine                        10   \n",
       "12     DB00126       Vitamin C                       0.3   \n",
       "13     DB00130     L-Glutamine                         5   \n",
       "14     DB00136      Calcitriol                      0.25   \n",
       "15     DB00137          Lutein                        20   \n",
       "16     DB00140      Riboflavin                      1.46   \n",
       "17     DB00142   Glutamic Acid                       325   \n",
       "18     DB00145         Glycine                       1.5   \n",
       "19     DB00146       Calcidiol                        30   \n",
       "\n",
       "   min dosage strength unit max dosage strength value  \\\n",
       "0                        mg                       500   \n",
       "1                      mg/1                      10.8   \n",
       "2                      mg/1                       240   \n",
       "3                        mg                         3   \n",
       "4                       NaN                       NaN   \n",
       "5                    mg/7mL                       500   \n",
       "6                   g/100mL                       100   \n",
       "7                        mg                      1000   \n",
       "8                        mg                      1000   \n",
       "9                     mL/mL                       500   \n",
       "10                       mg                       500   \n",
       "11                  g/100mL                       250   \n",
       "12                       mg                      1250   \n",
       "13                      g/1                         5   \n",
       "14                     ug/1                         3   \n",
       "15                   g/100g                        20   \n",
       "16                    mg/mL                       200   \n",
       "17                       mg                       325   \n",
       "18                  g/100mL                        15   \n",
       "19                     ug/1                        30   \n",
       "\n",
       "   max dosage strength unit          route  \\\n",
       "0                  mg/100mL    Intravenous   \n",
       "1                      mg/1   Subcutaneous   \n",
       "2                       mcg           Oral   \n",
       "3                        mg   Subcutaneous   \n",
       "4                       NaN            NaN   \n",
       "5                        mg    Intravenous   \n",
       "6                        mg     Ophthalmic   \n",
       "7                     ug/mL  Intramuscular   \n",
       "8                       mcg           Oral   \n",
       "9                       mcg        Topical   \n",
       "10                       mg           Oral   \n",
       "11                       mg    Intravenous   \n",
       "12                       mg           Oral   \n",
       "13                      g/1           Oral   \n",
       "14                     ug/g           Oral   \n",
       "15                   g/100g           Oral   \n",
       "16                       mg     Ophthalmic   \n",
       "17                       mg           Oral   \n",
       "18                       mg     Irrigation   \n",
       "19                     ug/1           Oral   \n",
       "\n",
       "                                            form  \\\n",
       "0                           Powder, for solution   \n",
       "1                                        Implant   \n",
       "2                                         Tablet   \n",
       "3                Injection, powder, for solution   \n",
       "4                                            NaN   \n",
       "5   Injection, powder, lyophilized, for solution   \n",
       "6                                         Liquid   \n",
       "7                                         Powder   \n",
       "8                                         Tablet   \n",
       "9                                         Liquid   \n",
       "10                                        Tablet   \n",
       "11                           Injection, solution   \n",
       "12                                      Solution   \n",
       "13                          Powder, for solution   \n",
       "14                        Capsule, liquid filled   \n",
       "15                                       Capsule   \n",
       "16                              Solution / drops   \n",
       "17                                       Capsule   \n",
       "18                                      Solution   \n",
       "19                     Capsule, extended release   \n",
       "\n",
       "                                                group  \\\n",
       "0                         [approved, investigational]   \n",
       "1                                          [approved]   \n",
       "2                                          [approved]   \n",
       "3                         [approved, investigational]   \n",
       "4                                          [approved]   \n",
       "5                         [approved, investigational]   \n",
       "6           [approved, investigational, vet_approved]   \n",
       "7                         [approved, investigational]   \n",
       "8                           [approved, nutraceutical]   \n",
       "9          [approved, investigational, nutraceutical]   \n",
       "10                          [approved, nutraceutical]   \n",
       "11                          [approved, nutraceutical]   \n",
       "12                          [approved, nutraceutical]   \n",
       "13         [approved, investigational, nutraceutical]   \n",
       "14                          [approved, nutraceutical]   \n",
       "15         [approved, investigational, nutraceutical]   \n",
       "16  [approved, investigational, nutraceutical, vet...   \n",
       "17                          [approved, nutraceutical]   \n",
       "18            [approved, nutraceutical, vet_approved]   \n",
       "19                          [approved, nutraceutical]   \n",
       "\n",
       "   kinase inhibitor category          cas  \\\n",
       "0                      False  128270-60-0   \n",
       "1                      False   65807-02-5   \n",
       "2                      False   16679-58-6   \n",
       "3                      False  120287-85-6   \n",
       "4                      False   11000-17-2   \n",
       "5                      False  103060-53-3   \n",
       "6                      False   59865-13-3   \n",
       "7                      False   83150-76-9   \n",
       "8                      False      68-19-9   \n",
       "9                      False      58-85-5   \n",
       "10                     False      62-49-7   \n",
       "11                     False      74-79-3   \n",
       "12                     False      50-81-7   \n",
       "13                     False      56-85-9   \n",
       "14                     False   32222-06-3   \n",
       "15                     False     127-40-2   \n",
       "16                     False      83-88-5   \n",
       "17                     False      56-86-0   \n",
       "18                     False      56-40-6   \n",
       "19                     False   19356-17-3   \n",
       "\n",
       "                                               smiles ALOGPS solubility value  \\\n",
       "0   CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@...                  0.0464   \n",
       "1   CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H...                  0.0283   \n",
       "2   NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)...                    0.11   \n",
       "3   CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H...                 0.00694   \n",
       "4                                                 NaN                     NaN   \n",
       "5   CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)...                  0.0173   \n",
       "6   CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\\C=C\\C)N...                     NaN   \n",
       "7   [H][C@]1(NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CN...                  0.0122   \n",
       "8   [C@H]1([C@@H]2[C@H]([C@@H](N3C4=CC(=C(C)C=C4[N...                     NaN   \n",
       "9    [H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2                    1.22   \n",
       "10                                     C[N+](C)(C)CCO                    3.61   \n",
       "11                          N[C@@H](CCCNC(N)=N)C(O)=O                    2.28   \n",
       "12               [H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO                     245   \n",
       "13                            N[C@@H](CCC(N)=O)C(O)=O                    97.8   \n",
       "14  C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\\C(...                 0.00667   \n",
       "15  C\\C(\\C=C\\C=C(/C)\\C=C\\[C@H]1C(C)=C[C@H](O)CC1(C...                0.000732   \n",
       "16  CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO)C3=N...                   0.657   \n",
       "17                            N[C@@H](CCC(O)=O)C(O)=O                    80.6   \n",
       "18                                           NCC(O)=O                     552   \n",
       "19  C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\\C(...                  0.0022   \n",
       "\n",
       "   ALOGPS solubility unit  \n",
       "0                     g/l  \n",
       "1                     g/l  \n",
       "2                     g/l  \n",
       "3                     g/l  \n",
       "4                     NaN  \n",
       "5                     g/l  \n",
       "6                     NaN  \n",
       "7                     g/l  \n",
       "8                     NaN  \n",
       "9                     g/l  \n",
       "10                    g/l  \n",
       "11                    g/l  \n",
       "12                    g/l  \n",
       "13                    g/l  \n",
       "14                    g/l  \n",
       "15                    g/l  \n",
       "16                    g/l  \n",
       "17                    g/l  \n",
       "18                    g/l  \n",
       "19                    g/l  "
      ]
     },
     "execution_count": 90,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print(df_drugbank_sm.shape)\n",
    "df_drugbank_sm.head(20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 91,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(1724, 14)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugbank_id</th>\n",
       "      <th>name</th>\n",
       "      <th>min dosage strength value</th>\n",
       "      <th>min dosage strength unit</th>\n",
       "      <th>max dosage strength value</th>\n",
       "      <th>max dosage strength unit</th>\n",
       "      <th>route</th>\n",
       "      <th>form</th>\n",
       "      <th>group</th>\n",
       "      <th>kinase inhibitor category</th>\n",
       "      <th>cas</th>\n",
       "      <th>smiles</th>\n",
       "      <th>ALOGPS solubility value</th>\n",
       "      <th>ALOGPS solubility unit</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>DB00006</td>\n",
       "      <td>Bivalirudin</td>\n",
       "      <td>250</td>\n",
       "      <td>mg</td>\n",
       "      <td>500</td>\n",
       "      <td>mg/100mL</td>\n",
       "      <td>Intravenous</td>\n",
       "      <td>Powder, for solution</td>\n",
       "      <td>[approved, investigational]</td>\n",
       "      <td>False</td>\n",
       "      <td>128270-60-0</td>\n",
       "      <td>CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@...</td>\n",
       "      <td>0.0464</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>DB00014</td>\n",
       "      <td>Goserelin</td>\n",
       "      <td>3.6</td>\n",
       "      <td>mg/1</td>\n",
       "      <td>10.8</td>\n",
       "      <td>mg/1</td>\n",
       "      <td>Subcutaneous</td>\n",
       "      <td>Implant</td>\n",
       "      <td>[approved]</td>\n",
       "      <td>False</td>\n",
       "      <td>65807-02-5</td>\n",
       "      <td>CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H...</td>\n",
       "      <td>0.0283</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>DB00035</td>\n",
       "      <td>Desmopressin</td>\n",
       "      <td>0.1</td>\n",
       "      <td>mg/1</td>\n",
       "      <td>240</td>\n",
       "      <td>mcg</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Tablet</td>\n",
       "      <td>[approved]</td>\n",
       "      <td>False</td>\n",
       "      <td>16679-58-6</td>\n",
       "      <td>NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)...</td>\n",
       "      <td>0.11</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>DB00050</td>\n",
       "      <td>Cetrorelix</td>\n",
       "      <td>0.25</td>\n",
       "      <td>mg</td>\n",
       "      <td>3</td>\n",
       "      <td>mg</td>\n",
       "      <td>Subcutaneous</td>\n",
       "      <td>Injection, powder, for solution</td>\n",
       "      <td>[approved, investigational]</td>\n",
       "      <td>False</td>\n",
       "      <td>120287-85-6</td>\n",
       "      <td>CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H...</td>\n",
       "      <td>0.00694</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>DB00067</td>\n",
       "      <td>Vasopressin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[approved]</td>\n",
       "      <td>False</td>\n",
       "      <td>11000-17-2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  drugbank_id          name min dosage strength value  \\\n",
       "0     DB00006   Bivalirudin                       250   \n",
       "1     DB00014     Goserelin                       3.6   \n",
       "2     DB00035  Desmopressin                       0.1   \n",
       "3     DB00050    Cetrorelix                      0.25   \n",
       "4     DB00067   Vasopressin                       NaN   \n",
       "\n",
       "  min dosage strength unit max dosage strength value max dosage strength unit  \\\n",
       "0                       mg                       500                 mg/100mL   \n",
       "1                     mg/1                      10.8                     mg/1   \n",
       "2                     mg/1                       240                      mcg   \n",
       "3                       mg                         3                       mg   \n",
       "4                      NaN                       NaN                      NaN   \n",
       "\n",
       "          route                             form                        group  \\\n",
       "0   Intravenous             Powder, for solution  [approved, investigational]   \n",
       "1  Subcutaneous                          Implant                   [approved]   \n",
       "2          Oral                           Tablet                   [approved]   \n",
       "3  Subcutaneous  Injection, powder, for solution  [approved, investigational]   \n",
       "4           NaN                              NaN                   [approved]   \n",
       "\n",
       "  kinase inhibitor category          cas  \\\n",
       "0                     False  128270-60-0   \n",
       "1                     False   65807-02-5   \n",
       "2                     False   16679-58-6   \n",
       "3                     False  120287-85-6   \n",
       "4                     False   11000-17-2   \n",
       "\n",
       "                                              smiles ALOGPS solubility value  \\\n",
       "0  CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@...                  0.0464   \n",
       "1  CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H...                  0.0283   \n",
       "2  NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)...                    0.11   \n",
       "3  CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H...                 0.00694   \n",
       "4                                                NaN                     NaN   \n",
       "\n",
       "  ALOGPS solubility unit  \n",
       "0                    g/l  \n",
       "1                    g/l  \n",
       "2                    g/l  \n",
       "3                    g/l  \n",
       "4                    NaN  "
      ]
     },
     "execution_count": 91,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Save dataframe to csv\n",
    "df_drugbank_sm.to_csv(\"dosage_strength_of_approved_small_molecule_drugs.csv\")\n",
    "print(df_drugbank_sm.shape)\n",
    "df_drugbank_sm.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(832, 14)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugbank_id</th>\n",
       "      <th>name</th>\n",
       "      <th>min dosage strength value</th>\n",
       "      <th>min dosage strength unit</th>\n",
       "      <th>max dosage strength value</th>\n",
       "      <th>max dosage strength unit</th>\n",
       "      <th>route</th>\n",
       "      <th>form</th>\n",
       "      <th>group</th>\n",
       "      <th>kinase inhibitor category</th>\n",
       "      <th>cas</th>\n",
       "      <th>smiles</th>\n",
       "      <th>ALOGPS solubility value</th>\n",
       "      <th>ALOGPS solubility unit</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>DB00035</td>\n",
       "      <td>Desmopressin</td>\n",
       "      <td>0.1</td>\n",
       "      <td>mg/1</td>\n",
       "      <td>240</td>\n",
       "      <td>mcg</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Tablet</td>\n",
       "      <td>[approved]</td>\n",
       "      <td>False</td>\n",
       "      <td>16679-58-6</td>\n",
       "      <td>NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)...</td>\n",
       "      <td>0.11</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>DB00115</td>\n",
       "      <td>Cyanocobalamin</td>\n",
       "      <td>0.025</td>\n",
       "      <td>mg</td>\n",
       "      <td>1000</td>\n",
       "      <td>mcg</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Tablet</td>\n",
       "      <td>[approved, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>68-19-9</td>\n",
       "      <td>[C@H]1([C@@H]2[C@H]([C@@H](N3C4=CC(=C(C)C=C4[N...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>DB00122</td>\n",
       "      <td>Choline</td>\n",
       "      <td>100</td>\n",
       "      <td>mg</td>\n",
       "      <td>500</td>\n",
       "      <td>mg</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Tablet</td>\n",
       "      <td>[approved, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>62-49-7</td>\n",
       "      <td>C[N+](C)(C)CCO</td>\n",
       "      <td>3.61</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>DB00126</td>\n",
       "      <td>Vitamin C</td>\n",
       "      <td>0.3</td>\n",
       "      <td>mg</td>\n",
       "      <td>1250</td>\n",
       "      <td>mg</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Solution</td>\n",
       "      <td>[approved, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>50-81-7</td>\n",
       "      <td>[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO</td>\n",
       "      <td>245</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>DB00130</td>\n",
       "      <td>L-Glutamine</td>\n",
       "      <td>5</td>\n",
       "      <td>g/1</td>\n",
       "      <td>5</td>\n",
       "      <td>g/1</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Powder, for solution</td>\n",
       "      <td>[approved, investigational, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>56-85-9</td>\n",
       "      <td>N[C@@H](CCC(N)=O)C(O)=O</td>\n",
       "      <td>97.8</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>DB00136</td>\n",
       "      <td>Calcitriol</td>\n",
       "      <td>0.25</td>\n",
       "      <td>ug/1</td>\n",
       "      <td>3</td>\n",
       "      <td>ug/g</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Capsule, liquid filled</td>\n",
       "      <td>[approved, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>32222-06-3</td>\n",
       "      <td>C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\\C(...</td>\n",
       "      <td>0.00667</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>DB00137</td>\n",
       "      <td>Lutein</td>\n",
       "      <td>20</td>\n",
       "      <td>g/100g</td>\n",
       "      <td>20</td>\n",
       "      <td>g/100g</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Capsule</td>\n",
       "      <td>[approved, investigational, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>127-40-2</td>\n",
       "      <td>C\\C(\\C=C\\C=C(/C)\\C=C\\[C@H]1C(C)=C[C@H](O)CC1(C...</td>\n",
       "      <td>0.000732</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>DB00142</td>\n",
       "      <td>Glutamic Acid</td>\n",
       "      <td>325</td>\n",
       "      <td>mg</td>\n",
       "      <td>325</td>\n",
       "      <td>mg</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Capsule</td>\n",
       "      <td>[approved, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>56-86-0</td>\n",
       "      <td>N[C@@H](CCC(O)=O)C(O)=O</td>\n",
       "      <td>80.6</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>DB00146</td>\n",
       "      <td>Calcidiol</td>\n",
       "      <td>30</td>\n",
       "      <td>ug/1</td>\n",
       "      <td>30</td>\n",
       "      <td>ug/1</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Capsule, extended release</td>\n",
       "      <td>[approved, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>19356-17-3</td>\n",
       "      <td>C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\\C(...</td>\n",
       "      <td>0.0022</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>DB00150</td>\n",
       "      <td>L-Tryptophan</td>\n",
       "      <td>1</td>\n",
       "      <td>g</td>\n",
       "      <td>750</td>\n",
       "      <td>mg</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Tablet</td>\n",
       "      <td>[approved, nutraceutical, withdrawn]</td>\n",
       "      <td>False</td>\n",
       "      <td>73-22-3</td>\n",
       "      <td>N[C@@H](CC1=CNC2=CC=CC=C12)C(O)=O</td>\n",
       "      <td>1.36</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  drugbank_id            name min dosage strength value  \\\n",
       "0     DB00035    Desmopressin                       0.1   \n",
       "1     DB00115  Cyanocobalamin                     0.025   \n",
       "2     DB00122         Choline                       100   \n",
       "3     DB00126       Vitamin C                       0.3   \n",
       "4     DB00130     L-Glutamine                         5   \n",
       "5     DB00136      Calcitriol                      0.25   \n",
       "6     DB00137          Lutein                        20   \n",
       "7     DB00142   Glutamic Acid                       325   \n",
       "8     DB00146       Calcidiol                        30   \n",
       "9     DB00150    L-Tryptophan                         1   \n",
       "\n",
       "  min dosage strength unit max dosage strength value max dosage strength unit  \\\n",
       "0                     mg/1                       240                      mcg   \n",
       "1                       mg                      1000                      mcg   \n",
       "2                       mg                       500                       mg   \n",
       "3                       mg                      1250                       mg   \n",
       "4                      g/1                         5                      g/1   \n",
       "5                     ug/1                         3                     ug/g   \n",
       "6                   g/100g                        20                   g/100g   \n",
       "7                       mg                       325                       mg   \n",
       "8                     ug/1                        30                     ug/1   \n",
       "9                        g                       750                       mg   \n",
       "\n",
       "  route                       form  \\\n",
       "0  Oral                     Tablet   \n",
       "1  Oral                     Tablet   \n",
       "2  Oral                     Tablet   \n",
       "3  Oral                   Solution   \n",
       "4  Oral       Powder, for solution   \n",
       "5  Oral     Capsule, liquid filled   \n",
       "6  Oral                    Capsule   \n",
       "7  Oral                    Capsule   \n",
       "8  Oral  Capsule, extended release   \n",
       "9  Oral                     Tablet   \n",
       "\n",
       "                                        group kinase inhibitor category  \\\n",
       "0                                  [approved]                     False   \n",
       "1                   [approved, nutraceutical]                     False   \n",
       "2                   [approved, nutraceutical]                     False   \n",
       "3                   [approved, nutraceutical]                     False   \n",
       "4  [approved, investigational, nutraceutical]                     False   \n",
       "5                   [approved, nutraceutical]                     False   \n",
       "6  [approved, investigational, nutraceutical]                     False   \n",
       "7                   [approved, nutraceutical]                     False   \n",
       "8                   [approved, nutraceutical]                     False   \n",
       "9        [approved, nutraceutical, withdrawn]                     False   \n",
       "\n",
       "          cas                                             smiles  \\\n",
       "0  16679-58-6  NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)...   \n",
       "1     68-19-9  [C@H]1([C@@H]2[C@H]([C@@H](N3C4=CC(=C(C)C=C4[N...   \n",
       "2     62-49-7                                     C[N+](C)(C)CCO   \n",
       "3     50-81-7               [H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO   \n",
       "4     56-85-9                            N[C@@H](CCC(N)=O)C(O)=O   \n",
       "5  32222-06-3  C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\\C(...   \n",
       "6    127-40-2  C\\C(\\C=C\\C=C(/C)\\C=C\\[C@H]1C(C)=C[C@H](O)CC1(C...   \n",
       "7     56-86-0                            N[C@@H](CCC(O)=O)C(O)=O   \n",
       "8  19356-17-3  C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\\C(...   \n",
       "9     73-22-3                  N[C@@H](CC1=CNC2=CC=CC=C12)C(O)=O   \n",
       "\n",
       "  ALOGPS solubility value ALOGPS solubility unit  \n",
       "0                    0.11                    g/l  \n",
       "1                     NaN                    NaN  \n",
       "2                    3.61                    g/l  \n",
       "3                     245                    g/l  \n",
       "4                    97.8                    g/l  \n",
       "5                 0.00667                    g/l  \n",
       "6                0.000732                    g/l  \n",
       "7                    80.6                    g/l  \n",
       "8                  0.0022                    g/l  \n",
       "9                    1.36                    g/l  "
      ]
     },
     "execution_count": 101,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Select only oral drugs\n",
    "\n",
    "df_drugbank_sm_oral = df_drugbank_sm.loc[df_drugbank_sm[\"route\"] == \"Oral\"]\n",
    "df_drugbank_sm_oral = df_drugbank_sm_oral.reset_index(drop=True)\n",
    "df_drugbank_sm.to_csv(\"dosage_strength_of_approved_oral_small_molecule_drugs.csv\")\n",
    "print(df_drugbank_sm_oral.shape)\n",
    "df_drugbank_sm_oral.head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(808, 14)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drugbank_id</th>\n",
       "      <th>name</th>\n",
       "      <th>min dosage strength value</th>\n",
       "      <th>min dosage strength unit</th>\n",
       "      <th>max dosage strength value</th>\n",
       "      <th>max dosage strength unit</th>\n",
       "      <th>route</th>\n",
       "      <th>form</th>\n",
       "      <th>group</th>\n",
       "      <th>kinase inhibitor category</th>\n",
       "      <th>cas</th>\n",
       "      <th>smiles</th>\n",
       "      <th>ALOGPS solubility value</th>\n",
       "      <th>ALOGPS solubility unit</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>DB00035</td>\n",
       "      <td>Desmopressin</td>\n",
       "      <td>0.1</td>\n",
       "      <td>mg/1</td>\n",
       "      <td>0.24</td>\n",
       "      <td>mg</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Tablet</td>\n",
       "      <td>[approved]</td>\n",
       "      <td>False</td>\n",
       "      <td>16679-58-6</td>\n",
       "      <td>NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)...</td>\n",
       "      <td>0.11</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>DB00115</td>\n",
       "      <td>Cyanocobalamin</td>\n",
       "      <td>0.025</td>\n",
       "      <td>mg</td>\n",
       "      <td>1</td>\n",
       "      <td>mg</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Tablet</td>\n",
       "      <td>[approved, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>68-19-9</td>\n",
       "      <td>[C@H]1([C@@H]2[C@H]([C@@H](N3C4=CC(=C(C)C=C4[N...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>DB00122</td>\n",
       "      <td>Choline</td>\n",
       "      <td>100</td>\n",
       "      <td>mg</td>\n",
       "      <td>500</td>\n",
       "      <td>mg</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Tablet</td>\n",
       "      <td>[approved, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>62-49-7</td>\n",
       "      <td>C[N+](C)(C)CCO</td>\n",
       "      <td>3.61</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>DB00126</td>\n",
       "      <td>Vitamin C</td>\n",
       "      <td>0.3</td>\n",
       "      <td>mg</td>\n",
       "      <td>1250</td>\n",
       "      <td>mg</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Solution</td>\n",
       "      <td>[approved, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>50-81-7</td>\n",
       "      <td>[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO</td>\n",
       "      <td>245</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>DB00130</td>\n",
       "      <td>L-Glutamine</td>\n",
       "      <td>5000</td>\n",
       "      <td>mg/1</td>\n",
       "      <td>5000</td>\n",
       "      <td>mg/1</td>\n",
       "      <td>Oral</td>\n",
       "      <td>Powder, for solution</td>\n",
       "      <td>[approved, investigational, nutraceutical]</td>\n",
       "      <td>False</td>\n",
       "      <td>56-85-9</td>\n",
       "      <td>N[C@@H](CCC(N)=O)C(O)=O</td>\n",
       "      <td>97.8</td>\n",
       "      <td>g/l</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  drugbank_id            name min dosage strength value  \\\n",
       "0     DB00035    Desmopressin                       0.1   \n",
       "1     DB00115  Cyanocobalamin                     0.025   \n",
       "2     DB00122         Choline                       100   \n",
       "3     DB00126       Vitamin C                       0.3   \n",
       "4     DB00130     L-Glutamine                      5000   \n",
       "\n",
       "  min dosage strength unit max dosage strength value max dosage strength unit  \\\n",
       "0                     mg/1                      0.24                       mg   \n",
       "1                       mg                         1                       mg   \n",
       "2                       mg                       500                       mg   \n",
       "3                       mg                      1250                       mg   \n",
       "4                     mg/1                      5000                     mg/1   \n",
       "\n",
       "  route                  form                                       group  \\\n",
       "0  Oral                Tablet                                  [approved]   \n",
       "1  Oral                Tablet                   [approved, nutraceutical]   \n",
       "2  Oral                Tablet                   [approved, nutraceutical]   \n",
       "3  Oral              Solution                   [approved, nutraceutical]   \n",
       "4  Oral  Powder, for solution  [approved, investigational, nutraceutical]   \n",
       "\n",
       "  kinase inhibitor category         cas  \\\n",
       "0                     False  16679-58-6   \n",
       "1                     False     68-19-9   \n",
       "2                     False     62-49-7   \n",
       "3                     False     50-81-7   \n",
       "4                     False     56-85-9   \n",
       "\n",
       "                                              smiles ALOGPS solubility value  \\\n",
       "0  NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)...                    0.11   \n",
       "1  [C@H]1([C@@H]2[C@H]([C@@H](N3C4=CC(=C(C)C=C4[N...                     NaN   \n",
       "2                                     C[N+](C)(C)CCO                    3.61   \n",
       "3               [H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO                     245   \n",
       "4                            N[C@@H](CCC(N)=O)C(O)=O                    97.8   \n",
       "\n",
       "  ALOGPS solubility unit  \n",
       "0                    g/l  \n",
       "1                    NaN  \n",
       "2                    g/l  \n",
       "3                    g/l  \n",
       "4                    g/l  "
      ]
     },
     "execution_count": 100,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# I will calculate strenght values in terms of mg (i.e. mg/1)\n",
    "\n",
    "# Keep the strength value as it is if strength unit is mg or mg/1\n",
    "# Multiply strength value by 0.001 if strength unit us ug or ug/1\n",
    "# Multiply strength value by 1000 if strength unit us ug or ug/1\n",
    "\n",
    "\n",
    "df_drugbank_oral_fixed_unit = pd.DataFrame(columns=df_drugbank_sm_oral.columns)\n",
    "\n",
    "# Correct min strength values and units\n",
    "for i, row in enumerate(df_drugbank_sm_oral.iterrows()):\n",
    "    \n",
    "    unit = row[1][\"min dosage strength unit\"]\n",
    "    strength = row[1][\"min dosage strength value\"]\n",
    "    \n",
    "    # Keep the strength value as it is if strength unit is mg or mg/1\n",
    "    if unit == \"mg\" or unit == \"mg/1\":\n",
    "        df_drugbank_oral_fixed_unit.loc[i,:] = row[1]\n",
    "    \n",
    "    # Multiply strength value by 0.001 if strength unit us ug or ug/1 or mcg\n",
    "    if unit == \"ug\" or unit == \"ug/1\" or unit == \"mcg\":\n",
    "        corrected_strength = strength * 0.001\n",
    "        if unit == \"ug\" or unit == \"mcg\" :\n",
    "            corrected_unit = \"mg\"\n",
    "        if unit == \"ug/1\":\n",
    "            corrected_unit = \"mg/1\"\n",
    "        df_drugbank_oral_fixed_unit.loc[i,:] = row[1]\n",
    "        df_drugbank_oral_fixed_unit.loc[i,\"min dosage strength value\"] = corrected_strength\n",
    "        df_drugbank_oral_fixed_unit.loc[i,\"min dosage strength unit\"] = corrected_unit\n",
    "        \n",
    "    # Multiply strength value by 1000 if strength unit us ug or ug/1\n",
    "    if unit == \"g\" or unit == \"g/1\":\n",
    "        corrected_strength = strength * 1000\n",
    "        if unit == \"g\":\n",
    "            corrected_unit = \"mg\"\n",
    "        if unit == \"g/1\":\n",
    "            corrected_unit = \"mg/1\"\n",
    "        df_drugbank_oral_fixed_unit.loc[i,:] = row[1]\n",
    "        df_drugbank_oral_fixed_unit.loc[i,\"min dosage strength value\"] = corrected_strength\n",
    "        df_drugbank_oral_fixed_unit.loc[i,\"min dosage strength unit\"] = corrected_unit\n",
    "\n",
    "# Correct max strength values and units\n",
    "for i, row in enumerate(df_drugbank_oral_fixed_unit.iterrows()):\n",
    "    \n",
    "    unit = row[1][\"max dosage strength unit\"]\n",
    "    strength = row[1][\"max dosage strength value\"]\n",
    "    \n",
    "    # Keep the strength value as it is if strength unit is mg or mg/1\n",
    "    if unit == \"mg\" or unit == \"mg/1\":\n",
    "        df_drugbank_oral_fixed_unit.loc[i,:] = row[1]\n",
    "    \n",
    "    # Multiply strength value by 0.001 if strength unit us ug or ug/1 or mcg\n",
    "    if unit == \"ug\" or unit == \"ug/1\" or unit == \"mcg\":\n",
    "        corrected_strength = strength * 0.001\n",
    "        if unit == \"ug\" or unit == \"mcg\" :\n",
    "            corrected_unit = \"mg\"\n",
    "        if unit == \"ug/1\":\n",
    "            corrected_unit = \"mg/1\"\n",
    "        df_drugbank_oral_fixed_unit.loc[i,:] = row[1]\n",
    "        df_drugbank_oral_fixed_unit.loc[i,\"max dosage strength value\"] = corrected_strength\n",
    "        df_drugbank_oral_fixed_unit.loc[i,\"max dosage strength unit\"] = corrected_unit\n",
    "        \n",
    "    # Multiply strength value by 1000 if strength unit us ug or ug/1\n",
    "    if unit == \"g\" or unit == \"g/1\":\n",
    "        corrected_strength = strength * 1000\n",
    "        if unit == \"g\":\n",
    "            corrected_unit = \"mg\"\n",
    "        if unit == \"g/1\":\n",
    "            corrected_unit = \"mg/1\"\n",
    "        df_drugbank_oral_fixed_unit.loc[i,:] = row[1]\n",
    "        df_drugbank_oral_fixed_unit.loc[i,\"max dosage strength value\"] = corrected_strength\n",
    "        df_drugbank_oral_fixed_unit.loc[i,\"max dosage strength unit\"] = corrected_unit\n",
    "\n",
    "print(df_drugbank_oral_fixed_unit.shape)  \n",
    "df_drugbank_oral_fixed_unit.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 167,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df_drugbank_oral_fixed_unit.to_csv(\"dosage_strength_of_approved_oral_small_molecule_drugs_with_fixed_units.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 171,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x2956c6128>"
      ]
     },
     "execution_count": 171,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAnYAAAHACAYAAAAvLyUMAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nBAV2hBBCCCGrxD8h8QYE5zmUggAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x2955fc4e0>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "x = np.array(df_drugbank_oral_fixed_unit[\"min dosage strength value\"].values, dtype=np.float64)\n",
    "x = pd.Series(x, name=\"min dose strength (mg)\")\n",
    "sns.distplot(x, hist= True, rug = True, kde=False, color = 'red')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 112,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of approved oral small molecules:\n",
      "808\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x281ee6c50>"
      ]
     },
     "execution_count": 112,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAoMAAAHACAYAAADZSmLRAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nQmCC\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x282dd2978>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# I want to plot only 0-5000 mg region for all approved oral small molecule drugs.\n",
    "print(\"Number of approved oral small molecules:\")\n",
    "print(df_drugbank_oral_fixed_unit.shape[0])\n",
    "\n",
    "x = np.array(df_drugbank_oral_fixed_unit[\"min dosage strength value\"].values, dtype=np.float64)\n",
    "x = x[x <= 5000]\n",
    "x = pd.Series(x, name=\"dose strength (mg)\")\n",
    "sns.distplot(x, hist= True, rug = True, color = 'red')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 115,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of approved oral small molecules:\n",
      "808\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x283fd3f60>"
      ]
     },
     "execution_count": 115,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAoMAAAHACAYAAADZSmLRAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x27ff48f60>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# I want to plot only 0-1000 mg region for all approved oral small molecule drugs.\n",
    "print(\"Number of approved oral small molecules:\")\n",
    "print(df_drugbank_oral_fixed_unit.shape[0])\n",
    "\n",
    "x = np.array(df_drugbank_oral_fixed_unit[\"min dosage strength value\"].values, dtype=np.float64)\n",
    "x = x[x <= 1000]\n",
    "x = pd.Series(x, name=\"dose strength (mg)\")\n",
    "sns.distplot(x, hist= True, rug = True, color = 'red')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 164,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of approved oral kinase inhibitors:\n",
      "47\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "(0, 388.42865671648076)"
      ]
     },
     "execution_count": 164,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAoMAAAHACAYAAADZSmLRAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x293bbe198>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Plot distribution for all approved oral kinase inhibitors\n",
    "df_drugbank_oral_fixed_unit_kinase = df_drugbank_oral_fixed_unit.loc[df_drugbank_oral_fixed_unit[\"kinase inhibitor category\"] == \"True\"]\n",
    "print(\"Number of approved oral kinase inhibitors:\")\n",
    "print(df_drugbank_oral_fixed_unit_kinase.shape[0])\n",
    "\n",
    "k = np.array(df_drugbank_oral_fixed_unit_kinase[\"min dosage strength value\"].values, dtype=np.float64)\n",
    "k = pd.Series(k, name=\"dose strength (mg)\")\n",
    "sns.distplot(k, hist= True, rug = True, color = 'blue')\n",
    "plt.xlim(0, None)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 165,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of approved oral kinase inhibitors:\n",
      "47\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAm0AAAHSCAYAAAC+f/yDAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x292cecb70>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Plot distribution for all approved oral kinase inhibitors\n",
    "df_drugbank_oral_fixed_unit_kinase = df_drugbank_oral_fixed_unit.loc[df_drugbank_oral_fixed_unit[\"kinase inhibitor category\"] == \"True\"]\n",
    "print(\"Number of approved oral kinase inhibitors:\")\n",
    "print(df_drugbank_oral_fixed_unit_kinase.shape[0])\n",
    "\n",
    "k = np.array(df_drugbank_oral_fixed_unit_kinase[\"min dosage strength value\"].values, dtype=np.float64)\n",
    "k = pd.Series(k, name=\"dose strength (mg)\")\n",
    "sns.distplot(k, bins = 10, hist= True, rug = True, kde = False, color = 'blue')\n",
    "plt.xlim(0, None)\n",
    "plt.title(\"Approved Oral Kinase Inhibitors\")\n",
    "plt.savefig(\"dose_strength_histogram_of_approved_oral_kinase_inhibitors.svg\")\n",
    "plt.savefig(\"dose_strength_histogram_of_approved_oral_kinase_inhibitors.pdf\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 166,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of approved oral small molecules:\n",
      "808\n",
      "Number of approved oral kinase inhibitors:\n",
      "47\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "(0, 1049.99999)"
      ]
     },
     "execution_count": 166,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAnYAAAHACAYAAAAvLyUMAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x28ce65438>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# I want to plot only 0-1000 mg region for all approved oral small molecule drugs.\n",
    "print(\"Number of approved oral small molecules:\")\n",
    "print(df_drugbank_oral_fixed_unit.shape[0])\n",
    "\n",
    "x = np.array(df_drugbank_oral_fixed_unit[\"min dosage strength value\"].values, dtype=np.float64)\n",
    "x = x[x <= 1000]\n",
    "x = pd.Series(x, name=\"min dose strength (mg)\")\n",
    "sns.distplot(x, hist= True, rug = True, kde = False, color = 'red')\n",
    "\n",
    "# Plot distribution for all approved oral kinase inhibitors\n",
    "df_drugbank_oral_fixed_unit_kinase = df_drugbank_oral_fixed_unit.loc[df_drugbank_oral_fixed_unit[\"kinase inhibitor category\"] == \"True\"]\n",
    "print(\"Number of approved oral kinase inhibitors:\")\n",
    "print(df_drugbank_oral_fixed_unit_kinase.shape[0])\n",
    "\n",
    "k = np.array(df_drugbank_oral_fixed_unit_kinase[\"min dosage strength value\"].values, dtype=np.float64)\n",
    "k = pd.Series(k, name=\"min dose strength (mg)\")\n",
    "sns.distplot(k, hist= True, rug = True, kde = False, color = 'blue')\n",
    "plt.xlim(0, None)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Non-nutrient non-kinase inhibitor oral small molecule drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 127,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(788, 14)\n"
     ]
    }
   ],
   "source": [
    "# Let's remove nutritional small molecules from small molecule database\n",
    "df_drugbank_oral_fixed_unit_nonnut = pd.DataFrame(columns=df_drugbank_sm_oral.columns)\n",
    "\n",
    "for i, row in enumerate(df_drugbank_oral_fixed_unit.iterrows()):\n",
    "    group = row[1][\"group\"]\n",
    "    if \"nutraceutical\" in group:\n",
    "        continue\n",
    "    else:\n",
    "        df_drugbank_oral_fixed_unit_nonnut.loc[i,:] = row[1]\n",
    "\n",
    "print(df_drugbank_oral_fixed_unit_nonnut.shape)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 168,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df_drugbank_oral_fixed_unit_nonnut.to_csv(\"dosage_strength_of_approved_oral_non-nutritional_small_molecule_drugs_with_fixed_units.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 146,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(741, 14)\n"
     ]
    }
   ],
   "source": [
    "# Let's remove kinase inhibitors from small molecule database\n",
    "df_drugbank_oral_fixed_unit_nonnut_nonki = pd.DataFrame(columns=df_drugbank_sm_oral.columns)\n",
    "\n",
    "for i, row in enumerate(df_drugbank_oral_fixed_unit_nonnut.iterrows()):\n",
    "    kinase_inhibitor = row[1][\"kinase inhibitor category\"]\n",
    "    if kinase_inhibitor == \"True\":\n",
    "        continue\n",
    "    else:\n",
    "        df_drugbank_oral_fixed_unit_nonnut_nonki.loc[i,:] = row[1]\n",
    "\n",
    "print(df_drugbank_oral_fixed_unit_nonnut_nonki.shape)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 172,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of approved oral small molecules that are not kinases or nutritional:\n",
      "741\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAnYAAAHSCAYAAABhMYacAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x2947a0da0>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "print(\"Number of approved oral small molecules that are not kinases or nutritional:\")\n",
    "print(df_drugbank_oral_fixed_unit_nonnut_nonki.shape[0])\n",
    "\n",
    "x = np.array(df_drugbank_oral_fixed_unit_nonnut_nonki[\"min dosage strength value\"].values, dtype=np.float64)\n",
    "x = pd.Series(x, name=\"min dose strength (mg)\")\n",
    "sns.distplot(x, hist= True, rug = True, kde = False, color = 'red')\n",
    "plt.title(\"Approved oral small molecules (not kinase inhibitors or nutritional)\")\n",
    "plt.savefig(\"dose_strength_histogram_of_approved_oral_small_molecules.svg\")\n",
    "plt.savefig(\"dose_strength_histogram_of_approved_oral_small_molecules.pdf\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 151,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of approved oral small molecules:\n",
      "741\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAngAAAHSCAYAAAB/+LYvAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nYII=\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x28da2ffd0>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Let's ignore 2 outlier molecules and focus to < 10000 mg region\n",
    "# I want to plot only 0-1000 mg region for all approved oral small molecule drugs.\n",
    "print(\"Number of approved oral small molecules:\")\n",
    "print(df_drugbank_oral_fixed_unit_nonnut_nonki.shape[0])\n",
    "\n",
    "x = np.array(df_drugbank_oral_fixed_unit_nonnut_nonki[\"min dosage strength value\"].values, dtype=np.float64)\n",
    "x = x[x <= 10000]\n",
    "x = pd.Series(x, name=\"dose strength (mg)\")\n",
    "sns.distplot(x, hist= True, rug = True, kde = False, color = 'red')\n",
    "plt.title(\"Approved oral small molecules (not kinase inhibitors or nutritional, strength < 10000)\")\n",
    "plt.savefig(\"dose_strength_histogram_of_approved_oral_small_molecules_strength10000.svg\")\n",
    "plt.savefig(\"dose_strength_histogram_of_approved_oral_small_molecules_strength10000.pdf\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 158,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of approved oral small molecules:\n",
      "741\n",
      "Number of approved oral kinase inhibitors:\n",
      "47\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAApkAAAHSCAYAAACn2NBgAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\ngg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x29066b438>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# I want to plot only 0-1000 mg region for all approved oral small molecule drugs.\n",
    "print(\"Number of approved oral small molecules:\")\n",
    "print(df_drugbank_oral_fixed_unit_nonnut_nonki.shape[0])\n",
    "\n",
    "x = np.array(df_drugbank_oral_fixed_unit_nonnut_nonki[\"min dosage strength value\"].values, dtype=np.float64)\n",
    "x = x[x <= 1000]\n",
    "x = pd.Series(x, name=\"Min dose strength (mg)\")\n",
    "sns.distplot(x, hist= True, rug = True, kde = False, color = 'red')\n",
    "\n",
    "# Plot distribution for all approved oral kinase inhibitors\n",
    "df_drugbank_oral_fixed_unit_kinase = df_drugbank_oral_fixed_unit.loc[df_drugbank_oral_fixed_unit[\"kinase inhibitor category\"] == \"True\"]\n",
    "print(\"Number of approved oral kinase inhibitors:\")\n",
    "print(df_drugbank_oral_fixed_unit_kinase.shape[0])\n",
    "\n",
    "k = np.array(df_drugbank_oral_fixed_unit_kinase[\"min dosage strength value\"].values, dtype=np.float64)\n",
    "k = pd.Series(k, name=\"min dose strength (mg)\")\n",
    "sns.distplot(k, hist= True, rug = True, kde = False, color = 'blue')\n",
    "\n",
    "plt.title(\"Approved oral small molecules(red) vs kinase inhibitors(blue) (not nutritional, strength < 1000)\")\n",
    "plt.savefig(\"dose_strength_hist_comparison_of_kinase_inh_and_other_oral_small_molecules_strength1000.svg\")\n",
    "plt.savefig(\"dose_strength_hist_comparison_of_kinase_inh_and_other_oral_small_molecules_strength1000.pdf\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 163,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of approved oral small molecules:\n",
      "741\n",
      "Number of approved oral kinase inhibitors:\n",
      "47\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA0oAAAHSCAYAAADScDvqAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x28eef85c0>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# I want to plot only 0-1000 mg region for all approved oral small molecule drugs.\n",
    "print(\"Number of approved oral small molecules:\")\n",
    "print(df_drugbank_oral_fixed_unit_nonnut_nonki.shape[0])\n",
    "\n",
    "x = np.array(df_drugbank_oral_fixed_unit_nonnut_nonki[\"min dosage strength value\"].values, dtype=np.float64)\n",
    "x = x[x <= 1000]\n",
    "x = pd.Series(x, name=\"min dose strength (mg)\")\n",
    "sns.distplot(x, hist= False, rug = True, kde = True, color = 'red')\n",
    "\n",
    "# Plot distribution for all approved oral kinase inhibitors\n",
    "df_drugbank_oral_fixed_unit_kinase = df_drugbank_oral_fixed_unit.loc[df_drugbank_oral_fixed_unit[\"kinase inhibitor category\"] == \"True\"]\n",
    "print(\"Number of approved oral kinase inhibitors:\")\n",
    "print(df_drugbank_oral_fixed_unit_kinase.shape[0])\n",
    "\n",
    "k = np.array(df_drugbank_oral_fixed_unit_kinase[\"min dosage strength value\"].values, dtype=np.float64)\n",
    "k = pd.Series(k, name=\"min dose strength (mg)\")\n",
    "sns.distplot(k, hist= False, rug = True, kde = True, color = 'blue')\n",
    "\n",
    "plt.xlim(0, None)\n",
    "plt.title(\"Probability density plot of approved oral small molecules(red) vs kinase inhibitors(blue) (not nutritional, strength < 1000)\")\n",
    "plt.savefig(\"min_dose_strength_kde_comparison_of_kinase_inh_and_other_oral_small_molecules_strength1000.svg\")\n",
    "plt.savefig(\"min_dose_strength_kde_comparison_of_kinase_inh_and_other_oral_small_molecules_strength1000.pdf\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 169,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of approved oral small molecules:\n",
      "741\n",
      "Number of approved oral kinase inhibitors:\n",
      "47\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA2oAAAHSCAYAAACdLTg6AAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n+qQVGQAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x294fefba8>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# I want to plot only 0-1000 mg region for all approved oral small molecule drugs.\n",
    "print(\"Number of approved oral small molecules:\")\n",
    "print(df_drugbank_oral_fixed_unit_nonnut_nonki.shape[0])\n",
    "\n",
    "x = np.array(df_drugbank_oral_fixed_unit_nonnut_nonki[\"max dosage strength value\"].values, dtype=np.float64)\n",
    "x = x[x <= 1000]\n",
    "x = pd.Series(x, name=\"max dose strength (mg)\")\n",
    "sns.distplot(x, hist= False, rug = True, kde = True, color = 'orange')\n",
    "\n",
    "# Plot distribution for all approved oral kinase inhibitors\n",
    "df_drugbank_oral_fixed_unit_kinase = df_drugbank_oral_fixed_unit.loc[df_drugbank_oral_fixed_unit[\"kinase inhibitor category\"] == \"True\"]\n",
    "print(\"Number of approved oral kinase inhibitors:\")\n",
    "print(df_drugbank_oral_fixed_unit_kinase.shape[0])\n",
    "\n",
    "k = np.array(df_drugbank_oral_fixed_unit_kinase[\"max dosage strength value\"].values, dtype=np.float64)\n",
    "k = pd.Series(k, name=\"max dose strength (mg)\")\n",
    "sns.distplot(k, hist= False, rug = True, kde = True, color = 'green')\n",
    "\n",
    "plt.xlim(0, None)\n",
    "plt.title(\"Probability density plot of approved oral small molecules(yellow) vs kinase inhibitors(green) (not nutritional, strength < 1000)\")\n",
    "plt.savefig(\"max_dose_strength_kde_comparison_of_kinase_inh_and_other_oral_small_molecules_strength1000.svg\")\n",
    "plt.savefig(\"max_dose_strength_kde_comparison_of_kinase_inh_and_other_oral_small_molecules_strength1000.pdf\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 173,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAuUAAAH7CAYAAABrDuGIAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x296d97f98>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_drugbank_sm_sorted = df_drugbank_oral_fixed_unit_kinase.sort_values(\"min dosage strength value\",ascending=True)\n",
    "df_drugbank_sm_sorted = df_drugbank_sm_sorted.reset_index(drop=True)\n",
    "\n",
    "x = df_drugbank_sm_sorted.index\n",
    "names = df_drugbank_sm_sorted[\"name\"]\n",
    "min_dosage = df_drugbank_sm_sorted[\"min dosage strength value\"]\n",
    "\n",
    "plt.close()\n",
    "plt.style.use([\"seaborn-talk\", \"seaborn-whitegrid\"])\n",
    "plt.rcParams['axes.labelsize'] = 18\n",
    "plt.rcParams['xtick.labelsize'] = 14\n",
    "plt.rcParams['ytick.labelsize'] = 16\n",
    "\n",
    "width = 0.5\n",
    "plt.bar(x, min_dosage, width, color = \"firebrick\")\n",
    "plt.xticks(x, names, rotation=90)\n",
    "plt.xlabel(\"Approved Kinase Inhibitors\")\n",
    "plt.ylabel(\"Minimum dosage strength (mg)\")\n",
    "plt.tight_layout()\n",
    "\n",
    "plt.savefig(\"min_dosage_strength_barplot_for_approved_small_molecules.pdf\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 175,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAuUAAAH7CAYAAABrDuGIAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nUCgy5v8ATSk3oa1dC+oAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x294fef2b0>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_drugbank_ki_sorted = df_drugbank_oral_fixed_unit_kinase.sort_values(\"max dosage strength value\",ascending=True)\n",
    "df_drugbank_ki_sorted = df_drugbank_ki_sorted.reset_index(drop=True)\n",
    "\n",
    "x = df_drugbank_ki_sorted.index\n",
    "names = df_drugbank_ki_sorted[\"name\"]\n",
    "\n",
    "max_dosage = df_drugbank_ki_sorted[\"max dosage strength value\"]\n",
    "\n",
    "plt.close()\n",
    "plt.style.use([\"seaborn-talk\", \"seaborn-whitegrid\"])\n",
    "plt.rcParams['axes.labelsize'] = 18\n",
    "plt.rcParams['xtick.labelsize'] = 14\n",
    "plt.rcParams['ytick.labelsize'] = 16\n",
    "\n",
    "width = 0.5   \n",
    "plt.bar(x, max_dosage, width, color = \"firebrick\")\n",
    "plt.xticks(x, names, rotation=90)\n",
    "plt.xlabel(\"Approved Kinase Inhibitors\")\n",
    "plt.ylabel(\"Maximum Dosage strength (mg)\")\n",
    "plt.tight_layout()\n",
    "\n",
    "plt.savefig(\"max_dosage_strength_barplot_for_approved_kinase_inhibitors.pdf\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 176,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAuUAAAH7CAYAAABrDuGIAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nQAvcz03XmIIAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x29738ef28>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_drugbank_ki_sorted = df_drugbank_oral_fixed_unit_kinase.sort_values(\"min dosage strength value\",ascending=True)\n",
    "df_drugbank_ki_sorted = df_drugbank_ki_sorted.reset_index(drop=True)\n",
    "\n",
    "x = df_drugbank_ki_sorted.index\n",
    "names = df_drugbank_ki_sorted[\"name\"]\n",
    "min_dosage = df_drugbank_ki_sorted[\"min dosage strength value\"]\n",
    "max_dosage = df_drugbank_ki_sorted[\"max dosage strength value\"]\n",
    "\n",
    "plt.close()\n",
    "plt.style.use([\"seaborn-talk\", \"seaborn-whitegrid\"])\n",
    "plt.rcParams['axes.labelsize'] = 18\n",
    "plt.rcParams['xtick.labelsize'] = 14\n",
    "plt.rcParams['ytick.labelsize'] = 16\n",
    "\n",
    "width = 0.4    \n",
    "plt.bar(x, min_dosage, width, label = \"Min dosage\", color = \"firebrick\")\n",
    "plt.bar(x+width, max_dosage, width, label = \"Max dosage\", color = \"darkgrey\")\n",
    "\n",
    "plt.xticks(x , names, rotation=90)\n",
    "plt.xlabel(\"Approved Kinase Inhibitors\")\n",
    "plt.ylabel(\"Dosage strength (mg)\")\n",
    "plt.legend(loc='best')\n",
    "plt.tight_layout()\n",
    "\n",
    "plt.savefig(\"min_and_max_dosage_strength_barplot_for_approved_kinase_inhibitors.pdf\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.5.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 1
}
